azathioprine has been researched along with methotrexate in 1013 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 269 (26.55) | 18.7374 |
| 1990's | 142 (14.02) | 18.2507 |
| 2000's | 232 (22.90) | 29.6817 |
| 2010's | 289 (28.53) | 24.3611 |
| 2020's | 81 (8.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Knuckley, B; Luo, Y; Thompson, PR | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Nêmec, M; Nouza, K; Novotný, J; Viklický, V | 1 |
| Schulze, P | 1 |
| Lurati, M; Mertens, HG | 2 |
| Rassner, G | 1 |
| de Andres, C; Esteban, A; Giménez-Roldán, S; López-Fraile, IP | 1 |
| Matthay, RA; Putman, CE; Sostman, HD | 1 |
| Schein, PS; Winokur, SH | 1 |
| Canavese, JC | 1 |
| Goubeaud, G; Schütterle, G | 1 |
| McMeekin, TO; Moschella, SL | 1 |
| Abbou, CC; Beaudoin, JG; Chassot, PG; Guttman, RD; Jeffery, J; Klassen, J; Knaack, J; Morehouse, DD | 1 |
| Mansour, A; Nelson, DS | 1 |
| Morgan-Hughes, JA; Riddoch, D | 1 |
| Jacobs, JC | 2 |
| Turkevich, IuM | 1 |
| Sieber, SM | 1 |
| Alberecht-Nebe, H; Apostoloff, E; Schulze, P; Sönnichsen, N | 1 |
| Fallet, GH; Gerster, JC | 1 |
| Hawrlylak, E; Kiczak, J; Wysocka, K | 1 |
| Blaszczyk, B; Gieldanowski, J; Karakoz, I | 1 |
| Dráber, P; Horáková, L; Nouza, K | 1 |
| Fellner, MJ; Katz, JM; McCabe, JB | 1 |
| Flenker, I; Ricken, D | 1 |
| Wilmanns, W | 2 |
| Buselmaier, W; Herbold, B | 1 |
| Müller, AE; Thiele, HG | 1 |
| Cooke, D; De Rose, G; Wilcox, LD | 1 |
| Lever, WF; Schaumburg-Lever, G | 1 |
| Chlud, K | 3 |
| Barnes, CG; Feldges, DH | 2 |
| Chang, YH; Otterness, IG | 1 |
| Friedman-Birnbaum, R; Haim, S | 1 |
| Gallego, RE; Lynch, PJ; Saied, NK | 1 |
| Green, D | 2 |
| Jonsson, V | 1 |
| Holm, O | 1 |
| Hyman, LR; Kovacs, K; Steinberg, AD | 1 |
| Baker, H | 1 |
| Lorenzen, I | 1 |
| Kaiser, E; Müller, MM | 1 |
| Boxley, JD; Dawber, RP; Summerly, R | 1 |
| Blichfeldt, P | 1 |
| Gmeiner, B; Raab, W | 1 |
| Blair, LS; Campbell, WC | 1 |
| Lyell, A | 1 |
| Callahan, LF; Marcum, SB; Pincus, T | 1 |
| Nishioka, K | 1 |
| Calabrese, LH; Chou, SM; Sayers, ME | 1 |
| Alarcón, GS; Bartolucci, AA; Boerbooms, AM; Drosos, AA; Furst, DE; López-Méndez, A; Rau, R; Russell, AS; Walter, J | 1 |
| Boyce, E | 1 |
| Bellamy, N; Dewar, CL | 1 |
| Assmann, KJ; Boerbooms, AM; Fast, JH; Jeurissen, ME; Kerstens, PJ; van de Putte, LB | 1 |
| Fehr, K; Michel, BA; Neidhart, M; Neidl, K; Stoll, T; Wagenhäuser, FJ; Wassmer, P | 1 |
| Balabanova, RM; Chiklikchi, AS; Filipowicz-Sosnowska, A; Garwolińska, H; Oliunin, IuA; Solov'ev, SK; Stanisławska, E | 1 |
| Belaiche, J; Delwaide, J; Gast, P; Louis, E | 2 |
| Chiche, A; Colombel, JF; Cortot, A; Gower-Rousseau, C; Mesnard, B; Paris, JC | 1 |
| Berger, RG; Box, JH; Fiechtner, JJ; Fudman, EJ; Hudson, NP; Marks, CR; McKendry, RJ; Stablein, DM; Urowitz, MB; Willkens, RF | 1 |
| Bloch, DA; Fries, JF; Singh, G; Spitz, P; Williams, CA; Zatarain, E | 1 |
| Hayashi, S; Inuzuka, S; Muranishi, H; Nagata, N; Shigematsu, N | 1 |
| Belfort, R; de Abreu, MT; Kim, MK; Lottemberg, C; Martins, MC; Neves, RA; Pavesio, CE; Petrilli, AM | 1 |
| Clough, JD; Wilke, WS | 1 |
| Counihan, TJ; Feighery, C | 1 |
| Andreeva, NE; Chernokhvostova, EV; German, GP; Kotova, TS; Varlamova, EIu | 1 |
| Filipaviciute, R; Luksiene, A | 1 |
| Boerbooms, AM; Doesburg, WH; Haverman, JF; Jeurissen, ME; Kruijsen, MW; Mulder, J; Muller, WH; Rasker, JJ; van Beusekom, HJ; van de Putte, LB | 1 |
| Calin, A; Elswood, J | 1 |
| Arnold, MH; Brooks, PM; Schwarzer, AC | 1 |
| Forrest, DE; Kahn, DR; Otto, DA | 1 |
| Boerbooms, AM; Doesburg, WH; Jeurissen, ME; Lemmens, AM; van de Putte, LB | 1 |
| Lee, P; Urowitz, MB | 1 |
| Kaplan, MM | 2 |
| Egger, MJ; Paulus, HE; Ward, JR; Williams, HJ | 1 |
| Dahl, SL; Karg, M; Samuelson, CO; Ward, JR; Williams, HJ | 1 |
| Arnold, MH; Beller, EM; Brooks, PM; Kelly, DE; McCredie, M; O'Callaghan, J | 1 |
| Bicker, U; Herrmann, DB | 1 |
| Callen, JP | 2 |
| Asherson, RA; Cervera, R; D'Cruz, D; Hughes, GR; Khamashta, MA; Ramírez, G | 1 |
| McKendry, RJ | 1 |
| Gore, ME; Malpas, JS; McElwain, TJ; Meldrum, M; Millar, BC | 1 |
| Guseva, SA | 1 |
| Hardin, JG | 1 |
| Fox, DA; McCune, WJ | 2 |
| Ehrenfeld, M; Kaplinsky, N; Langevitz, P; Pras, M | 1 |
| Rubino, MJ; Walker, D | 1 |
| Przybilla, B; Schill, WB | 1 |
| Clements, PJ; Davis, J | 1 |
| Brooks, PM; O'Callaghan, JW | 1 |
| Clegg, DO; Ward, JR | 1 |
| Crossley, MJ; Hunneyball, IM; Spowage, M | 1 |
| Onetti, CM | 1 |
| Cyr, M; McKendry, RJ | 1 |
| Fiechtner, JJ; Miller, DR; Starkebaum, G | 1 |
| Smolle, J | 1 |
| Grechikhina, EN; Idel'son, LI; Kolesnikova, AS; Pivnik, AV; Ter-Grigorov, VS | 1 |
| Pugh, CB; Pugh, MC | 1 |
| Meyer, E; Nahir, M; Scharf, JA; Scharf, JM; Zonis, S | 1 |
| Dugowson, CE; Gilliland, BC | 1 |
| Polisson, RP; St Clair, EW | 1 |
| Schaumburg-Lever, G | 1 |
| Hamdy, H; Liver, JA; McKendry, RJ; Mierins, E | 1 |
| Bloch, D; Fries, J; Sherrer, Y; Strober, S | 1 |
| Becker, H; Helmke, K | 1 |
| Browne, CD; Champion, GD; Cohen, ML; Compton, P; Day, RO; de Jager, J; Sambrook, PN | 1 |
| Bernstein, RM; Coppen, J; Halnan, KE; Hughes, GR; Morgan, SH | 1 |
| Anderson, C | 2 |
| Nashel, DJ | 1 |
| Kovarsky, J | 1 |
| Achurra Castillo, AF; Benítez, R; Bulgín, O; Llerena, JM; López, RI; Sandoval, E; Villarreal, V | 1 |
| Hazleman, B | 1 |
| Anderson, CD; Groth, O | 1 |
| Hardt, F | 1 |
| Nakamoto, S; Popowniak, KL | 1 |
| Hartwich, G | 1 |
| Filipp, G | 1 |
| Loughridge, LW | 1 |
| Husberg, BS | 1 |
| Almeyda, J; Levantine, A | 1 |
| Baethke, R; Kampf, D | 1 |
| Miescher, PA; Schrago, R | 1 |
| Dantzig, PI | 1 |
| Levy, L | 2 |
| Beck, FJ; Levy, L; Whitehouse, MW | 1 |
| Gerebtzoff, A | 1 |
| Braunsteiner, H; Günther, R; Huber, C; Huber, H; Michlmayr, G | 1 |
| Schwartz, RS; Swanson, MA | 1 |
| Cruchaud, A; Pometta, D; Rousso, C | 3 |
| Ogawa, Y; Yamagata, H; Yamamura, Y | 1 |
| Wojnarowski, M; Wyszyńska, T | 1 |
| Balzereit, F; Leipert, M; Mertens, HG | 1 |
| Fink, U | 1 |
| Boden, B; Fünfhausen, G; Stinner, G | 1 |
| Holtz, G; Martin, H; Schubert, H; Schubert, JC | 1 |
| Decker, JL; Healey, LA | 1 |
| Angstwurm, H; Frick, E; Strauss, G | 1 |
| Matousek, V; Müllerova, M; Nouza, K; Pekárek, J; Svejcar, J; Trnka, L | 1 |
| Cassidy, EP; Fischer, DS; Welch, AD | 1 |
| Blumenstock, D; Castermans, A; Grosjean, O | 1 |
| Caldwell, JR | 1 |
| Amiel, JL; Cattan, A; Mathé, G; Schlumberger, JR; Schneider, M; Schwarzenberg, L | 1 |
| Scheiffarth, F; Warnatz, H | 1 |
| Bertino, JR; Capizzi, RL | 1 |
| Kölle, G | 2 |
| Kott, HS | 1 |
| Currey, HL | 3 |
| Aarli, JA | 1 |
| Diem, E; Oppolzer, R | 1 |
| Goldschmidt, E; Lochte, J | 1 |
| Cendrowski, W; Riekkinen, PJ; Rinne, UK | 1 |
| Patkowski, J | 1 |
| Moeschlin, S | 1 |
| Petrus, B; Wysocka, K | 1 |
| Haustein, UF | 1 |
| Dygin, VP; Samtsov, VI; Shaposhnikov, OK; Viazitskiĭ, PO | 1 |
| Delespesse, G; Duchateau, J; Kennes, B | 1 |
| Kapanci, Y; Miescher, PA; Zubler, RH | 1 |
| Akimoto, T; Mizushima, Y; Tsukada, W | 1 |
| Andreis, M | 1 |
| Shepard, TH | 1 |
| Halterman, RH; Herberman, RB; Levine, PH; McCoy, JL; Rosenberg, EB; Wunderlich, JR | 1 |
| Cobau, CD; Kirsner, AB; Sheon, RP | 1 |
| Schwartz, RS; Skinner, MD | 1 |
| Hackenthal, E; Schmidt-Gayk, H; Seyberth, HW | 1 |
| Cockrell, JV; Hardy, JD; Isin, E; Kondo, Y | 1 |
| Klein, G | 1 |
| Beaudoin, JG; Guttmann, RD; Morehouse, DD | 1 |
| Alican, F; Cockrell, JV; Isin, E | 1 |
| Gayrard, P; Lebreuil, G; Noirclerc, M; Orehek, J | 1 |
| Bareham, CR; Calabresi, P; Griswold, DE | 1 |
| Herzberg, JJ | 1 |
| Calabresi, P; Kaplan, SR | 1 |
| Perkins, ES | 1 |
| Tuffanelli, DL | 1 |
| Cockrell, JV; Hardy, JD; Kondo, Y; Kuwahara, O | 1 |
| Martenet, AC | 2 |
| Fischer, H; Keitel, W; Kunze, M; Oppermann, J; Paliege, R; Tanner, E | 1 |
| Jordon, RE; Muller, SA | 1 |
| Pulgram, A; Weippl, G; Zimprich, H | 1 |
| Forbes, IJ | 1 |
| Chan, WC; Dukes, M; Willoughby, DA | 1 |
| Müllerová, M; Nouza, K; Trnka, L | 1 |
| Haas, DC | 1 |
| Fogel, M; Lewis, M; Segel, D; Shadduck, RK; Stolzer, BL; Winkelstein, A | 1 |
| Frei, PC | 1 |
| Gross, R; Hirschmann, WD; Oerkermann, H | 1 |
| Buxton, PH; Lewkonia, RM | 1 |
| Clément, F | 1 |
| Kerl, H; Klein, G; Sandhofer, M | 1 |
| Krzakowski, Z | 1 |
| Fujimura, S; Kawakami, M; Nakada, T; Suzuki, C; Watanabe, A | 1 |
| Rothermich, NO | 1 |
| Crampton, R; Lawrence, W; Miller, D; Terz, JJ | 1 |
| Mackay, IR | 1 |
| Aronson, SB | 1 |
| Baum, J; Vaughan, J | 1 |
| Floersheim, GL | 1 |
| Baldini, L; Brambilla, G; Cavanna, M; Parodi, S | 1 |
| Blaszczyk, M; Chorzelski, T; Jablonska, S | 1 |
| Ashton, H; Beveridge, GW; Stevenson, CJ | 1 |
| Cohen, ML; Weiss, EB | 1 |
| Kutsch Lojenga, JC | 1 |
| Grob, PJ | 1 |
| Enderlin, M; Fehr, K; Gross, D | 1 |
| Enderlin, M; Gross, D | 1 |
| Anderson, DR; DeHart, RL; Eltringham, JR | 1 |
| Balner, H; de Vries, MJ; Muller-Bérat, CN; van Bekkum, DW; van Putten, LM | 1 |
| Mackaness, GB; Tripathy, SP | 2 |
| Gieldanowski, J; Patkowski, J; Szaga, B | 1 |
| Hitchings, GH | 1 |
| Deicher, H; Fricke, R; Krull, P | 1 |
| Pichlmayr, R | 1 |
| Deicher, H; Fricke, R; Kruli, P | 1 |
| Lever, WF | 1 |
| Bach, JF; Bach, MA | 1 |
| Forbes, IJ; Hunter, GA | 1 |
| Damasio, E; Marmont, A | 1 |
| Lambert, PH; Miescher, PA | 1 |
| Brambilla, G; Caraceni, CE; Cavanna, M; Parodi, S | 2 |
| Górkiewicz, A; Kostanecki, W; Mazurkiewicz, W; Zborzil, J | 1 |
| Bied, JC; Vignon, G | 1 |
| Enderlin, M | 1 |
| Stacher, A | 1 |
| Rowland, LP | 1 |
| Krampac, I | 1 |
| Adams, WE; Benfield, JR; Gago, O; Nigro, SL | 1 |
| Ellison, LT; Ellison, RG; Parker, JL; Toyohara, H; Yeh, TJ | 1 |
| Boese, J; Busse, V; Eisele, R; Kaspar, F | 1 |
| Datko, LJ; Kassarich, J; Rosenthale, ME; Schneider, F | 1 |
| De Vita, VT; Kies, MW; Lisak, RP; Vogel, CL | 1 |
| Rassner, G; Wenig, KH | 1 |
| Schuppli, R | 2 |
| Katsuta, Y; Matsuo, H | 1 |
| Dawber, RP | 1 |
| Genovesi, E | 1 |
| Beurey, J; Gilgenkrantz, S; Grandidier, M; Weber, M | 1 |
| Beurey, J; Touret, D; Vadot, J; Weber, M | 1 |
| Hunziker, N; Laugier, P | 1 |
| Connors, TA | 1 |
| Asamer, H; Dittrich, M | 1 |
| Carlisle, H; Spector, RG | 1 |
| Makulu, DR; Wright, P | 1 |
| Gross, D | 1 |
| Fosdick, WM | 1 |
| Dawson, AA; Ogston, D; Philip, JF | 1 |
| Gluckman, MI; Rosenthale, ME | 1 |
| Carcassi, U | 1 |
| Cowan, RB; Domingo, EO; Warren, KS | 1 |
| Stutzman, WJ | 1 |
| Jensen, MK | 1 |
| Jacquillat, C; Meshaka, G; Sultan, Y | 1 |
| Revell, PA; Soretire, EA | 1 |
| Collis, CH | 1 |
| Woolley, PV | 1 |
| Gerber, RC | 1 |
| Bieber, CP; Holm, BI; Hoppe, RT; Jamieson, SW; Modry, DL; Pennock, JL; Schroder, J; Stinson, EB; Strober, S; Suomalainen, H | 1 |
| Katz, P | 2 |
| Beris, P; Miescher, PA | 1 |
| Ali-Osman, F; Maurer, HR | 1 |
| Bittner, H; Gläser, A | 1 |
| Schmid, BP | 1 |
| Pascual Gómez, E | 1 |
| Bickers, DR; Callen, JP; Hanno, R; Hawkins, C; Voorhees, JJ; Woo, TY | 1 |
| Ansell, BM | 1 |
| Doskocz, W; Giełdanowski, J | 1 |
| Brennan, MF; Devereux, DF; Shamberger, RC | 1 |
| Cooper, AJ; Fraser, JD | 1 |
| Calin, A | 1 |
| Salaman, JR | 1 |
| Bieber, CP; Gottlieb, MS; Hoppe, RT; Kaplan, HS; Koretz, SH; Pennock, J; Reitz, BA; Strober, S | 1 |
| Geary, CG | 1 |
| Otterness, IG | 1 |
| Serushan, M; Weiss, VC | 1 |
| Miller, TE; Ormrod, DJ; Wilson, DM | 1 |
| Doherty, NS | 1 |
| Goerz, G; Merk, H | 1 |
| Niaudet, P | 1 |
| Blanco, FJ; De La Mata, J; Gómez-Reino, JJ | 1 |
| Dohy, H; Kakishita, E; Kanamaru, A; Kasai, M; Katoh, S; Kodera, Y; Moriyama, Y; Saitoh, H; Shibata, A; Takemoto, Y | 1 |
| Chan, GL; Vijayanagar, RR; Weinstein, SS | 1 |
| Korelitz, BI; Present, DH | 1 |
| Korelitz, BI | 2 |
| Carrier, M; Ferraro, P; Pelletier, GB; Pelletier, LC; White, M | 1 |
| Boerbooms, AM; Kerstens, PJ; Mulder, J; van de Putte, LB; van Loenhout, JW | 1 |
| Demetris, AJ; Miyazawa, H; Murase, N; Nakamura, K; Starzl, TE; Tanabe, M; Valdivia, LA | 1 |
| Calabrese, LH; Cannon, GW; Cohen, SB; Lee, ML; Lipsky, PE; Lorenz, TJ; Nelson, B; Olsen, NJ; Strand, V; Wiesenhutter, C | 1 |
| Boerbooms, AM; Jeurissen, ME; Kerstens, PJ; Mulder, J; van de Putte, LB; Van Erp, A; Westgeest, TA | 1 |
| Boerbooms, AM; De Graaf, TW; Kerstens, PJ; Van der Stelt, ME; Van Dijk, W; Van Ommen, EC | 1 |
| Conn, DL; Valente, RM | 1 |
| Anglade, E; Whitcup, SM | 1 |
| Adams, LB; King, LE; Olsen, NJ; Park, JH | 1 |
| van de Kerkhof, PC; van Dooren-Greebe, RJ | 1 |
| Dijkmans, BA; Hermans, J; Westedt, ML | 1 |
| Meenan, RF; Prashker, MJ | 1 |
| Stark, ME; Tremaine, WJ | 1 |
| Barrera, P; Boerbooms, AM; Demacker, PN; Sauerwein, RW; van de Putte, LB; van der Meer, JW | 1 |
| van Hogezand, RA | 1 |
| George, J; Kornbluth, A; Sachar, DB | 1 |
| Sigidin, IaA; Usova, SB | 1 |
| Lynch, JP; McCune, WJ; Vallance, DK | 1 |
| Hirose, M; Kuroda, Y; Ninomiya, T; Okamoto, Y; Sano, T; Takahashi, Y; Ushiroguchi, Y; Watanabe, T | 1 |
| van 't Hof, M; van de Putte, LB; van der Heijde, DM; van Riel, PL | 1 |
| Callahan, LF; Pincus, T | 1 |
| Furst, DE | 1 |
| Baratz, M; Gilat, T; Hallak, A; Halpern, Z; Rabau, M; Santo, M; Werbin, N | 1 |
| Pincus, T | 1 |
| McCarty, DJ | 2 |
| Madhok, R; Menon, N | 1 |
| Kutzer, JE; Medsger, TA; Mientus, JM; Mulvihill, JJ; Ramsey-Goldman, R | 1 |
| Fraser, DD; Hicks, JE; Joffe, MM; Leff, RL; Love, LA; Miller, FW; Plotz, PH; Targoff, IN | 1 |
| Fraser, DD; Hicks, J; Leff, RL; Miller, FW; Plotz, PH | 1 |
| Barrera, P; Boerbooms, AM; de Boo, T; Demacker, PN; Gallati, H; Janssen, EM; Mulder, J; Sauerwein, RW; van de Putte, LB; van der Meer, JW | 1 |
| Daum, F; Grancher, K; Mandel, F; Markowitz, J | 1 |
| Calin, A; Jones, SM | 1 |
| Jelkmann, W; Wolff, M | 1 |
| Bloch, DA; Fries, JF; Ramey, D; Williams, CA | 1 |
| Kozarek, RA | 1 |
| Briedigkeit, L; Göbel, U; Gross, WL; Natusch, R; Rheinhold-Keller, E; Ulmer, M | 1 |
| Spencer-Green, G | 1 |
| Pullar, T; Veale, D | 1 |
| Grassanovich, JL; Harman, JG; Klein, JP; McCarty, DJ; Qian, C | 1 |
| Sandborn, WJ | 1 |
| Armona, J; Blanco, R; Fernández-Sueiro, JL; González-Gay, MA; González-Vela, MC; Martínez-Taboada, VM; Rodríguez-Valverde, V | 1 |
| Stein, CM | 1 |
| Finn, J; Jones, M; Symmons, D; Wolfe, F | 1 |
| Stablein, D; Willkens, RF | 1 |
| Bermas, BL; Hill, JA | 1 |
| Marks, C; Sharp, JT; Stablein, D; Willkens, RF; Wortmann, R | 1 |
| Amato, AA; Barohn, RJ; Bryan, WW; Gronseth, GS; Jackson, CE; Katz, JS; Wolfe, GI | 1 |
| Silverman, E | 1 |
| Lichtenstein, GR; Stotland, BR | 1 |
| Berchtold, P; Seitz, M | 1 |
| Callen, JP; Kasteler, JS | 1 |
| Adams, EM; Villalba, L | 1 |
| Ramsey-Goldman, R; Schilling, E | 1 |
| Mader, R | 1 |
| Liu, HN; Wong, CK | 1 |
| Tremaine, WJ | 1 |
| Schmied, M; Vass, K | 1 |
| Breedveld, FC; Dijkmans, BA; Hermans, J; ten Wolde, S | 1 |
| Haagsma, CJ; van Riel, PL | 1 |
| Jayne, DR; Rasmussen, N | 1 |
| Miller, E | 1 |
| Derie, A; Oosterlinck, W | 1 |
| Klama, K; Lacki, JK; Mackiewicz, S; Michels, H; Muller, W; Truckenbrodt, H | 1 |
| Schölmerich, J | 1 |
| Modigliani, R | 2 |
| Grassi, M; Manzi, P; Raffa, S; Schiffino, L | 1 |
| Wollenhaupt, J; Zeidler, H | 1 |
| Liu, Y; Luo, Q; Tian, H; Tong, N; Wei, S; Yu, Y | 1 |
| Auzuki, A; Matsuoka, Y | 1 |
| Baert, F; Rutgeerts, P | 2 |
| Dörr, HG; Haas, JP; Höper, J; Höper, K; Leipold, G | 1 |
| Adams, EM; Burgess, SH; Gourley, MF; Hicks, JE; Leff, RL; Miller, FW; Plotz, PH; Sherman, JB; Thornton, BC; Villalba, L | 1 |
| Aranda, R; Horgan, K | 1 |
| Dutz, JP; Ho, VC | 1 |
| McCune, WJ; Singer, NG | 1 |
| Tytgat, GN; van Deventer, SJ | 1 |
| Abbattista, AD; Catena, G; Di Donato, R; La Vigna, G; Parisi, F; Squitieri, C; Vinciguerra, G | 1 |
| Hansen, A; Jensen, T | 1 |
| Hoffman, GS; Lynch, JP | 1 |
| Klippel, JH | 1 |
| Roblot, P | 1 |
| Dick, AD; Forrester, JV; Kilmartin, DJ | 1 |
| Becker, C; Germann, T; Hildner, K; Märker-Hermann, E; Meyer zum Büschenfelde, KH; Neurath, MF; Schlaak, JF; Schmitt, E | 1 |
| Baert, F; D'Haens, G; Rutgeerts, P; Vandeputte, L | 1 |
| Pongprasit, P; Wananukul, S | 1 |
| Heathcote, EJ | 1 |
| Carter, JL; Cohen, JA; Kinkel, RP; Schwid, SR | 1 |
| Kaplan, HJ; Van Gelder, RN | 1 |
| Bräunig, E; Eidner, T; Hein, G; Wendt, T | 1 |
| Kougo, Y | 1 |
| Keysser, C; Keysser, G; Keysser, M | 1 |
| Antonello, RM; Bragadin, LM; Cazzato, G; De Masi, R; Moretti, R; Nasuelli, D; Torre, P; Zivadinov, R; Zorzon, M | 1 |
| Cherikuri, A; Donnelly, S; Farrell, RJ; Keeling, PW; Kelleher, D; Long, A; Mahmud, N; Murphy, A; O'Toole, D; Weir, DG | 1 |
| Ewe, K; Gassull, MA; Geboes, K; Jewell, D; Meuwissen, SG; Pallone, F; Rachmilewitz, D; Rask-Madsen, J; Riddell, BH; Sandborn, BJ; Schmuck, ML | 1 |
| Giner, RM; Góngora, L; Máñez, S; Recio, MC; Ríos, JL | 1 |
| Brooks, P; Crotty, M; Jones, G | 2 |
| Boerbooms, AM; de Graaf, R; Jeurissen, ME; Kerstens, PJ; Mulder, J; van de Putte, LB | 1 |
| Coustans, M; Edan, G | 1 |
| Chiang, BL; Lin, YT; Tsai, MJ; Yang, YH | 1 |
| Martio, J | 1 |
| Lémann, M | 1 |
| Simon, LS | 1 |
| Foster, CS; Gion, N; Stavrou, P | 1 |
| Flores, F; Kerdel, FA | 1 |
| Bryant, J; Clegg, A; Milne, R | 1 |
| Faubion, WA; Sandborn, WJ | 1 |
| Blond, S; de Seze, J; Decoulx, M; Destée, A; Ferriby, D; Hachulla, E; Hatron, PY; Stojkovic, T; Vermersch, P; Wallaert, B | 1 |
| Oddis, CV | 2 |
| Dassopoulos, T; Hanauer, SB | 1 |
| Al Mazyad, AS | 1 |
| Ohashi, H; Ohno, R | 1 |
| Kaklamani, VG; Kaklamanis, PG | 1 |
| Bryant, J; Clegg, A | 1 |
| Caspers-Velu, LE | 1 |
| Bedocs, NM; Crook, S; Hellmann, DB; Hoffman, GS; Stone, JH; Uhlfelder, ML | 1 |
| Rutgeerts, PJ | 1 |
| Lichtenstein, GR | 1 |
| Langford, CA | 1 |
| Kanda, H; Kubo, K; Mimura, T | 1 |
| Folch Ramos, J; Sainz De La Maza Serra, M | 1 |
| Hellmann, DB; Regan, MJ; Stone, JH | 1 |
| Paré, P | 1 |
| Koler, RA; Montemarano, A | 1 |
| Pisetsky, DS; St Clair, EW | 1 |
| Ahmed, AR; Baltatzis, S; Foster, CS; Miserocchi, E; Roque, MR | 1 |
| Barilla-LaBarca, ML; Brasington, RD; Lenschow, DJ | 1 |
| Carey, TE; Hawkshaw, M; Lasak, JM; Lyons, KM; Sataloff, RT; Spiegel, JR | 1 |
| Baltatzis, S; Ekong, A; Foster, CS; Michel, SS | 1 |
| Bambara, LM; Biasi, D; Canestrini, S; Caramaschi, P; Carletto, A; Scambi, C; Scarperi, A | 1 |
| Freedman, MS; MacLean, HJ | 1 |
| Cunliffe, RN; Scott, BB | 1 |
| Airò, P; Antonioli, CM; Toniati, P; Vianelli, M | 1 |
| Lublin, FD | 1 |
| Colombel, JF; Cortot, A; Cosnes, J; Dewit, O; Hafraoui, S; Lémann, M; Marteau, P; Modigliani, R | 1 |
| Hommes, OR; Weiner, HL | 2 |
| Albertioni, F; Almer, S; Peterson, C; Pettersson, B; Söderhäll, S | 1 |
| Jayne, DR | 1 |
| Hoffman, GS | 3 |
| Niemelä, S | 1 |
| Abbs, IC; Alba, P; Cuadrado, MJ; D'Cruz, DP; Hughes, GR; Karim, MY; Khamashta, MA | 1 |
| Baughman, RP | 1 |
| Lashner, BA; Wolf, JM | 1 |
| Nakaseko, C; Nishimura, M; Saito, Y; Uehara, T; Yokota, A | 1 |
| Reinhold-Keller, E | 1 |
| Schnabel, A | 1 |
| Konishi, M; Takahashi, K; Yoneda, K; Yoshimoto, E | 1 |
| Crispino, P; Iacopini, F; Iannoni, C; Marcheggiano, A; Paoluzi, OA; Paoluzi, P; Pica, R; Rivera, M | 1 |
| Pender, MP; Wolfe, NP | 1 |
| McLeod, HL; Siva, C; Yokoyama, WM | 1 |
| Baldini, C; Bombardieri, S; Colangelo, C; Della Rossa, A; Neglia, D; Puccini, R; Sambuceti, G; Tavoni, A; Tognetti, A | 1 |
| D'Haens, G; Daperno, M | 1 |
| Bevan, J; Homer, D; Jobanputra, P; Maggs, F | 1 |
| Belgi, G; Friedmann, PS | 1 |
| Aletaha, D; Smolen, JS | 1 |
| Baranauskaite, A; Misiūniene, N | 1 |
| Alstead, EM; Nelson-Piercy, C | 1 |
| Hoffmann, J; Zeitz, M | 1 |
| Fleig, WE | 1 |
| Göke, B; Ochsenkühn, T; Sackmann, M | 1 |
| Encke, J; Erb, G; Flosdorff, P; Ganten, M; Grüber-Hoffmann, B; Hansmann, J | 1 |
| Baughman, RP; Lynch, JP | 1 |
| Beglinger, Ch | 1 |
| Balow, JE; Langford, CA | 1 |
| Ferrero, S; Ragni, N | 1 |
| Chowers, Y; Eliakim, R; Lavy, A; Odes, HS | 1 |
| Arlet, P; Astudillo, L; Carreiro, M; Dahan, S; Ollier, S; Sailler, L | 1 |
| Pariente, A | 1 |
| Dück, N; Heiligenhaus, A; Hudde, T; Koch, J; Michel, D; Steuhl, KP | 1 |
| Hartung, HP; Kieseier, BC | 1 |
| ELLISON, LT; ELLISON, RG; YEH, TJ | 1 |
| BLUMENSTOCK, DA; COLLINS, JA; FERREBEE, JW; HECHTMAN, HB; HOSBEIN, DJ; LEMPERT, N; THOMAS, ED | 1 |
| EPSTEIN, WL; MAIBACH, HI | 1 |
| Ardizzone, S; Bianchi Porro, G; Bollani, S; Colombo, E; Imbesi, V; Manzionna, G | 1 |
| Múzes, G | 1 |
| Anhalt, GJ; Cummins, DL; David, M; Kouba, DJ; Mimouni, D; Nousari, CH | 1 |
| Pleyer, U | 1 |
| Eberle, M; Jacobowitz, G; Krinsky, G; Mitnick, H; Riles, T; Rockman, C; Rosenzweig, B; Willis, D | 1 |
| Käser, L; Kolyvanos Naumann, U; Vetter, W | 1 |
| Blumenstein, I; Schröder, O; Schulte-Bockholt, A; Stein, J | 1 |
| Atul, S; Mohan, H; Sarbmeet, L; Singh, R; Vikas, A | 1 |
| Black, MM; Reynaert, S | 1 |
| Ho, GT; Lees, C; Satsangi, J | 1 |
| Friedman, S | 1 |
| Bebb, JR; Scott, BB | 1 |
| Boehmer, LN; John, J; Siegel, JM; Wu, MF | 1 |
| Deighton, CM; Ellis, IO; Macmillan, RD; Raj, N | 1 |
| De Ramón, E; Fernández, O; Fernández, V | 1 |
| Job-Deslandre, C; Kahan, A; Sornay-Soares, C | 1 |
| Ansari, A; Hirst, J; Raoof, S; Sanderson, JD; Soon, SY; Yaneza, M | 1 |
| Kamm, MA | 1 |
| Emery, P; Suarez-Almazor, M | 1 |
| Dignass, AU; Herrlinger, K; Schölmerich, J | 1 |
| Dejaco, C; Knoflach, P; Petritsch, W; Reinisch, W; Tilg, H; Vogelsang, H | 1 |
| Alves, A; Bouhnik, Y; Joly, F; Lavergne-Slove, A; Panis, Y; Pocard, M; Valleur, P | 1 |
| Aringer, M; Graninger, WB; Smolen, JS; Steiner, G | 1 |
| Broughton, SS; Cohen, SB; Meyerhoff, WE | 1 |
| Herrlinger, K; Stange, EF | 1 |
| Heath, M; Raugi, GJ | 1 |
| Angelucci, E; Caprilli, R; Cocco, A; Viscido, A; Zippi, M | 1 |
| Issa, SN; Ruderman, EM | 1 |
| Jeffery, DR | 1 |
| Siegmund, B; Zeitz, M | 1 |
| Afchain, P; Beaugerie, L; Cosnes, J; Gendre, JP; Nion-Larmurier, I; Tiret, E | 1 |
| Beaugerie, L; Bouhnik, Y; Cosnes, J; Etienney, I; Gendre, JP; Lémann, M; Matuchansky, C; Modigliani, R; Rambaud, JC | 1 |
| Fernández, A; Iglesias, A; Matteson, EL; Quintana, G; Restrepo, JF | 1 |
| Bouros, C; Kokotis, P; Sfikakis, PP; Theodossiadis, P | 1 |
| Aberra, FN; Lichtenstein, GR | 1 |
| Cummings, JR; Gorard, DA; Herrlinger, KR; Jewell, DP; McIntyre, AS; Travis, SP | 1 |
| Hyams, JS; Markowitz, JF | 1 |
| Audisio, RA; Prabhu, S; Zaniboni, A | 1 |
| Brockhurst, I; Chapman, CS; Harris, KP | 1 |
| Goek, ON; Stone, JH | 1 |
| Ahmed, M; Foster, CS; Kiss, S; Letko, E | 1 |
| Choy, EH; Hoogendijk, JE; Lecky, B; Winer, JB | 1 |
| Finelli, PF | 1 |
| Barthel, HR; Gille, T; Halbsguth, A; Kramer, M | 1 |
| Aries, PM; Reinhold-Keller, E | 1 |
| Bansal, A; Singh, S | 1 |
| Kruis, W | 1 |
| Bieber, T; Tüting, T; Uerlich, M; Wenzel, J | 1 |
| Eschmann, M; Fritz, J; Horger, M | 1 |
| Gross, WL; Hellmich, B; Lamprecht, P | 1 |
| de Groot, K; Jayne, D | 1 |
| Genth, E; Hunzelmann, N; Kaufmann, J; Krieg, T | 1 |
| Baldassano, RN; Jacobstein, DA; Leonard, M; Mamula, P; Markowitz, JE | 1 |
| Kanno, J; Kure, S; Matsubara, Y; Sato, K; Tominaga, T | 1 |
| Ranganathan, P | 2 |
| Yoshida, M | 1 |
| Abreu, MT; Cohen, R; Lichtenstein, GR; Tremaine, W | 2 |
| Barta, Z; Tóth, L; Zeher, M | 1 |
| Hausner-Sypek, DL; Noss, EH; Weinblatt, ME | 1 |
| Bachta, A; Tłustochowicz, M | 1 |
| Lesiak, A; McCauliffe, DP; Salamon, M; Sysa-Jedrzejowska, A; Wozniacka, A | 1 |
| Brocq, O; Cantagrel, A; Combe, B; Debiais, F; Deslandre, CJ; Kara-Terki, R; Kuntz, JL; Loet, XL; Mariette, X; Pavy, S; Perdriger, A | 1 |
| De Pedro-Esteban, A; González-Carro, P; Legaz-Huidobro, ML; Pérez-Roldán, F; Roncero García-Escribano, O; Ruiz-Carrillo, F; Soto-Fernández, S; Valbuena-González, M | 1 |
| Pierik, M; Rutgeerts, P; Vermeire, S; Vlietinck, R | 1 |
| Moser, C; Schmidt, C; Stallmach, A; Wittig, BM; Zeitz, M | 1 |
| Barclay, ML; Begg, EJ; Clark, DW; Frampton, CM; Gardiner, SJ; Gearry, RB; Hansen, P; Priest, VL | 1 |
| Mosekilde, L; Rejnmark, L; Vestergaard, P | 1 |
| Baughman, RP; Bradley, DA; Lower, EE | 1 |
| Büning, C; Lochs, H | 1 |
| Belbouab, R; Cézard, JP; Goulet, O; Narebski, K; Ruemmele, FM; Schmitz, J; Turck, D; Uhlen, S | 1 |
| Bank, I; Ben-Horin, S; Langevitz, P; Levi, Y; Livneh, A; Schiby, G; Tweezer-Zaks, N | 1 |
| Aboín González, S; Barchino Ortiz, L; Díaz Ley, B; García Acebes, CR; Ruiz Fernández, P; Sánchez de Paz, F | 1 |
| Aringer, M; Graninger, WB; Höfler, E; Smolen, JS; Steiner, CW; Steiner, G | 1 |
| Jindal, SK | 1 |
| Baert, F; D'Haens, G; Noman, M; Rutgeerts, P; Van Assche, G; Vermeire, S | 1 |
| Guillevin, L; Guilpain, P; Pagnoux, C | 1 |
| Garrido Gómez, E; López San Román, A; Milicua Salamero, JM; Rivero Fernández, M; Rodríguez Gandía, MA; Ruiz Del Arbol Olmos, L | 1 |
| Guillevin, L; Pagnoux, C | 1 |
| de Groot, K; Flossmann, O | 1 |
| Ozaki, S | 1 |
| Beaugerie, L; Cosnes, J; Daniel, F; Marteau, P; Seksik, P | 1 |
| Akikusa, JD; Harvey, EA; Hebert, D; Laxer, RM; Schneider, R; Silverman, ED; Thorner, PS | 1 |
| Stuart, WH | 1 |
| Lakatos, L; Lakatos, PL | 1 |
| Ali, Y; Gladman, DD; Ibañez, D; Urowitz, MB | 1 |
| Matsuda, T; Ohtsubo, H | 1 |
| Glück, T; Müller-Ladner, U | 1 |
| Angelucci, E; Baert, F; Caprilli, R | 1 |
| Chaperon, J; Coustans, M; Edan, G; Le Page, E; Leray, E; Morrissey, SP; Taurin, G | 1 |
| Akobeng, AK | 1 |
| Brouwers, JR; de Jong-van den Berg, LT; van den Berg, PB; van Roon, EN; Vroom, F | 1 |
| Goodemote, P; Hoffman, R; Jamieson, B | 1 |
| Cid, MC; Espígol-Frigolé, G; García-Martínez, A; Hernández-Rodríguez, J; Lozano, E | 1 |
| Baldassano, R; Gilman, AR; Griffiths, AM; Grossman, AB; Kugathasan, S; Rosh, J; Turner, D | 1 |
| Depla, JA; Van Calster, J | 1 |
| Aitken, S; Arnott, ID; Dahele, A; Din, S; Fennel, J; Satsangi, J; Shand, AG | 1 |
| Pipitone, N; Salvarani, C | 1 |
| Baert, F; Caenepeel, P; Coche, JR; D'Haens, G; De Vos, M; Donner, A; Feagan, BG; Hommes, D; Lambrecht, GL; Mana, F; Ochsenkühn, T; Rutgeerts, P; Stitt, L; Tuynman, H; van Assche, G; van Bodegraven, AA; Van De Mierop, FJ; van der Woude, J; van Deventer, S; Van Hootegem, PP; Vergauwe, P; Vermeire, S | 1 |
| Marquina Barcos, A; Monón Ballarín, S; Mozota Duarte, J; Ruiz-Ruiz, FJ; Sáenz Abad, D | 1 |
| Hartmann, U; Reuss-Borst, M; Schmitt, S | 1 |
| Iorizzo, LJ; Jorizzo, JL | 1 |
| Baert, F; D'Haens, G; Magdelaine-Beuzelin, C; Noman, M; Paintaud, G; Rutgeerts, P; Ternant, D; Van Assche, G; Vermeire, S; Watier, H | 1 |
| Agnholt, J | 1 |
| Daniel, E; Foster, CS; Gangaputra, S; Helzlsouer, KJ; Jabs, DA; Kempen, JH; Levy-Clarke, GA; Nussenblatt, RB; Rosenbaum, JT; Suhler, EB; Thorne, JE | 1 |
| Dunn, JP; Galor, A; Jabs, DA; Kedhar, SR; Leder, HA; Peters, GB; Thorne, JE | 1 |
| Benedetti, MD; Invernizzi, P; Monaco, S; Poli, S | 1 |
| Rogler, G | 1 |
| Burakoff, R | 1 |
| Bendtsen, F; Caspersen, S; Elkjaer, M; Hansen, TS; Jess, T; Moesgaard, F; Mortensen, C; Munkholm, P; Pedersen, N; Riis, L; Sarto, P; Wewer, V | 1 |
| Al-Hemidan, AI; Tabbara, KF | 1 |
| Koning, E; Lerebours, E; Michot, F; Savoye, G; Savoye-Collet, C; Tougeron, D | 1 |
| Carbonnel, F | 1 |
| Boffa, JJ; Cohen, P; Cordier, JF; Ducroix, JP; Guillevin, L; Hamidou, MA; Khellaf, M; Kyndt, X; Lambert, M; Le Noach, J; Lifermann, F; Mahr, A; Merrien, D; Mouthon, L; Pagnoux, C; Papo, T; Puéchal, X; Ruivard, M; Vinzio, S | 1 |
| Rogler, G; Vavricka, SR | 1 |
| Broussolle, C; Candessanche, JP; Marignier, R; Ninet, J; Rousset, H; Sève, P; Varron, L | 1 |
| Brasington, R | 1 |
| Bonesrønning, JH; Dalaker, M | 1 |
| Gergely, P; Poór, G | 1 |
| Mimori, T | 1 |
| Chiche, L; Jourde, N; Mancini, J | 1 |
| Gelber, AC | 1 |
| Watts, R | 1 |
| Hounoki, H; Kawagishi, Y; Ogawa, R; Shinoda, K; Sugiyama, E; Taki, H; Tobe, K | 1 |
| Usui, J; Yamagata, K | 1 |
| Hirayama, K; Kobayashi, M; Koyama, A; Yamagata, K | 1 |
| Feller, ER; Harris, A; Shah, SA | 1 |
| Broide, E; Bujanover, Y; Fradkin, A; Lerner, A; Levine, A; Shapiro, R; Weiss, B | 1 |
| Bart, PA; Chakour, R; Leimgruber, A; Spertini, F | 1 |
| Aguado, L; España Alonso, A; Fernández, S; Marquina, M; Panizo, C; Pretel, M; Sánchez-Ibarrola, A | 1 |
| Camacho, FM; Coronel-Pérez, IM; Pérez-Bernal, AM; Rodríguez-Rey, EM | 1 |
| Förger, F; Østensen, M | 1 |
| Arrighi, HM; Hass, S; Marehbian, J; Sandborn, WJ; Tian, H | 1 |
| Baxter, LM; Bloom, SL; Limdi, JK; Lindsay, JO; Louis-Auguste, JR; McCartney, SA; Wahed, M | 1 |
| Avinash, B; Chacko, A; Dutta, AK | 1 |
| Burkhart, CN; Morrell, DS; Shaw, MG | 1 |
| Denton, CP; Quillinan, NP | 1 |
| Ruemmele, FM | 1 |
| Bar-Meir, S | 1 |
| Choy, EH; Gordon, P; Hoogendijk, JE; Lecky, B; Winer, JB | 1 |
| Croft, NM; Dawson, R; Goodhand, J; Hefferon, M; Lindsay, JO; Swanson, G; Tshuma, N; Wahed, M | 1 |
| Wimmersberger, Y; Zuercher, D | 1 |
| Koulaouzidis, A | 1 |
| Sharaf, PH; Yazici, Y | 1 |
| Curry, JL; Diwan, AH; Duvic, M; Jones, DM; Prieto, VG; Vega, F | 1 |
| Andrade, RJ; Cotta, J; Lucena, MA; Robles, M; Toscano, E | 1 |
| Cury, DB; Moss, AC | 1 |
| Belaiche, J; Louis, E; Reenaers, C | 1 |
| Lakatos, PL | 1 |
| Reichel, C; Streit, J; Wunsch, S | 1 |
| Einarson, A; Jin, C; Koren, G; Lee, CY; Mata, AM; Tanaka, T | 1 |
| Chau, TN; Cheung, WI; Lai, KB; Lee, CK; Leung, VK; Lin, CK; Lo, FH | 1 |
| Erwig, LP; Savage, CO | 1 |
| Borhani Haghighi, A; Safari, A | 1 |
| Bischoff, A | 1 |
| Calderón, R; Delgado, E; Enciso, C; Estrada, S; García-Campos, F; Ramírez de la Piscina, P; Salvador, M; Zabaleta, S | 1 |
| Knott, HM; Martínez, JD | 1 |
| McFadden, JP; Wee, JS; White, IR; White, JM | 1 |
| Ganser, G; Goebel, JC; Heiligenhaus, A; Heinz, C; Michels, H; Roesel, M | 1 |
| Beaugerie, L; Carrat, F; Cosnes, J; Nion-Larmurier, I; Seksik, P; Sokol, H; Vienne, A | 1 |
| Karjalainen, A; Pettersson, T | 1 |
| Börzsönyi, B; Csanád, M; Demendi, C; Joó, JG; Nagy, ZB; Rigó, J; Tóth, K | 1 |
| Fleck, M; Haerle, P; Lehmann, P; Schoelmerich, J | 1 |
| Akhlaghi, M; Chams-Davatchi, C; Davatchi, F; Faezi, T; Naderi, N; Nadji, A; Rezaipoor, M; Sadeghi-Abdollahi, B; Shahram, F; Shams, H | 1 |
| Houtman, PM; Jansen, TL; Kwakernaak, AJ; Spoorenberg, JP; Weel, JF | 1 |
| Bonsmann, G; Kuhn, A; Ruland, V | 1 |
| Bush, A; Saglani, S | 1 |
| Doran, RM; Jackson, TE; Pathak, S | 1 |
| Hughes, RA; Mahdi-Rogers, M; Swan, AV; van Doorn, PA | 1 |
| Revington, PJ; Williams, JV | 1 |
| Thonhofer, R | 1 |
| Christopher-Stine, L; Connors, GR; Danoff, SK; Oddis, CV | 1 |
| Belleannée, G; Capdepont, M; Chabrun, E; de Lédinghen, V; Laharie, D; Razaire, S; Reffet, A; Subtil, C | 1 |
| Kouroumalis, EA; Koutroubakis, IE; Malliaraki, N; Messaritakis, I; Oustamanolakis, P; Sfiridaki, A | 1 |
| Lémann, M; Peyrin-Biroulet, L | 1 |
| Ford, AC; Hamlin, PJ; Jackson, EL | 1 |
| Dubinsky, MC; Ford, AC; Khan, KJ; Moayyedi, P; Talley, NJ; Ullman, TA | 1 |
| Gudkova, RB; Khomeriki, SG; Kniazev, OV; Konopliannikov, AG; Konopliannikova, OA; Lazebnik, LB; Mikhaĭlova, ZF; Parfenov, AI; Rogozina, VA; Ruchkina, IN; Shcherbakov, PL; Tsaregorodtseva, TM | 1 |
| Bos, JD; Leeflang, MM; Roekevisch, E; Schmitt, J; Schram, ME; Spuls, PI | 1 |
| Blumenstein, I; Bock, H; Dignass, A; Filmann, N; Hartmann, F; Herrmann, E; Schröder, O; Stein, J; Tacke, W; Zeuzem, S; Zosel, C | 1 |
| Simon, D | 1 |
| Lynch, JP; Tazelaar, H | 1 |
| Belperio, JA; Lynch, JP; Wang, T; Weigt, SS | 1 |
| Castro Laria, L; Castro Márquez, C; Caunedo Álvarez, A; Cordero Ruiz, P; Herrerías Gutiérrez, JM; Méndez Rufián, V; Romero Vázquez, J | 1 |
| Antonini, G; Benedetti, L; Briani, C; Cocito, D; Falcone, Y; Fazio, R; Grimaldi, S; Jann, S; Matà, S; Nobile-Orazio, E; Paolasso, I; Sabatelli, M | 1 |
| Badri, M; Bateman, K; Heckmann, JM; Rawoot, A; Renison, R | 1 |
| Denniston, AK; Murray, PI; Sreekantam, S | 1 |
| Duijvestein, M; Fibbe, WE; Hommes, DW; Molendijk, I; Reinders, ME; Roelofs, H; van den Brink, GR; Verhaar, AP; Verspaget, HW; Vos, AC; Wildenberg, ME | 1 |
| Mishra, OP; Mittal, R; Prasad, R; Singh, UK | 1 |
| Dankó, K; Vincze, M | 1 |
| Bereznai, B; Boczán, J; Lovas, G; Molnár, MJ; Pál, Z | 1 |
| Borradori, L; Daniel, BS; Hall, RP; Murrell, DF | 1 |
| Kiss, CG; Kiss, E; Poór, G | 1 |
| Allenbach, Y; Benveniste, O; Brady, S; Dubourg, O; Eymard, B; Freebody, J; Guiguet, M; Herson, S; Hilton-Jones, D; Leite, MI; Maisonobe, T; Squier, W; Stojkovic, T | 1 |
| Ye, BD | 1 |
| Dábague Guzmán, J; Pedroza Granados, J; Zúñiga Varga, J | 1 |
| Amoura, Z; Barete, S; Benveniste, O; Bourgeois, P; Cacoub, P; Dubourg, O; Francès, C; Gatfossé, M; Lebeaux, D; Maisonobe, T; Piette, JC; Renoux, J; Sène, D; Wechsler, B | 1 |
| Adler, S; Baumgartner, I; Villiger, PM | 1 |
| Aghdassi, E; Fortin, PR; Gladman, DD; Hirschfield, GM; Huang, D; Mosko, J; Su, J; Urowitz, MB | 1 |
| Balogh, M; David, G; Erdelyi, Z; Golovics, PA; Horvath, A; Kiss, LS; Komaromi, E; Lakatos, L; Lakatos, PL; Lovasz, BD; Mester, G; Molnar, C; Pandur, T; Szathmari, M; Szipocs, I; Veres, G | 1 |
| Fujiki, Y; Hanafusa, T; Hata, K; Makino, S; Ozaki, T; Takeuchi, T; Yoshida, S; Yoshikawa, A | 1 |
| Crofford, LJ; MacDonald, PM; Phillips, K; Schiopu, E; Somers, EC | 1 |
| Borchers, AT; Gershwin, ME | 1 |
| Ford, AC; Greer, D; Hamlin, J; Sprakes, MB; Warren, L | 1 |
| Bigard, MA; Billioud, V; Bronowicki, JP; Chevaux, JB; Gibot, S; Guéant, JL; Massin, F; Oussalah, A; Peyrin-Biroulet, L; Williet, N | 1 |
| Artifoni, M; Puéchal, X | 1 |
| Brunet, P; Burtey, S; Dussol, B; Seck, SM | 1 |
| Cheon, JH; Choi, CH; Jang, BI; Kim, YH; Lee, H; Lee, KM; Shin, SJ; Yang, SK; Ye, BD | 1 |
| Gisbert, JP; Gomollón, F; Hinojosa, J; López San Román, A | 1 |
| Armuzzi, A; D'Haens, G; Griffiths, A; Lukas, M; Pineton de Chambrun, G; Preiss, JC; Reinisch, W; Sladek, M; Van Assche, G | 1 |
| Castiglione, E; Mellado, F; Talesnik, E | 1 |
| Devoto, MH; Fernández Romero, DS; Georgiett, D; Juri, MC; Malbrán, A; Zárate, JO | 1 |
| de Heij, T; de Jong, DJ; de Vries, HS; Peters, WH; Roelofs, HM; te Morsche, RH | 1 |
| Beck, LA; Denby, KS | 1 |
| Ahmed, SF; Bakhshi, A; Bishop, J; Garrick, V; Malik, S; Mason, A; McGrogan, P; Russell, RK; Young, D | 1 |
| Miller, AV; Ranatunga, SK | 1 |
| Kher, A; Kher, V | 1 |
| Becker, ML | 1 |
| Barclay, ML; Roberts, RL | 1 |
| Boyle, B; Colletti, RB; Crandall, WV; Kappelman, MD; King, E; Lee, GJ; Pratt, JM | 1 |
| Makol, A; Sokumbi, O; Warrington, KJ; Wetter, DA | 1 |
| Gibert, C; Puget, M; Zenone, T | 1 |
| Brun, JG; Kajalainen, A; Kautiainen, H; Knight, A; Ljung, L; Luukkainen, R; Nordström, D; Pettersson, T; Proven, A; Rantalaiho, V; van Vollenhoven, R | 1 |
| Bremer, JP; Gross, WL; Hellmich, B; Holl-Ulrich, K; Holle, JU; Laudien, M; Matthis, C; Metzler, C; Moosig, F; Nölle, B; Richardt, G | 1 |
| Campainha, S; Carvalho, A; Duarte, R; Gomes, T | 1 |
| Aggarwal, R; Oddis, CV | 1 |
| Brito, MJ; Conde, M; Queirós, G; Romeira, AM | 1 |
| El-Serag, HB; Hou, JK; Kramer, JR; Richardson, P; Sansgiry, S | 1 |
| Ammendola, A; Diculescu, M; Dietrich, B; Fellermann, K; Hartmann, H; Hentsch, B; Herrlinger, KR; Howaldt, S; Nikolov, R; Otte, JM; Petrov, A; Reindl, W; Stange, EF; Stoynov, S; Strauch, U; Sturm, A; Voiosu, R | 1 |
| Awadie, H; Ben-Horin, S; Chowers, Y; Fudim, E; Kopylov, U; Picard, O; Waterman, M; Weiss, B; Yavzori, M | 1 |
| Gonzalez, ME; Tan, AU | 1 |
| Feagan, BG; Macdonald, JK; McDonald, JW; Tsoulis, DJ | 1 |
| Karni, A; Kolb, H; Stankiewicz, JM; Weiner, HL | 1 |
| Herfarth, HH; Isaacs, KL; Long, MD | 1 |
| Aranow, C; Askanase, A; Bae, SC; Barr, SG; Bernatsky, S; Blanco, I; Boivin, JF; Clarke, AE; Costenbader, KH; Criswell, LA; Dooley, MA; Dreyer, L; Edworthy, SM; Feldman, CH; Fortin, PR; Ginzler, EM; Gladman, DD; Gordon, C; Isenberg, D; Jacobsen, S; Joseph, L; Kamen, DL; Manzi, S; Nived, O; Patel, NM; Peschken, CA; Petri, MA; Rahman, A; Ramsey-Goldman, R; Romero-Diaz, J; Ruiz-Irastorza, G; St Pierre, Y; Sturfelt, GK; Urowitz, MB; Wallace, DJ; Witte, T; Yelin, E | 1 |
| Baughman, RP; Lower, EE; Nunes, H; Sweiss, NJ | 1 |
| Bezuidenhout, E; Bosch, FJ; Buchel, OC; de K Grundling, H; de Vries, CS; Fevery, J; Janse van Rensburg, J; Middlecote, BD; van Zyl, JH | 1 |
| Bjerrum, JT; Herfarth, H; Nielsen, OH; Rogler, G | 1 |
| Elsone, L; George, J; Jacob, A; Kitley, J; Leite, MI; Palace, J; Vincent, A; Waters, P; Woodhall, M | 1 |
| Kane, SV; Yarur, A | 1 |
| Mouthon, L | 1 |
| Deneer, VHM; Grutters, JC; Thomeer, M; van Moorsel, CHM; Veltkamp, M; Vorselaars, ADM; Vorselaars, VMM; Wuyts, WA; Zanen, P | 1 |
| Adedokun, OJ; Collins, J; Colombel, JF; Feagan, BG; Gibson, PR; Guzzo, C; Hibi, T; Järnerot, G; Johanns, J; Marano, C; Reinisch, W; Rutgeerts, P; Sandborn, WJ; Strauss, R; Zhang, H | 1 |
| Bartsch, M; Effelsberg, NM; Hässler, F; Hentze, C; Miehle, N; Peter, HH; Salzer, U; Schlesier, M; Sic, H; Thiel, J; Venhoff, N; Voll, RE; Warnatz, K | 1 |
| Kirshner, H; Lagrange, AH; Moses, H; Olmez, I; Pawate, S; Sriram, S | 1 |
| Hughes, RA; Mahdi-Rogers, M; van Doorn, PA | 1 |
| Korsten, P; Mirsaeidi, M; Sweiss, NJ | 1 |
| Flohr, C; Irvine, AD | 1 |
| Mudter, J; Neurath, MF | 1 |
| Arakawa, T; Fujiwara, Y; Fukushima, W; Hagihara, Y; Hirota, Y; Kamata, N; Maeda, K; Ohfuji, S; Shiba, M; Sogawa, M; Tanigawa, T; Tominaga, K; Watanabe, K; Watanabe, T; Yamagami, H | 1 |
| Deneer, VH; Grutters, JC; van Moorsel, CH; Vorselaars, AD | 1 |
| Baker, S; Baldassano, R; Cohen, S; Crandall, W; Denson, LA; Dubinsky, M; Essers, J; Evans, J; Griffiths, AM; Guthery, SL; Heyman, MB; Hyams, JS; Kellermayer, R; Kim, MO; Kim, S; Kirschner, B; Kugathasan, S; LeLeiko, N; Liu, C; Mack, D; Markowitz, J; Moulton, D; Oliva-Hemker, M; Otley, A; Patel, AS; Pfefferkorn, M; Rosh, J; Stephens, M; Walters, TD; Ziring, D | 1 |
| Bellando-Randone, S; Cappelli, S; Guiducci, S; Matucci-Cerinic, M | 1 |
| Cottone, M; Orlando, A; Renna, S | 1 |
| Bosse-Henck, A; Brähler, E; Fleischer, M; Hinz, A; Wirtz, H | 1 |
| Falck-Ytter, YT; Gruss, CB; Heidelbaugh, JJ; Sultan, S; Terdiman, JP | 1 |
| Dassopoulos, T; Falck-Ytter, YT; Hanauer, SB; Inadomi, JM; Sultan, S | 1 |
| Kuester, D; Limpens, J; Roekevisch, E; Schmitt, J; Spuls, PI | 1 |
| Cherin, P; Diot, E; Dominique, S; Hachulla, E; Hatron, PY; Jouen, F; Marie, I; Menard, JF; Vittecoq, O | 1 |
| Cuthbertson, D; Hoffman, GS; Krischer, JP; Langford, CA; McAlear, CA; Merkel, PA; Monach, PA; Seo, P; Specks, U; Ytterberg, SR | 1 |
| Amoiridis, G; Bertsias, G; Boumpas, DT; Fanouriakis, A; Mastorodemos, V; Pamfil, C; Papadaki, E; Plaitakis, A; Sidiropoulos, P | 1 |
| Becker, ML; Polk, BI | 1 |
| Adelowo, OO; Edomwonyi, U; Olaosebikan, H | 1 |
| Feldman, BM; Gross, WL; Guillevin, L; Hazlewood, GS; Metzler, C; Pagnoux, C; Tomlinson, GA | 1 |
| Joshi, L; Lightman, S; McCluskey, P; Sandhu, S; Talat, L; Taylor, SR; Wakefield, D; Yaganti, S | 1 |
| Cross, RK; McLean, LP | 1 |
| Hoffman, GS; Langford, CA; Nutter, B; Springer, J; Villa-Forte, A | 1 |
| Dassopoulos, T; Gutierrez, A | 1 |
| Abrahams, A; Auret, J; Heckmann, JM; Prince, S | 1 |
| Habal, FM; Huang, VW | 1 |
| Begolka, WS; Berger, TG; Bergman, JN; Block, J; Chamlin, SL; Cohen, DE; Cooper, KD; Cordoro, KM; Davis, DM; Eichenfield, LF; Elmets, CA; Feldman, SR; Hanifin, JM; Harrod, CG; Krol, A; Margolis, DJ; Paller, AS; Schwarzenberger, K; Sidbury, R; Silverman, RA; Simpson, EL; Tom, WL; Williams, HC | 1 |
| Amiot, A; Bastuji-Garin, S; Belhassan, M; Chauvin, A; Delchier, JC; Le Baleur, Y; Le Thuaut, A; Mesli, F | 1 |
| Amil Dias, J; Barabino, A; Braegger, CP; Bronsky, J; Buderus, S; De Ridder, L; Dignass, A; Eliakim, A; Escher, JC; Fagerberg, UL; Griffiths, A; Hugot, JP; Kierkus, J; Kolacek, S; Koletzko, S; Kolho, KL; Levine, A; Lionetti, P; Martín-de-Carpi, J; Miele, E; Navas López, VM; Paerregaard, A; Ruemmele, FM; Russell, RK; Serban, DE; Shaoul, R; Turner, D; Van Rheenen, P; Veereman, G; Veres, G; Weiss, B; Wilson, D; Winter, H | 1 |
| Irving, PM | 1 |
| Antunes, O; Filippi, J; Hébuterne, X; Peyrin-Biroulet, L | 1 |
| Azar, L; Hoffman, GS; Langford, CA; Springer, J | 1 |
| Dieleman, LA; Fedorak, DK; Fedorak, RN; Halloran, BP; Huang, V; Kroeker, KI; Ma, C | 1 |
| Colombel, JF; Dulai, PS; Peyrin-Biroulet, L; Sandborn, WJ; Siegel, CA | 1 |
| Pedroza-Seres, M; Serna-Ojeda, JC | 1 |
| Andrews, J; Barr, G; Chapman, G; Colliwshaw, J; Huang, T; Jones, DB; Kariyawasam, VC; Katelaris, PH; Leong, RW; Lunney, PC; McDonald, C; Middleton, K; Selinger, CP; Wang, RR | 1 |
| Feagan, BG; MacDonald, JK; McDonald, JW; Tsoulis, DJ; Wang, Y | 1 |
| Coskun, M; Nielsen, OH; Rogler, G; Steenholdt, C | 1 |
| Armuzzi, A; Bruzzese, V; Diamanti, AP; Gatta, L; Hassan, C; Laganà, B; Lorenzetti, R; Migliore, A; Ridola, L; Zullo, A | 1 |
| Dulai, PS; Peyrin-Biroulet, L; Siegel, CA | 1 |
| Fisher, SE; Rabinowitz, SS; Schwarz, SM; Vo, HD; Xu, J | 1 |
| Batat, E; Bitterman, H; Cohen, AD; Cohen, S; Comanesther, D; Feldhamer, I; Greenberg-Dotan, S; Shalom, G; Zisman, D | 1 |
| Bunce, C; Calder, VL; Haskard, DO; Lightman, S; Longhurst, H; Lynn, W; Moots, R; Stanford, M; Taylor, SR; Tomkins-Netzer, O; Yang, D | 1 |
| Brown, N; Burns, A; Carr, S; Croft, AP; Hamilton, P; Harper, L; Morgan, MD; Pusey, CD; Salama, AD; Smith, SW; Venning, M; Youssouf, S | 1 |
| Sicilia, B | 1 |
| Amlani, B; Goldberg, JW; Sehgal, R; Yachoui, R | 1 |
| Katsanos, KH; Papadakis, KA | 1 |
| Hellmich, B | 2 |
| Beau-Salinas, F; Bejan-Angoulvant, T; Cissoko, H; Jonville-Béra, AP; Lengellé, C | 1 |
| López-González, R; Martín-Martínez, MA; Pérez-Vicente, S; Silva-Fernández, L | 1 |
| Czaja-Bulsa, G; Czkwianianc, E; Dadalski, M; Grzybowska-Chlebowczyk, U; Iwańczak, B; Kierkuś, J; Korczowski, B; Krzesiek, E; Maślana, J; Mierzwa, G; Szymańska, E; Sładek, M; Toporowska-Kowalska, E; Wegner, A; Więcek, S; Żabka, A; Łazowska, I | 1 |
| Horneff, G; Nimmrich, S | 1 |
| Andersen, RM; Johansen, JD; Menné, T; Skov, L | 1 |
| Huang, WW; Jorizzo, JL; Moustafa, FA; Sandoval, LF | 1 |
| Bailey, C; Fuller, LC; Laftah, Z; Lewis, F; Setterfield, J; Zaheri, S | 1 |
| Aït el Ghaz-Poignant, S; Bienvenu, B; Blockmans, D; Cohen, P; de Wazières, B; Diot, E; Fain, O; Godmer, P; Guillevin, L; Kyndt, X; le Berruyer, PY; Lidove, O; Mahr, A; Mouthon, L; Ninet, J; Pagnoux, C; Perrodeau, E; Puéchal, X; Quéméneur, T; Ravaud, P; Reny, JL; Rollot, F; Vanhille, P | 1 |
| Ben-Horin, S; Bossuyt, P; Bouguen, G; Dotan, I; Jussila, A; Karmiris, K; Katsanos, KH; Kruis, W; Legido, J; Li, AC; Moreels, T; Naismith, GD; Preiss, JC; Scarcelli, A; Sorrentino, D; Steinwurz, F; Subramaniam, K; Tarabar, D; Yanai, H; Zaganas, IV | 1 |
| de Bruin-Weller, MS; Deinum, J; Garritsen, FM; Roekevisch, E; Spuls, PI; van der Schaft, J | 1 |
| Karatzas, P; Mantzaris, GJ; Papamichael, K | 1 |
| Hojsak, I; Jadrešin, O; Kolaček, S; Mišak, Z; Močić Pavić, A | 1 |
| Azar, L; Hoffman, GS | 1 |
| Besada, E; Diamantopoulos, AP | 1 |
| Liu, X; Zhang, M | 1 |
| Büning, J; Fellermann, K; Lehnert, H; Mackenroth, T; Möller, S; Olsen, V; Schmidt, KJ; Schröder, T; Sina, C | 1 |
| Chen, CJ; Cheng, TT; Lin, JC; Lin, KM | 1 |
| Baughman, RP; Lower, EE | 1 |
| Braddock, M; Chen, YP; Huang, GQ; Huang, S; Lin, YQ; Shi, KQ; Wang, JT; Wang, LR; Wu, YM; Zheng, MH; Zhou, MT; Zhou, ZR; Zhu, GQ | 1 |
| McHugh, NJ; Tansley, SL; Vermaak, E | 1 |
| Bitton, A; Bressler, B; D'Haens, G; Donner, A; Feagan, BG; Greenberg, GR; Khanna, R; Levesque, BG; MacIntosh, D; Morris, JC; Panaccione, R; Paré, P; Sandborn, WJ; Stitt, LW; Vandervoort, MK; Vermeire, S; Zou, G | 1 |
| Luger, TA; Tsianakas, A | 1 |
| Boffa, JJ; Cohen, P; Delaval, P; Guillevin, L; Hamidou, M; Hanrotel-Saliou, C; Imbert, B; Khouatra, C; Kyndt, X; Lambert, M; Le Jeunne, C; Leské, C; Lifermann, F; Ly, KH; Merrien, D; Mouthon, L; Pagnoux, C; Papo, T; Perrodeau, É; Pertuiset, E; Puéchal, X; Ravaud, P; Roblot, P; Ruivard, M; Smail, A; Subra, JF; Terrier, B; Viallard, JF | 1 |
| Ballet, V; Bollen, L; Ferrante, M; Gils, A; van Assche, G; Vande Casteele, N; Vermeire, S | 1 |
| Chande, N; Feagan, BG; Marshall, JK; Nelson, S; Parker, CE; Sandborn, WJ; Seow, CH | 1 |
| Notaro, ER; Sidbury, R | 1 |
| Khan, WA; Qureshi, JA | 1 |
| Bazsó, A; Kiss, E; Pálfi, P; Poór, G; Szabó, MZ | 1 |
| Dankó, K; Farkas, F; Nagy-Vince, M; Szalmás, O | 1 |
| Mas, E; Moreau, J | 1 |
| Day, AS; Eliadou, E; Gearry, RB; Inns, SJ; Rowbotham, DS; Schultz, M; Thompson-Fawcett, MW; Walmsley, R | 1 |
| Andrew, NH; Kearney, D; McKelvie, P; McNab, A; Selva, D; Sladden, N; Sun, MT; Wu, A | 1 |
| Fayad, A; González, G; Robaina Sindín, J; Smuclir Quevedo, A; Vazquez, V | 1 |
| Antunes, O; Filipe, V; Filippi, J; Hébuterne, X; Louis, E; Peyrin-Biroulet, L; Reenaers, C; Roblin, X; Salleron, J | 1 |
| Danaei, G; Desai, RJ; Kim, SC; Liao, KP; Schneeweiss, S; Solomon, DH | 1 |
| Elfving, P; Kaipiainen-Seppänen, O; Kautiainen, H; Pohjolainen, T; Puolakka, K; Virta, LJ | 1 |
| Wang, L; Zhang, FC; Zhang, X | 1 |
| Clowse, ME; Noviani, M; Wasserman, S | 1 |
| Amazan, E; Boralevi, F; Ezzedine, K; Milpied, B; Seneschal, J; Taïeb, A; Védie, AL | 1 |
| Chen, GS; Hu, SC; Lin, CL; Lin, YC; Wang, TN; Yen, FL | 1 |
| Begun, J | 1 |
| Hoek, A; Sanders, JS; Stegeman, CA; Tuin, J; van Beek, AP | 1 |
| Afzali, A; Hu, JK; Lee, SD; Park, CJ; Sharma, P; Sinanan, MN; Zhu, K | 1 |
| Benseler, SM; Cabral, DA; Campillo, S; Canter, DL; Charuvanij, S; Dancey, P; Eberhard, BA; Elder, ME; Hersh, A; Higgins, GC; Huber, AM; Khubchandani, R; Kim, S; Klein-Gitelman, M; Kostik, MM; Lawson, EF; Lee, T; Lubieniecka, JM; McCurdy, D; Moorthy, LN; Morishita, KA; Muscal, E; Nanda, K; Nielsen, SM; O'Neil, KM; Reiff, A; Ristic, G; Robinson, AB; Sarmiento, A; Shenoi, S; Spalding, SJ; Toth, MB; Twilt, M; Van Mater, HA; Wagner-Weiner, L; Wahezi, DM; Weiss, JE; White, AJ; Yeung, RS | 1 |
| Lodhia, N; Thomas, A | 1 |
| Boursi, B; Brensinger, CM; Chen, L; Clark, AS; Curtis, JR; Lewis, JD; Mamtani, R; Osterman, MT; Scott, FI; Xie, F; Yun, H | 1 |
| Chandratre, S; Halfpenny, C; Hemingway, C; Leite, MI; O'Brien, F; Palace, J; Rocha, J; Tackley, G; Wasiewski, W; Wassmer, E; Waters, P; Woodhall, M | 1 |
| Grossman, AB; Maxwell, EC | 1 |
| Orchard, D; Yee, J | 1 |
| Charpentier, C; Cheddani, H; Dauchet, L; Dupas, JL; Fumery, M; Gower-Rousseau, C; Marie Bouvier, A; Pariente, B; Peyrin-Biroulet, L; Savoye, G | 1 |
| Jones, N | 1 |
| Kolfenbach, JR; Ozzello, DJ; Palestine, AG | 1 |
| Christopher-Stine, L; Paik, JJ | 1 |
| Chan, YC; Chandran, NS; Ho, MS; Koh, MJ; Lim, YL; Tang, MB; Tay, YK; Thirumoorthy, T | 1 |
| Deleuran, MS; Hjuler, KF; Iversen, L; Jakobsen, L; Olsen, M; Riis, JL; Vestergaard, C | 1 |
| Cordoro, K; Eichenfield, LF; Flohr, C; Lara-Corrales, I; Logan, K; Paller, AS; Proudfoot, L; Schmitt, J; Siegfried, E; Sugarman, J; Tom, W; Totri, CR | 1 |
| Bar-Gil Shitrit, A; Ben-Horin, S; Chowers, Y; Eliakim, R; Engel, T; Fudim, E; Kopylov, U; Lang, A; Paul, S; Picard, O; Roblin, X; Ungar, B; Williet, N; Yavzori, M | 1 |
| Delshad, S; Mirsafaei, HS; Tavakolpour, S | 1 |
| Abraham, S; Augustin, M; Bieber, T; Elsner, P; Fölster-Holst, R; Homey, B; Kleinheinz, A; Novak, N; Schmitt, J; Stephan, V; Sticherling, M; Trautmann, F; Weidinger, S; Werfel, T | 1 |
| Bos, JD; Campbell, LE; Irwin McLean, WH; Kezic, S; Leeflang, MMG; Middelkamp-Hup, MA; Roekevisch, E; Schram, ME; Spuls, PI | 1 |
| Amoura, Z; Cohen-Aubart, F; Grenier, P; Haroche, J; Hie, M; Mathian, A; Miyara, M; Pha, M | 1 |
| Bienvenu, B; de Boysson, H; Samson, M; Watelet, B | 1 |
| Hameeteman, WH; Jeuring, SF; Jonkers, DM; Liu, LY; Masclee, AA; Oostenbrug, LE; Pierik, MJ; Romberg-Camps, MJ; van den Heuvel, TR; Zeegers, MP | 1 |
| Boice, J; Colombel, JF; Cornillie, F; D'Haens, G; Ghosh, S; Hommes, DW; Huang, Z; Huyck, S; Lindgren, S; Panes, J; Prantera, C; Reinisch, W | 1 |
| Chalk, CH; Frost, C; Hughes, RA; Lunn, MP; Oaklander, AL; van Schaik, IN | 1 |
| Franzen, D; Greutmann, M; Kolios, A; Liebscher, F; Pfammatter, T | 1 |
| Muratore, F; Pipitone, N; Salvarani, C | 1 |
| Chao, K; Gao, X; Hu, P; Huang, Z; Li, M; Tang, J; Zhi, M | 1 |
| Al-Kali, A; Castro, J; Dueck, A; Ertz-Archambault, N; Finn, L; Foran, J; Gauthier, S; Kelemen, K; Kosiorek, H; Marino, R; Mesa, RA; Palmer, J; Sproat, LZ; Taylor, GE; Tibes, R | 1 |
| Gladman, DD; Pakchotanon, R; Polachek, A; Su, J; Tselios, K; Urowitz, MB; Yap, KS | 1 |
| Chong, JH; Koh, MJA | 1 |
| Davidson, BR; Eusebi, LH; Gurusamy, KS; Saffioti, F; Thorburn, D; Tsochatzis, E | 1 |
| Benseler, SM; Cabral, DA; Charuvanij, S; Dancey, P; Eberhard, BA; Elder, ME; Foell, D; Hersh, AO; Huber, AM; Klein-Gitelman, M; Kostik, MM; Lawson, EF; Lee, T; Li, SC; Lubieniecka, JM; Luqmani, RA; Moorthy, LN; Morishita, KA; Nielsen, SM; Ristic, G; Shenoi, S; Toth, MB; Twilt, M; Yeung, RSM | 1 |
| Davis, LS; Reimold, AM | 1 |
| Clowse, ME; Machen, L | 1 |
| de Bruin-Weller, MS; Fidder, HH; Garritsen, FM; Spuls, PI; van den Broek, MPH; van Zuilen, AD | 1 |
| Brassington, R; Gunn, AA; Hughes, RA; Mahdi-Rogers, M; van Doorn, PA | 1 |
| Baouendi, N; Belfeki, N; Ben Ghorbel, I; Ben Salem, T; Houman, MH | 1 |
| Beck, LA; Prezzano, JC | 1 |
| Cooper, MA; Keppel, MP; Orandi, AB; Utterson, EC; Vogel, TP | 1 |
| Agarwal, P; Agarwal, US; Prakash, C; Sharma, P | 1 |
| Feagan, BG; Jairath, V; Khanna, R | 1 |
| de Silva, P; Friedman, S; Jølving, LR; Larsen, MD; Magnussen, B; Nørgård, BM | 1 |
| Borok, J; Davis, DM; Lio, P; Spergel, J; Udkoff, J | 1 |
| Bloom, JL; Bohnsack, JF; Galambos, C; Guthery, S; Imundo, L; Lin, C; Lowichik, A; Stepenaskie, S | 1 |
| Cordero-Coma, M; Espinosa, G; Gómez-Gómez, A; Herreras, JM; Loza, E; Morales, JMGR; Muñoz-Fernández, S; Rosario, MP | 1 |
| de Boer, NKH; Simsek, M | 1 |
| Bos, JD; Brouwer, MWD; Gerbens, LAA; Leeflang, MMG; Roekevisch, E; Schram, ME; Spuls, PI | 1 |
| Du, L; Kijlstra, A; Liang, L; Qi, J; Wang, C; Wu, L; Yang, P; Ye, Z; Zhou, Q | 1 |
| Brouwer, MWD; Gerbens, LAA; Hamann, SAS; Leeflang, MMG; Roekevisch, E; Spuls, PI | 1 |
| Kandolf-Sekulović, L; Mijušković, Ž; Milenković, Z; Pecelj-Broćić, T; Tarabar, D; Tarabar, O; Tatomirović, Ž | 1 |
| Budić, I; Djordjević, J; Djurić, Z; Pavlović, V; Šaranac, L | 1 |
| Campanilho-Marques, R; Deakin, CT; Moraitis, E; Pilkington, CA; Pullenayegum, E; Simou, S; Wedderburn, LR | 1 |
| Baert, FJ; Benninga, MA; Caenepeel, P; D'Haens, GR; De Vos, M; Hoekman, DR; Hommes, DW; Stibbe, JA; Vergauwe, P; Vermeire, SA | 1 |
| Lacour, JP | 1 |
| Aomori, T; Ishioka, E; Jibiki, A; Kaneko, Y; Nakamura, T; Otsuka, N; Suzuki, S; Takeuchi, T; Tsuchiya, A | 1 |
| Barclay, M; Bots, S; D'Haens, G; Gecse, K | 1 |
| Arkema, EV; Askling, J; Eklund, A; Grunewald, J; Kullberg, S; Rossides, M | 1 |
| Bruijnzeel-Koomen, CAFM; de Bruin-Weller, MS; Garritsen, FM; Maitland-van der Zee, AH; van den Broek, MPH; van den Heuvel, JM | 1 |
| Berman, JS; Govender, P; Raghu, G | 1 |
| Long, MD; Vanga, R | 1 |
| Płusa, T | 1 |
| Fei, Y; Feng, R; Lai, Y; Peng, L; Wang, L; Wang, M; Zeng, X; Zhang, F; Zhang, P; Zhang, W; Zhang, X; Zhao, Y | 1 |
| Arenas, CM; Chalela, JG; Ordóñez Rubiano, MF | 1 |
| Keyßer, G; Kornhuber, M; Zierz, S | 1 |
| Europa, TA; Heckmann, JM; Nel, M | 1 |
| Agnholt, J; Dahlerup, J; Dige, A; Kragstrup, T; Magnusson, MK; Öhman, L; Rasmussen, TK; Uhrenholt, C | 1 |
| Svensson, Å; von Kobyletzki, LB | 1 |
| Chua, EP; Dahiya, S; Mallett, RB | 1 |
| Beck, LA; Bieber, T; Irvine, AD; Kabashima, K; Weidinger, S | 1 |
| Ng, SC; Shi, HY | 1 |
| Hanauer, SB; Lichtenstein, GR; Sandborn, WJ | 1 |
| Dassopoulos, T; Johnson, CM | 1 |
| Doostkam, S; Fritsch, B; Guggenberger, K; Schaefer, HE; Venhoff, N; Whittaker, K | 1 |
| Dale, RC; Mohammad, SS; Nosadini, M; Sartori, S; Toldo, I | 1 |
| Aviña, A; Benchimol, EI; Bernstein, CN; Coward, S; Jones, J; Kaplan, G; Leung, S; Lix, L; Murthy, SK; Nguyen, GC; Peña-Sánchez, JN; Singh, H; Targownik, LE; Tennakoon, A | 1 |
| Yates, M | 1 |
| Amoura, Z; Benameur, N; Cohen Aubart, F; Cotteret, C; Haroche, J; Hie, M; Junot, H; Mathian, A; Miyara, M; Riller, Q; Tilleul, P | 1 |
| Alexander, H; Flohr, C; Jabbar-Lopez, ZK; Manca, A; Patton, T | 1 |
| Daoud, YJ; Mustafa, OM | 1 |
| Ahmad, T; Bewshea, C; Bouri, S; Chanchlani, N; Cummings, JRF; Gaya, DR; Goodhand, JR; Green, HD; Hamilton, B; Hart, AL; Heap, GA; Heerasing, NM; Hendy, P; Irving, PM; Kennedy, NA; Lees, CW; Lin, S; Lindsay, J; Mansfield, JC; McDonald, TJ; McGovern, D; Nice, R; Parkes, M; Perry, MH; Russell, RK; Sebastian, S; Selinger, CP; Thomas, A; Walker, GJ | 1 |
| Guex-Crosier, Y; Ribi, C; Rossi, DC | 1 |
| Afif, W; Bernstein, CN; Bitton, A; Borgaonkar, M; Bressler, B; Chauhan, U; Halloran, B; Jones, J; Kennedy, E; Khanna, R; Leontiadis, GI; Loftus, EV; Marshall, JK; Meddings, J; Moayyedi, P; Murthy, S; Panaccione, R; Plamondon, S; Rosenfeld, G; Schwartz, D; Seow, CH; Steinhart, AH; Targownik, L; Williams, C | 1 |
| Figueroa Corona, C; Flores Pérez, L; Ibáñez Lazo, P; Quera Pino, R; Sedano Muñoz, R | 1 |
| Akikusa, J; Alsaleem, A; Chiang, GPK; Laxer, RM; Lee, JJY; Limenis, E; Sontichai, W; Yeung, RSM | 1 |
| Pan, L; Wang, Q; Xia, JX; Yang, QR; Zheng, JN; Zhu, GQ | 1 |
| Bonnotte, B; Ghesquière, T; Greigert, H; Samson, M | 1 |
| Bonamonte, D; Darrigade, AS; Eyraud, A; Mascia, P; Milpied, B; Seneschal, J; Taïeb, A | 1 |
| Gomez, A; Hernández-Breijo, B; Johansson, P; Parodis, I; Soukka, S | 1 |
| Malhotra, R; Sehgal, VN | 1 |
| Bredemeier, M; Busato, VB; da Silveira, RG; de David Cruz, C; Provenzi, VO; Ritter, CG; Zamboni, S | 1 |
| Chen, Y; Cong, Y; Dong, L; Omar, D | 1 |
| Amiri, N; Baldwin, C; De Vera, MA; Rebić, N; Sayre, EC; Zusman, EZ | 1 |
| Benvenuti, F; Doria, A; Gatto, M; Iaccarino, L; Larosa, M; Montesso, G; Saccon, F; Zen, M | 1 |
| Baron, M; Baxter, CA; Nevskaya, T; Pope, JE; Ramey, DR; Zheng, B | 1 |
| Alqanatish, JT; Alshanwani, JR | 1 |
| Casanova, MJ; Gisbert, JP; Rojo, E | 1 |
| Bavaharan, B; Kawali, A; Mahendradas, P; Mohan, A; Sanjay, S; Shetty, B | 1 |
| Bombardier, C; Deardon, R; Hazlewood, GS; Kaplan, GG; Ma, C; Marshall, DA; Panaccione, R; Pokharel, G; Seow, CH; Tomlinson, G | 1 |
| Biedroń, G; Brzosko, I; Brzosko, M; Czuszyńska, Z; Dębska-Ślizień, A; Głuszko, P; Hawrot-Kawecka, A; Jakuszko, K; Jeleniewicz, R; Klinger, M; Kucharz, EJ; Kur-Zalewska, J; Madej, M; Majdan, M; Masiak, A; Musiał, J; Rowaiye, OO; Storoniak, H; Szczeklik, W; Sznajd, J; Tłustochowicz, W; Wawrzycka-Adamczyk, K; Wisłowska, M; Wójcik, K; Włudarczyk, A; Zdrojewski, Z | 1 |
| Cash, K; Greenberg, SA; Hissaria, P; Koszyca, B; Limaye, VS; Patel, S; Smith, C | 1 |
| Silverberg, JI; Singh, P | 1 |
| Chen, D; Gao, J; Li, ZG; Liu, Y; Shen, D; Wang, K; Wang, Y; Wang, Z; Xia, C; Yang, F; Yu, G; Zeng, Q; Zhang, S; Zhu, L | 1 |
| Miloslavsky, EM; Wallace, ZS | 1 |
| Arents, BWM; Bohdanowicz, M; Burton, T; Di Giorgio, S; Drucker, AM; Ellis, AG; Flohr, C; Küster, D; Mashayekhi, S; Rochwerg, B; Schmitt, J; Siegels, D; Spuls, PI; Yiu, ZZN | 1 |
| Çinar, M; Çolak, S; Tekgöz, E; Yilmaz, S | 1 |
| Biglia, A; Bozzalla Cassione, E; Cavagna, L; Codullo, V; Montecucco, C; Zanframundo, G | 1 |
| Ansari, F; Singh, S | 1 |
| Dhaliwal, A; Dhindsa, BS; Eichele, D; Mashiana, HS; Mubder, M; Ohning, G; Saghir, SM; Sayles, H | 1 |
| Aloi, M; Bigot, L; Croft, NM; de Ridder, L; Harris, RE; Koletzko, S; Levine, A; Neyt, M; Ruemmele, FM; Russell, RK; Turner, D; Veereman, G | 1 |
| Benchimol, EI; Bernstein, CN; Coward, S; Jones, J; Kaplan, GG; Kuenzig, ME; Murthy, SK; Nguyen, GC; Peña-Sánchez, JN; Singh, H; Targownik, LE; Tennakoon, A; Zubieta, AA | 1 |
| Ahuja, V; Andoh, A; Chen, M; Han, DS; Hibi, T; Hilmi, IN; Hu, PJ; Jeen, YT; Kim, HJ; Leung, WK; Matsuoka, K; Ng, SC; Ooi, CJ; Qian, J; Ran, Z; Sollano, J; Suzuki, Y; Watanabe, M; Wei, SC; Wu, K; Yang, SK | 1 |
| Lai, VWY; Sinclair, R | 1 |
| Cortazar, FB; Huizenga, NR; Laliberte, K; Niles, JL; Rhee, EP; Rosenthal, JM; Wallace, ZS; Zonozi, R | 1 |
| Kjeldsen, J; Knudsen, T; Larsen, MD; Lund, K; Mertz Nørgård, B; Nielsen, RG | 1 |
| Bertsias, G; Boumpas, DT; Fanouriakis, A; Tziolos, N | 1 |
| Heron, V; Loftus, EV | 1 |
| Hammad, I; Porter, TF | 1 |
| Baert, F; Bossuyt, P; Buisson, A; D'Haens, G; Laharie, D; Lambrecht, G; Oldenburg, B; Pariente, B; Peyrin-Biroulet, L; Rivière, P; Vermeire, S | 1 |
| Ahmadinejad, Z; Assari, R; Ayoobi Yazdi, N; Javanshayani, P; Khalili Afousi, H; Mazloomi, SH; Ziaee, V | 1 |
| Charan, N; Kam, JK; Leong, RW; Loh, ZW; Thong, BY | 1 |
| Fraser, AG | 1 |
| Con, D; Nicolaides, S; van Langenberg, DR; Vasudevan, A | 1 |
| Calabrese, G; Castiglione, F; Di Luna, I; Foggia, M; Imperatore, N; Nardone, OM; Patturelli, M; Pellegrini, L; Ricciolino, S; Rispo, A; Testa, A; Tosone, G | 1 |
| Arkema, EV; Askling, J; Di Giuseppe, D; Eklund, A; Grunewald, J; Kullberg, S; Rossides, M | 1 |
| Birring, S; Brex, P; Galloway, J; Larkin, G; Murgatroyd, F; Paolino, A; Patel, A; Sado, D; Walsh, S | 1 |
| Bennett, C; Chen, S; Hannon, CW; Lima, HC; McCourt, C | 1 |
| Altincatal, A; Berdofe, A; Centonze, D; de Moor, C; Jung, E; Kim, M; Nagpal, A; Naylor, ML; Popescu, C; Radhakrishnan, M; Rajbhandari, R; Reder, AT; Sandrock, AW; Smirnakis, K | 1 |
| Dovrish, Z; Erez, D; Levy, Y; Natour, A; Shoenfeld, Y; Tayer-Shifman, OE | 1 |
| Bayerl, C; Herr, R; Kromer, C; Pino Lopez, J; Schaarschmidt, ML; Schmieder, A | 1 |
| Caputo, VD; Casado, G; Morales, NS; Rivero, E; Romeo, C; Smichowski, AM | 1 |
| Anikhindi, SA; Arora, A; Bansal, N; Gupta, P; Kumar, A; Sharma, P; Singla, V; Walinjkar, S | 1 |
| Al-Obaidi, M; Ciurtin, C; Doolan, G; Faizal, NM; Foley, C; Jury, EC; Lieberman, SM; Price, E; Ramanan, AV | 1 |
| Lee, YH; Song, GG | 1 |
| Bonanno, C; Brizzi, T; Lupica, A; Musumeci, O; Nicocia, G; Pugliese, A; Rodolico, C; Toscano, A; Trimarchi, G | 1 |
| Hanauer, SB; Malter, L; Sattler, L | 1 |
| Classen, JM; Ebigbo, A; Fleischmann, C; Messmann, H; Muzalyova, A; Nagl, S; Römmele, C; Schnoy, E | 1 |
| Kawahata, K; Shimizu, J; Suzuki, N; Yamano, Y | 1 |
| Arı, D; Gökbulut, V; Kalkan, İH; Kayaçetin, E; Kılıç, ZMY; Özin, Y; Yüksel, M | 1 |
| Abdel-Kawi, SH; Abdel-Reheim, ES; Abdul-Hamid, M; Allam, A; Alwaele, MA; Hegazy, W; Othman, SI | 1 |
| Adams, J; Barnes, N; Barrett, R; Batchelor, J; Culliford, D; Edwards, CJ; Fraser, SD; Holroyd, C; Howard, C; Ibrahim, K; Johnson, R; Lin, SX; Rischin, A; Roderick, P; Rutter, P; Stammers, M | 1 |
| Heller, T; Kleiner, DE; Lanis, A; Rider, LG; Shenoi, S; Vittal, A; Volochayev, R | 1 |
| Filippa, MG; Panopoulos, S; Sfikakis, PP; Spanos, E; Spanos, G; Tektonidou, MG; Yavropoulou, MP | 1 |
| Agner, T; Alfonso, JH; de Graaf, M; De Schepper, S; Deleuran, M; Despontin, K; Elenius, V; Ghislain, PD; Huilaja, L; Janmohamed, SR; Johansson, EK; Kvenshagen, BK; Mandelin, JM; Olset, H; Schuttelaar, MLA; Svensson, A; Thyssen, JP; van Tuyll van Serooskerken, AM; Vestergaard, C | 1 |
| Kotar, AM; Smedslund, G; Uhlig, T | 1 |
| Hsieh, CY; Tsai, TF | 1 |
| Ahuja, V; Das, P; Kante, B; Kedia, S; Kumar, P; Madhusudhan, KS; Makharia, G; Panwar, R; Ranjan, MK; Sahu, P; Sharma, R; Virmani, S; Vuyyuru, SK | 1 |
| Duruöz, MT; Esen, İ; Gezer, HH; Karabulut, Y; Öz, N | 1 |
| Garcia, J; Madruga Dias, J; Mestre, B | 1 |
| Bech, R; Beck, S; Jemec, GB; Kaae, J; Ring, HC; Taudorf, EH; Vestergaard, C | 1 |
| Cheirif-Wolosky, O; Elizalde-Jiménez, IG; Romero, MTG | 1 |
| Abdel-Kawi, SH; Abdel-Reheim, ES; Abdul-Hamid, M; Allam, AA; ALqhtani, H; Hegazy, W; Othman, SI | 1 |
| Akagha, C; Allognon, C; Ayo Bivigou, E; Beyeme Beyeme, OU; Boguikouma, JB; Iba Ba, J; Soto Lores, LF | 1 |
| Edwards Mayhew, RG; Leslie, L; Li, T; McCann, P; Palestine, AG; Strong Caldwell, A | 1 |
| Barrett, R; Culliford, D; Edwards, CJ; Fraser, S; Lin, SX | 1 |
| Adiao, KJB; Prado, MB | 1 |
| Amescua, G; Basu, S; Donthineni, PR; Kate, A; Quinones, VLP; Shanbhag, SS | 1 |
| Tomimitsu, H | 1 |
| Damjanov, N; Jelovac, M; Kotur, N; Pavlovic, D; Pavlovic, S; Ristivojevic, B; Spasovski, V; Zukic, B | 1 |
| Acar Arslan, E; Aksoy, A; Aksoy, E; Aliyeva, N; Ayanoğlu, M; Bektaş, Ö; Bodur, M; Canpolat, M; Çobanoğulları Direk, M; Gençpınar, P; Güleç, A; Gümüş, H; Gürkaş, E; Hız Kurul, S; Kanmaz, S; Keskin Yılmaz, S; Kızılırmak, AB; Kömür, M; Okuyaz, Ç; Olgaç Dündar, N; Öz Tuncer, G; Öztoprak, Ü; Öztürk, S; Per, H; Sarıkaya Uzan, G; Teber, S; Tekgül, H; Tosun, A; Ünalp, A; Ünay, B; Vural, A; Yıldırım, Ç; Yılmaz, Ü; Yiş, U; Yousefi, M; Yüksel, D | 1 |
| Birt, J; Dean, A; Delbecque, L; O'brien, D; Sudaria, T; Vadhariya, A; Vasey, J; Wu, J | 1 |
| Choi, H; Costenbader, KH; Jorge, A; Materne, E; Zhang, Y; Zhou, B | 1 |
| Bozkurt, ZY; Coşkun, BN; Dalkılıç, E; Ekin, A; Lermi, N; Ocak, T; Ötegeçeli, MA; Pehlivan, Y; Yağız, B | 1 |
| Huang, KH; Lin, CD; Lin, HC; Wu, PC | 1 |
| Acharya, NR; Artornsombudh, P; Begum, HA; Bhatt, NP; Buchanich, JM; Daniel, E; Dreger, KA; Dunn, JP; Fitzgerald, TD; Foster, CS; Gangaputra, SS; Goldstein, DA; Helzlsouer, KJ; Holland, GN; Jabs, DA; Kaçmaz, RO; Kempen, JH; Khachatryan, N; Kothari, S; Leiderman, YI; Levy-Clarke, GA; Liesegang, TL; Lowder, CY; Maghsoudlou, A; Newcomb, CW; Nussenblatt, RB; Pak, CM; Payal, AR; Pujari, SS; Read, RW; Rosenbaum, JT; Sen, HN; Sobrin, L; Suga, HK; Suhler, EB; Thorne, JE; Washington, TL | 1 |
| Bei, W; Feng, H; Kai, C; Liuqing, C; Qian, J; Ruili, J; Zilu, Q | 1 |
| Aatif Siddique, R; Iftikhar, S; Mehreen, S; Muhammad, A; Shahid, S | 1 |
| Lomanto Silva, R; Magnani, JW; Sattui, SE; Swabe, GM | 1 |
345 review(s) available for azathioprine and methotrexate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Indications and limits of long-term therapy with immunosuppressive (and cytostatic) agents in various chronic skin diseases].
Topics: Arthritis, Reactive; Azathioprine; Chronic Disease; Cyclophosphamide; Dermatomyositis; Humans; Immunosuppressive Agents; Impetigo; Long-Term Care; Lupus Erythematosus, Discoid; Methotrexate; Pemphigus; Penicillamine; Polyarteritis Nodosa; Prednisolone; Psoriasis; Pyoderma; Scleroderma, Systemic; Skin Diseases; Wissler's Syndrome | 1977 |
Immunosuppressive and cytotoxic chemotherapy: long-term complications.
Topics: Alkylating Agents; Antineoplastic Agents; Azathioprine; Bleomycin; Busulfan; Carcinogens; Chemical and Drug Induced Liver Injury; Daunorubicin; Doxorubicin; Female; Fetus; Folic Acid Antagonists; Follow-Up Studies; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infertility, Female; Infertility, Male; Liver; Lung Diseases; Male; Mercaptopurine; Methotrexate; Myocarditis; Neoplasms; Ovary; Pregnancy; Procarbazine; Streptozocin; Testis; Urologic Diseases | 1975 |
[Lupus erythematosus, modern aspects (author's transl)].
Topics: Antacids; Antibodies, Antinuclear; Antigen-Antibody Complex; Azathioprine; Chlorambucil; Cyclophosphamide; Cystitis; Diabetes Mellitus; DNA; Female; Herpes Zoster; Humans; Hypertension; Immunosuppression Therapy; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Menopause; Methotrexate; Neutrophils; Prednisone | 1977 |
Iatrogenic complications of dermatologic therapy. Primum non nocere.
Topics: Adrenal Cortex Hormones; Azathioprine; Cryosurgery; Cyclophosphamide; Electrosurgery; Erythromycin; Hexachlorocyclohexane; Humans; Hydroxyurea; Iatrogenic Disease; Methotrexate; Podophyllin; Radiotherapy; Skin Diseases; Tetracycline; Ultraviolet Therapy | 1979 |
[Current pharmacotherapy of pemphigus].
Topics: Adrenal Cortex Hormones; Anabolic Agents; Antiviral Agents; Azathioprine; Cyclophosphamide; Estrogens; Humans; Immunosuppressive Agents; Metals; Methotrexate; Pemphigus; Vitamins | 1977 |
The action of antitumor agents: a double-edged sword?
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Azathioprine; Burkitt Lymphoma; Choriocarcinoma; Cyclophosphamide; Dactinomycin; Female; Hodgkin Disease; Humans; Immunosuppressive Agents; Kidney Neoplasms; Leukemia, Myeloid, Acute; Lymphoma; Mechlorethamine; Melphalan; Mercaptopurine; Methotrexate; Mice; Multiple Myeloma; Neoplasms; Prednisone; Pregnancy; Procarbazine; Time Factors; Vincristine | 1977 |
[Immunosuppressive therapy in auto-immune diseases i. general fundamentals (author's transl)].
Topics: Antigen-Antibody Reactions; Autoimmune Diseases; Azathioprine; B-Lymphocytes; Chlorambucil; Cyclophosphamide; Glucocorticoids; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Methotrexate; T-Lymphocytes | 1978 |
Psoriasis: a review. II.
Topics: Adrenal Cortex Hormones; Anthralin; Azathioprine; Azauridine; Fluorouracil; Humans; Hydroxyurea; Lomustine; Mechlorethamine; Methotrexate; Psoriasis; Tars; Tretinoin; Ultraviolet Therapy | 1975 |
Treatment of rheumatoid arthritis with cytostatic drugs.
Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Cyclophosphamide; Gold; Humans; Immunosuppression Therapy; Methotrexate; Time Factors | 1975 |
[Current concept of the management of rheumatoid arthritis based on the pathogenesis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Genetic Therapy; Humans; Methotrexate; Prednisolone; Retroviridae Infections; Synovial Membrane | 1992 |
Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta-analysis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Azathioprine; Female; Humans; Male; Methotrexate; Middle Aged; Radiography; Severity of Illness Index | 1992 |
Pharmacology of antiarthritic drugs.
Topics: Adrenal Cortex Hormones; Antimalarials; Arthritis, Rheumatoid; Aurothioglucose; Azathioprine; Cyclophosphamide; Gold Sodium Thiomalate; Humans; Methotrexate; Penicillamine; Sulfasalazine | 1992 |
[Polymyositis: disease course and therapy with intravenously administered immunoglobulins].
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Clinical Enzyme Tests; Cyclophosphamide; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Magnetic Resonance Imaging; Methotrexate; Polymyositis | 1992 |
[Therapeutic alternatives in Crohn disease and in ulcero-hemorrhagic rectocolitis: current findings].
Topics: Antineoplastic Agents; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Methotrexate | 1992 |
Cytotoxic drugs in intermediate uveitis.
Topics: Azathioprine; Chlorambucil; Cyclophosphamide; Humans; Methotrexate; Treatment Outcome; Uveitis, Intermediate | 1992 |
Therapy for rheumatoid arthritis: combinations of disease-modifying drugs and new paradigms of treatment.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Penicillamine | 1991 |
Immunosuppressive therapy in autoimmune disease--a review.
Topics: Adrenal Cortex Hormones; Autoimmune Diseases; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporins; Drug Therapy, Combination; Humans; Immunoglobulins, Intravenous; Immunosuppression Therapy; Leukapheresis; Methotrexate; Plasmapheresis | 1991 |
Guidelines for management of patients with psoriasis. Workshop of the Research Unit of the Royal College of Physicians of London; Department of Dermatology, University of Glasgow; British Association of Dermatologists.
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclosporins; Humans; Hydroxyurea; Methotrexate; Phototherapy; Psoriasis; Retinoids; Skin | 1991 |
Combination therapy in rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antimalarials; Arthritis, Rheumatoid; Azathioprine; Drug Therapy, Combination; Humans; Methotrexate; Penicillamine; Sulfasalazine; Time Factors | 1990 |
[Immunosuppressive treatment and Crohn's disease].
Topics: Adrenal Cortex Hormones; Azathioprine; Crohn Disease; Cyclosporins; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Multicenter Studies as Topic; Opportunistic Infections | 1991 |
The risks of antimalarial retinopathy, azathioprine lymphoma and methotrexate hepatotoxicity during the treatment of rheumatoid arthritis.
Topics: Antimalarials; Arthritis, Rheumatoid; Azathioprine; Chemical and Drug Induced Liver Injury; Humans; Lymphoma; Methotrexate; Retinal Diseases; Risk Factors | 1990 |
Medical approaches to primary sclerosing cholangitis.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antipruritics; Azathioprine; Cholangitis, Sclerosing; Cholestasis; Cholestyramine Resin; Humans; Mercaptopurine; Methotrexate; Penicillamine; Ursodeoxycholic Acid; Vitamins | 1991 |
Drugs in autoimmune diseases.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibody Formation; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Cyclosporins; Humans; Immunity, Cellular; Immunosuppressive Agents; Methotrexate | 1990 |
Immunosuppressive and cytotoxic drugs: uses in the dermatologic patient.
Topics: Azathioprine; Chlorambucil; Cyclophosphamide; Drug Interactions; Female; Humans; Immunosuppressive Agents; Methotrexate; Pregnancy; Skin Diseases | 1990 |
Azathioprine and methotrexate as combination chemotherapy in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Azathioprine; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Methotrexate; Multicenter Studies as Topic; Structure-Activity Relationship | 1990 |
Rheumatoid arthritis therapy: the slow-acting agents.
Topics: Age Factors; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Arthritis, Rheumatoid; Auranofin; Aurothioglucose; Azathioprine; Cyclophosphamide; Gold; Gold Sodium Thiomalate; Humans; Methotrexate; Penicillamine; Prognosis; Steroids; Sulfasalazine; Time Factors | 1989 |
Immunologic and clinical effects of cytotoxic drugs used in the treatment of rheumatoid arthritis and systemic lupus erythematosus.
Topics: Arthritis, Rheumatoid; Autoimmune Diseases; Azathioprine; B-Lymphocytes; Cyclophosphamide; Humans; Killer Cells, Natural; Lupus Erythematosus, Systemic; Lymphocytes; Methotrexate; T-Lymphocytes | 1989 |
[Side effects of drugs on male fertility].
Topics: Anabolic Agents; Animals; Antifungal Agents; Antineoplastic Agents; Azathioprine; Colchicine; Dacarbazine; Depression, Chemical; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Fertility; Glucocorticoids; Gonadal Steroid Hormones; Histamine H1 Antagonists; Humans; Male; Methotrexate; Retinoids; Sperm Motility; Sperm Transport; Spermatogenesis | 1985 |
Cytotoxic drugs: their clinical application to the rheumatic diseases.
Topics: Arthritis; Arthritis, Rheumatoid; Azathioprine; Behcet Syndrome; Bone Marrow; Cell Division; Chemical and Drug Induced Liver Injury; Chlorambucil; Cyclophosphamide; Depression, Chemical; Dermatomyositis; Drug Evaluation; Female; Fertility; Gastrointestinal Diseases; Granulomatosis with Polyangiitis; Humans; Leukopenia; Lupus Erythematosus, Systemic; Male; Methotrexate; Myositis; Neoplasms; Polyarteritis Nodosa; Psoriasis; Pulmonary Fibrosis; Rheumatic Diseases | 1986 |
Disease-modifying agents and immunosuppressive drugs in the elderly.
Topics: Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents; Antimalarials; Azathioprine; Cyclophosphamide; Gold; Humans; Immunosuppressive Agents; Kinetics; Methotrexate; Penicillamine; Rheumatic Diseases; Sulfasalazine | 1986 |
Current concepts in clinical therapeutics: disease-modifying drugs for rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Arthritis, Rheumatoid; Azathioprine; Bone Marrow; Cyclophosphamide; Digestive System; Female; Gold; HLA Antigens; Humans; Joints; Male; Methotrexate; Penicillamine; Prognosis; Synovitis | 1987 |
Management of rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Arthritis, Juvenile; Arthritis, Rheumatoid; Azathioprine; Chloroquine; Cyclophosphamide; Drug Therapy, Combination; Felty Syndrome; Gold; Humans; Hydroxychloroquine; Immunosuppressive Agents; Leukapheresis; Lung Diseases; Lymphoid Tissue; Methotrexate; Penicillamine; Plasmapheresis; Radiotherapy; Rheumatic Diseases; Salicylates; Sjogren's Syndrome; Spinal Diseases; Vasculitis | 1986 |
Therapeutic approaches to the treatment of rheumatoid disease.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antimalarials; Arthritis, Rheumatoid; Azathioprine; Blood Component Removal; Cyclophosphamide; Exercise Therapy; Gold; Humans; Injections; Methotrexate; Patient Education as Topic; Penicillamine; Rest; Salicylates; Self-Help Devices | 1986 |
The effect of selected immunomodulating agents on experimental contact reactions.
Topics: Animals; Azathioprine; Basophils; Cell Division; Croton Oil; Cyclophosphamide; Cyclosporins; Dermatitis, Contact; Disease Models, Animal; Drug Administration Schedule; Female; Guinea Pigs; Hypersensitivity, Delayed; Immunity, Cellular; Immunosuppression Therapy; Mast Cells; Methotrexate; Oxazolone | 1985 |
Mechanisms of action and clinical applications of cytotoxic drugs in rheumatic disorders.
Topics: Arthritis, Reactive; Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Collagen Diseases; Cyclophosphamide; Dermatomyositis; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; Neoplasms; Psoriasis; Vasculitis | 1985 |
Immunosuppressive therapy in renal transplantation.
Topics: Adolescent; Adult; Animals; Anticoagulants; Antigens; Antilymphocyte Serum; Asparaginase; Azathioprine; Child; Cyclophosphamide; Cytarabine; Dactinomycin; Dogs; Drainage; Evaluation Studies as Topic; Female; Glucocorticoids; Graft Rejection; Humans; Immunosuppression Therapy; Infections; Kidney Transplantation; Lectins; Male; Methods; Methotrexate; Middle Aged; Phenothiazines; Procarbazine; Rabbits; Radiation Effects; Thoracic Duct; Transplantation, Homologous | 1971 |
[Cancerogenicity of cytostatics].
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Azathioprine; Cell Transformation, Neoplastic; Dactinomycin; Humans; Immunosuppression Therapy; Methotrexate; Mitosis; Neoplasms; Rats; RNA, Messenger; RNA, Neoplasm | 1971 |
Drugs and other agents in renal transplantation.
Topics: Antilymphocyte Serum; Antineoplastic Agents; Azaserine; Azathioprine; Cyclophosphamide; Dactinomycin; Glucocorticoids; Graft Rejection; Humans; Kidney Transplantation; Mercaptopurine; Methotrexate; Radiotherapy; Spleen; Thoracic Duct; Thymectomy; Transplantation, Homologous | 1972 |
Drug reactions. XXIV. Cutaneous reactions to cytostatic agents.
Topics: Alopecia; Aminopterin; Antineoplastic Agents; Asparaginase; Azathioprine; Bleomycin; Busulfan; Chlorambucil; Cyclophosphamide; Dactinomycin; Drug Eruptions; Erythema; Fluorouracil; Gynecomastia; Humans; Hydroxyurea; Methotrexate; Photosensitivity Disorders; Pigmentation Disorders; Radiation Injuries; Stomatitis; Vinblastine | 1974 |
[Therapy of lupus-nephritis using corticosteroids and immunosuppressive agents].
Topics: Adrenal Cortex Hormones; Antibodies, Antinuclear; Azathioprine; Beta-Globulins; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Germany, West; Glomerulonephritis; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; Nephritis; Recurrence | 1974 |
Immunosuppressive and cytotoxic drugs in dermatology.
Topics: Animals; Antineoplastic Agents; Azathioprine; Azauridine; Bleomycin; Chlorambucil; Cyclophosphamide; Cytarabine; Dactinomycin; Humans; Hydroxyurea; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Procarbazine; Skin Diseases; Skin Neoplasms; Vinblastine; Vincristine | 1974 |
[Indications for immunosuppressive treatment in kidney diseases of children].
Topics: Alkylating Agents; Anti-Bacterial Agents; Antimetabolites; Antineoplastic Agents; Azathioprine; Child; Chlorambucil; Cyclophosphamide; Dactinomycin; Glomerulonephritis; Humans; Immunosuppressive Agents; Mechlorethamine; Mercaptopurine; Methotrexate | 1969 |
[Immunosuppressive therapy].
Topics: Antigen-Antibody Reactions; Antilymphocyte Serum; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Dactinomycin; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Steroids; Transplantation Immunology | 1969 |
Cytotoxic drugs in treatment of nonmalignant diseases.
Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Colitis, Ulcerative; Crohn Disease; Cyclophosphamide; Granulomatosis with Polyangiitis; Hepatitis; Humans; Immune Complex Diseases; Immunosuppressive Agents; Infections; Liver Cirrhosis, Biliary; Lupus Erythematosus, Systemic; Mercaptopurine; Methotrexate; Nephrotic Syndrome; Ophthalmia, Sympathetic; Psoriasis; Thioguanine; Uveitis | 1972 |
[Long-term therapy of immunologic diseases with special reference to the use of immunosuppressive agents].
Topics: Adrenocorticotropic Hormone; Alkylating Agents; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Antimetabolites; Arthritis, Rheumatoid; Autoimmune Diseases; Azathioprine; Colitis, Ulcerative; Cyclophosphamide; Humans; Immunosuppressive Agents; Liver Cirrhosis; Lupus Erythematosus, Systemic; Methotrexate; Nephritis; Thrombocytopenia; Time Factors | 1969 |
Immunosuppressive drugs in rheumatoid arthritis.
Topics: Adrenocorticotropic Hormone; Aminopterin; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Azathioprine; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Nitrogen Mustard Compounds; Penicillamine | 1971 |
[Immunosuppressive treatment in neurological disorders].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Animals; Antilymphocyte Serum; Azathioprine; Cyclophosphamide; Encephalomyelitis, Autoimmune, Experimental; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Multiple Sclerosis; Myasthenia Gravis; Polyradiculopathy; Thymectomy | 1973 |
Immunosuppressive therapy in neurological diseases.
Topics: Adrenocorticotropic Hormone; Azathioprine; Central Nervous System Diseases; Cyclophosphamide; Cytarabine; Encephalitis; Female; Humans; Hydrocortisone; Immunity, Cellular; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphocyte Activation; Methotrexate; Multiple Sclerosis; Myasthenia Gravis; Myositis; Neuritis; Polyradiculopathy; Prednisone; Virus Diseases | 1974 |
The nephrotic syndrome: current concepts.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Azathioprine; Basement Membrane; Biopsy; Child; Cyclophosphamide; Female; Fluorescent Antibody Technique; Humans; Immunoglobulins; Kidney Glomerulus; Male; Methotrexate; Microscopy, Electron; Middle Aged; Nephrotic Syndrome; Prognosis | 1972 |
Immunosuppressive therapy. 1.
Topics: Alkylating Agents; Anemia, Hemolytic, Autoimmune; Antibodies; Antimetabolites; Arthritis, Rheumatoid; Azathioprine; Blood Coagulation Disorders; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Cyclophosphamide; Dermatomyositis; Factor VIII; Hepatitis; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mercaptopurine; Methotrexate; Prednisolone; Purpura, Thrombocytopenic; Scleroderma, Systemic | 1972 |
Drug therapy: immunosuppressive agents (second of two parts).
Topics: Antimetabolites; Arthritis, Rheumatoid; Azathioprine; Child; Drug Therapy, Combination; Folic Acid Antagonists; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; Psoriasis; Purines; Sulfhydryl Compounds | 1973 |
Recent advances in the study of uveitis.
Topics: Adult; Antibodies; Antigen-Antibody Reactions; Aqueous Humor; Azathioprine; Cell Migration Inhibition; Chlorambucil; Cyclophosphamide; Female; Histocompatibility Antigens; Humans; Immunity, Cellular; Intraocular Pressure; Lectins; Lymphocyte Activation; Methotrexate; Multiple Sclerosis; Prostaglandins; Spondylitis, Ankylosing; Syphilis; Uveitis; Virus Diseases | 1974 |
An updated look at antirheumatic drugs.
Topics: Allopurinol; Anti-Inflammatory Agents; Arthritis; Azathioprine; Chloroquine; Cyclophosphamide; Glucocorticoids; Humans; Immunosuppressive Agents; Indomethacin; Methotrexate; Nitrogen Mustard Compounds; Rheumatic Diseases; Salicylates | 1967 |
The uvea.
Topics: Anaphylaxis; Animals; Azathioprine; Chlorambucil; Epidemiologic Methods; Humans; Methotrexate; Steroids; Syphilis; Toxoplasma; Treponema; Tuberculosis; Typhoid-Paratyphoid Vaccines; Uveitis | 1969 |
Immunosuppressive drugs in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Mechlorethamine; Mercaptopurine; Methotrexate; Prednisolone; Pregnancy | 1969 |
Immunosuppressants in the treatment of pemphigus.
Topics: Adult; Aged; Azathioprine; Drug Resistance, Microbial; Female; Humans; Infections; Male; Methotrexate; Middle Aged; Mucous Membrane; Pemphigus; Prednisone; Skin Diseases; Triamcinolone | 1970 |
Therapeutics. XI. Immunosuppressive drugs.
Topics: Adrenal Cortex Hormones; Animals; Antibody Formation; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mercaptopurine; Methotrexate; Pemphigus; Skin Diseases | 1970 |
Treatment of rheumatoid arthritis with cytotoxic and antimetabolic drugs.
Topics: Alopecia; Aminopterin; Antimetabolites; Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Bone Marrow Diseases; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Cystitis; Female; Herpes Zoster; Humans; Jaundice; Mechlorethamine; Mercaptopurine; Methotrexate | 1970 |
[Antimetabolites].
Topics: Allopurinol; Animals; Antimetabolites; Azathioprine; Cell Division; Chemical Phenomena; Chemistry; Cytarabine; DNA, Neoplasm; Fluorouracil; Folic Acid Antagonists; Humans; Leukemia; Mercaptopurine; Methotrexate; Neoplasms; Pyrimidines; Thioguanine | 1971 |
[Immunosuppressive agents].
Topics: Abnormalities, Drug-Induced; Animals; Antigens; Antineoplastic Agents; Azathioprine; Chemical Phenomena; Chemistry; DNA; Drug Interactions; Female; Humans; Immunosuppressive Agents; Lethal Dose 50; Lymphocytes; Mercaptopurine; Methotrexate; Mice; Pregnancy; Rabbits; Rats; Transplantation Immunology | 1971 |
[Current status of immunosuppressive therapy in non-neoplastic disorders].
Topics: Arthritis; Autoimmune Diseases; Azathioprine; Bone Marrow; Bone Marrow Diseases; Chemical Phenomena; Chemistry; Cyclophosphamide; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infections; Kidney Diseases; Methotrexate; Prognosis; Skin Diseases | 1970 |
[Immunosuppresive therapy of progredient chronic polyarthritis using antimetabolites and cytostatics].
Topics: Adrenal Cortex Hormones; Antigen-Antibody Reactions; Antimetabolites; Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Blood Sedimentation; Humans; Immunosuppressive Agents; Injections, Intra-Arterial; Leukocyte Count; Methotrexate; Purines; Rheumatoid Factor; Thiotepa | 1967 |
Chemotherapy and comparative biochemistry: G. H. A. Clowes memorial lecture.
Topics: Allopurinol; Animals; Antimetabolites; Azathioprine; Binding Sites; Drug Therapy; Enzyme Inhibitors; Enzyme Precursors; Folic Acid; Folic Acid Antagonists; Humans; Lactobacillus; Leukemia, Myeloid; Liver; Mercaptopurine; Methotrexate; Mice; Molecular Weight; Neoplasms; Nucleic Acids; Proteus; Purines; Research; Species Specificity; Thymine; Transferases; Uric Acid; Xanthine Oxidase | 1969 |
[Treatment of chronic diseases of connective tissue by cytostatic drugs].
Topics: Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Collagen Diseases; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Mercaptopurine; Methotrexate; Spondylitis, Ankylosing; Thiotepa; Triaziquone | 1970 |
Lung damage from cytotoxic drugs.
Topics: Antineoplastic Agents; Azathioprine; Bleomycin; Busulfan; Carmustine; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Humans; Lung; Melphalan; Mercaptopurine; Methotrexate; Mitomycins; Oxygen Inhalation Therapy; Pneumonia; Procarbazine; Radiation Injuries | 1980 |
Hepatic and pancreatic damage produced by cytotoxic drugs.
Topics: Aminoacridines; Amsacrine; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Asparaginase; Azathioprine; Chlorambucil; Dacarbazine; Drug Therapy, Combination; Humans; Intercalating Agents; Liver; Mercaptopurine; Methotrexate; Nitrosourea Compounds; Pancreas; Plicamycin; Procarbazine; Pyrrolizidine Alkaloids; Streptozocin | 1983 |
Immunosuppressant therapy.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antilymphocyte Serum; Arthritis, Rheumatoid; Azathioprine; Cyclophosphamide; Cyclosporins; Fluorouracil; Humans; Immunosuppressive Agents; Leukocytes; Methotrexate; Vinca Alkaloids | 1984 |
Immunosuppressive therapy in the treatment of autoimmune diseases.
Topics: Adolescent; Adrenal Cortex Hormones; Alkylating Agents; Anemia; Anemia, Aplastic; Anemia, Hemolytic, Autoimmune; Antilymphocyte Serum; Arthritis, Rheumatoid; Autoimmune Diseases; Azathioprine; Colchicine; Cyclosporins; Danazol; Female; Hepatitis, Chronic; Humans; Immunoglobulin G; Immunosuppressive Agents; Levamisole; Lupus Erythematosus, Systemic; Male; Mercaptopurine; Methotrexate; Multiple Sclerosis; Pregnancy | 1984 |
The effect of chemotherapeutic agents on wound healing.
Topics: Adrenal Cortex Hormones; Anemia; Animals; Antineoplastic Agents; Azathioprine; Collagen; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Fluorouracil; Humans; Leukopenia; Mechlorethamine; Mercaptopurine; Methotrexate; Neoplasms; Tensile Strength; Thiotepa; Time Factors; Wound Healing | 1981 |
Pharmacological immunosuppressive agents.
Topics: Alkylating Agents; Antimetabolites; Azathioprine; Cyclophosphamide; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Mercaptopurine; Methotrexate; Steroids; Tissue Donors; Transplantation, Homologous | 1981 |
International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC publication no. 6: do treatments available for psoriasis patients carry a genetic or carcinogenic risk?
Topics: Anthralin; Azathioprine; Carcinogens; Coal Tar; Humans; Hydroxyurea; Methotrexate; Mutagenicity Tests; Mutagens; Mutation; Probability; Psoriasis; PUVA Therapy; Risk; Salmonella typhimurium | 1981 |
Immunosuppressive therapy of inflammatory bowel disease: a historical perspective.
Topics: Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Female; History, 20th Century; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Pregnancy; Pregnancy Complications | 1995 |
Infections during low-dose methotrexate treatment in rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Azathioprine; Double-Blind Method; Female; Humans; Incidence; Male; Methotrexate; Middle Aged; Opportunistic Infections; Prospective Studies; Psoriasis | 1995 |
Current therapies for systemic vasculitis.
Topics: Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Dapsone; Humans; Immunization, Passive; Methotrexate; Plasmapheresis; Vasculitis | 1994 |
The diagnosis and management of uveitis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Cyclosporins; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Uveitis | 1995 |
Maintenance of symptomatic remission in patients with Crohn's disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Azathioprine; Clinical Trials as Topic; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Mesalamine; Methotrexate; Recurrence; Remission Induction; Sulfasalazine | 1993 |
Medical management of patients with difficult-to-treat inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Mercaptopurine; Mesalamine; Methotrexate; Metronidazole | 1994 |
Immunosuppressive drugs in Crohn's disease.
Topics: Azathioprine; Crohn Disease; Cyclosporins; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Remission Induction | 1994 |
Immunosuppressive drug therapy.
Topics: Adrenal Cortex Hormones; Azathioprine; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Methotrexate; Myositis; Pulmonary Fibrosis | 1994 |
Optimizing combination chemotherapy for rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Azathioprine; Cyclosporine; Drug Therapy, Combination; Humans; Methotrexate; Penicillamine | 1993 |
Immunosuppressive drug therapy of systemic lupus erythematosus.
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Leukocyte Count; Lupus Erythematosus, Systemic; Lymphocyte Subsets; Lymphocytes; Mechlorethamine; Methotrexate | 1994 |
Review article: immunosuppressive therapy for inflammatory bowel disease.
Topics: Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate | 1993 |
Drug treatment of arthritis. Update on conventional and less conventional methods.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aurothioglucose; Azathioprine; Glucosamine; Gold Sodium Thiomalate; Humans; Hydroxychloroquine; Methotrexate; Osteoarthritis; Ribose | 1993 |
A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate.
Topics: Algorithms; Azathioprine; Controlled Clinical Trials as Topic; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate | 1996 |
Acute febrile toxic reaction in patients with refractory rheumatoid arthritis who are receiving combined therapy with methotrexate and azathioprine.
Topics: Acute Disease; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cohort Studies; Drug Therapy, Combination; Female; Fever; Humans; Leukocytosis; Male; Methotrexate; Retrospective Studies; Time Factors; Vasculitis, Leukocytoclastic, Cutaneous | 1996 |
Effects of immunosuppressive drugs during pregnancy.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Animals; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Infertility, Female; Mercaptopurine; Methotrexate; Mice; Pregnancy; Pregnancy Complications; Rheumatic Diseases | 1995 |
What's new in the treatment of pediatric SLE.
Topics: Anticoagulants; Azathioprine; Child, Preschool; Cyclophosphamide; Humans; Lupus Erythematosus, Systemic; Methotrexate | 1996 |
Newer treatments for inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate; Nutritional Physiological Phenomena | 1996 |
[Immunosuppression--a tightrope walk between iatrogenic harm and therapy].
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclophosphamide; Cyclosporins; Humans; Iatrogenic Disease; Immunosuppressive Agents; Methotrexate; Opportunistic Infections | 1996 |
Update on therapy for refractory dermatomyositis and polymyositis.
Topics: Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Dermatomyositis; Drug Therapy, Combination; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Polymyositis; Tacrolimus | 1996 |
Immunosuppressive drug use during pregnancy.
Topics: Adrenal Cortex Hormones; Animals; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Female; Humans; Immunosuppressive Agents; Methotrexate; Pregnancy; Pregnancy Complications; Rheumatic Diseases | 1997 |
[Treating polymyositis: methotrexate or azathioprine?].
Topics: Azathioprine; Humans; Methotrexate; Polymyositis | 1997 |
Refractory IBD: medical management.
Topics: Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Interleukin-10; Methotrexate | 1997 |
[Current therapy of multiple sclerosis].
Topics: Azathioprine; Cladribine; Cyclophosphamide; Glatiramer Acetate; Humans; Interferon-beta; Methotrexate; Mitoxantrone; Multiple Sclerosis; Peptides; Plasmapheresis; Randomized Controlled Trials as Topic | 1996 |
Combination of second-line antirheumatic drugs.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Azathioprine; Child; Cyclosporine; Drug Therapy, Combination; Humans; Hydroxychloroquine; Methotrexate; Sulfasalazine; Treatment Outcome | 1997 |
Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.
Topics: Adrenal Cortex Hormones; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Drug Administration Schedule; Europe; Humans; Immunosuppressive Agents; International Cooperation; Methotrexate; Methylprednisolone; Severity of Illness Index; Vasculitis | 1997 |
The use of cytotoxic agents in the treatment of immune-mediated diseases of dogs and cats.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Azathioprine; Cat Diseases; Cats; Chlorambucil; Cyclophosphamide; DNA; Dog Diseases; Dogs; Immune System Diseases; Methotrexate | 1997 |
New data on diagnosis and medical treatment of retroperitoneal fibrosis.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Hormonal; Antirheumatic Agents; Azathioprine; Cortisone; Cyclophosphamide; Fibromatosis, Aggressive; Gallium Radioisotopes; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Methotrexate; Penicillamine; Radionuclide Imaging; Radiopharmaceuticals; Retroperitoneal Fibrosis; Tamoxifen | 1997 |
Immunosuppressive treatment for refractory ulcerative colitis--where do we stand and where are we going?
Topics: Azathioprine; Colitis, Ulcerative; Cyclosporine; Humans; Immunosuppressive Agents; Interleukin-10; Mercaptopurine; Methotrexate | 1997 |
Drug therapy for ulcerative colitis during pregnancy.
Topics: Adrenal Cortex Hormones; Antidiarrheals; Azathioprine; Breast Feeding; Colitis, Ulcerative; Cyclosporine; Female; Humans; Mercaptopurine; Methotrexate; Pregnancy; Pregnancy Complications; Sulfasalazine | 1997 |
[Current aspects of therapy of primary biliary cirrhosis].
Topics: Adult; Age Factors; Anti-Inflammatory Agents; Azathioprine; Bile Acids and Salts; Cholagogues and Choleretics; Colchicine; Cortisone; Female; Humans; Italy; Liver Cirrhosis; Male; Methotrexate; Middle Aged; Prevalence; Risk Assessment; Sex Factors | 1997 |
[Combined administration of long-acting antirheumatic drugs in the treatment of chronic polyarthritis].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Clinical Trials as Topic; Cyclosporins; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Humans; Hydroxychloroquine; Immunosuppressive Agents; Methotrexate; Organogold Compounds; Penicillamine; Prospective Studies; Randomized Controlled Trials as Topic; Sulfasalazine | 1997 |
[Current treatment of collagen diseases. 4. Immunosuppressive agents: key points in their application].
Topics: Azathioprine; Collagen Diseases; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Methotrexate; Ribonucleosides | 1997 |
Immunosuppressive drugs in the treatment of inflammatory bowel disease.
Topics: Adult; Azathioprine; Cyclosporine; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate | 1998 |
Immunosuppressive agents in dermatology. An update.
Topics: Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Cyclosporine; Dermatology; Humans; Immunosuppressive Agents; Methotrexate; Monitoring, Physiologic; Practice Guidelines as Topic; Skin Diseases; Treatment Outcome | 1998 |
Update on immunosuppressive therapy.
Topics: Adult; Arthritis, Juvenile; Azathioprine; Behcet Syndrome; Child; Cladribine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Granulomatosis with Polyangiitis; Humans; Hydroxychloroquine; Immunosuppressive Agents; Liver; Lung; Lung Injury; Lupus Erythematosus, Systemic; Methotrexate; Pemphigoid, Benign Mucous Membrane; Retina; Tacrolimus; Thalidomide | 1998 |
[Drug treatment of Crohn's disease].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Clinical Protocols; Crohn Disease; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Mesalamine; Methotrexate; Prednisone; Remission Induction; Treatment Outcome | 1998 |
[Combination therapy of rheumatoid arthritis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Auranofin; Azathioprine; Chloroquine; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Methotrexate; Penicillamine; Randomized Controlled Trials as Topic; Sulfasalazine | 1998 |
Indications for, and use of, cytotoxic agents in SLE.
Topics: Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate | 1998 |
[Immunosuppressive agents in Horton's disease. Which drug for which indication?].
Topics: Anti-Inflammatory Agents; Azathioprine; Drug Resistance; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Methotrexate; Patient Selection; Steroids | 1998 |
Immunosuppressive drugs in the treatment of Crohn's disease.
Topics: Azathioprine; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Methotrexate; Treatment Outcome | 1998 |
Evidence-based therapy of primary biliary cirrhosis.
Topics: Azathioprine; Bile Acids and Salts; Chlorambucil; Colchicine; Cyclosporine; Drug Therapy, Combination; Evidence-Based Medicine; Female; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Methotrexate; Prednisolone; Treatment Outcome | 1999 |
Therapy of relapsing multiple sclerosis. Treatment approaches for nonresponders.
Topics: Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Multiple Sclerosis; Recurrence; Treatment Failure; Treatment Outcome | 1999 |
Immunosuppression in uveitis therapy.
Topics: Administration, Oral; Administration, Topical; Animals; Arrestin; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Immunotherapy; Methotrexate; Rats; Steroids; Tacrolimus; Uveitis | 1999 |
[Recent progress in therapy of inflammatory bowel diseases].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Enteral Nutrition; Humans; Immunoglobulins, Intravenous; Leukapheresis; Mesalamine; Methotrexate; Receptors, Glucocorticoid; Steroids | 1999 |
[Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis].
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Azathioprine; Clinical Trials as Topic; Forecasting; Glatiramer Acetate; Humans; Hydroxyquinolines; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferons; Methotrexate; Multiple Sclerosis; Peptides; Polymers; Recurrence; Retrospective Studies | 1999 |
Interventions for psoriatic arthritis.
Topics: Antirheumatic Agents; Arthritis, Psoriatic; Auranofin; Azathioprine; Dermatologic Agents; Etretinate; Fumarates; Humans; Immunosuppressive Agents; Methotrexate; Sulfasalazine | 2000 |
[Is immunosuppression a future therapeutic strategy for multiple sclerosis?].
Topics: Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Methotrexate; Mitoxantrone; Multiple Sclerosis | 2000 |
[Cytostatic drugs in the treatment of rheumatic and connective tissue diseases].
Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Humans; Methotrexate; Podophyllotoxin | 1998 |
[Use of immunosuppressors in chronic inflammatory intestinal diseases].
Topics: Azathioprine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate; Recurrence; Severity of Illness Index; Time Factors | 1999 |
Interventions for psoriatic arthritis.
Topics: Antirheumatic Agents; Arthritis, Psoriatic; Auranofin; Azathioprine; Dermatologic Agents; Etretinate; Fumarates; Humans; Immunosuppressive Agents; Methotrexate; Sulfasalazine | 2000 |
DMARDs in the treatment of rheumatoid arthritis: current agents and future developments.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Auranofin; Azathioprine; Cyclosporins; Drug Therapy, Combination; Gold Sodium Thiomalate; Humans; Isoxazoles; Methotrexate; Penicillamine; Treatment Outcome | 2000 |
Other novel immunosuppressants.
Topics: Azathioprine; Chlorambucil; Cyclosporine; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Skin Diseases; Tacrolimus; Thioguanine | 2000 |
Disease-modifying drugs for multiple sclerosis: a rapid and systematic review.
Topics: Adjuvants, Immunologic; Azathioprine; Cladribine; Cost-Benefit Analysis; Cyclophosphamide; Drug Costs; Glatiramer Acetate; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-beta; Methotrexate; Mitoxantrone; Multiple Sclerosis; Peptides; Research Design; Technology Assessment, Biomedical; Treatment Outcome | 2000 |
Clinical pharmacology of inflammatory bowel disease therapies.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biomarkers; Colitis, Ulcerative; Crohn Disease; Drug Resistance; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Mucosa; Mesalamine; Methotrexate; Pharmacogenetics; Receptors, Glucocorticoid | 2000 |
Clinical trials review: idiopathic inflammatory myopathy.
Topics: Azathioprine; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate; Myositis; Vidarabine | 2000 |
Evolving treatment strategies for inflammatory bowel disease.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cyclosporins; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Methotrexate; Mycophenolic Acid; Steroids; Tacrolimus | 2001 |
[Immunodeficiency induced by immunosuppressive agents].
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Diagnosis, Differential; Humans; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Methotrexate; Opportunistic Infections; Prednisolone; Prognosis; Tacrolimus | 2000 |
Immunosuppressive and cytotoxic drugs in the treatment of rheumatic skin disorders.
Topics: Adult; Alkylating Agents; Antimetabolites; Azathioprine; Child; Chlorambucil; Cladribine; Cyclophosphamide; Cyclosporine; Drug Interactions; Female; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Pregnancy; Pregnancy Complications; Rheumatic Diseases; Skin Diseases; Thioguanine | 2001 |
Immunomodulatory drugs for multiple sclerosis: a systematic review of clinical and cost effectiveness.
Topics: Azathioprine; Cladribine; Cost-Benefit Analysis; Cyclophosphamide; Drug Costs; Glatiramer Acetate; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-beta; Methotrexate; Mitoxantrone; Multiple Sclerosis; Peptides | 2001 |
[Treatment of uveitis with immunosuppressives: antimetabolites and alkylating agents].
Topics: Adult; Aged; Antimetabolites; Antineoplastic Agents, Alkylating; Azathioprine; Child; Chlorambucil; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Uveitis | 2001 |
Conventional treatment of Crohn's disease: objectives and outcomes.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Clinical Trials as Topic; Crohn Disease; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Methotrexate; Prednisone; Quality of Life; Recurrence; Sulfasalazine; Treatment Outcome | 2001 |
Approach to corticosteroid-dependent and corticosteroid-refractory Crohn's disease.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Clinical Trials as Topic; Crohn Disease; Cyclosporine; Etanercept; Female; Gastrointestinal Agents; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Methotrexate; Receptors, Tumor Necrosis Factor; Thalidomide; Treatment Outcome | 2001 |
Management of systemic vasculitis.
Topics: Azathioprine; Cyclophosphamide; Drug Combinations; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Methotrexate; Vasculitis | 2001 |
[Treatment of steroid-resistant polymyositis and dermatomyositis].
Topics: Animals; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Dermatomyositis; Drug Resistance; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lung Diseases, Interstitial; Methotrexate; Mycophenolic Acid; Polymyositis; Steroids; Tacrolimus | 2001 |
Treatment of Wegener's granulomatosis.
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclophosphamide; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Methotrexate; Remission Induction; Trimethoprim, Sulfamethoxazole Drug Combination | 2001 |
Management of fistulas in patients with Crohn's disease: antibiotic to antibody.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Azathioprine; Colonic Diseases; Crohn Disease; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Intestinal Fistula; Mercaptopurine; Methotrexate; Rectal Fistula; Thalidomide | 2001 |
Dermatomyositis.
Topics: Adult; Azathioprine; Child; Dermatologic Agents; Dermatomyositis; Diagnosis, Differential; Female; Humans; Hydroxychloroquine; Methotrexate; Polymyositis; Prednisone; Prognosis | 2001 |
Progress in the treatment of rheumatoid arthritis.
Topics: Analgesics; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cyclosporine; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Penicillamine; Receptors, Tumor Necrosis Factor; Sulfasalazine | 2001 |
Polymyalgia rheumatica/temporal arteritis: recent advances.
Topics: Adrenal Cortex Hormones; Aged; Azathioprine; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Methotrexate; Middle Aged; Polymyalgia Rheumatica; Randomized Controlled Trials as Topic; Treatment Outcome | 2002 |
Maintenance drugs for inflammatory bowel disease.
Topics: Aminosalicylic Acids; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Gastrointestinal Agents; Glucocorticoids; Humans; Infliximab; Methotrexate; Treatment Outcome | 2001 |
Immunologic therapy for relapsing-remitting multiple sclerosis.
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Autoimmune Diseases; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Disease Progression; Drug Administration Schedule; Forecasting; Glatiramer Acetate; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Immunotherapy; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Longitudinal Studies; Methotrexate; Mitoxantrone; Multiple Sclerosis; Peptides; Plasma Exchange; Plasmapheresis; Steroids; Treatment Outcome | 2001 |
Review article: monitoring for drug side-effects in inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Azathioprine; Blood Cell Count; Creatinine; Drug Monitoring; Inflammatory Bowel Diseases; Liver Function Tests; Mercaptopurine; Methotrexate | 2002 |
Therapeutic approaches to secondary progressive multiple sclerosis.
Topics: Anti-Inflammatory Agents; Azathioprine; Bone Marrow Transplantation; Cladribine; Clinical Trials as Topic; Cyclosporine; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Methotrexate; Methylprednisolone; Mitoxantrone; Multiple Sclerosis, Chronic Progressive | 2002 |
Conventional treatment and outcome of Wegener's granulomatosis and microscopic polyangiitis.
Topics: Azathioprine; Cyclophosphamide; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Kidney Diseases; Methotrexate; Microcirculation; Secondary Prevention; Treatment Outcome; Vasculitis | 2002 |
Treatment of giant-cell arteritis: where we have been and why we must move on.
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Aortic Aneurysm; Azathioprine; Drug Therapy, Combination; Giant Cell Arteritis; Humans; Methotrexate; Prednisolone | 2002 |
[Drug therapy of Crohn disease].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Crohn Disease; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Methotrexate; Secondary Prevention; Treatment Outcome | 2001 |
Therapeutic options for sarcoidosis: new and old.
Topics: Adjuvants, Immunologic; Anti-Bacterial Agents; Azathioprine; Disease Progression; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Minocycline; Respiratory Mechanics; Sarcoidosis; Sarcoidosis, Pulmonary; Tumor Necrosis Factor-alpha | 2002 |
Inflammatory bowel disease: sorting out the treatment options.
Topics: Anti-Inflammatory Agents; Azathioprine; Clinical Trials as Topic; Cyclosporine; Fish Oils; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Practice Guidelines as Topic; Steroids; Sulfasalazine | 2002 |
[Non-steroid therapy for sarcoidosis].
Topics: Anti-Inflammatory Agents; Antimalarials; Azathioprine; Chlorambucil; Chloroquine; Cyclophosphamide; Cyclosporine; Humans; Methotrexate; Sarcoidosis; Steroids | 2002 |
Prevention of autoimmune attack and disease progression in multiple sclerosis: current therapies and future prospects.
Topics: Adjuvants, Immunologic; Autoimmune Diseases; Azathioprine; B-Lymphocytes; Cyclophosphamide; Disease Progression; Genetic Predisposition to Disease; Glatiramer Acetate; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Interferon-beta; Magnetic Resonance Imaging; Methotrexate; Methylprednisolone; Mitoxantrone; Models, Theoretical; Multiple Sclerosis; Peptides | 2002 |
Pharmacogenetics in rheumatology: the prospects and limitations of an emerging field.
Topics: Analgesics, Opioid; Antirheumatic Agents; Azathioprine; Drug Design; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Female; Forecasting; Genetics, Population; Humans; Male; Methotrexate; Pharmacogenetics; Rheumatic Diseases; Rheumatology; Risk Assessment; United States | 2002 |
Advances in medical therapy for Crohn's disease.
Topics: Antibodies, Monoclonal; Azathioprine; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Mercaptopurine; Methotrexate; Treatment Outcome | 2002 |
Traditional therapies: glucocorticoids, azathioprine, methotrexate, hydroxyurea.
Topics: Azathioprine; Dermatologic Agents; Glucocorticoids; Humans; Hydroxyurea; Immunosuppressive Agents; Methotrexate; Skin Diseases | 2002 |
[Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Budesonide; Colitis, Ulcerative; Colonoscopy; Crohn Disease; Cyclosporins; Diagnosis, Differential; Gastrointestinal Agents; Humans; Ileostomy; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Meta-Analysis as Topic; Methotrexate; Parenteral Nutrition; Prednisolone; Quality of Life; Time Factors; Ultrasonography | 2003 |
Difficult treatment issues in sarcoidosis.
Topics: Antibodies, Monoclonal; Antimalarials; Azathioprine; Cyclophosphamide; Decision Making; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Sarcoidosis; Thalidomide | 2003 |
[Treatment of Crohn's disease].
Topics: Acute Disease; Adjuvants, Immunologic; Adrenal Cortex Hormones; Algorithms; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Case-Control Studies; Clinical Trials as Topic; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Methotrexate; Metronidazole; Osteoporosis; Prednisolone; Prednisone; Randomized Controlled Trials as Topic; Time Factors | 2003 |
New insights into the immunopathogenesis and treatment of small vessel vasculitis of the kidney.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Disease Models, Animal; Humans; Kidney; Kidney Diseases; Methotrexate; Mice; Mycophenolic Acid; Rituximab; Vasculitis | 2003 |
Inflammatory bowel disease: management issues during pregnancy.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Azathioprine; Breast Feeding; Contraindications; Cyclosporine; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Maternal Nutritional Physiological Phenomena; MEDLINE; Mercaptopurine; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Outcome | 2004 |
[Auto-immune hepatitis: therapeutic management].
Topics: Anti-Inflammatory Agents; Antimetabolites; Azathioprine; Calcineurin Inhibitors; Cyclophosphamide; Cyclosporine; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Mycophenolic Acid; Recurrence; Remission Induction; Risk Factors; Steroids; Tacrolimus; Treatment Outcome | 2003 |
Current disease-modifying therapies in multiple sclerosis.
Topics: Adjuvants, Immunologic; Analgesics; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Cyclophosphamide; Cyclosporine; Glatiramer Acetate; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-beta; Methotrexate; Mitoxantrone; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Peptides; Plasma Exchange | 2003 |
[Treatment of autoimmune hepatitis].
Topics: Azathioprine; Folic Acid Antagonists; Hepatitis, Autoimmune; Humans; Immunity, Cellular; Immunosuppressive Agents; Interferon-gamma; Liver Transplantation; Methotrexate; Mycophenolic Acid; Tacrolimus; Tumor Necrosis Factor-alpha | 2003 |
[Immunomodulation in penetrating keratoplasty. Current status and perspectives].
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Animals; Antiviral Agents; Azathioprine; Clinical Trials as Topic; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Keratitis, Herpetic; Keratoplasty, Penetrating; Methotrexate; Mice; Multicenter Studies as Topic; Mycophenolic Acid; Pilot Projects; Prospective Studies; Risk Factors; Sirolimus; Tacrolimus | 2003 |
[Wegener's granulomatosis (morbus Wegener)].
Topics: Adult; Anti-Infective Agents; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Diagnosis, Differential; Drug Therapy, Combination; Follow-Up Studies; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone Hemisuccinate; Prednisone; Prognosis; Radiography, Thoracic; Recurrence; Time Factors; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2003 |
Treating immunobullous diseases: an update.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Cyclosporine; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Plasmapheresis; Rituximab; Skin Care; Skin Diseases, Vesiculobullous | 2004 |
Pharmacogenetics and inflammatory bowel disease: progress and prospects.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Drug Therapy, Combination; Female; Forecasting; Genetic Predisposition to Disease; Genotype; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Male; Mercaptopurine; Methotrexate; Pharmacogenetics; Prognosis; Risk Assessment; Treatment Outcome | 2004 |
General principles of medical therapy of inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Antibodies, Monoclonal; Azathioprine; Cyclosporine; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Mercaptopurine; Methotrexate; Quality of Life | 2004 |
How effective are the usual treatments for Crohn's disease?
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Humans; Infliximab; Mercaptopurine; Methotrexate; Randomized Controlled Trials as Topic | 2004 |
Azathioprine and methotrexate in multiple sclerosis.
Topics: Azathioprine; Clinical Trials as Topic; Disease Progression; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Methotrexate; Multiple Sclerosis; Secondary Prevention; Treatment Outcome | 2004 |
Review article: chronic active disease and maintaining remission in Crohn's disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Chronic Disease; Crohn Disease; Humans; Infliximab; Mercaptopurine; Mesalamine; Methotrexate; Prognosis; Steroids; Thalidomide | 2004 |
Rheumatoid arthritis.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Auranofin; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Penicillamine; Receptors, Tumor Necrosis Factor; Sulfasalazine | 2003 |
[Chronic inflammatory bowel diseases].
Topics: Adrenal Cortex Hormones; Adult; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Azathioprine; Budesonide; Colitis, Ulcerative; Colonoscopy; Controlled Clinical Trials as Topic; Crohn Disease; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Magnetic Resonance Imaging; Mercaptopurine; Methotrexate; Metronidazole; Pouchitis; Remission Induction; Tacrolimus; Time Factors; Tomography, X-Ray Computed; Ultrasonography | 2004 |
Evidence-based evaluation of immunomodulatory therapy for the cutaneous manifestations of lupus.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimalarials; Azathioprine; Cladribine; Cyclophosphamide; Cyclosporine; Evidence-Based Medicine; Humans; Immunoglobulin G; Immunologic Factors; Immunotherapy; Isoxazoles; Leflunomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Rituximab; Tacrolimus; Thalidomide | 2004 |
Efficacy of conventional immunosuppressive drugs in IBD.
Topics: Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate; Mycophenolic Acid; Tacrolimus; Thalidomide | 2004 |
Damage control in rheumatoid arthritis. Hard-hitting, early treatment is crucial to curbing joint destruction.
Topics: Arthritis, Rheumatoid; Azathioprine; Disease Progression; Humans; Hydroxychloroquine; Immunologic Factors; Isoxazoles; Leflunomide; Methotrexate; Sulfasalazine | 2004 |
Use of combination therapy with immunomodulators and immunosuppressants in treating multiple sclerosis.
Topics: Azathioprine; Drug Antagonism; Drug Resistance; Drug Therapy, Combination; Humans; Immunologic Factors; Immunosuppressive Agents; Inflammation; Interferon-beta; Methotrexate; Mitoxantrone; Multiple Sclerosis | 2004 |
Therapeutic approaches in inflammatory bowel disease based on the immunopathogenesis.
Topics: Antibodies, Monoclonal; Azathioprine; Cell Adhesion; Cell Movement; Cyclophosphamide; Cyclosporine; Gastrointestinal Agents; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Interleukin-10; Interleukin-12; Interleukin-18; Interleukins; Methotrexate; Oligodeoxyribonucleotides, Antisense; Phosphorothioate Oligonucleotides; Thionucleotides; Treatment Outcome; Tumor Necrosis Factor-alpha | 2004 |
Review article: monitoring of immunomodulators in inflammatory bowel disease.
Topics: Azathioprine; Cyclosporine; Drug Monitoring; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate | 2005 |
Can we alter the natural history of Crohn disease in children?
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Child; Crohn Disease; Disease-Free Survival; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Mercaptopurine; Methotrexate | 2005 |
Chemotherapy and anaesthetic drugs: too little is known.
Topics: Analgesics; Anesthetics; Antineoplastic Agents; Azathioprine; Bleomycin; Cyclophosphamide; Drug Interactions; Humans; Hypnotics and Sedatives; Methotrexate | 2005 |
Randomized controlled trials in vasculitis associated with anti-neutrophil cytoplasmic antibodies.
Topics: Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Cyclophosphamide; Etanercept; Granulomatosis with Polyangiitis; Humans; Immunoglobulin G; Immunosuppressive Agents; Methotrexate; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Treatment Outcome | 2005 |
Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
Topics: Azathioprine; Blood Component Removal; Cyclosporine; Dermatomyositis; Humans; Immunosuppressive Agents; Methotrexate; Plasma Exchange; Polymyositis; Randomized Controlled Trials as Topic | 2005 |
[Crohn's disease--standards of treatment 2004].
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Algorithms; Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Child; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Mercaptopurine; Methotrexate; Mycophenolic Acid; Practice Guidelines as Topic; Prognosis; Remission Induction; Risk Factors; Time Factors | 2005 |
[Systemic treatment of cutaneous lupus erythematosus].
Topics: Acute Disease; Administration, Oral; Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antimalarials; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Dapsone; Dermatologic Agents; Female; Gold; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon-alpha; Lupus Erythematosus, Cutaneous; Male; Methotrexate; Plasmapheresis; Pregnancy; Retinoids; Thalidomide; Time Factors | 2003 |
Advances in the therapy of Wegener's granulomatosis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Etanercept; Granulomatosis with Polyangiitis; Guanidines; Humans; Immunoglobulin G; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Mycophenolic Acid; Plasmapheresis; Receptors, Tumor Necrosis Factor; Recurrence; Rituximab | 2006 |
What is new in the therapy of ANCA-associated vasculitides? Take home messages from the 12th workshop on ANCA and systemic vasculitides.
Topics: Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Mycophenolic Acid; Prednisolone; Receptors, Tumor Necrosis Factor; Vasculitis | 2005 |
[The clinical spectrum of dermatomyositis].
Topics: Adult; Age Factors; Azathioprine; Biopsy; Child; Clinical Trials as Topic; Cyclophosphamide; Cyclosporine; Dermatologic Agents; Dermatomyositis; Disease Progression; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Muscles; Mycophenolic Acid; Paraneoplastic Syndromes; Plasmapheresis; Prognosis; Sex Factors; Time Factors | 2005 |
Pharmacogenetics of therapies in rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Humans; Immunologic Factors; Methotrexate; Pharmacogenetics; Sulfasalazine | 2005 |
[Wegener's granulomatosis: Pathogenesis, pathophysiology, and therapy].
Topics: Antibodies, Antineutrophil Cytoplasmic; Cyclophosphamide; Drug Therapy, Combination; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Practice Guidelines as Topic; Prednisolone; Prognosis; Pulse Therapy, Drug; Tumor Necrosis Factor-alpha | 2006 |
American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Calcineurin Inhibitors; Cyclosporine; Drug Interactions; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Infliximab; Mercaptopurine; Methotrexate; Mycophenolic Acid; Recurrence | 2006 |
[Systemic management of autoimmune anterior uveitis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Autoimmune Diseases; Azathioprine; Cyclosporine; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Prednisolone; Uveitis, Anterior | 2005 |
Pharmacogenetics in inflammatory bowel disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Mercaptopurine; Mesalamine; Methotrexate; Methyltransferases; Pharmacogenetics; Polymorphism, Genetic; Sulfasalazine; Treatment Outcome | 2006 |
Conventional therapy for Crohn's disease.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Crohn Disease; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Methotrexate; Nutrition Therapy; Randomized Controlled Trials as Topic; Remission Induction | 2006 |
[Mycobacterium marinum infection. Case report and review of the literature].
Topics: Aged; Anti-Bacterial Agents; Azathioprine; Doxycycline; Foot Injuries; Foot Ulcer; Humans; Immunocompromised Host; Immunosuppressive Agents; Leg Ulcer; Male; Methotrexate; Mycobacterium Infections, Nontuberculous; Mycobacterium marinum; Seawater; Spondylitis, Ankylosing; Wound Infection | 2006 |
Practical issues and challenges in the diagnosis and treatment of pulmonary sarcoidosis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Methotrexate; Sarcoidosis, Pulmonary | 2007 |
[Microscopic polyangiitis].
Topics: Adrenal Cortex Hormones; Age Factors; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Biological Therapy; Clinical Trials as Topic; Cyclophosphamide; Diagnosis, Differential; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulonephritis; Humans; Immunosuppressive Agents; Infant, Newborn; Lung Diseases; Male; Methotrexate; Middle Aged; Plasma Exchange; Polyarteritis Nodosa; Prognosis; Recurrence; Remission Induction; Skin Diseases; Time Factors; Vasculitis | 2007 |
[Treatment of ANCA-associated vascularitides].
Topics: Adrenal Cortex Hormones; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Biological Therapy; Churg-Strauss Syndrome; Clinical Trials as Topic; Cyclophosphamide; Granulomatosis with Polyangiitis; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Infliximab; Interleukin-5; Methotrexate; Plasma Exchange; Prednisone; Prognosis; Prospective Studies; Remission Induction; Rituximab; Time Factors; Tumor Necrosis Factor-alpha; Vasculitis | 2007 |
ANCA-associated vasculitis: diagnostic and therapeutic strategy.
Topics: Adrenal Cortex Hormones; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Biological Products; Churg-Strauss Syndrome; Cyclophosphamide; Drug Therapy, Combination; Granulomatosis with Polyangiitis; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Methotrexate; Myeloblastin; Peroxidase; Remission Induction; Severity of Illness Index; Treatment Outcome; Vasculitis | 2007 |
[Refractory proctitis].
Topics: Administration, Oral; Adrenal Cortex Hormones; Algorithms; Anesthetics, Local; Antibodies, Monoclonal; Aspirin; Azathioprine; Biopsy; Cyclosporine; Drug Therapy, Combination; Escherichia coli; Forecasting; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Lidocaine; Methotrexate; Nicotine; Patient Compliance; Probiotics; Proctitis; Randomized Controlled Trials as Topic; Rectum; Suppositories; Time Factors | 2007 |
Combination therapy for the treatment of multiple sclerosis: challenges and opportunities.
Topics: Adrenal Cortex Hormones; Analgesics; Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Cytotoxins; Drug Therapy, Combination; Glatiramer Acetate; Humans; Immunosuppressive Agents; Immunotherapy; Methotrexate; Mitoxantrone; Multiple Sclerosis; Peptides | 2007 |
[Medical therapy of inflammatory bowel diseases: Crohn's disease].
Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Chronic Disease; Crohn Disease; Fistula; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Mesalamine; Methotrexate; Severity of Illness Index | 2007 |
[Effective combination therapy of TNF antagonists with DMARDs].
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cysteine; Drug Therapy, Combination; Etanercept; Humans; Hydroxychloroquine; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Receptors, Tumor Necrosis Factor; Sulfasalazine; Tumor Necrosis Factor-alpha | 2007 |
[Do DMARDs contibute to impaired healing after surgery? Should they be discontinued before surgery?].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Azathioprine; Biological Products; Cyclophosphamide; Glucocorticoids; Humans; Isoxazoles; Leflunomide; Methotrexate; Rheumatic Diseases; Surgical Wound Infection; Tumor Necrosis Factor-alpha; Wound Healing | 2007 |
Review article: the evidence base for interventions used to maintain remission in Crohn's disease.
Topics: Adalimumab; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Crohn Disease; Enteral Nutrition; Fatty Acids, Omega-3; Humans; Infliximab; Mesalamine; Methotrexate; Natalizumab; Probiotics; Randomized Controlled Trials as Topic | 2008 |
Five clinical conundrums in the management of giant cell arteritis.
Topics: Abortifacient Agents, Nonsteroidal; Aorta; Aortography; Azathioprine; Dilatation, Pathologic; Giant Cell Arteritis; Glucocorticoids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Methotrexate; Prednisone; Pulse Therapy, Drug; Tomography, Spiral Computed; Vision Disorders | 2007 |
Improving therapeutic options for patients with giant cell arteritis.
Topics: Antibodies, Monoclonal; Azathioprine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Randomized Controlled Trials as Topic; Tumor Necrosis Factor-alpha | 2008 |
Pharmacogenomics in rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Biotransformation; Genetic Predisposition to Disease; Genotype; Humans; Methotrexate; Patient Selection; Pharmacogenetics; Phenotype; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha | 2008 |
The treatment and prognosis of dermatomyositis: an updated review.
Topics: Adrenal Cortex Hormones; Alkylating Agents; Azathioprine; Cyclosporine; Dermatomyositis; Drug Administration Schedule; Exercise Therapy; Humans; Immunoglobulins, Intravenous; Methotrexate; Mycophenolic Acid; Plasma Exchange; Prognosis | 2008 |
Azathioprine in multiple sclerosis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Chemistry, Pharmaceutical; Cyclophosphamide; Drug Design; Fingolimod Hydrochloride; Humans; Immunologic Factors; Immunosuppressive Agents; Methotrexate; Methyltransferases; Mitoxantrone; Models, Chemical; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Propylene Glycols; Sphingosine | 2008 |
[Benefits and risks of immunosuppression in chronic inflammatory bowel diseases].
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate; Quality of Life; Remission Induction; Risk Assessment; Risk Factors | 2008 |
[Treatment of Crohn's disease].
Topics: Adrenal Cortex Hormones; Azathioprine; Biological Products; Colectomy; Combined Modality Therapy; Crohn Disease; Humans; Mercaptopurine; Mesalamine; Methotrexate | 2009 |
[New ways in the management of rheumatoid arthritis in Hungary].
Topics: Abatacept; Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; Autoimmunity; Azathioprine; Chloroquine; Cyclophosphamide; Cyclosporine; Diagnosis, Differential; Early Diagnosis; Etanercept; Humans; Hungary; Immunoconjugates; Immunoglobulin G; Immunologic Factors; Immunosuppressive Agents; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Prognosis; Receptors, Tumor Necrosis Factor; Rituximab; Sulfasalazine; Tumor Necrosis Factor-alpha | 2007 |
[Immunosuppressants].
Topics: Azathioprine; Calcineurin Inhibitors; Collagen Diseases; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Rheumatic Diseases; Ribonucleosides; Risk Assessment; Tacrolimus | 2009 |
[Treatment of rapidly progressive glomerulonephritis].
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Blood Component Removal; Cyclophosphamide; Disease Progression; Drug Therapy, Combination; Glomerulonephritis; Humans; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Mycophenolic Acid; Plasma Exchange; Pulse Therapy, Drug | 2009 |
Management of RA medications in pregnant patients.
Topics: Abatacept; Acetaminophen; Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Contraindications; Cyclosporine; Female; Gestational Age; Glucocorticoids; Humans; Immunoconjugates; Isoxazoles; Leflunomide; Methotrexate; Pregnancy; Pregnancy Complications; Rituximab; Sulfasalazine; Young Adult | 2009 |
Systemic therapies for pediatric atopic dermatitis: a review for the primary care physician.
Topics: Algorithms; Anti-Bacterial Agents; Antiviral Agents; Azathioprine; Child; Child, Preschool; Cyclosporine; Dermatitis, Atopic; Emollients; Glucocorticoids; Histamine Antagonists; Humans; Immunoglobulins; Immunologic Factors; Infant; Infusions, Intravenous; Interferon-gamma; Methotrexate; Mycophenolic Acid; Phototherapy; Primary Health Care; Severity of Illness Index; Treatment Outcome | 2009 |
Disease-modifying treatment in systemic sclerosis: current status.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Autoantigens; Azathioprine; Collagen Type I; Connective Tissue Growth Factor; Cyclophosphamide; Evidence-Based Practice; Fibrosis; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Plasmapheresis; Rituximab; Scleroderma, Systemic; Transforming Growth Factor beta; Transplantation, Autologous; Tumor Necrosis Factor-alpha | 2009 |
Mild to moderate Crohn's disease: still room for step-up therapies?
Topics: Antibodies, Monoclonal; Azathioprine; Clinical Trials as Topic; Crohn Disease; Humans; Infliximab; Methotrexate; Remission Induction | 2009 |
WITHDRAWN: Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
Topics: Azathioprine; Blood Component Removal; Cyclosporine; Dermatomyositis; Humans; Immunosuppressive Agents; Methotrexate; Plasma Exchange; Polymyositis; Randomized Controlled Trials as Topic | 2009 |
Necrotizing vasculitis--a 2009 update.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Behcet Syndrome; Churg-Strauss Syndrome; Evidence-Based Medicine; Female; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Male; Methotrexate; Microscopic Polyangiitis; Necrosis; Randomized Controlled Trials as Topic; Treatment Outcome; Vasculitis | 2009 |
ANCA-associated vasculitides: advances in pathophysiology and treatment.
Topics: Animals; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Cyclophosphamide; Disease Models, Animal; Disease Progression; Humans; Immunoglobulin G; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid | 2010 |
[Diagnosis and management of small vessel vasculitides].
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Disease Progression; Glucocorticoids; Humans; Immunologic Factors; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Mycophenolic Acid; Plasmapheresis; Rituximab; Vasculitis | 2010 |
Cutaneous lupus erythematosus: update of therapeutic options part II.
Topics: Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Clofazimine; Cyclophosphamide; Cyclosporine; Dapsone; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-alpha; Isoxazoles; Leflunomide; Lenalidomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Retinoids; Rituximab; Thalidomide; Tumor Necrosis Factor-alpha | 2011 |
Management of severe asthma in children.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Allergens; Anti-Asthmatic Agents; Asthma; Azathioprine; Bronchial Provocation Tests; Bronchodilator Agents; Budesonide; Budesonide, Formoterol Fumarate Drug Combination; Child; Clinical Trials as Topic; Comorbidity; Cyclosporine; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Eosinophils; Ethanolamines; Formoterol Fumarate; House Calls; Humans; Immunoglobulin E; Interdisciplinary Communication; Methotrexate; Off-Label Use; Risk Factors; Severity of Illness Index; Spirometry; Terbutaline; Tobacco Smoke Pollution; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Anti-Inflammatory Agents; Azathioprine; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon beta-1a; Interferon-beta; Methotrexate; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Randomized Controlled Trials as Topic | 2010 |
Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Biomarkers; Biopsy, Needle; Bronchoscopy; Comorbidity; Cyclophosphamide; Disease Progression; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Methotrexate; Myositis; Prognosis; Respiratory Function Tests; Risk Assessment; Severity of Illness Index; Survival Analysis; Time Factors; Tomography, X-Ray Computed | 2010 |
Review article: remission rates achievable by current therapies for inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antibodies, Monoclonal; Azathioprine; Enteral Nutrition; Humans; Inflammatory Bowel Diseases; Infliximab; Methotrexate; Remission Induction; Tumor Necrosis Factor-alpha | 2011 |
Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.
Topics: Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Injections, Intramuscular; Mercaptopurine; Methotrexate; Remission Induction; Secondary Prevention; Treatment Failure | 2011 |
What does the future hold for clinical studies in vasculitis?
Topics: Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Glucocorticoids; History, 20th Century; History, 21st Century; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-5; Methotrexate; Randomized Controlled Trials as Topic; Rituximab; Severity of Illness Index; Treatment Outcome; Vasculitis | 2011 |
Systemic therapy of atopic dermatitis in children and adults.
Topics: Adrenal Cortex Hormones; Adult; Alitretinoin; Antibodies, Monoclonal; Azathioprine; Child; Cyclosporine; Dermatitis, Atopic; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Interferon-gamma; Methotrexate; Mycophenolic Acid; Recombinant Proteins; Tretinoin | 2011 |
Immunosuppressive and cytotoxic therapy: pharmacology, toxicities, and monitoring.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Time Factors | 2011 |
Immunosuppressive therapy in children.
Topics: Antilymphocyte Serum; Autoimmune Diseases; Azathioprine; Child; Cyclophosphamide; Cyclosporine; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mercaptopurine; Methotrexate; Mycophenolic Acid; Nitriles; Sirolimus; Tacrolimus | 2011 |
[New therapeutic approaches for polymyositis and dermatomyositis].
Topics: Adrenal Cortex Hormones; Algorithms; Antineoplastic Agents; Azathioprine; Biological Therapy; Cell Movement; Cyclophosphamide; Cyclosporine; Dermatomyositis; Exercise Therapy; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Paraneoplastic Syndromes; Physical Therapy Modalities; Polymyositis; T-Lymphocytes; Tacrolimus | 2011 |
Evidence-based management of bullous pemphigoid.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Autoantibodies; Azathioprine; Clinical Trials as Topic; Dermatologic Agents; Evidence-Based Medicine; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Niacinamide; Pemphigoid, Bullous; Randomized Controlled Trials as Topic | 2011 |
[Systemic autoimmune disorders and pregnancy].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antimalarials; Antiphospholipid Syndrome; Arthritis, Rheumatoid; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Remission Induction; Sjogren's Syndrome; Sulfasalazine; Teratogens; Tumor Necrosis Factor-alpha | 2011 |
[Inflammatory bowel disease and lymphoproliferative disorders].
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Lymphoproliferative Disorders; Methotrexate; Risk Factors | 2011 |
[Maintainance treatment of anti-neutrophil cytoplasm associated antibodies (ANCA)].
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Early Diagnosis; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Induction Chemotherapy; Isoxazoles; Leflunomide; Maintenance Chemotherapy; Methotrexate; Randomized Controlled Trials as Topic; Rituximab; Severity of Illness Index; Trimethoprim, Sulfamethoxazole Drug Combination | 2011 |
Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment.
Topics: Aorta; Aortic Aneurysm; Aspirin; Azathioprine; Dendritic Cells; Female; Giant Cell Arteritis; Humans; Macrophages; Magnetic Resonance Angiography; Male; Methotrexate; Positron-Emission Tomography; Sex Factors; T-Lymphocytes; Temporal Arteries; Ultrasonography | 2012 |
How to treat refractory arthritis in lupus?
Topics: Abatacept; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antimalarials; Antirheumatic Agents; Arthritis; Azathioprine; Drug Resistance; Drug Therapy, Combination; Glucocorticoids; Humans; Immunoconjugates; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lupus Erythematosus, Systemic; Methotrexate; Mycophenolic Acid; Rituximab | 2012 |
Update on systemic therapies for atopic dermatitis.
Topics: Azathioprine; Cyclosporine; Dermatitis, Atopic; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; Kaposi Varicelliform Eruption; Male; Methotrexate; Mycophenolic Acid; Randomized Controlled Trials as Topic; Risk Factors | 2012 |
Immunotherapies in rheumatologic disorders.
Topics: Abatacept; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Azathioprine; Certolizumab Pegol; Colchicine; Cyclophosphamide; Cyclosporine; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoconjugates; Immunoglobulin Fab Fragments; Immunoglobulin G; Infliximab; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Methotrexate; Minocycline; Mycophenolic Acid; Polyethylene Glycols; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Rheumatic Diseases; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2012 |
Immunotherapy in renal diseases.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Diseases; Methotrexate; Plasmapheresis; Prognosis; Recurrence; Rituximab | 2012 |
Pharmacogenomics in pediatric rheumatology.
Topics: Antimetabolites; Antirheumatic Agents; Azathioprine; Biological Products; Child; Humans; Methotrexate; Models, Biological; Mycophenolic Acid; Pharmacogenetics; Precision Medicine; Rheumatic Diseases; Rheumatology | 2012 |
Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease.
Topics: Antibodies, Monoclonal; Azathioprine; Biotransformation; Crohn Disease; Drug Hypersensitivity; Drug Interactions; Genetic Markers; Genetic Predisposition to Disease; Genetic Testing; Humans; Immunologic Factors; Infliximab; Mercaptopurine; Methotrexate; Patient Selection; Pharmacogenetics; Phenotype; Polymorphism, Genetic; Precision Medicine; Purine-Pyrimidine Metabolism, Inborn Errors; Risk Assessment; Risk Factors; Tumor Necrosis Factor-alpha | 2012 |
Therapeutic advances in myositis.
Topics: Azathioprine; Cyclosporine; Dermatomyositis; Drug Resistance; Drug Therapy, Combination; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunomodulation; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Polymyositis; Randomized Controlled Trials as Topic; Tacrolimus | 2012 |
Management of severe atopic dermatitis in children.
Topics: Administration, Cutaneous; Adolescent; Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Baths; Child; Child, Preschool; Cyclosporine; Dermatitis, Atopic; Disinfectants; Humans; Immunosuppressive Agents; Infant; Methotrexate; Mycophenolic Acid; Sodium Hypochlorite; Ultraviolet Therapy | 2012 |
Methotrexate for induction of remission in refractory Crohn's disease.
Topics: Antibodies, Monoclonal; Azathioprine; Crohn Disease; Humans; Immunosuppressive Agents; Induction Chemotherapy; Infliximab; Mercaptopurine; Methotrexate; Prednisone; Randomized Controlled Trials as Topic; Steroids | 2012 |
Role of immunosuppressive therapy for the treatment of multiple sclerosis.
Topics: Adult; Azathioprine; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Mitoxantrone; Multiple Sclerosis; Mycophenolic Acid | 2013 |
Methotrexate: underused and ignored?
Topics: Azathioprine; Colitis, Ulcerative; Crohn Disease; Humans; Methotrexate; Patient Preference; Treatment Outcome | 2012 |
Established and experimental medical therapy of pulmonary sarcoidosis.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Clinical Trials as Topic; Dyspnea; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Positron-Emission Tomography; Quality of Life; Radiography, Thoracic; Research Design; Respiratory Function Tests; Sarcoidosis, Pulmonary; Therapies, Investigational; Treatment Outcome | 2013 |
Recent advances using immunomodulators for inflammatory bowel disease.
Topics: Azathioprine; Colitis, Ulcerative; Crohn Disease; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate | 2013 |
L52. Vasculitis treatment: is it time to change the standard of care for ANCA-associated vasculitis?
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cooperative Behavior; Cyclophosphamide; Drug Therapy, Combination; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Interdisciplinary Communication; Methotrexate; Mycophenolic Acid; Randomized Controlled Trials as Topic; Remission Induction; Rituximab; Secondary Prevention; Standard of Care; Treatment Outcome | 2013 |
Update on pregnancy and breastfeeding in the era of biologics.
Topics: Adalimumab; Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Breast Feeding; Certolizumab Pegol; Colitis, Ulcerative; Contraindications; Crohn Disease; Cyclosporine; Female; Fertility; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Infliximab; Mercaptopurine; Methotrexate; Natalizumab; Polyethylene Glycols; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Tacrolimus | 2013 |
L44. Management of relapses in vasculitis.
Topics: Anti-Inflammatory Agents; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Combined Modality Therapy; Cyclophosphamide; Drug Therapy, Combination; Glucocorticoids; Humans; Immunization, Passive; Immunosuppressive Agents; Methotrexate; Plasma Exchange; Prognosis; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Rituximab; Tumor Necrosis Factor-alpha | 2013 |
Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Anti-Inflammatory Agents; Azathioprine; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon beta-1a; Interferon-beta; Methotrexate; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Randomized Controlled Trials as Topic | 2013 |
Nonsteroidal therapy of sarcoidosis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biological Products; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Sarcoidosis, Pulmonary; Treatment Outcome; Tumor Necrosis Factor-alpha | 2013 |
[Treatment of chronic inflammatory bowel disease based on evidence and according to stage: top down].
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Biological Products; Colitis, Ulcerative; Crohn Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Early Medical Intervention; Evidence-Based Medicine; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Treatment Outcome | 2013 |
Current therapy in sarcoidosis, the role of existing drugs and future medicine.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Humans; Immunosuppressive Agents; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Sarcoidosis | 2013 |
Is immunosuppressive therapy the anchor treatment to achieve remission in systemic sclerosis?
Topics: Azathioprine; Biological Products; Cyclophosphamide; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Remission Induction; Scleroderma, Systemic | 2014 |
Comparing medical treatments for Crohn's disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Azathioprine; Biological Factors; Budesonide; Crohn Disease; Humans; Intestinal Fistula; Methotrexate; Probiotics; Randomized Controlled Trials as Topic; Secondary Prevention | 2013 |
American Gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.
Topics: Azathioprine; Crohn Disease; Gastroenterology; Humans; Mercaptopurine; Methotrexate; Remission Induction; Societies, Medical; Tumor Necrosis Factor-alpha; United States | 2013 |
Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review.
Topics: Azathioprine; Cyclosporine; Dermatitis, Atopic; Glucocorticoids; Humans; Immunosuppressive Agents; Interferon-gamma; Methotrexate; Mycophenolic Acid | 2014 |
Pharmacogenomics in childhood rheumatic disorders: a foundation for future individualized therapy.
Topics: Antirheumatic Agents; Azathioprine; Biological Products; Biomarkers; Child; Genome, Human; Genotype; Humans; Methotrexate; Mycophenolic Acid; Pharmacogenetics; Phenotype; Precision Medicine; Rheumatic Diseases | 2013 |
Inflammatory myopathies in Nigerians: case series and literature review.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Dermatomyositis; Electromyography; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Nigeria; Polymyositis; Retrospective Studies; Young Adult | 2013 |
Non-biologic remission maintenance therapy in adult patients with ANCA-associated vasculitis: a systematic review and network meta-analysis.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Randomized Controlled Trials as Topic; Remission Induction; Treatment Outcome | 2014 |
Adverse events in IBD: to stop or continue immune suppressant and biologic treatment.
Topics: Antibodies, Anti-Idiotypic; Azathioprine; Biological Products; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Integrins; Mercaptopurine; Methotrexate; Risk Assessment; Tumor Necrosis Factor-alpha; Withholding Treatment | 2014 |
Positioning therapy for Crohn's disease.
Topics: Azathioprine; Crohn Disease; Drug Monitoring; Gastrointestinal Agents; Humans; Mercaptopurine; Methotrexate; Tumor Necrosis Factor-alpha | 2014 |
From conception to delivery: managing the pregnant inflammatory bowel disease patient.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Anti-Bacterial Agents; Azathioprine; Biological Products; Breast Feeding; Cyclosporine; Female; Fertility; Humans; Inflammatory Bowel Diseases; Maternal Exposure; Mercaptopurine; Methotrexate; Pregnancy; Pregnancy Complications; Sulfasalazine | 2014 |
Can we get more from our current treatments?
Topics: Azathioprine; Crohn Disease; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate | 2014 |
Treatment algorithms in Crohn's - up, down or something else?
Topics: Adalimumab; Algorithms; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Certolizumab Pegol; Crohn Disease; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Infliximab; Mercaptopurine; Methotrexate; Polyethylene Glycols; Practice Guidelines as Topic; Tumor Necrosis Factor-alpha | 2014 |
Systematic review: Monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD.
Topics: Adult; Antibodies, Monoclonal; Azathioprine; Comparative Effectiveness Research; Disease Management; Drug Interactions; Drug Therapy, Combination; Female; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Male; Mercaptopurine; Methotrexate; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Treatment Outcome; Tumor Necrosis Factor-alpha | 2014 |
Methotrexate for induction of remission in refractory Crohn's disease.
Topics: Antibodies, Monoclonal; Azathioprine; Crohn Disease; Humans; Immunosuppressive Agents; Induction Chemotherapy; Infliximab; Mercaptopurine; Methotrexate; Prednisone; Randomized Controlled Trials as Topic; Steroids | 2014 |
The role and advances of immunomodulator therapy for inflammatory bowel disease.
Topics: Azathioprine; Humans; Immunologic Factors; Immunomodulation; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate; Treatment Outcome | 2015 |
Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Certolizumab Pegol; Drug Therapy, Combination; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Incidence; Inflammatory Bowel Diseases; Infliximab; Methotrexate; Polyethylene Glycols; Psoriasis; Randomized Controlled Trials as Topic; Recurrence; Rheumatic Diseases; Risk Factors; Tuberculosis; Tumor Necrosis Factor-alpha | 2014 |
Anti-tumor necrosis factor-α monotherapy versus combination therapy with an immunomodulator in IBD.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Drug Therapy, Combination; Humans; Immunomodulation; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Methotrexate; Patient Participation; Tumor Necrosis Factor-alpha | 2014 |
The liver in pediatric gastrointestinal disease.
Topics: Adolescent; Antibodies, Monoclonal; Azathioprine; Celiac Disease; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cystic Fibrosis; Humans; Infant; Inflammatory Bowel Diseases; Infliximab; Liver Diseases; Liver Function Tests; Mercaptopurine; Methotrexate; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid | 2014 |
Pharmacogenetics of inflammatory bowel disease.
Topics: Adalimumab; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Humans; Inactivation, Metabolic; Inflammatory Bowel Diseases; Infliximab; Methotrexate; Methyltransferases; Pharmacogenetics; Polymorphism, Single Nucleotide | 2014 |
Treatment of Sarcoidosis.
Topics: Anti-Inflammatory Agents; Azathioprine; Clinical Trials as Topic; Drug Administration Schedule; Granuloma; Humans; Immunologic Factors; Infliximab; Isoxazoles; Leflunomide; Lung; Methotrexate; Mycophenolic Acid; Prednisone; Respiratory Function Tests; Sarcoidosis; Skin; Tomography, X-Ray Computed | 2015 |
Optimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysis.
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Bezafibrate; Bile Ducts; Colchicine; Cyclosporine; Drug Therapy, Combination; Female; Humans; Liver Cirrhosis, Biliary; Male; Methotrexate; Middle Aged; Penicillamine; Treatment Outcome; Ursodeoxycholic Acid | 2015 |
The evidence for immunotherapy in dermatomyositis and polymyositis: a systematic review.
Topics: Adrenal Cortex Hormones; Azathioprine; Biological Products; Cyclosporine; Dermatomyositis; Evidence-Based Medicine; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Leukapheresis; Methotrexate; Plasmapheresis; Polymyositis; Practice Guidelines as Topic; Rituximab; Treatment Outcome | 2015 |
New Applications for Traditional Drugs in Inflammatory Bowel Disease: What Do Cochrane Reviews Tell Us?
Topics: Anti-Inflammatory Agents; Azathioprine; Budesonide; Colitis, Ulcerative; Congresses as Topic; Crohn Disease; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Maintenance Chemotherapy; Mesalamine; Methotrexate; Review Literature as Topic; Secondary Prevention | 2015 |
Systemic Agents for Severe Atopic Dermatitis in Children.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Child; Cyclosporine; Dermatitis, Atopic; Drug Administration Routes; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Severity of Illness Index; Thalidomide | 2015 |
[Recent advances in the treatment of antineutrophil cytoplasm antibody associated vasculitides].
Topics: Algorithms; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Clinical Trials as Topic; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Kidney Transplantation; Methotrexate; Microscopic Polyangiitis; Mycophenolic Acid; Plasmapheresis; Prognosis; Rituximab; Severity of Illness Index; Terminology as Topic | 2015 |
Drug resistance in inflammatory bowel diseases.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Drug Resistance; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate; Tumor Necrosis Factor-alpha | 2015 |
Therapeutic advances for primary biliary cholangitis: the old and the new.
Topics: Abatacept; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cyclosporine; Enzyme Inhibitors; Fibric Acids; Glucocorticoids; Humans; Immunosuppressive Agents; Indoles; Liver Cirrhosis, Biliary; Mesenchymal Stem Cell Transplantation; Methotrexate; Mycophenolic Acid; Pyridones; Rituximab; Tacrolimus; Ursodeoxycholic Acid; Ustekinumab | 2016 |
Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease.
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Azathioprine; Colitis, Ulcerative; Crohn Disease; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Middle Aged; Odds Ratio; Postoperative Complications; Preoperative Period; Retrospective Studies; Sepsis; Tumor Necrosis Factor-alpha; Young Adult | 2016 |
Update on the pharmacological treatment of adult myositis.
Topics: Adrenocorticotropic Hormone; Adult; Azathioprine; Cyclophosphamide; Cyclosporine; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Myositis; Tacrolimus | 2016 |
Advances in Pediatric Inflammatory Bowel Disease.
Topics: Adalimumab; Adolescent; Adrenal Cortex Hormones; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Azathioprine; Colitis, Ulcerative; Crohn Disease; Enteral Nutrition; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Mesalamine; Methotrexate; Sulfasalazine; Tacrolimus | 2016 |
Monitoring recommendations for oral azathioprine, methotrexate and cyclosporin in a paediatric dermatology clinic and literature review.
Topics: Administration, Oral; Adolescent; Azathioprine; Blood Cell Count; Child; Child, Preschool; Creatinine; Cyclosporine; Drug Monitoring; Electrolytes; Female; Humans; Immunoglobulin E; Immunosuppressive Agents; Liver Function Tests; Male; Methotrexate; Methyltransferases; Retrospective Studies; Skin Diseases; Urea | 2018 |
Guidelines for the Management of Atopic Dermatitis in Singapore.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Anti-Bacterial Agents; Azathioprine; Calcineurin Inhibitors; Coinfection; Cyclosporine; Dermatitis, Atopic; Dermatology; Disease Management; Emollients; Food Hypersensitivity; Humans; Immunosuppressive Agents; Methotrexate; Patient Education as Topic; Phototherapy; Practice Guidelines as Topic; Referral and Consultation; Severity of Illness Index; Singapore | 2016 |
Management of pemphigus disease in pregnancy.
Topics: Adrenal Cortex Hormones; Azathioprine; Female; Fetal Development; Humans; Immunoglobulins, Intravenous; Infertility, Male; Male; Methotrexate; Mycophenolic Acid; Pemphigus; Pregnancy; Pregnancy Complications; Skin | 2017 |
Relapsing polychondritis: A 2016 update on clinical features, diagnostic tools, treatment and biological drug use.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; Azathioprine; Biological Products; Cyclophosphamide; Humans; Methotrexate; Mycophenolic Acid; Polychondritis, Relapsing | 2016 |
Treatment of giant-cell arteritis, a literature review.
Topics: Antirheumatic Agents; Azathioprine; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Giant Cell Arteritis; Glucocorticoids; Humans; Medication Therapy Management; Methotrexate; Tumor Necrosis Factor-alpha | 2017 |
Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.
Topics: Adrenal Cortex Hormones; Azathioprine; Dexamethasone; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon beta-1a; Methotrexate; Methylprednisolone; Plasma Exchange; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Prednisone; Randomized Controlled Trials as Topic; Review Literature as Topic | 2017 |
Standard and biological treatment in large vessel vasculitis: guidelines and current approaches.
Topics: Animals; Antibodies, Monoclonal; Azathioprine; Biological Therapy; Clinical Trials as Topic; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Lymphotoxin-alpha; Methotrexate; Practice Guidelines as Topic; Recurrence; Remission Induction; Takayasu Arteritis | 2017 |
Non-topical management of recalcitrant paediatric atopic dermatitis.
Topics: Azathioprine; Child; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Humans; Immunosuppressive Agents; Medicine, Chinese Traditional; Methotrexate; Mycophenolic Acid; Phototherapy; Prebiotics; Probiotics; Recurrence; Ultraviolet Therapy | 2017 |
Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.
Topics: Azathioprine; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Chronic Disease; Colchicine; Cyclosporine; Humans; Immunosuppressive Agents; Methotrexate; Mitochondria; Network Meta-Analysis; Penicillamine; Quality of Life; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 2017 |
Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus.
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Azathioprine; Cyclophosphamide; Drug Discovery; Glucocorticoids; Humans; Hydroxychloroquine; Immunologic Factors; Immunosuppressive Agents; Interleukin-2; Lupus Erythematosus, Systemic; Methotrexate; Molecular Targeted Therapy; Mycophenolic Acid; Recombinant Fusion Proteins; Rituximab; Ustekinumab; Vitamin D | 2017 |
Vasculitis and Pregnancy.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Behcet Syndrome; Contraindications; Cyclophosphamide; Deprescriptions; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Pregnancy; Pregnancy Complications; Takayasu Arteritis; Tumor Necrosis Factor-alpha; Vasculitis | 2017 |
Pregnancy and fetal outcomes after paternal exposure to azathioprine, methotrexate or mycophenolic acid: a critically appraised topic.
Topics: Abnormalities, Drug-Induced; Antibiotics, Antineoplastic; Azathioprine; Female; Humans; Immunosuppressive Agents; Infant, Low Birth Weight; Male; Methotrexate; Mycophenolic Acid; Paternal Exposure; Pregnancy; Pregnancy Complications; Pregnancy Outcome | 2017 |
Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
Topics: Anti-Inflammatory Agents; Azathioprine; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Interferon beta-1a; Interferon-beta; Methotrexate; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Randomized Controlled Trials as Topic; Treatment Outcome | 2017 |
Long-Term Treatment of Atopic Dermatitis.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Azathioprine; Baths; Calcineurin Inhibitors; Cyclosporine; Dermatitis, Atopic; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Phototherapy; Randomized Controlled Trials as Topic; Skin Cream; Time Factors | 2017 |
The Evolution of Treatment Paradigms in Crohn's Disease: Beyond Better Drugs.
Topics: Adrenal Cortex Hormones; Algorithms; Azathioprine; Crohn Disease; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Prognosis; Tumor Necrosis Factor-alpha | 2017 |
Atopic dermatitis: phototherapy and systemic therapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Humans; Immunosuppressive Agents; Interleukin-13; Interleukin-4; Methotrexate; Mycophenolic Acid; Phototherapy | 2017 |
Efficacy and safety of immunomodulatory drugs in patients with anterior uveitis: A systematic literature review.
Topics: Adalimumab; Adult; Antibodies, Monoclonal; Azathioprine; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Treatment Outcome; Uveitis, Anterior | 2017 |
Therapeutic role of methotrexate in pediatric Crohn's disease.
Topics: Adolescent; Azathioprine; Child; Crohn Disease; Drug Administration Schedule; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Patient Safety; Remission Induction; Treatment Outcome; Tumor Necrosis Factor-alpha | 2018 |
Combination Immunosuppression in IBD.
Topics: Antibodies, Monoclonal, Humanized; Azathioprine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Methotrexate; Randomized Controlled Trials as Topic; Treatment Outcome; Tumor Necrosis Factor-alpha | 2018 |
Treatment of Sarcoidosis.
Topics: Adrenal Cortex Hormones; Azathioprine; Enzyme Inhibitors; Humans; Hydroxychloroquine; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Sarcoidosis | 2018 |
Contemporary Management of Ulcerative Colitis.
Topics: Azathioprine; Colectomy; Colitis, Ulcerative; Drug Monitoring; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Infliximab; Methotrexate; Tumor Necrosis Factor-alpha | 2018 |
[Advances in differential diagnosis and treatment of patients with sarcoidosis].
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal, Humanized; Antifibrinolytic Agents; Azathioprine; Biological Therapy; Diagnosis, Differential; Humans; Methotrexate; Practice Guidelines as Topic; Sarcoidosis; Stem Cell Transplantation | 2018 |
Atopic dermatitis.
Topics: Administration, Topical; Adrenal Cortex Hormones; Azathioprine; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Calcineurin Inhibitors; Chronic Disease; Dermatitis, Atopic; Filaggrin Proteins; Genetic Predisposition to Disease; Humans; Immunosuppressive Agents; Intermediate Filament Proteins; Methotrexate; Phosphodiesterase 4 Inhibitors; Quality of Life; Severity of Illness Index; Urticaria | 2018 |
The state of the art on treatment of Crohn's disease.
Topics: Adrenal Cortex Hormones; Asia; Azathioprine; Crohn Disease; Drug Monitoring; Humans; Immunomodulation; Immunosuppressive Agents; Incidence; Infliximab; Methotrexate; Purines; Remission Induction; Thalidomide; Thionucleosides; Treatment Outcome; Tumor Necrosis Factor-alpha | 2018 |
Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.
Topics: Anti-Inflammatory Agents; Azathioprine; Biological Products; Clinical Decision-Making; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Mercaptopurine; Methotrexate; Purines; Risk Factors; Thioguanine; Treatment Outcome | 2019 |
Update on the Use of Thiopurines and Methotrexate in Inflammatory Bowel Disease.
Topics: Antibodies, Monoclonal, Humanized; Azathioprine; Biological Factors; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate; Purines; Sulfur Compounds; Tumor Necrosis Factor-alpha | 2018 |
Mycophenolate mofetil, azathioprine and methotrexate usage in paediatric anti-NMDAR encephalitis: A systematic literature review.
Topics: Adolescent; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Azathioprine; Child; Child, Preschool; Female; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Mycophenolic Acid | 2019 |
Novel systemic therapies in atopic dermatitis: what do we need to fulfil the promise of a treatment revolution?
Topics: Azathioprine; Cyclosporine; Dermatitis, Atopic; Humans; Methotrexate; Randomized Controlled Trials as Topic | 2019 |
Treatment of chronic non-infectious uveitis and scleritis.
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclosporine; Enzyme Inhibitors; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Scleritis; Uveitis | 2019 |
Aminosalicylates, thiopurines and methotrexate in inflammatory bowel disease: Is it possible to discontinue the treatment?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Methotrexate; Remission Induction; Withholding Treatment | 2019 |
Hallmark trials in ANCA-associated vasculitis (AAV) for the pediatric rheumatologist.
Topics: Adult; Anti-Inflammatory Agents; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Child; Churg-Strauss Syndrome; Cyclophosphamide; Drug Substitution; Drug Therapy, Combination; Forecasting; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Leflunomide; Methotrexate; Mycophenolic Acid; Plasma Exchange; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Rituximab; Severity of Illness Index | 2019 |
[Treatment of giant cell arteritis].
Topics: Abatacept; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Aspirin; Azathioprine; Drug Administration Schedule; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Leflunomide; Methotrexate; Prednisone; Ustekinumab | 2019 |
Glucocorticoids and steroid sparing medications monotherapies or in combination for IgG4-RD: a systematic review and network meta-analysis.
Topics: Antirheumatic Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Glucocorticoids; Humans; Immunoglobulin G4-Related Disease; Immunosuppressive Agents; Maintenance Chemotherapy; Mercaptopurine; Methotrexate; Mycophenolic Acid; Network Meta-Analysis; Odds Ratio; Recurrence; Remission Induction; Rituximab; Tacrolimus | 2020 |
Relapsing polychondritis in children: A review.
Topics: Adolescent; Adrenal Cortex Hormones; Antirheumatic Agents; Azathioprine; Child; Delayed Diagnosis; Humans; Methotrexate; Polychondritis, Relapsing | 2020 |
Treatment of microscopic colitis: the role of budesonide and new alternatives for refractory patients.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antidiarrheals; Antimetabolites; Azathioprine; Biological Products; Budesonide; Colitis, Collagenous; Colitis, Lymphocytic; Colitis, Microscopic; Diarrhea; Humans; Loperamide; Malabsorption Syndromes; Mesalamine; Methotrexate; Prednisolone; Quality of Life; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Time Factors | 2020 |
Management of ANCA associated vasculitis.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Cyclophosphamide; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Remission Induction; Rituximab | 2020 |
Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis: A Systematic Review and Network Meta-analysis.
Topics: Adult; Antibodies, Monoclonal, Humanized; Azathioprine; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Humans; Immunologic Factors; Methotrexate; Network Meta-Analysis; Pruritus; Quality of Life; Severity of Illness Index; Treatment Outcome | 2020 |
[Treatment of Takayasu arteritis].
Topics: Azathioprine; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Remission Induction; Takayasu Arteritis | 2020 |
Reversal of anti-drug antibodies against tumor necrosis factor inhibitors with addition of immunomodulators: A systematic review and meta-analysis.
Topics: Antibodies; Antibody Formation; Immunologic Factors; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate; Treatment Outcome; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha | 2020 |
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acid; Asia; Azathioprine; Colitis, Ulcerative; Crohn Disease; Diagnosis, Differential; Female; Gastroenterology; Humans; Immunosuppressive Agents; Male; Methotrexate; Monitoring, Physiologic; Pacific Islands; Practice Guidelines as Topic; Pregnancy; Remission Induction; Societies, Medical; Tuberculosis, Gastrointestinal | 2021 |
Update οn the diagnosis and management of systemic lupus erythematosus.
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal, Humanized; Autoantibodies; Azathioprine; Calcineurin Inhibitors; Cardiovascular Diseases; Cyclophosphamide; Disease Management; Female; Glucocorticoids; Heart Valve Diseases; Humans; Hydroxychloroquine; Hypertension, Pulmonary; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Lupus Vasculitis, Central Nervous System; Macrophage Activation Syndrome; Methotrexate; Mycophenolic Acid; Myocarditis; Outcome Assessment, Health Care; Pericarditis; Phenotype; Pregnancy; Pregnancy Complications; Prognosis; Purpura, Thrombocytopenic, Idiopathic; Quality of Life; Recurrence; Rituximab; Severity of Illness Index; Survival Rate; Uterine Cervical Neoplasms | 2021 |
Nonbiologic Immune Suppression in Ulcerative Colitis.
Topics: Azathioprine; Colitis, Ulcerative; Contraindications, Drug; Glucocorticoids; Humans; Immunosuppressive Agents; Maintenance Chemotherapy; Mercaptopurine; Meta-Analysis as Topic; Methotrexate; Piperidines; Pyrimidines; Remission Induction | 2020 |
An Update on Biologic Agents During Pregnancy.
Topics: Abnormalities, Drug-Induced; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Autoimmune Diseases; Azathioprine; Biological Products; Cyclophosphamide; Cyclosporine; Female; Fetal Growth Retardation; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Leflunomide; Methotrexate; Mycophenolic Acid; Pregnancy; Pregnancy Complications; Premature Birth; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2020 |
Interventions for cutaneous disease in systemic lupus erythematosus.
Topics: Age of Onset; Azathioprine; Bias; Biological Factors; Chloroquine; Cosmetic Techniques; Cyclosporine; Dermatologic Agents; Exanthema; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Male; Medicine, Chinese Traditional; Methotrexate; Placebos; Quality of Life; Randomized Controlled Trials as Topic; Skin Diseases; Symptom Flare Up | 2021 |
Clinical experience with biologic treatment in resistant eosinophilic fasciitis: Case reports and review of the literature.
Topics: Azathioprine; Biological Products; Biopsy; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Eosinophilia; Fascia; Fasciitis; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Male; Methotrexate; Middle Aged; Prednisone; Rituximab; Symptom Flare Up; Treatment Outcome | 2021 |
Treatment strategies for Sjögren's syndrome with childhood onset: a systematic review of the literature.
Topics: Antirheumatic Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Glucocorticoids; Humans; Hydroxychloroquine; Methotrexate; Rituximab; Sjogren's Syndrome | 2022 |
Comparative efficacy and safety of rituximab, mycophenolate, methotrexate, and cyclophosphamide versus azathioprine as maintenance therapy in antineutrophil cytoplasmic antibody-associated vasculitis: A Bayesian network meta-analysis of randomized control
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Methotrexate; Network Meta-Analysis; Randomized Controlled Trials as Topic; Remission Induction; Rituximab; Treatment Outcome | 2022 |
Immunomodulatory Agents for Treatment of Patients with Inflammatory Bowel Disease (Review safety of anti-TNF, Anti-Integrin, Anti IL-12/23, JAK Inhibition, Sphingosine 1-Phosphate Receptor Modulator, Azathioprine / 6-MP and Methotrexate).
Topics: Azathioprine; Humans; Immunologic Factors; Immunomodulating Agents; Inflammatory Bowel Diseases; Integrins; Interleukin-12; Methotrexate; Sphingosine-1-Phosphate Receptors; Tumor Necrosis Factor Inhibitors | 2021 |
Sarcoidosis with musculoskeletal manifestations: systematic review of non-pharmacological and pharmacological treatments.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Humans; Hydroxychloroquine; Methotrexate; Sarcoidosis; Tumor Necrosis Factor Inhibitors | 2022 |
Management of Coexisting Bullous Pemphigoid and Psoriasis: A Review.
Topics: Acitretin; Adrenal Cortex Hormones; Anti-Bacterial Agents; Azathioprine; Biological Factors; Biological Products; Cyclosporins; Dermatologic Agents; Etanercept; Humans; Immunosuppressive Agents; Methotrexate; Niacinamide; Pemphigoid, Bullous; Psoriasis; Rituximab; Ustekinumab; Vitamins | 2022 |
[Bullous skin diseases].
Topics: Autoimmune Diseases; Azathioprine; Glucocorticoids; Humans; Methotrexate; Pemphigus; Rituximab; Skin Diseases, Vesiculobullous | 2022 |
Non-biologic, steroid-sparing therapies for non-infectious intermediate, posterior, and panuveitis in adults.
Topics: Adult; Antirheumatic Agents; Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Inflammation; Macular Edema; Methotrexate; Mycophenolic Acid; Panuveitis; Steroids; Tacrolimus | 2022 |
Methotrexate in generalized myasthenia gravis: a systematic review.
Topics: Azathioprine; Drug-Related Side Effects and Adverse Reactions; Humans; Immunosuppressive Agents; Methotrexate; Myasthenia Gravis; Observational Studies as Topic; Prednisone; Randomized Controlled Trials as Topic | 2023 |
Role of topical and systemic immunosuppression in aqueous-deficient dry eye disease.
Topics: Azathioprine; Dry Eye Syndromes; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Inflammation; Methotrexate | 2023 |
Relapsing autoimmune inner ear disease with significant response to methotrexate and azathioprine combination therapy: A case report and mini literature review.
Topics: Adrenal Cortex Hormones; Adult; Autoimmune Diseases; Azathioprine; Female; Hearing Loss, Sensorineural; Humans; Immunosuppressive Agents; Labyrinth Diseases; Methotrexate; Methylprednisolone; Recurrence | 2023 |
Comparing four immunosuppressive agents for chronic spontaneous urticaria-A network meta-analysis.
Topics: Anti-Allergic Agents; Azathioprine; Chronic Disease; Chronic Urticaria; Cyclosporine; Drug-Related Side Effects and Adverse Reactions; Glycosides; Histamine Antagonists; Histamine H1 Antagonists; Humans; Immunosuppressive Agents; Methotrexate; Network Meta-Analysis; Omalizumab; Randomized Controlled Trials as Topic; Treatment Outcome; Urticaria | 2023 |
70 trial(s) available for azathioprine and methotrexate
| Article | Year |
|---|---|
Accelerated nodulosis during low dose methotrexate therapy for rheumatoid arthritis. An analysis of ten cases.
Topics: Aged; Aged, 80 and over; Arthritis, Rheumatoid; Azathioprine; Dose-Response Relationship, Drug; Double-Blind Method; Echocardiography; Female; Humans; Lung; Male; Methotrexate; Middle Aged; Myocardium; Radiography, Thoracic; Rheumatoid Nodule; Skin | 1992 |
[A comparative evaluation of combined immunocorrective therapy in rheumatoid arthritis with systemic manifestations (joint Soviet-Polish research)].
Topics: Adult; Aged; Arthritis, Rheumatoid; Azathioprine; Combined Modality Therapy; Cyclophosphamide; Drug Therapy, Combination; Female; Hemoperfusion; Humans; Male; Methotrexate; Middle Aged; Poland; USSR | 1992 |
[Methotrexate treatment in Crohn disease].
Topics: Administration, Oral; Adolescent; Adult; Azathioprine; Crohn Disease; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Male; Methotrexate; Retrospective Studies; Time Factors | 1992 |
Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Azathioprine; Digestive System; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Liver; Male; Methotrexate; Middle Aged; Statistics as Topic; Time Factors | 1992 |
Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cyclophosphamide; Female; Follow-Up Studies; Gold; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Penicillamine | 1991 |
Methotrexate versus azathioprine in the treatment of rheumatoid arthritis. A forty-eight-week randomized, double-blind trial.
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Azathioprine; Double-Blind Method; Female; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Male; Methotrexate; Middle Aged; Time Factors | 1991 |
Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis. A randomized, double-blind study.
Topics: Aged; Arthritis, Rheumatoid; Azathioprine; Double-Blind Method; Female; Foot; Hand; Humans; Male; Methotrexate; Middle Aged; Radiography; Wrist Joint | 1991 |
Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. The Cooperative Systematic Studies of Rheumatic Diseases Group.
Topics: Anti-Inflammatory Agents; Arthritis, Rheumatoid; Auranofin; Azathioprine; Double-Blind Method; Drug Therapy, Combination; Gold Sodium Thiomalate; Humans; Methotrexate; Middle Aged; Penicillamine; Placebo Effect; Prospective Studies; Randomized Controlled Trials as Topic | 1990 |
Second-line antirheumatic drugs in the elderly with rheumatoid arthritis: a post hoc analysis of three controlled trials.
Topics: Administration, Oral; Aged; Arthritis, Rheumatoid; Auranofin; Azathioprine; Double-Blind Method; Drug Evaluation; Female; Gold Sodium Thiomalate; Humans; Injections, Intramuscular; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Penicillamine; Prospective Studies; Random Allocation; Time Factors | 1990 |
Comparative controlled trial of low-dose weekly methotrexate versus azathioprine in rheumatoid arthritis: 3-year prospective study.
Topics: Activities of Daily Living; Adult; Aged; Arthritis, Rheumatoid; Azathioprine; Blood Chemical Analysis; Blood Sedimentation; Clinical Trials as Topic; Female; Humans; Male; Methotrexate; Middle Aged; Movement; Pain Measurement; Prospective Studies; Random Allocation | 1990 |
Azathioprine and methotrexate as combination chemotherapy in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Azathioprine; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Methotrexate; Multicenter Studies as Topic; Structure-Activity Relationship | 1990 |
Low-dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. A twenty-four-week controlled clinical trial.
Topics: Arthritis, Rheumatoid; Azathioprine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Methotrexate; Middle Aged; Prospective Studies; Random Allocation | 1987 |
Immunosuppressive drugs in rheumatoid arthritis.
Topics: Adrenocorticotropic Hormone; Aminopterin; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Azathioprine; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Nitrogen Mustard Compounds; Penicillamine | 1971 |
Immunosuppressive therapy. 1.
Topics: Alkylating Agents; Anemia, Hemolytic, Autoimmune; Antibodies; Antimetabolites; Arthritis, Rheumatoid; Azathioprine; Blood Coagulation Disorders; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Cyclophosphamide; Dermatomyositis; Factor VIII; Hepatitis; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mercaptopurine; Methotrexate; Prednisolone; Purpura, Thrombocytopenic; Scleroderma, Systemic | 1972 |
[Differential therapy of chronic progressive polyarthritis].
Topics: Arthritis, Rheumatoid; Azathioprine; Chronic Disease; Clinical Trials as Topic; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged | 1972 |
[Immunosuppressive therapy of the rheumatoid arthritis. mutual evaluation of establishments within the frame of the AFG rheumatology in jena].
Topics: Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Evaluation Studies as Topic; Germany, East; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Procarbazine; Triaziquone | 1974 |
[Treatment of pemphigus].
Topics: Adult; Antimetabolites, Antineoplastic; Azathioprine; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Pemphigus; Prednisone | 1974 |
Treatment of rheumatoid arthritis with cytotoxic and antimetabolic drugs.
Topics: Alopecia; Aminopterin; Antimetabolites; Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Bone Marrow Diseases; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Cystitis; Female; Herpes Zoster; Humans; Jaundice; Mechlorethamine; Mercaptopurine; Methotrexate | 1970 |
FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group.
Topics: Acute Disease; Adolescent; Adult; Azathioprine; Bone Marrow Transplantation; Child; Chronic Disease; Cyclosporine; Female; Flushing; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Methotrexate; Middle Aged; Nausea; Prednisolone; Tacrolimus; Treatment Outcome | 1995 |
Infections during low-dose methotrexate treatment in rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Azathioprine; Double-Blind Method; Female; Humans; Incidence; Male; Methotrexate; Middle Aged; Opportunistic Infections; Prospective Studies; Psoriasis | 1995 |
Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators Group.
Topics: Adult; Aged; Antibodies, Monoclonal; Antigens, CD; Arthritis, Rheumatoid; Azathioprine; CD5 Antigens; Cell Count; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Immunotoxins; Male; Methotrexate; Middle Aged; Prospective Studies; Ricin; T-Lymphocytes; Treatment Outcome | 1993 |
Antiperinuclear factor and disease activity in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy.
Topics: Adult; Aged; Antibodies, Antinuclear; Arthritis, Rheumatoid; Azathioprine; Double-Blind Method; Female; Humans; Longitudinal Studies; Male; Methotrexate; Middle Aged | 1994 |
Effects of low dose methotrexate therapy on the concentration and the glycosylation of alpha 1-acid glycoprotein in the serum of patients with rheumatoid arthritis: a longitudinal study.
Topics: alpha 1-Antitrypsin; Arthritis, Rheumatoid; Azathioprine; Double-Blind Method; Female; Glycosylation; Haptoglobins; Humans; Longitudinal Studies; Male; Methotrexate; Middle Aged; Orosomucoid | 1994 |
[Comparison of azathioprine and methotrexate in rheumatoid arthritis: an open-randomized clinical study].
Topics: Adult; Aged; Arthritis, Rheumatoid; Azathioprine; Female; Humans; Immunoglobulin M; Male; Methotrexate; Middle Aged; Rheumatoid Factor | 1994 |
[A comparative evaluation of the treatment results with cyclosporin A, methotrexate and azathioprine in rheumatoid arthritis patients (a preliminary report)].
Topics: Arthritis, Rheumatoid; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Remission Induction; Time Factors | 1993 |
Validity of single variables and indices to measure disease activity in rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Azathioprine; Blood Sedimentation; C-Reactive Protein; Disabled Persons; Hemoglobins; Humans; Hydroxychloroquine; Joints; Methotrexate; Pain; Reproducibility of Results; Severity of Illness Index; Sulfasalazine | 1993 |
The treatment of inclusion body myositis: a retrospective review and a randomized, prospective trial of immunosuppressive therapy.
Topics: Adult; Aged; Autoantibodies; Azathioprine; Drug Therapy, Combination; Female; Humans; Immunosuppression Therapy; Inclusion Bodies; Leucovorin; Male; Methotrexate; Middle Aged; Muscles; Myositis; Prednisone; Prospective Studies; Retrospective Studies | 1993 |
Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy.
Topics: Arthritis, Rheumatoid; Azathioprine; Cytokines; Double-Blind Method; Humans; Interleukin-6; Longitudinal Studies; Methotrexate; Prospective Studies; Receptors, Cell Surface; Receptors, Interleukin-2; Receptors, Tumor Necrosis Factor; Treatment Outcome; Tumor Necrosis Factor-alpha | 1993 |
The relative toxicity of disease-modifying antirheumatic drugs.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Azathioprine; Humans; Hydroxychloroquine; Longitudinal Studies; Methotrexate; Penicillamine; Prednisone; Prospective Studies | 1993 |
Results of controlled study of combination therapy with azathioprine and methotrexate in the treatment of rheumatoid arthritis revisited: comment on the article by Willkens et al.
Topics: Arthritis, Rheumatoid; Azathioprine; Drug Therapy, Combination; Humans; Methotrexate | 1996 |
Combination treatment of rheumatoid arthritis using azathioprine and methotrexate: a 48 week controlled clinical trial.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Arthrography; Azathioprine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Prospective Studies | 1996 |
Comparison of azathioprine, methotrexate, and the combination of the two in the treatment of rheumatoid arthritis. A forty-eight-week controlled clinical trial with radiologic outcome assessment.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Arthrography; Azathioprine; Blood Sedimentation; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Prospective Studies; Treatment Outcome; United States | 1995 |
Treatment of refractory myositis: a randomized crossover study of two new cytotoxic regimens.
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Antirheumatic Agents; Azathioprine; Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Leucovorin; Male; Methotrexate; Middle Aged; Myositis; Salvage Therapy | 1998 |
Radiological and clinical results of longterm treatment of rheumatoid arthritis with methotrexate and azathioprine.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Azathioprine; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Radiography; Treatment Outcome | 2000 |
Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety.
Topics: Adult; Aged; Antirheumatic Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Immunoglobulin G; Male; Methotrexate; Middle Aged; Patient Compliance; Receptors, Tumor Necrosis Factor; Treatment Outcome | 2001 |
Anti-tumour necrosis factor treatment with infliximab in a case of giant cell arteritis resistant to steroid and immunosuppressive drugs.
Topics: Aged; Antibodies, Monoclonal; Antirheumatic Agents; Azathioprine; Drug Resistance; Drug Therapy, Combination; Female; Giant Cell Arteritis; Health Status; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Pain; Pain Measurement; Prednisone; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha | 2002 |
[Mycophenolate mofetil in refractory Crohn's disease after failure of treatments by azathioprine or methotrexate].
Topics: Adult; Azathioprine; Cohort Studies; Crohn Disease; Female; Humans; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Remission Induction; Retrospective Studies; Treatment Failure | 2002 |
Differences between children and adults in thiopurine methyltransferase activity and metabolite formation during thiopurine therapy: possible role of concomitant methotrexate.
Topics: Adult; Age Factors; Antimetabolites, Antineoplastic; Azathioprine; Child; Drug Therapy, Combination; Erythrocytes; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Methotrexate; Methyltransferases; Polymorphism, Genetic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thioinosine; Thionucleotides | 2002 |
Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents.
Topics: Adult; Antibodies, Antinuclear; Azathioprine; Cyclophosphamide; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Proteinuria; Racial Groups; Statistics, Nonparametric; Time Factors; Treatment Failure | 2002 |
Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission.
Topics: Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Colitis, Ulcerative; Drug Administration Schedule; Drug Resistance; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prednisone; Remission Induction; Single-Blind Method; Treatment Outcome | 2002 |
Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study.
Topics: Adult; Aged; Antimetabolites; Azathioprine; Crohn Disease; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Outcome Assessment, Health Care; Treatment Outcome | 2003 |
Pulse cyclophosphamide therapy for inflammatory bowel disease.
Topics: Adult; Aged; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Pilot Projects; Prospective Studies; Pulse Therapy, Drug; Remission Induction | 2006 |
Effects of short-term infliximab therapy on autoantibodies in systemic lupus erythematosus.
Topics: Antibodies, Monoclonal; Apoptosis; Autoantibodies; Azathioprine; Dermatologic Agents; DNA; Drug Combinations; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique, Indirect; Humans; Immunosuppressive Agents; Infliximab; Leukocytes, Mononuclear; Lupus Erythematosus, Systemic; Methotrexate; Radioimmunoassay; Tumor Necrosis Factor-alpha | 2007 |
Outcomes in patients with active lupus nephritis requiring immunosuppressives who never received cyclophosphamide.
Topics: Adult; Azathioprine; Cohort Studies; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Methotrexate; Mycophenolic Acid; Prognosis; Severity of Illness Index; Survival Rate; Treatment Outcome | 2007 |
Medical therapy for Crohn's disease: top-down or step-up?
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Biomarkers; Crohn Disease; Denmark; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Remission Induction; Risk Factors; United States | 2007 |
Mitoxantrone as induction treatment in aggressive relapsing remitting multiple sclerosis: treatment response factors in a 5 year follow-up observational study of 100 consecutive patients.
Topics: Adult; Antineoplastic Agents; Antiviral Agents; Azathioprine; Brain; Demography; Disability Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Glatiramer Acetate; Humans; Immunosuppressive Agents; Interferon-beta; Magnetic Resonance Imaging; Male; Methotrexate; Methylprednisolone; Mitoxantrone; Multiple Sclerosis, Relapsing-Remitting; Observation; Peptides; Prevalence; Recurrence | 2008 |
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Belgium; Chi-Square Distribution; Crohn Disease; Female; Germany; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Netherlands; Statistics, Nonparametric; Treatment Outcome | 2008 |
Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Belgium; C-Reactive Protein; Crohn Disease; Drug Administration Schedule; Drug Therapy, Combination; Female; France; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Infusions, Intravenous; Intestinal Mucosa; Male; Mercaptopurine; Methotrexate; Middle Aged; Prospective Studies; Treatment Outcome | 2008 |
Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
Topics: Adult; Aged; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisone; Prospective Studies; Pulse Therapy, Drug; Remission Induction; Vasculitis; Young Adult | 2008 |
[Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide].
Topics: Adrenal Cortex Hormones; Adult; Autoantibodies; Autoantigens; Azathioprine; Cyclophosphamide; Desmoglein 1; Desmoglein 3; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Nausea; Pemphigus; Remission Induction | 2009 |
Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study).
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Behcet Syndrome; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Iran; Male; Methotrexate; Middle Aged; Papilledema; Pilot Projects; Prednisolone; Retinal Vasculitis; Rituximab; Severity of Illness Index; Single-Blind Method; Time Factors; Treatment Outcome; Uveitis, Anterior; Uveitis, Posterior; Visual Acuity; Young Adult | 2010 |
Mucosal healing with methotrexate in Crohn's disease: a prospective comparative study with azathioprine and infliximab.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Azathioprine; Colonoscopy; Crohn Disease; Epidemiologic Methods; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Intestinal Mucosa; Male; Methotrexate; Middle Aged; Treatment Outcome; Wound Healing; Young Adult | 2011 |
[Allogeneic mesenchymal stromal cells in patients with ulcerative colitis: two years of observation].
Topics: Adult; Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Methotrexate; Middle Aged; Prednisolone; Remission Induction; Stromal Cells; Transplantation, Homologous | 2010 |
A randomized trial of methotrexate versus azathioprine for severe atopic eczema.
Topics: Adult; Azathioprine; Dermatitis, Atopic; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Quality of Life; Severity of Illness Index; Treatment Outcome | 2011 |
Efficacy of adalimumab in patients with Crohn's disease and failure to infliximab therapy: a clinical series.
Topics: Abdominal Abscess; Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; C-Reactive Protein; Crohn Disease; Disease Susceptibility; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infliximab; Intestinal Fistula; Male; Methotrexate; Prednisone; Tuberculosis, Meningeal; Tumor Necrosis Factor-alpha | 2011 |
A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis.
Topics: Adult; Azathioprine; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myasthenia Gravis; Prednisone; Single-Blind Method | 2011 |
Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study.
Topics: Adult; Antirheumatic Agents; Azathioprine; Female; Humans; Interleukin 1 Receptor Antagonist Protein; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Receptors, Interleukin-1; Remission Induction; Still's Disease, Adult-Onset; Sulfasalazine; Treatment Outcome | 2012 |
Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the ENTRANCE study.
Topics: Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Biphenyl Compounds; Blood Sedimentation; C-Reactive Protein; Colitis, Ulcerative; Crohn Disease; Dicarboxylic Acids; Dihydroorotate Dehydrogenase; Enzyme Inhibitors; Feces; Female; Humans; Immunologic Factors; Immunosuppressive Agents; Intention to Treat Analysis; Leukocyte L1 Antigen Complex; Male; Methotrexate; Middle Aged; Oxidoreductases Acting on CH-CH Group Donors; Prednisolone; Remission Induction; Severity of Illness Index; Young Adult | 2013 |
Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis.
Topics: Adrenal Cortex Hormones; Adult; Aminosalicylic Acids; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Injections, Subcutaneous; Male; Mercaptopurine; Methotrexate; Middle Aged; Quality of Life; Remission Induction; Treatment Outcome; Tumor Necrosis Factor-alpha | 2014 |
Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17.
Topics: Adrenal Cortex Hormones; Adult; Antiviral Agents; Azathioprine; Behcet Syndrome; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Lymphocyte Count; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Polyethylene Glycols; Quality of Life; Recombinant Proteins; Single-Blind Method; Surveys and Questionnaires; T-Lymphocytes, Regulatory; Tacrolimus; Th17 Cells; Treatment Outcome | 2015 |
Monotherapy with infliximab versus combination therapy in the maintenance of clinical remission in children with moderate to severe Crohn disease.
Topics: Adolescent; Azathioprine; Child; Crohn Disease; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Maintenance Chemotherapy; Male; Methotrexate; Remission Induction; Severity of Illness Index | 2015 |
Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapy.
Topics: Adrenal Cortex Hormones; Aged; Aged, 80 and over; Azathioprine; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Remission Induction; Systemic Vasculitis; Treatment Outcome | 2015 |
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial.
Topics: Adalimumab; Adult; Antimetabolites; Azathioprine; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunosuppression Therapy; Infliximab; Male; Mercaptopurine; Methotrexate; Treatment Outcome; Tumor Necrosis Factor-alpha | 2015 |
Long-Term Outcomes Among Participants in the WEGENT Trial of Remission-Maintenance Therapy for Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis.
Topics: Azathioprine; Disease-Free Survival; Follow-Up Studies; Granulomatosis with Polyangiitis; Humans; Kidney; Methotrexate; Microscopic Polyangiitis; Multivariate Analysis; Prognosis; Remission Induction; Treatment Outcome | 2016 |
Patients with atopic dermatitis with filaggrin loss-of-function mutations show good but lower responses to immunosuppressive treatment.
Topics: Adult; Azathioprine; Dermatitis, Atopic; Female; Filaggrin Proteins; Humans; Immunosuppressive Agents; Intermediate Filament Proteins; Loss of Function Mutation; Male; Methotrexate; Middle Aged; Treatment Outcome | 2017 |
Methotrexate and azathioprine for severe atopic dermatitis: a 5-year follow-up study of a randomized controlled trial.
Topics: Adult; Azathioprine; Dermatitis, Atopic; Dermatologic Agents; Drug Administration Schedule; Drug Substitution; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Methotrexate; Off-Label Use; Single-Blind Method; Treatment Outcome | 2018 |
Long-term Outcome of Early Combined Immunosuppression Versus Conventional Management in Newly Diagnosed Crohn's Disease.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Biological Products; Colonoscopy; Crohn Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Hospitalization; Humans; Immunosuppressive Agents; Infliximab; Intestinal Fistula; Intestinal Mucosa; Male; Mercaptopurine; Methotrexate; Retrospective Studies; Symptom Flare Up; Time Factors; Tumor Necrosis Factor-alpha; Wound Healing; Young Adult | 2018 |
Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course.
Topics: Adalimumab; Adolescent; Anti-Inflammatory Agents; Azathioprine; Child; Crohn Disease; Female; Humans; Immunosuppressive Agents; Maintenance Chemotherapy; Male; Methotrexate; Multicenter Studies as Topic; Prospective Studies; Randomized Controlled Trials as Topic; Remission Induction | 2020 |
Location but Not Severity of Endoscopic Lesions Influences Endoscopic Remission Rates in Crohn's Disease: A Post Hoc Analysis of TAILORIX.
Topics: Adult; Azathioprine; Colon; Colonoscopy; Crohn Disease; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Ileum; Immunosuppressive Agents; Infliximab; Intestinal Mucosa; Maintenance Chemotherapy; Male; Mercaptopurine; Methotrexate; Middle Aged; Rectum; Remission Induction; Severity of Illness Index; Treatment Outcome; Young Adult | 2021 |
Infection risk in sarcoidosis patients treated with methotrexate compared to azathioprine: A retrospective 'target trial' emulated with Swedish real-world data.
Topics: Adult; Azathioprine; Female; Humans; Immunosuppressive Agents; Methotrexate; Retrospective Studies; Sarcoidosis; Sweden | 2021 |
603 other study(ies) available for azathioprine and methotrexate
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Profiling Protein Arginine Deiminase 4 (PAD4): a novel screen to identify PAD4 inhibitors.
Topics: Arthritis, Rheumatoid; Chlortetracycline; Combinatorial Chemistry Techniques; Enzyme Inhibitors; Fluorescent Dyes; Hydrolases; Minocycline; Models, Biological; Molecular Structure; Protein-Arginine Deiminase Type 4; Protein-Arginine Deiminases; Streptomycin; Tetracycline | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Influence of the properties of skin allografts on the "graft survival promoting effect" of antilymphocyte serum.
Topics: Animals; Antilymphocyte Serum; Azathioprine; Cyclophosphamide; Female; Genotype; Graft vs Host Reaction; Histocompatibility Antigens; Hydrocortisone; Male; Methotrexate; Mice; Radiation Effects; Skin Transplantation; Tissue Survival; Transplantation Immunology; Transplantation, Homologous | 1976 |
[Immunosuppressive treatment of polymyositis].
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Azathioprine; Child; Dactinomycin; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Middle Aged; Myositis; Prednisolone; Time Factors | 1975 |
[Practical aspects of the cytostatic therapy of psoriasis].
Topics: Antineoplastic Agents; Azathioprine; Bleomycin; Busulfan; Chemical and Drug Induced Liver Injury; Humans; Methotrexate; Psoriasis; Time Factors | 1976 |
[Immunosuppression in subacute sclerosing panencephalitis. A controlled study on the evolutive status of cerebrospinal fluid gamma globulin].
Topics: Administration, Oral; Azathioprine; Child; Drug Evaluation; Drug Therapy, Combination; gamma-Globulins; Humans; Immunosuppressive Agents; Injections, Intravenous; Methotrexate; Subacute Sclerosing Panencephalitis | 1976 |
Cytotoxic drug-induced lung disease.
Topics: Antibiotics, Antineoplastic; Azathioprine; Bleomycin; Busulfan; Cyclophosphamide; Dose-Response Relationship, Drug; Humans; Lung Diseases; Lung Neoplasms; Mercaptopurine; Methotrexate; Radiography | 1977 |
[Possibilities and limitations of immunosuppressive therapy for glomerulonephritis].
Topics: Acute Disease; Antilymphocyte Serum; Azathioprine; Chlorambucil; Chronic Disease; Cyclophosphamide; Dactinomycin; Glomerulonephritis; Humans; Immunosuppressive Agents; Kidney Glomerulus; Mercaptopurine; Methotrexate | 1977 |
Donor pretreatment as an adjunct to cadaver renal allotransplantation.
Topics: Adolescent; Adult; Azathioprine; Cadaver; Cyclophosphamide; Female; Graft Rejection; Histocompatibility Antigens; Humans; Kidney; Kidney Transplantation; Lectins; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisone; Transplantation, Homologous | 1975 |
Effect of hydrocortisone, cyclophosphamide, azathioprine and methotrexate on cutaneous delayed and arthus hypersensitivity in the rat.
Topics: Animals; Arthus Reaction; Azathioprine; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Hydrocortisone; Hypersensitivity, Delayed; Leucovorin; Male; Methotrexate; Rats | 1979 |
Prognosis in adult polymyositis.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Aged; Azathioprine; Clinical Enzyme Tests; Creatine Kinase; Diagnosis, Differential; Female; Humans; Male; Methotrexate; Middle Aged; Muscles; Myositis; Prednisone; Prognosis | 1975 |
Treatment of dermatomyositis.
Topics: Azathioprine; Child, Preschool; Dermatomyositis; Female; Humans; Male; Methotrexate; Prednisone | 1977 |
Methotrexate and azathioprine treatment of childhood dermatomyositis.
Topics: Azathioprine; Child; Child, Preschool; Dermatomyositis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Methotrexate; Prednisone; Remission, Spontaneous | 1977 |
[Immunosuppressive drugs in rheumatic diseases (author's transl)].
Topics: Antimetabolites; Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Cyclophosphamide; Humans; Immunosuppressive Agents; Methotrexate | 1979 |
[Remote results of combined immunosuppressive treatment of systemic lupus erythematosus (1969-1978)].
Topics: Adolescent; Adult; Aged; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged | 1979 |
Effect of various immunosuppressive drugs on experimental allergic encephalomyelitis in chickens.
Topics: Animals; Antineoplastic Agents; Azathioprine; Chickens; Cyclophosphamide; Dactinomycin; Demecolcine; Encephalomyelitis, Autoimmune, Experimental; Immunosuppressive Agents; Mercaptopurine; Methotrexate | 1977 |
"Nucleolar test" as a system for screening and analysis of immunosuppressive activity of chemical and biological agents.
Topics: Animals; Antilymphocyte Serum; Azathioprine; Cell Nucleolus; Cyclophosphamide; Hydrocortisone; Immunosuppressive Agents; Lymphocytes; Male; Methotrexate; Mice; RNA; Sheep | 1978 |
Successful use of cyclophosphamide and prednisone for initial treatment of pemphigus vulgaris.
Topics: Adult; Aged; Azathioprine; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Pemphigus; Prednisone | 1978 |
[Therapy of systemic lupus erythematosus and of pseudo-le-syndrome].
Topics: Aged; Azathioprine; Chloroquine; Cyclophosphamide; Diagnosis, Differential; Female; Glucocorticoids; Humans; Indomethacin; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Phenylbutazone; Prednisone; Salicylates; Sex Factors; Syndrome | 1978 |
[Drug induced megaloblastic anemia].
Topics: Anemia, Macrocytic; Anemia, Megaloblastic; Antineoplastic Agents; Azathioprine; Bone Marrow; Bone Marrow Cells; DNA; Folic Acid; Folic Acid Antagonists; Humans; Mercaptopurine; Methotrexate; Purines; Pyrimethamine; Tetrahydrofolate Dehydrogenase; Tetrahydrofolates | 1978 |
Induction of point mutations by different chemical mechanisms in the liver microsomal assay.
Topics: Animals; Azathioprine; Biotransformation; Captan; Cyclophosphamide; Diethylnitrosamine; Dimethylnitrosamine; Dose-Response Relationship, Drug; Genetic Code; Hydrazines; Isoniazid; Male; Mercaptopurine; Methotrexate; Methylnitronitrosoguanidine; Mice; Microsomes, Liver; Mutagens; Protein Biosynthesis; Salmonella typhimurium | 1976 |
[On the mode of action of antirheumatic drugs (author's transl)].
Topics: Antibiotics, Antineoplastic; Arthritis, Rheumatoid; Azathioprine; Chloroquine; Gold; Gold Sodium Thiosulfate; Humans; Methotrexate; Microsomes, Liver; Penicillamine | 1976 |
Use of the dog spleen for studying effects of irradiation and chemotherapeutic agents, with suggested uses of other organs.
Topics: Animals; Antineoplastic Agents; Azathioprine; Cyclophosphamide; Dogs; Fluorouracil; Leukocytes; Mechlorethamine; Methotrexate; Pneumococcal Infections; Prednisolone; Radiation Dosage; Radiation Effects; Spleen; Thiotepa; Time Factors; Vinblastine | 1976 |
Immunosuppressants and prednisone in pemphigus vulgaris: therapeutic results obtained in 63 patients between 1961 and 1975.
Topics: Adult; Aged; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Pemphigus; Prednisone; Recurrence | 1977 |
[Possibilities and limitations of immunosuppressive therapy (proceedings)].
Topics: Arthritis, Rheumatoid; Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Methotrexate; Podophyllin; Triaziquone | 1976 |
[Treatment of psoriasis arthropathy with either azathioprine or methotrexate (author's transl)].
Topics: Adult; Arthritis; Azathioprine; Female; Humans; Male; Methotrexate; Middle Aged; Psoriasis | 1976 |
Comparative study of cyclophosphamide, 6-mercaptopurine, azathiopurine and methotrexate. Relative effects on the humoral and the cellular immune response in the mouse.
Topics: Animals; Antibody Formation; Antigens, Neoplasm; Azathioprine; Cyclophosphamide; Dose-Response Relationship, Drug; Immunity, Cellular; Immunization; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Mice; Time Factors | 1976 |
Pyoderma gangrenosum in immunosuppressed patients.
Topics: Adult; Azathioprine; Humans; Immunosuppression Therapy; Male; Methotrexate; Middle Aged; Penis; Prednisone; Pyoderma; Skin Ulcer | 1976 |
Pemphigus -- a review.
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Aged; Autoimmune Diseases; Azathioprine; Blister; Cyclophosphamide; Ethnicity; Female; Gold; Humans; Male; Methotrexate; Middle Aged; Pemphigus; Prognosis | 1976 |
Factor VIII antibodies: immunosuppressive therapy.
Topics: Aged; Animals; Antibodies; Antibody Formation; Anticoagulants; Azathioprine; Blood Transfusion; Cattle; Child; Cyclophosphamide; Elbow; Factor VIII; Female; Gastrointestinal Hemorrhage; Hemarthrosis; Hematoma; Hemophilia A; Humans; Immunosuppressive Agents; Knee; Male; Mercaptopurine; Methotrexate; Middle Aged; Penicillin G Benzathine; Prednisone; Serum Sickness; Swine; Thigh | 1975 |
Influence of prednisone and cytostatics on human blood B-, T- and O-lymphocytes in diseases.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Azathioprine; B-Lymphocytes; Child; Chlorambucil; Collagen Diseases; Cyclophosphamide; Depression, Chemical; Drug Combinations; Female; Humans; Leukemia, Lymphoid; Lymphocytes; Male; Methotrexate; Middle Aged; Prednisone; Psoriasis; T-Lymphocytes | 1975 |
[Immunologic tissue damage and immunosuppression].
Topics: Abnormalities, Drug-Induced; Azathioprine; Cortisone; Cyclophosphamide; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infections; Infertility; Male; Mercaptopurine; Methotrexate; Neoplasms; T-Lymphocytes | 1976 |
Drug-induced tolerance: selective induction with immunosuppressive drugs and their synergistic interaction.
Topics: Ammonium Sulfate; Animals; Antigens; Azathioprine; Carbon Radioisotopes; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Synergism; Erythrocytes; Hemolytic Plaque Technique; Immune Tolerance; Immunosuppressive Agents; Injections, Intraperitoneal; Lethal Dose 50; Male; Methotrexate; Methylprednisolone; Mice; Mice, Inbred NZB; Poly I-C; Sheep; Spleen | 1975 |
[Regulation of purine metabolism and its modification by drugs].
Topics: Allopurinol; Antimetabolites; Azathioprine; Benzofurans; Chemical Phenomena; Chemistry; Erythrocytes; Folic Acid Antagonists; Glutamine; Gout; Humans; Metabolic Clearance Rate; Methotrexate; Purines; Time Factors; Transferases; Xanthine Oxidase | 1975 |
Generalized pustular psoriasis on withdrawal of clobetasol propionate ointment.
Topics: Azathioprine; Betamethasone; Female; Humans; Male; Methotrexate; Middle Aged; Ointments; Psoriasis; Steroids, Chlorinated | 1975 |
[Antiinflammatory drugs--Use of cytostatic drugs in rheumatic diseases].
Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Cyclophosphamide; Humans; Methotrexate | 1975 |
In vitro evaluation of methotrexate and azathioprine for antipsoriatic activity.
Topics: Acid Phosphatase; Azathioprine; Glucosephosphate Dehydrogenase; Humans; In Vitro Techniques; L-Lactate Dehydrogenase; Leucyl Aminopeptidase; Methotrexate; Oxygen Consumption; Pentosephosphates; Psoriasis; Skin | 1975 |
Failure to confirm reported lethal effect of cytotoxic drugs on encapsulated Trichinella spiralis larvae in mice.
Topics: Animals; Azathioprine; Cyclophosphamide; Guinea Pigs; Larva; Male; Methotrexate; Mice; Rabbits; Trichinella | 1975 |
Editorial: Immunosuppressive treatment for uveitis.
Topics: Adrenal Cortex Hormones; Azathioprine; Chlorambucil; Humans; Immunosuppressive Agents; Methotrexate; Nitrogen Mustard Compounds; Uveitis | 1975 |
Indications for systemic steroids in dermatology.
Topics: Adrenal Cortex Hormones; Azathioprine; Humans; Methotrexate; Skin Diseases | 1976 |
Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone.
Topics: Age Factors; Arthritis, Rheumatoid; Azathioprine; Drug Therapy, Combination; Gold; Humans; Hydroxychloroquine; Long-Term Care; Methotrexate; Middle Aged; Penicillamine; Prednisone; Private Practice | 1992 |
Inclusion body myositis: analysis of 32 cases.
Topics: Adult; Aged; Aged, 80 and over; Azathioprine; Biopsy; Cyclosporine; Demography; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Inclusion Bodies; Male; Methotrexate; Middle Aged; Muscles; Myositis; Prednisone; Retrospective Studies; Time Factors | 1992 |
Necrotizing mesenteric vasculitis after longstanding cutaneous polyarteritis nodosa.
Topics: Adult; Azathioprine; Cyclophosphamide; Dapsone; Female; Humans; Mesenteric Arteries; Methotrexate; Necrosis; Plasmapheresis; Polyarteritis Nodosa; Potassium Iodide; Prednisone; Vasculitis | 1992 |
Drugs for rheumatoid arthritis.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin; Azathioprine; Costs and Cost Analysis; Drugs, Investigational; Humans; Hydroxychloroquine; Methotrexate; Monitoring, Physiologic; Organogold Compounds; Penicillamine; Sulfasalazine | 1991 |
[Drug-induced interstitial lung diseases].
Topics: Antineoplastic Agents; Antirheumatic Agents; Azathioprine; Bleomycin; Humans; Methotrexate; Organogold Compounds; Penicillamine; Pulmonary Fibrosis | 1990 |
[An unusual case of heavy gamma-chain disease with several monoclonal components: IgG kappa, IgM lambda, Bence-Jones proteins kappa and lambda].
Topics: Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocols; Arthritis, Rheumatoid; Azathioprine; Bence Jones Protein; Combined Modality Therapy; Electrophoresis, Agar Gel; Female; Heavy Chain Disease; Humans; Immunoelectrophoresis; Immunoglobulin kappa-Chains; Immunoglobulin lambda-Chains; Lymphatic Diseases; Methotrexate; Middle Aged; Prednisolone; Splenectomy; Vincristine | 1991 |
Study of DNA repair in the peripheral blood lymphocytes of patients with rheumatic diseases under going treatment.
Topics: Adolescent; Adult; Arthritis, Rheumatoid; Azathioprine; DNA Repair; Humans; Lupus Erythematosus, Systemic; Lymphocytes; Methotrexate; Middle Aged; Prospidium; Reference Values | 1991 |
Methotrexate and rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Azathioprine; Humans; Methotrexate; Research Design | 1991 |
A prospective nationwide cross-sectional study of NSAID usage in 1331 patients with ankylosing spondylitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cross-Sectional Studies; Diclofenac; Female; Gold; Humans; Ibuprofen; Male; Methotrexate; Middle Aged; Naproxen; Penicillamine; Piroxicam; Prednisolone; Prospective Studies; Spondylitis, Ankylosing; Sulfasalazine; United Kingdom | 1990 |
Prolonged survival of rat cardiac allografts by donor pretreatment with methotrexate. Enhancement by combined immunosuppressant treatment of the recipient.
Topics: Animals; Azathioprine; Cyclosporins; Graft Rejection; Graft Survival; Heart Transplantation; Male; Methotrexate; Methylprednisolone; Rats; Rats, Inbred F344; Rats, Inbred Strains; Transplantation, Heterotopic; Transplantation, Homologous | 1991 |
Adult-onset polymyositis-dermatomyositis: description of 25 patients with emphasis on treatment.
Topics: Adult; Azathioprine; Cyclophosphamide; Dermatomyositis; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Myositis; Steroids | 1990 |
Intensive therapy for myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Bone Marrow Transplantation; Humans; Melphalan; Methotrexate; Methylprednisolone; Multiple Myeloma; Prednisolone; Vincristine | 1990 |
[The diagnostic significance of the test for spontaneous blood neutrophil damage in acute myeloid forms of leukemia].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Female; Humans; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Neutrophils; Prednisolone; Vincristine | 1990 |
Chronic liver diseases: current therapeutic options.
Topics: Adrenal Cortex Hormones; Autoimmune Diseases; Azathioprine; Cholangitis, Sclerosing; Chronic Disease; Colchicine; Diagnosis, Differential; Drug Therapy, Combination; Hepatitis B; Hepatitis C; Hepatitis, Chronic; Humans; Interferon Type I; Liver Cirrhosis, Biliary; Liver Diseases; Methotrexate | 1989 |
Drugs for rheumatoid arthritis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Azathioprine; Cyclophosphamide; Gold; Humans; Hydroxychloroquine; Methotrexate; Penicillamine; Salicylates; Sulfasalazine | 1989 |
Intractable RA--treatment with combined methotrexate, azathioprine and hydroxychloroquine.
Topics: Adult; Arthritis, Rheumatoid; Azathioprine; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Methotrexate; Middle Aged | 1989 |
Immunosuppression and murine polyomavirus infection.
Topics: Animals; Antibodies, Viral; Azathioprine; Brain; Cyclophosphamide; Immunosuppression Therapy; Immunosuppressive Agents; Kidney; Methotrexate; Mice; Mice, Inbred ICR; Polyomavirus; Prednisone; Time Factors; Tumor Virus Infections | 1988 |
Slow-acting anti-rheumatic drug therapy for rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Azathioprine; Cyclophosphamide; Gold; Humans; Hydroxychloroquine; Methotrexate; Penicillamine; Sulfasalazine | 1987 |
Studies on the effects of pharmacological agents on antigen-induced arthritis in BALB/c mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antigens; Arthritis; Arthritis, Experimental; Azathioprine; Chloroquine; Methotrexate; Mice; Mice, Inbred BALB C; Penicillamine; Sulfapyridine; Sulfasalazine; Tiopronin | 1987 |
[Treatment of rheumatoid arthritis: drugs which induce remission].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cyclophosphamide; Cyclosporins; Humans; Methotrexate; Organogold Compounds; Penicillamine | 1988 |
Toxicity of methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. A case-control study of 131 patients.
Topics: Actuarial Analysis; Arthritis, Rheumatoid; Azathioprine; Blood Urea Nitrogen; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Liver Function Tests; Male; Methotrexate; Middle Aged; Risk Factors; Time Factors | 1989 |
Reversal of neutropenia with methotrexate treatment in patients with Felty's syndrome. Correlation of response with neutrophil-reactive IgG.
Topics: Aged; Agranulocytosis; Azathioprine; Enzyme-Linked Immunosorbent Assay; Felty Syndrome; Female; Humans; Immunoglobulin G; Leukocyte Count; Methotrexate; Middle Aged; Neutropenia; Neutrophils; Prednisone | 1989 |
[Therapy of pemphigus. Critical remarks based on 44 clinical cases].
Topics: Adrenocorticotropic Hormone; Adult; Aged; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Pemphigus; Prednisone; Prognosis | 1985 |
[Remission in partial red cell aplasia achieved using a treatment with cyclosporin A].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Combined Modality Therapy; Cyclosporins; Female; Humans; Methotrexate; Plasmapheresis; Prednisolone; Red-Cell Aplasia, Pure; Remission Induction; Splenectomy; Vincristine | 1988 |
Effects of immunosuppressive drugs on the morphology of the microvilli in Sjögren's syndrome.
Topics: Azathioprine; Conjunctiva; Female; Humans; Immunosuppressive Agents; Methotrexate; Microvilli; Middle Aged; Sjogren's Syndrome | 1986 |
[Therapy of pemphigus and pemphigoid].
Topics: Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Humans; Methotrexate; Pemphigoid, Bullous; Pemphigus; Prednisone; Skin Diseases, Vesiculobullous | 1986 |
Comparative toxicity of total lymphoid irradiation and immunosuppressive drug treated patients with intractable rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Cyclophosphamide; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Immune Tolerance; Immunosuppressive Agents; Infections; Lymphoid Tissue; Male; Methotrexate; Middle Aged; Radiotherapy | 1987 |
[Immunomodulating therapy of collagen diseases].
Topics: Adrenal Cortex Hormones; Azathioprine; Collagen Diseases; Cyclophosphamide; Cyclosporins; Drug Administration Schedule; Humans; Immunization, Passive; Immunosuppressive Agents; Methotrexate | 1986 |
Comparison of methotrexate with azathioprine or 6-mercaptopurine in refractory rheumatoid arthritis: a life-table analysis.
Topics: Actuarial Analysis; Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Azathioprine; Female; Humans; Male; Mercaptopurine; Methotrexate; Middle Aged | 1986 |
Total body irradiation and the course of polymyositis.
Topics: Aged; Azathioprine; Biopsy; Combined Modality Therapy; Duodenal Ulcer; Female; Humans; Male; Methotrexate; Middle Aged; Muscles; Myositis; Peptic Ulcer Perforation; Postoperative Complications; Prednisolone; Radiotherapy Dosage; Whole-Body Irradiation | 1985 |
Slow acting anti-rheumatic drugs in the treatment of rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Aurothioglucose; Azathioprine; Cyclophosphamide; Gold; Gold Sodium Thiomalate; Humans; Hydroxychloroquine; Methotrexate; Penicillamine | 1985 |
The effect of some immunomodulating agents on the sensitization phase of experimental contact allergic reactions.
Topics: Animals; Azathioprine; Cyclophosphamide; Dermatitis, Atopic; Dermatitis, Contact; Dose-Response Relationship, Drug; Female; Guinea Pigs; Immunization; Methotrexate; Time Factors | 1986 |
[Polymyositis and dermatomyositis in the metropolitan hospital complex of the Panama Department of Social Security. 1973. Clinical review and effects of treatment].
Topics: Adolescent; Adult; Aged; Azathioprine; Child; Dermatomyositis; Female; Humans; Male; Methotrexate; Middle Aged; Myositis; Recurrence | 1985 |
Incidence of neoplasms in patients with rheumatoid arthritis exposed to different treatment regimens.
Topics: Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Cyclophosphamide; Cystitis; Humans; Immunosuppressive Agents; Leukemia; Lymphoma; Methotrexate; Neoplasms; Risk; Time Factors; Urinary Bladder Neoplasms | 1985 |
Cytostatic agents and contact allergy: the efferent limb.
Topics: Animals; Azathioprine; Basophils; Cyclophosphamide; Dermatitis, Contact; Female; Guinea Pigs; Immunity, Cellular; Immunoglobulin E; Immunosuppressive Agents; Leukocyte Count; Methotrexate; Oxazolone; Skin Tests; Time Factors | 1985 |
Acceleration of casein induced amyloidosis in mice by immunosuppressive agents.
Topics: Amyloid; Amyloidosis; Animals; Azathioprine; Busulfan; Caseins; Chloramphenicol; Cortisone; Dactinomycin; Daunorubicin; DNA; Female; Fluorouracil; Immunosuppressive Agents; Liver; Male; Mercaptopurine; Methotrexate; Mice; RNA; Spleen; Vinblastine | 1971 |
Is specific desensitization due to specific blocking antibodies or due to an immunological tolerance? New experiments on this problem.
Topics: Adrenal Cortex Hormones; Animals; Antibodies; Antibody Formation; Antigen-Antibody Complex; Antigens; Asthma; Autoradiography; Azathioprine; Desensitization, Immunologic; gamma-Globulins; Guinea Pigs; Horses; Humans; Immune Tolerance; Iodine Radioisotopes; Methotrexate; Pollen; Rhinitis, Allergic, Seasonal; Whooping Cough | 1972 |
In vitro studies of the cell-bound and antibody-mediated immunity evoked by murine renal allotransplants. Influence of presensitization, total body irradiation and immunosuppressive agents.
Topics: Animals; Antibody Formation; Antilymphocyte Serum; Azathioprine; Cells, Cultured; Dactinomycin; Disease Models, Animal; Female; Hot Temperature; Immunity, Cellular; Immunosuppressive Agents; Kidney; Kidney Transplantation; Leucovorin; Male; Methotrexate; Methylprednisolone; Radiation Effects; Rats; Thoracic Duct; Transplantation Immunology | 1973 |
[Immunosuppression of severe dermatomyositis with cytostatic drugs and thymectomy (author's transl)].
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Chronic Disease; Dactinomycin; Dermatomyositis; Female; Humans; Mercaptopurine; Methotrexate; Recurrence; Thymectomy | 1974 |
[The treatment of dermatomyositis].
Topics: Adolescent; Adrenocorticotropic Hormone; Alpha-Globulins; Antibodies, Antinuclear; Antimetabolites; Azathioprine; Blood Protein Electrophoresis; Calcinosis; Child; Creatine; Dermatomyositis; Electromyography; Exercise Therapy; Female; Fluorescent Antibody Technique; Fructose-Bisphosphate Aldolase; Growth Disorders; Humans; Immunosuppression Therapy; L-Lactate Dehydrogenase; Male; Mercaptopurine; Methotrexate; Middle Aged; Muscles; Prednisone; Remission, Spontaneous; Staphylococcal Infections; Transaminases | 1974 |
A contribution to the mechanism of drug inhibition of the graft vs host reaction.
Topics: Animals; Anti-Inflammatory Agents; Antibody Formation; Azathioprine; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Erythrocytes; Graft vs Host Reaction; Hemolytic Plaque Technique; Immunosuppressive Agents; Lymphoid Tissue; Methotrexate; Mice; Mice, Inbred Strains; Organ Size; Prednisolone; Sheep; Spleen; Splenomegaly; Transplantation, Homologous | 1973 |
The local graft versus host reaction in the rat as a tool for drug mechanism studies.
Topics: Alkylating Agents; Animals; Anti-Inflammatory Agents; Azathioprine; Dexamethasone; Dose-Response Relationship, Drug; Drug Interactions; Graft vs Host Reaction; Immunosuppressive Agents; In Vitro Techniques; Lymphocytes; Lymphoid Tissue; Male; Methotrexate; Organ Size; Phenylbutazone; Radiation Effects; Rats; Spleen; Structure-Activity Relationship; Time Factors; Transplantation Immunology | 1973 |
[Immunosuppressive agents].
Topics: Adrenal Cortex Hormones; Alkylating Agents; Anemia, Hemolytic, Autoimmune; Antibodies; Azathioprine; Blood Group Incompatibility; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; Polyarteritis Nodosa; Vascular Diseases | 1974 |
[DNA-synthesizing lymphocytes in the blood of patients with disseminated lupus erythematosus, rheumatoid arthritis, and panarteritis nodosa (author's transl)].
Topics: Adult; Aged; Arthritis, Rheumatoid; Azathioprine; Chloroquine; DNA; Female; Gold; Humans; Indomethacin; Leukocyte Count; Lupus Erythematosus, Systemic; Lymphocytes; Male; Methotrexate; Methylprednisolone; Middle Aged; Penicillamine; Polyarteritis Nodosa | 1973 |
Effect of predosing animals with immunosuppressive drugs on immune and non-immune induced inflammatory responses.
Topics: Adjuvants, Immunologic; Animals; Arthritis; Azathioprine; Carrageenan; Cyclophosphamide; Dexamethasone; Edema; Graft vs Host Reaction; Immunosuppressive Agents; Inflammation; Male; Methotrexate; Rats | 1974 |
Immunosuppressive therapy. The relation between clinical response and immunologic competence.
Topics: Adolescent; Adult; Anemia, Hemolytic, Autoimmune; Antibody Formation; Azathioprine; Chronic Disease; Colitis, Ulcerative; Female; gamma-Globulins; Hemagglutination Tests; Hemocyanins; Humans; Hypersensitivity, Delayed; Isoantibodies; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Myositis; Nephrotic Syndrome; Purpura, Thrombocytopenic; Skin Tests | 1967 |
Treatment of systemic lupus erythematosus (SLE) with immunosuppressive drugs 1: An analysis of immunologic data.
Topics: Adult; Aged; Antibodies, Antinuclear; Antibody Formation; Autoantibodies; Autoimmune Diseases; Azathioprine; Complement System Proteins; Diphtheria Toxoid; Female; Fluorescent Antibody Technique; gamma-Globulins; Humans; Hypersensitivity, Delayed; Latex Fixation Tests; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Nitrobenzenes; Salmonella paratyphi A; Tetanus Toxoid; Tuberculin Test; Vaccination | 1967 |
Prevention of tuberculous cavity formation by immunosuppressive drugs.
Topics: Animals; Azathioprine; Cyclophosphamide; Dactinomycin; Fluorouracil; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Rabbits; Tuberculosis, Pulmonary | 1968 |
The treatment of severe myasthenia gravis with immunosuppressive agents.
Topics: Adolescent; Adult; Age Factors; Agranulocytosis; Aminopterin; Azathioprine; Chemical and Drug Induced Liver Injury; Cholinesterase Inhibitors; Dactinomycin; Drug Synergism; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Middle Aged; Myasthenia Gravis; Time Factors | 1969 |
[Serological studies after homologous bone marrow transfusion].
Topics: Adult; Autoradiography; Azathioprine; Blood Group Antigens; Bone Marrow Transplantation; Female; Hemagglutination Tests; Hodgkin Disease; Humans; Methotrexate; Phenotype; Prednisone; Thymidine; Transplantation Immunology; Transplantation, Homologous; Tritium; Vinblastine | 1969 |
[Immunosuppressive long term therapy of visceral lupus erythematosus].
Topics: Adult; Amides; Antibodies, Antinuclear; Azathioprine; Dactinomycin; Female; Fluorescent Antibody Technique; Humans; Hydrazines; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Mercaptopurine; Methotrexate; Middle Aged; Neutrophils; Prednisone; Toluene | 1970 |
When to use cytotoxic drugs in rheumatoid arthritis.
Topics: Antigen-Antibody Complex; Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Informed Consent; Male; Mercaptopurine; Methotrexate; Nitrogen Mustard Compounds; Rheumatoid Factor; Synovial Membrane; Thiotepa | 1973 |
[Immunsuppressive treatment of multiple sclerosis. 2. Critical review of general results (author's transl)].
Topics: Antilymphocyte Serum; Azathioprine; Chronic Disease; Cyclophosphamide; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Long-Term Care; Mercaptopurine; Methotrexate; Multiple Sclerosis; Myelin Sheath; Nerve Tissue Proteins; Prednisolone; Prognosis; Tissue Extracts | 1974 |
Immunosuppression and experimental tuberculosis. II. The effects of immunosuppressive agents and antilymphocyte serum on the organ dissemination of mycobacteria and on the development of specific delayed hypersensitivity.
Topics: Animals; Antigens, Bacterial; Antilymphocyte Serum; Azathioprine; Azauridine; Cell Migration Inhibition; Chloramphenicol; Cyclophosphamide; Female; Hypersensitivity, Delayed; Immunosuppressive Agents; Kidney; Liver; Lung; Methotrexate; Mice; Mycobacterium tuberculosis; Spleen; Tuberculosis; Virulence | 1974 |
Immunosuppression by pyrimidine nucleoside analogs.
Topics: Animals; Antibody Formation; Antimetabolites; Azathioprine; Bromodeoxyuridine; Chloramphenicol; Cytarabine; Cytosine Nucleotides; Erythrocytes; Floxuridine; Hemagglutination Tests; Idoxuridine; Injections, Intraperitoneal; Injections, Subcutaneous; Mercaptoethanol; Mercaptopurine; Methotrexate; Mice; Nucleosides; Sheep | 1966 |
[Tolerance to the renal graft by combination, prior to transplantation, of immunosuppressive and antigenic treatments].
Topics: Animals; Azathioprine; Dogs; Immune Tolerance; Kidney Transplantation; Methotrexate; Nephrectomy; Transplantation Immunology; Transplantation, Homologous | 1967 |
Use of immunosuppressant drugs in nonneoplastic disease.
Topics: Antibody Formation; Azathioprine; Cyclophosphamide; DNA Replication; Humans; Immune Complex Diseases; Immunity, Cellular; Immunosuppressive Agents; Methotrexate | 1974 |
[Treatment of acute lymphoblastic leukemia during a remission by irradiation of the central nervous system and subsequent administration of 8 chemotherapeutic agents].
Topics: Adolescent; Adult; Alkaloids; Antineoplastic Agents; Azathioprine; Azirines; Child; Child, Preschool; Cyclophosphamide; Female; Humans; Injections, Intravenous; Leukemia, Lymphoid; Male; Mercaptopurine; Methotrexate; Prednisone; Vincristine | 1966 |
Methotrexate therapy of Wegener's granulomatosis.
Topics: Adrenocorticotropic Hormone; Adult; Azathioprine; Female; Granulomatosis with Polyangiitis; Humans; Male; Methotrexate; Middle Aged; Oxacillin; Prednisone; Time Factors | 1971 |
[Long term therapy of rheumatoid arthritis in children].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Arthritis, Juvenile; Azathioprine; Child; Chloroquine; Gold; Humans; Indomethacin; Long-Term Care; Manipulation, Orthopedic; Methotrexate; Phenylbutazone; Physical Therapy Modalities; Pyrazoles; Salicylates; Synovectomy; Uveitis, Anterior | 1970 |
The treatment of multiple sclerosis.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Azathioprine; Cyclophosphamide; Diet Therapy; Dietary Fats; Humans; Mercaptopurine; Methotrexate; Multiple Sclerosis; Physical Therapy Modalities | 1972 |
[Reiter's disease].
Topics: Adrenocorticotropic Hormone; Adult; Arthritis, Reactive; Azathioprine; Foot Dermatoses; Hand Dermatoses; Humans; Male; Methotrexate; Phenylbutazone; Skin Manifestations | 1974 |
Treatment of a case of sympathetic ophthalmia.
Topics: Acetates; Anti-Inflammatory Agents; Antilymphocyte Serum; Azathioprine; Cataract; Child; Chlorambucil; Dexamethasone; Esters; Humans; Intraocular Pressure; Male; Methotrexate; Mydriatics; Ophthalmia, Sympathetic; Ophthalmic Solutions; Prednisolone; Triamcinolone Acetonide; Visual Acuity | 1974 |
On the mode of action of some immunosuppressant drugs.
Topics: Animals; Azathioprine; Fluorouracil; Immunosuppressive Agents; Iodine Isotopes; Male; Methotrexate; Nitrogen Mustard Compounds; Rabbits; Skin Transplantation; Transplantation Immunology; Transplantation, Homologous; Triaziquone | 1968 |
[Treatment of autoimmune diseases].
Topics: Adrenal Cortex Hormones; Aged; Anemia, Hemolytic, Autoimmune; Antilymphocyte Serum; Autoimmune Diseases; Azathioprine; Blood Protein Disorders; Child, Preschool; Chloramphenicol; Chronic Disease; Colitis, Ulcerative; Crohn Disease; Drug Synergism; Female; Hepatitis; Humans; Immunosuppressive Agents; Long-Term Care; Lupus Vulgaris; Male; Methotrexate; Middle Aged; Nephrosis, Lipoid; Pemphigus; Polyarteritis Nodosa; Postoperative Complications; Purpura, Thrombocytopenic; Scleroderma, Systemic; Transplantation, Homologous | 1971 |
[Long-term treatment with imuran and methotrexate in rheumatoid conditions].
Topics: Arthritis, Rheumatoid; Azathioprine; Dermatomyositis; Humans; Methotrexate; Polyarteritis Nodosa; Time Factors | 1972 |
[Theoretical basis of immunosuppression in autoimmune diseases].
Topics: Antigens; Autoimmune Diseases; Azathioprine; Drug Synergism; Glucocorticoids; Humans; Immune Tolerance; Immunity; Immunity, Cellular; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mercaptopurine; Methotrexate; Pemphigus; Polyarteritis Nodosa | 1972 |
[Experience in using immunosuppressive-cytostatics in the treatment of psoriasis].
Topics: Adult; Aged; Azathioprine; Female; Humans; Male; Mercaptopurine; Methotrexate; Middle Aged; Psoriasis | 1974 |
Treatment of psoriatic arthropathy with either azathioprine or methotrexate.
Topics: Adult; Arthritis; Azathioprine; Female; Humans; Male; Methotrexate; Middle Aged; Psoriasis | 1974 |
[Autoimmune diseases and immunosuppressive therapy. I. Immunosuppressive agents].
Topics: Adrenal Cortex Hormones; Autoimmune Diseases; Azathioprine; Chlorambucil; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Male; Methotrexate | 1974 |
[A case of interstitial lymphoid pneumonia treated with immunosuppressors].
Topics: Adult; Azathioprine; Carbon Dioxide; Cyclophosphamide; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Male; Methotrexate; Partial Pressure; Prednisone; Pulmonary Alveoli; Pulmonary Fibrosis; Spirometry; Vital Capacity | 1974 |
Some aspects of anti-inflammatory action of immunosuppressive drugs.
Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents; Arthritis; Arthritis, Rheumatoid; Azathioprine; Carrageenan; Connective Tissue; Connective Tissue Cells; Cyclophosphamide; Edema; Female; Hydrocortisone; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Mycobacterium; Rats; Time Factors | 1974 |
Immunosuppression in the treatment of rheumatoid arthritis. Basic principles and available substances.
Topics: Alkylating Agents; Antimetabolites; Arthritis, Rheumatoid; Autoimmune Diseases; Azathioprine; Erythrocytes; Humans; Immunosuppressive Agents; Lymphocyte Activation; Methotrexate; Mitosis; Nitrogen Mustard Compounds | 1974 |
Teratogenicity from drugs--an increasing problem.
Topics: Abnormalities, Drug-Induced; Adrenal Cortex Hormones; Aminopterin; Amniocentesis; Animals; Anti-Bacterial Agents; Azathioprine; Azauridine; Busulfan; Chlorambucil; Colchicine; Contraceptives, Oral; Cyclophosphamide; Diethylstilbestrol; Ethanol; Female; Fetus; Genotype; Humans; Iodine Radioisotopes; Mercaptopurine; Methotrexate; Mice; Nitrogen Mustard Compounds; Phenotype; Pregnancy; Pregnancy, Animal; Prenatal Diagnosis; Radiation Genetics; Rats; Species Specificity; Thalidomide; Tranquilizing Agents | 1974 |
Lymphocyte cytotoxicity reactions to leukemia-associated antigens in identical twins.
Topics: Adolescent; Adult; Aged; Antigens; Azathioprine; Child; Child, Preschool; Chromium Isotopes; Cyclophosphamide; Cytotoxicity Tests, Immunologic; Diseases in Twins; Female; Humans; Immunity, Cellular; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphocytes; Male; Methotrexate; Middle Aged; Prednisone | 1972 |
Immunosuppressive drugs and acute leukemia.
Topics: Aged; Arthritis, Rheumatoid; Azathioprine; Cyclophosphamide; Dose-Response Relationship, Drug; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Male; Methotrexate; Prednisone; Time Factors; Vascular Diseases | 1973 |
Toxicity, clearance and distribution of endotoxin in mice as influenced by actinomycin D, cycloheximide, -amanitin and lead acetate.
Topics: Acetates; Animals; Azathioprine; Chromium Isotopes; Cycloheximide; Cyclophosphamide; Dactinomycin; Endotoxins; Escherichia coli; Fluorouracil; Injections, Intraperitoneal; Injections, Intravenous; Lead; Lethal Dose 50; Male; Methotrexate; Mice; Mycotoxins; Protein Biosynthesis; RNA; Salmonella; Time Factors | 1972 |
One-stage bilateral allotransplantation of canine lungs; further studies. Early rejection and prolonged survival with immunosuppression.
Topics: Animals; Antilymphocyte Serum; Autopsy; Azathioprine; Dogs; Graft Rejection; Immunosuppressive Agents; Lung; Lung Transplantation; Methotrexate; Postoperative Care; Postoperative Complications; Prednisolone; Pulmonary Edema; Respiratory Function Tests; Time Factors; Transplantation, Homologous | 1972 |
Reduction of immunogenicity of human cadaver renal allografts by donor pretreatment.
Topics: Antigens; Azathioprine; Blood Pressure; Cadaver; Creatinine; Cyclophosphamide; Cytotoxicity Tests, Immunologic; Diuresis; Graft Rejection; Humans; Kidney; Kidney Transplantation; Methotrexate; Methylprednisolone; Prednisone | 1973 |
One-stage allotransplantation of both lungs in the dog.
Topics: Administration, Oral; Animals; Azathioprine; Blood; Blood Cell Count; Carbon Dioxide; Dogs; Female; Graft Rejection; Hydrogen-Ion Concentration; Immunosuppressive Agents; Injections, Intramuscular; Injections, Subcutaneous; Lung; Lung Transplantation; Male; Methods; Methotrexate; Oxygen; Postoperative Care; Prednisone; Radiography; Time Factors; Tissue Survival; Transplantation, Homologous | 1973 |
[Bronchography in the surgery of pulmonary transplantation. Homograft].
Topics: Animals; Antilymphocyte Serum; Azathioprine; Biopsy; Bronchi; Bronchiectasis; Bronchography; Dogs; Graft Rejection; Immunosuppression Therapy; Lung; Lung Transplantation; Methotrexate; Transplantation, Homologous | 1972 |
Synergism of methotrexate with imuran and with 5-fluorouracil and their effects on hemolysin plaque-forming cell production in the mouse.
Topics: Animals; Antibody-Producing Cells; Azathioprine; Drug Synergism; Female; Fluorouracil; Hemolytic Plaque Technique; Methotrexate; Mice; Mice, Inbred C3H; Time Factors | 1974 |
[Proceedings: Immunosuppression and treatment of psoriasis using cytostatic agents].
Topics: Aged; Antineoplastic Agents; Azathioprine; Bibliographies as Topic; Chemical and Drug Induced Liver Injury; Humans; Hydroxyurea; Immunosuppression Therapy; Male; Methotrexate; Psoriasis | 1973 |
Pemphigus.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Cyclophosphamide; Fluorescent Antibody Technique; Humans; Methotrexate; Middle Aged; Pemphigus | 1974 |
Histopathology of one-stage bilateral lung allografts.
Topics: Animals; Antilymphocyte Serum; Azathioprine; Bronchi; Dogs; Graft Rejection; Immunosuppression Therapy; Lung; Lung Transplantation; Methotrexate; Methylprednisolone; Prednisolone; Pulmonary Alveoli; Pulmonary Artery; Pulmonary Embolism; Respiratory Tract Infections; Sepsis; Time Factors; Transplantation, Homologous | 1974 |
[Indications for immunosuppression by use of cytostatics in ophthalmology].
Topics: Adolescent; Adult; Aged; Autoimmune Diseases; Azathioprine; Child; Corneal Transplantation; Cyclophosphamide; Eye Diseases; Graft Rejection; Humans; Immunosuppressive Agents; Infant; Methotrexate; Middle Aged; Monomethylhydrazine; Transplantation, Homologous; Uveitis; Vincristine | 1972 |
[Lupus erythematosus in childhood].
Topics: Anemia, Hemolytic, Autoimmune; Autoantibodies; Azathioprine; Child; Chloroquine; Female; Humans; Lupus Erythematosus, Systemic; Methotrexate; Prednisone | 1973 |
The clinical use of immunosuppressive drugs.
Topics: Adrenal Cortex Hormones; Aged; Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Infections; Male; Methotrexate; Pregnancy; Psoriasis | 1973 |
The effect of various immunosuppressive agents on the vascular and cellular response to carvageenan in the rat.
Topics: Animals; Azathioprine; Busulfan; Carrageenan; Chlorambucil; Cyclophosphamide; Edema; Immunosuppressive Agents; Inflammation; Leukocyte Count; Male; Mercaptopurine; Methotrexate; Rats; Time Factors | 1973 |
Immunosuppression and experimental tuberculosis. I. The effects of immunosuppressive agents, antilymphocyte serum and antimacrophage serum on the survival of animals with subacute experimental tuberculosis.
Topics: Animals; Antilymphocyte Serum; Azathioprine; Azauridine; Chloramphenicol; Cyclophosphamide; Female; Hydrocortisone; Immunosuppressive Agents; Methotrexate; Mice; Time Factors; Tuberculosis | 1973 |
Treatment of polymyositis with immunosuppressive drugs.
Topics: Adult; Aged; Aspartate Aminotransferases; Azathioprine; Child; Creatine Kinase; Cyclophosphamide; Drug Synergism; Evaluation Studies as Topic; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Middle Aged; Myositis; Prednisolone; Prednisone | 1973 |
Immunosuppressive therapy.
Topics: Anemia, Hemolytic, Autoimmune; Antigen-Antibody Reactions; Arthritis, Rheumatoid; Azathioprine; Crohn Disease; Cyclophosphamide; Female; Glomerulonephritis; Glucocorticoids; Hepatitis; Humans; Immunity; Immunity, Cellular; Immunosuppression Therapy; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Nephrotic Syndrome; Purpura, Thrombocytopenic | 1973 |
[Treatment of polyarthritis by immunosuppressive agents].
Topics: Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Cyclophosphamide; Evaluation Studies as Topic; Humans; Immunosuppressive Agents; Methotrexate | 1973 |
Studies on the novo synthesis of nucleic acids in stimulated human lymphocytes.
Topics: Asparaginase; Azathioprine; Carbon Radioisotopes; Glycine; Humans; Lectins; Lymphocyte Activation; Lymphocytes; Methotrexate; Nucleic Acids; Orotic Acid; Prednisolone; Purines; Pyrimidines | 1973 |
Myositis in father and daughter.
Topics: Adult; Alanine Transaminase; Azathioprine; Child; Creatine Kinase; Dermatomyositis; Female; Humans; Male; Methotrexate; Muscles; Myositis; Prednisolone; Pulmonary Artery | 1973 |
[Systemic lupus erythematosus. Etiopathogenesis and immunosuppressive therapy].
Topics: Adolescent; Adult; Antibody Formation; Azathioprine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Melphalan; Methotrexate; Middle Aged; Prednisone | 1973 |
[Treatment of "collagen and autoimmune" diseases (author's transl)].
Topics: Adolescent; Adult; Aminobenzoates; Azathioprine; Chloroquine; Cyclophosphamide; Dermatomyositis; Dextrans; Female; Humans; Indomethacin; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Norethindrone; Penicillamine; Pregnanes; Scleroderma, Localized; Scleroderma, Systemic | 1973 |
[Treatment of rheumatoid arthritis with cytostatics].
Topics: Adult; Aged; Arthritis, Rheumatoid; Azathioprine; Female; Humans; Male; Methotrexate; Middle Aged | 1974 |
[Clinical picture of rheumatologic diseases. Current status of cytostatic therapy].
Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Cyclophosphamide; Humans; Immunosuppression Therapy; Methotrexate; Neoplasms; Penicillamine; Time Factors; Triaziquone | 1974 |
Experimental studies of canine lung allotransplantation. The effect of cytotoxic agents and donor spleen cells for immunosuppressive treatment.
Topics: Adrenal Cortex Hormones; Animals; Azathioprine; Dogs; Immunosuppressive Agents; Leucovorin; Leukocyte Count; Lung; Lung Transplantation; Lymphocytes; Methotrexate; Spleen; Splenectomy; Transplantation Immunology; Transplantation, Homologous | 1968 |
Regional infusion chemotherapy for prolongation of kidney allografts.
Topics: Animals; Antimetabolites; Azathioprine; Dogs; Histocompatibility; Immunosuppressive Agents; Infusions, Parenteral; Kidney Transplantation; Mechlorethamine; Mercaptopurine; Methotrexate; Mortality; Prednisone; Transplantation Immunology; Transplantation, Homologous | 1969 |
Autoimmune disease.
Topics: Adolescent; Antibodies, Antinuclear; Antigen-Antibody Reactions; Autoantibodies; Autoimmune Diseases; Azathioprine; Child; Complement System Proteins; Corticosterone; Cyclophosphamide; Female; Fluorescent Antibody Technique; Humans; Hypersensitivity, Delayed; Hypersensitivity, Immediate; Immunosuppressive Agents; Kidney Diseases; Lupus Erythematosus, Systemic; Lymphoid Tissue; Male; Methotrexate | 1969 |
A study of combined treatment with chemical immunosuppressants and antilymphocytic serum to prolong skin allograft survival.
Topics: Animals; Antilymphocyte Serum; Azathioprine; Cyclophosphamide; Drug Synergism; Female; Histocompatibility; Hydrocortisone; Immunosuppressive Agents; Injections; Methotrexate; Mice; Skin Transplantation; Thymectomy; Thymus Gland; Transplantation Immunology | 1969 |
The immunodepressive activity of N-diazoacetylglycine amide in some transplantation systems.
Topics: Acetates; Amides; Animals; Azathioprine; Azo Compounds; Carcinoma, Ehrlich Tumor; Diazonium Compounds; Female; Glycine; Immunosuppressive Agents; Leukemia, Experimental; Male; Methotrexate; Mice; Neoplasm Transplantation; Skin Transplantation | 1970 |
Immunosuppressive drugs. I.
Topics: Adrenal Cortex Hormones; Animals; Antibodies; Antibody Formation; Antilymphocyte Serum; Antineoplastic Agents; Azathioprine; Cyclophosphamide; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Immunoglobulins; Immunosuppressive Agents; Kidney Transplantation; Mercaptopurine; Methotrexate; Neoplasms; Skin Transplantation; Transplantation Immunology | 1970 |
Pneumocystitis carinii pneumonia: percutaneous lung biopsy and review of literature.
Topics: Adolescent; Adult; Agammaglobulinemia; Amphotericin B; Anuria; Azathioprine; Biopsy; Bis-Trimethylammonium Compounds; Busulfan; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mycosis Fungoides; Pneumonia, Pneumocystis; Prednisone; Transplantation, Homologous; Vincristine | 1971 |
[Contribution on the therapy of progressive chronic polyarthritis with antimetabolites and cytostatics].
Topics: Adolescent; Antimetabolites; Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Betamethasone; Chronic Disease; Humans; Male; Mercaptopurine; Methotrexate; Middle Aged; Synovitis; Thiotepa | 1967 |
Effect of azathioprine and amethopterin on secondary disease in the rhesus monkey. SAM-TR-67-94.
Topics: Animals; Azathioprine; Bone Marrow Transplantation; Cobalt Isotopes; Female; Haplorhini; Male; Methotrexate; Radiation Injuries, Experimental; Transplantation, Homologous | 1967 |
Progress in the treatment and prevention of secondary disease after homologous bone marrow transplantation in monkeys. Effects of chemotherapy and of donor selection by histocompatibility testing.
Topics: Animals; Antilymphocyte Serum; Azathioprine; Bone Marrow Transplantation; Cyclophosphamide; Haplorhini; Histocompatibility; Methotrexate; Mice; Mosaicism; Radiation Effects; Sex Chromatin; Skin Transplantation; Time Factors; Transplantation Immunology; Transplantation, Homologous | 1968 |
The effect of cytotoxic agents on the passive transfer of cell-mediated immunity.
Topics: Animals; Azathioprine; Cyclophosphamide; Female; Immunity, Maternally-Acquired; Immunosuppressive Agents; Listeria monocytogenes; Liver; Methotrexate; Mice; Radiation Effects; Spleen; Vinblastine | 1969 |
The effect of cytotoxic agents on the primary immune response to Listeria monocytogenes.
Topics: Animals; Azathioprine; Cyclophosphamide; Female; Immunosuppressive Agents; Listeria monocytogenes; Listeriosis; Liver; Methotrexate; Mice; Spleen; Vinblastine | 1969 |
Studies on the influence of immunodepressant drugs on blastic transformation and tissue respiration in immunologically active organs.
Topics: Animals; Azathioprine; Immunosuppressive Agents; In Vitro Techniques; Lymph Nodes; Lymphocyte Activation; Lymphocytes; Mechlorethamine; Methotrexate; Oxygen Consumption; Rabbits; Skin Transplantation; Spleen; Thiotepa; Thymus Gland; Transplantation Immunology; Transplantation, Homologous; Triaziquone | 1969 |
[Treatment of chronic connective tissue diseases with cytostatics].
Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Chronic Disease; Collagen Diseases; Cyclophosphamide; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mercaptopurine; Methotrexate; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllum; Prednisolone; Spondylitis, Ankylosing; Thiotepa; Triaziquone | 1970 |
Immunosuppressive methods and antilymphocytic serum.
Topics: Antilymphocyte Serum; Azathioprine; Colchicine; Cortisone; Cyclophosphamide; Dactinomycin; DNA; Drainage; Fluorouracil; Histocompatibility Testing; Humans; Immune Tolerance; Immunosuppressive Agents; Lymph; Mercaptopurine; Methods; Methotrexate; Prednisone; Radiotherapy; Radiotherapy Dosage; Rh-Hr Blood-Group System; RNA; Splenectomy; Thymectomy; Transplantation Immunology; Triethylenemelamine | 1970 |
Dermatomyositis.
Topics: Adult; Azathioprine; Dermatomyositis; Humans; Male; Methotrexate; Prednisone; Remission, Spontaneous | 1972 |
Activities of immunosuppressive agents in vitro. II. Different timing of azathioprine and methotrexate in inhibition and stimulation of mixed lymphocyte reaction.
Topics: Antigens; Azathioprine; Cell Division; Cytotoxicity Tests, Immunologic; Depression, Chemical; Humans; Immune Adherence Reaction; In Vitro Techniques; Kinetics; Lymphocytes; Methotrexate; Stimulation, Chemical; Thymidine; Tritium; Trypan Blue | 1972 |
Treatment of pityriasis rubra pilaris with azathioprine.
Topics: Aged; Azathioprine; Betamethasone; Female; Humans; Male; Methotrexate; Middle Aged; Pityriasis Rubra Pilaris; Time Factors; Vitamin A | 1972 |
[Clinical aspects of immunosuppressive therapy in childhood rheumatoid arthritis].
Topics: Adrenal Cortex Hormones; Alkylating Agents; Arthritis, Juvenile; Azathioprine; Child; Humans; Immunity, Cellular; Immunosuppression Therapy; Methotrexate; Neoplasms; Penicillamine | 1972 |
[Therapy of idiopathic thrombocytopenic purpura. I. Clinical experience with immunodepressive cytotoxic treatment].
Topics: Adult; Aged; Asparaginase; Azathioprine; Cyclophosphamide; Female; Humans; Male; Methotrexate; Middle Aged; Purpura, Thrombocytopenic; Remission, Spontaneous; Splenectomy; Vinblastine | 1972 |
[Immunosuppressive therapy of systemic lupus erythematosus].
Topics: Azathioprine; Complement System Proteins; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; Prednisone; Time Factors | 1971 |
[Evaluation, in newborn Swiss mice, of the carcinogenic activity of some antineoplastic and immunosuppressive compounds].
Topics: Adenoma; Animals; Animals, Newborn; Antineoplastic Agents; Asparaginase; Azathioprine; Fluorouracil; Immunosuppressive Agents; Leukemia, Experimental; Leukemia, Lymphoid; Lung Neoplasms; Methotrexate; Mice; Neoplasms, Experimental | 1971 |
[Hair changes in immunosuppressive therapy].
Topics: Antineoplastic Agents; Azathioprine; Chlorambucil; Cyclophosphamide; Hair; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Melphalan; Mercaptopurine; Methotrexate; Neoplasms; Scleroderma, Systemic; Skin Diseases; Vinblastine | 1971 |
[Comparison of various immunosuppressive agents in the treatment of rheumatoid polyarthritis. 41 personal cases].
Topics: Arthritis, Rheumatoid; Azathioprine; Blood Sedimentation; Chlorambucil; Cyclophosphamide; Humans; Immunoelectrophoresis; Immunosuppressive Agents; Lymphocyte Activation; Mercaptopurine; Methotrexate; Rheumatoid Factor; Skin Manifestations; Statistics as Topic | 1971 |
A comparison of immunosuppressive and anti-inflammatory agents in the rat.
Topics: Animals; Anti-Inflammatory Agents; Antibody Formation; Antilymphocyte Serum; Arthritis; Azathioprine; Chlorambucil; Cyclophosphamide; Erythrocytes; Female; Freund's Adjuvant; Hindlimb; Hydrocortisone; Hypersensitivity, Delayed; Immunosuppressive Agents; Inflammation; Male; Methotrexate; Phenylbutazone; Rats; Sheep; Tuberculin Test | 1971 |
[Experiences with antimetabolite therapy of malignant forms of progressive chronic polyarthritis].
Topics: Antimetabolites; Arthritis, Rheumatoid; Azathioprine; Chronic Disease; Feeding and Eating Disorders; Humans; Mercaptopurine; Methotrexate; Nausea; Time Factors | 1966 |
[Progress in the therapy of leukoses].
Topics: Antineoplastic Agents; Azathioprine; Busulfan; Chlorambucil; Cyclophosphamide; Daunorubicin; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Mannitol; Methotrexate; Mitomycins; Triethylenemelamine; Vincristine | 1970 |
Immunosuppressive drugs in treatment of myasthenia gravis.
Topics: Adult; Autoimmune Diseases; Azathioprine; Blood Cell Count; Busulfan; Cyclophosphamide; Female; Humans; Hypersensitivity, Delayed; Immunosuppressive Agents; Male; Melphalan; Mercaptopurine; Methotrexate; Myasthenia Gravis | 1971 |
[Treatment of systemic lupus erythematosus with antimetabolites. Relations between the clinical course and immunological reactions].
Topics: Antibodies, Antinuclear; Autoantibodies; Azathioprine; Complement System Proteins; Humans; Lupus Erythematosus, Systemic; Methotrexate | 1967 |
[Positive and negative effects of cytostatic therapy in rheumatic patients].
Topics: Antineoplastic Agents; Azathioprine; Chlorambucil; Cyclophosphamide; Humans; Mercaptopurine; Methotrexate; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllum; Rheumatic Diseases; Triaziquone | 1970 |
[Treatment of systemic lupus erythematosus with antimetabolites. Relations between the clinical course and immunological reactions].
Topics: Antibodies, Antinuclear; Antigen-Antibody Reactions; Antimetabolites; Azathioprine; Humans; Immunoglobulins; Lupus Erythematosus, Systemic; Methotrexate | 1967 |
Left lower pulmonary lobe transplantation.
Topics: Angiography; Animals; Azathioprine; Blood Cell Count; Bronchospirometry; Dogs; Lung; Lung Transplantation; Methotrexate; Transplantation Immunology; Transplantation, Homologous | 1965 |
Pulmonary function in dogs after lung homotransplantation.
Topics: Animals; Azathioprine; Bronchoscopy; Dogs; Lung Transplantation; Methotrexate; Respiratory Function Tests; Transplantation, Homologous | 1966 |
[On the modification of tolerance in skin transplantations by various measures (cytostatics, Trasylol, thymectomy, splenectomy)].
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Aprotinin; Azathioprine; Immune Tolerance; Methotrexate; Rats; Skin Transplantation; Splenectomy; Thymectomy; Transplantation Immunology; Transplantation, Homologous; Triaziquone | 1966 |
Chemotherapy of experimental allergic encephalomyelitis (EAE).
Topics: Allopurinol; Aminocaproates; Analgesics; Animals; Antineoplastic Agents; Azathioprine; Body Weight; Chloroquine; Colchicine; Cortisone; Cyclophosphamide; Cyproheptadine; Diazoxide; Dimethyl Sulfoxide; Encephalomyelitis, Autoimmune, Experimental; Hydrocortisone; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Methyldopa; Nialamide; Oils; Organ Size; Rats; Strychnine; Talc; Thalidomide; Thioguanine; Thiomalates | 1969 |
Suppression of experimental allergic encephalomyelitis by NSC 82196, a new imidazole carboxamide derivative.
Topics: Amides; Animals; Azathioprine; Cyclophosphamide; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Imidazoles; Immunosuppressive Agents; Methotrexate; Nitrogen Mustard Compounds; Rats | 1969 |
[Cytostatic and antimetabolite therapy in chronic inflammatory joint diseases and collagen diseases].
Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Biopsy; Collagen Diseases; Cyclophosphamide; Humans; Immunosuppressive Agents; Injections, Intravenous; Methotrexate; Phytotherapy; Plants, Medicinal; Plants, Toxic; Podophyllin; Podophyllum; Synovial Membrane; Triaziquone | 1969 |
[Immunosuppressive therapy in pemphigus vulgaris].
Topics: Adult; Aged; Azathioprine; Desoxycorticosterone; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Middle Aged; Pemphigus; Prednisone; Triamcinolone | 1970 |
[Practical use of immunosuppressive and cytostatic drugs in dermatological diseases].
Topics: Antineoplastic Agents; Azathioprine; Condylomata Acuminata; Fluorouracil; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mercaptopurine; Methotrexate; Papilloma; Pemphigus; Precancerous Conditions; Psoriasis; Scleroderma, Systemic; Skin Diseases; Skin Neoplasms; Virus Diseases | 1970 |
[Preliminary studies of the evaluation of immunodepressive activity in L1210 leukemia allografts in mice].
Topics: Amides; Animals; Azathioprine; Azo Compounds; Busulfan; Cyclophosphamide; Glycine; Immunosuppressive Agents; Leukemia L1210; Methotrexate; Mice; Neoplasm Transplantation; Transplantation, Homologous | 1970 |
[Collagen diseases].
Topics: Arthritis, Rheumatoid; Azathioprine; Collagen Diseases; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mercaptopurine; Methotrexate; Thioguanine | 1970 |
[Treatment of dermatologic lesions using immunosuppressive agents and cytostatics].
Topics: Antineoplastic Agents; Azathioprine; Dermatomyositis; Fluorouracil; Humans; Immunosuppressive Agents; Methotrexate; Pemphigus; Psoriasis; Scleroderma, Systemic; Skin Diseases; Skin Neoplasms | 1970 |
The effect of methotrexate, corticosteroids and azathioprine on fingernail growth in psoriasis.
Topics: Azathioprine; Humans; Methotrexate; Nails; Prednisone; Psoriasis | 1970 |
[Our experience in the therapy of acute leukemia in childhood. Pharmacotherapy--enzymetherapy--immunotherapy].
Topics: Antibiotics, Antineoplastic; Asparaginase; Azathioprine; Child; Child, Preschool; Cyclophosphamide; Humans; Immunization, Passive; Immunotherapy; Leukemia; Methotrexate; Prednisone | 1970 |
[Immunosuppressive agents and cytogenetics].
Topics: Azathioprine; Chromosome Aberrations; Cytogenetics; Female; Humans; Immunosuppressive Agents; Leukemia, Radiation-Induced; Male; Meiosis; Methotrexate; Psoriasis | 1970 |
[Immunosuppressive agents and bullous diseases].
Topics: Adult; Aged; Autoantibodies; Azathioprine; Dermatitis Herpetiformis; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Pemphigus | 1970 |
[2 cases of systemic lupus erythematosus treated with immunosuppressive agents].
Topics: Azathioprine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; Prednisone | 1970 |
Mechanism of action of cytotoxic agents.
Topics: Animals; Antimetabolites; Antineoplastic Agents; Azathioprine; Cell Division; Cyclophosphamide; Methotrexate; Mice | 1970 |
QImmunosuppressive therapy of glomerulonephritis.
Topics: Azathioprine; Biopsy; Glomerulonephritis; Humans; Immunosuppressive Agents; Methotrexate; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone | 1970 |
Suppression of an antibody to factor VIII by a combination of factor VIII and cyclophosphamide.
Topics: Antibodies; Antigen-Antibody Reactions; Antigens; Azathioprine; Blood Coagulation Disorders; Blood Coagulation Tests; Chromatography, Gel; Cyclophosphamide; Drug Synergism; Factor VIII; Female; Hematoma; Hemorrhage; Humans; Immune Tolerance; Immunoglobulin G; Immunosuppression Therapy; Melena; Methotrexate; Middle Aged; Precipitin Tests; Psoriasis; Respiratory Tract Infections; Triamcinolone | 1971 |
The effect of anti-metabolites on leptazol induced fits in rats.
Topics: Animals; Antimetabolites; Azathioprine; Brain; Cytarabine; Daunorubicin; Fluorouracil; Folic Acid; Folic Acid Antagonists; Methotrexate; Pentylenetetrazole; Pyrimethamine; Rats; Seizures | 1971 |
Immune response to insulin in guinea pigs.
Topics: Adjuvants, Immunologic; Animals; Antibody Formation; Azathioprine; Body Weight; Cattle; Chromatography; Cyclophosphamide; Drug Hypersensitivity; Guinea Pigs; Immunization; Immunoassay; Immunoglobulin G; Immunosuppressive Agents; Insulin; Insulin Antibodies; Insulin, Long-Acting; Male; Mercaptopurine; Methotrexate; Oils; Prednisolone; Protein Binding; Swine | 1971 |
[Immunosuppressive therapy with antimetabolites].
Topics: Adrenal Cortex Hormones; Antimetabolites; Arthritis; Azathioprine; Blood Sedimentation; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate | 1967 |
Cytotoxic therapy in rheumatoid arthritis.
Topics: Antibody Formation; Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Cyclophosphamide; Humans; Immunity; Mechlorethamine; Methotrexate | 1968 |
Methotrexate and the platelet count.
Topics: Antineoplastic Agents; Azathioprine; Blood Cell Count; Blood Platelets; Fluorouracil; Humans; Leukopenia; Methotrexate; Neoplasms; Thrombocytopenia; Thrombocytosis; Time Factors | 1968 |
Immunopharmacologic activity of 1-aminocyclopentane-1-carboxylic acid.
Topics: Anaphylaxis; Animals; Azathioprine; Cortisone; Cyclopentanes; Cyclophosphamide; Encephalomyelitis, Autoimmune, Experimental; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Rats; Thioguanine | 1968 |
[Modern therapeutic possibilities in Cooley's disease].
Topics: Adolescent; Antibody Formation; Azathioprine; Betamethasone; Blood Transfusion; Child; Child, Preschool; Deferoxamine; Drug Tolerance; Humans; Immune Tolerance; Infant; Methotrexate; Thalassemia | 1966 |
The inhibition of granuloma formation around Schistosoma mansoni eggs. I. Immunosuppressive drugs.
Topics: Animals; Azathioprine; Dactinomycin; Fluocinolone Acetonide; Granuloma; Methotrexate; Mice; Schistosoma; Thioguanine | 1967 |
Combined effects of temperature and immunosuppressive drug therapy on allograft rejection in goldfish.
Topics: Animals; Azathioprine; Cyprinidae; Drug Synergism; Inflammation; Methotrexate; Temperature; Transplantation Immunology; Transplantation, Homologous | 1967 |
Chromosome studies in patients treated with azathioprine and amethopterin.
Topics: Adult; Autoimmune Diseases; Azathioprine; Bone Marrow; Bone Marrow Cells; Chromosome Aberrations; Chromosome Disorders; Female; Humans; Lymphocytes; Male; Methotrexate; Middle Aged | 1967 |
[The immunosuppressive agents. 3. The immunosuppressive agents in hematology].
Topics: Anemia, Hemolytic, Autoimmune; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mercaptopurine; Methotrexate; Nitrogen Mustard Compounds; Purpura, Thrombocytopenic; Thioguanine | 1967 |
Kurloff cell levels in the peripheral blood of normal guinea-pigs treated with cytotoxic drugs.
Topics: Animals; Antineoplastic Agents; Azathioprine; Blood Cell Count; Blood Cells; Busulfan; Cyclophosphamide; Female; Guinea Pigs; Melphalan; Methotrexate | 1980 |
Diagnosis and management of Reiter's syndrome.
Topics: Adult; Anti-Inflammatory Agents; Arthritis, Reactive; Azathioprine; Child; Diagnosis, Differential; Female; HLA Antigens; HLA-B27 Antigen; Humans; Indomethacin; Male; Methotrexate; Phenylbutazone; Prognosis | 1984 |
Induction of specific unresponsiveness to heart allografts in mongrel dogs treated with total lymphoid irradiation and antithymocyte globulin.
Topics: Animals; Antilymphocyte Serum; Azathioprine; Bone Marrow Transplantation; Combined Modality Therapy; Dogs; Female; Graft Survival; Heart Transplantation; Immune Tolerance; Lymphoid Tissue; Male; Methotrexate; Rabbits; Radiation Chimera; T-Lymphocytes; Whole-Body Irradiation | 1984 |
Comparison of cytostatic sensitivities of L 1210 cells and human stimulated lymphocytes in three cell proliferation assays.
Topics: Animals; Antimetabolites, Antineoplastic; Azathioprine; Cell Division; Cells, Cultured; Cytarabine; Dose-Response Relationship, Drug; Growth Inhibitors; Humans; Kinetics; Leukemia L1210; Lymphocytes; Methotrexate; Thymidine | 1980 |
[Xenogeneic transplantation of human malignant melanoma under high-dose immunosuppression].
Topics: Animals; Azathioprine; Humans; Immunosuppression Therapy; Male; Melanoma; Methotrexate; Neoplasm Transplantation; Rats; Rats, Inbred Strains; Transplantation, Heterologous | 1984 |
Monitoring of organ formation in rat embryos after in vitro exposure to azathioprine, mercaptopurine, methotrexate or cyclosporin A.
Topics: Abnormalities, Drug-Induced; Animals; Azathioprine; Brain; Cyclosporins; Dose-Response Relationship, Drug; Female; Male; Mercaptopurine; Methotrexate; Organ Culture Techniques; Pregnancy; Rats; Rats, Inbred Strains | 1984 |
Therapy for immunologic disease. New ways of using old drugs.
Topics: Adrenal Cortex Hormones; Azathioprine; Cyclophosphamide; Cytotoxicity, Immunologic; Drug Administration Schedule; Humans; Immune System Diseases; Methotrexate | 1983 |
[The use of immunosuppressive drugs in the treatment of rheumatoid arthritis].
Topics: Arthritis, Rheumatoid; Azathioprine; Chlorambucil; Cyclophosphamide; Humans; Immunosuppressive Agents; Methotrexate; Neoplasms; Risk | 1983 |
Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine.
Topics: Adenocarcinoma; Adolescent; Adult; Azathioprine; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Prednisone; Uterine Neoplasms | 1984 |
Management of polymyositis and dermatomyositis.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Calcinosis; Child; Child, Preschool; Dermatomyositis; Digitalis Glycosides; Female; Humans; Male; Methotrexate; Middle Aged; Myositis; Plasmapheresis; Skin | 1984 |
Immunosuppressive drugs in the treatment of immunologic iridocyclitis in the rabbit.
Topics: Animals; Aqueous Humor; Azathioprine; Busulfan; Drug Evaluation, Preclinical; Female; Hypersensitivity, Immediate; Immunosuppressive Agents; Male; Methotrexate; Orosomucoid; Rabbits; Sialic Acids; Thiotepa; Uveitis, Anterior | 1980 |
Cyclophosphamide pretreatment in tumor cryotherapy: a comparison with alternative drugs.
Topics: Animals; Antineoplastic Agents; Azathioprine; Cryosurgery; Cyclophosphamide; Drug Administration Schedule; Methotrexate; Mice; Mice, Inbred A; Sarcoma, Experimental | 1983 |
Reiter's syndrome--1982.
Topics: Arthritis, Reactive; Azathioprine; Female; HLA Antigens; HLA-B27 Antigen; Humans; Indomethacin; Male; Methotrexate; Phenylbutazone | 1982 |
Organ transplantation in mongrel dogs using total lymphoid irradiation (TLI).
Topics: Animals; Antilymphocyte Serum; Azathioprine; Bone Marrow Transplantation; Dogs; Dose-Response Relationship, Radiation; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Lymphoid Tissue; Methotrexate; X-Rays | 1981 |
Lymphoma and leukaemia due to drugs.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Bone Marrow Diseases; Child; Female; Hodgkin Disease; Humans; Immunosuppression Therapy; Kidney; Kidney Transplantation; Leukemia; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Methotrexate | 1980 |
Comparative activity of CP-17,193 and five established immunosuppressives toward the antigens SRBC and EL4.
Topics: Animals; Antibody Formation; Antigens; Azathioprine; Cyclophosphamide; Erythrocytes; Hemagglutination Tests; Hemolytic Plaque Technique; Immunity, Cellular; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Mice; Mice, Inbred BALB C; Pyrazoles; Pyridines | 1981 |
Kaposi's sarcoma in a patient with dermatomyositis receiving immunosuppressive therapy.
Topics: Azathioprine; Cell Count; Dermatomyositis; Female; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Prednisone; Sarcoma, Kaposi | 1982 |
Synergism between immunosuppressive agents and uremia?
Topics: Animals; Antibody Formation; Azathioprine; Cyclophosphamide; Female; Immunosuppressive Agents; Methotrexate; Rats; Uremia | 1982 |
Selective effects of immunosuppressive agents against the delayed hypersensitivity response and humoral response to sheep red blood cells in mice.
Topics: Animals; Antibody Formation; Azathioprine; Cyclophosphamide; Erythrocytes; Hypersensitivity, Delayed; Immunosuppressive Agents; Male; Methotrexate; Mice; Procarbazine; Sheep | 1981 |
[Medicamental immunosuppression in dermatology (author's transl)].
Topics: Autoimmune Diseases; Azathioprine; Chlorambucil; Collagen Diseases; Cyclophosphamide; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Outcome and Process Assessment, Health Care; Skin Diseases | 1981 |
[Immunosuppressive agents].
Topics: Alkylating Agents; Antilymphocyte Serum; Azathioprine; Humans; Immune System Diseases; Immunosuppressive Agents; Methotrexate; Postoperative Complications; Transplantation | 1980 |
[Failures of cytostatic treatment in ophthalmology (author's transl)].
Topics: Adult; Azathioprine; Child; Corneal Diseases; Cyclophosphamide; Eye Diseases; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Procarbazine; Uveitis | 1980 |
Survival analysis of disease modifying antirheumatic drugs in Spanish rheumatoid arthritis patients.
Topics: Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Female; Humans; Male; Methotrexate; Middle Aged; Organogold Compounds; Penicillamine; Probability; Sex Factors; Spain; Statistics, Nonparametric; Survival Analysis; Time Factors; Treatment Outcome | 1995 |
Treatment of recalcitrant cardiac allograft rejection with methotrexate. Cardiac Transplant Team.
Topics: Administration, Oral; Azathioprine; Bacterial Infections; Case-Control Studies; Combined Modality Therapy; Cyclosporine; Drug Administration Schedule; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Humans; Leukocyte Count; Lymphatic Irradiation; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisone; Recurrence; Retrospective Studies; Transplantation, Homologous | 1995 |
Methotrexate for Crohn's disease.
Topics: Azathioprine; Crohn Disease; Humans; Mercaptopurine; Methotrexate; Prednisone; Remission Induction | 1995 |
Antithymocyte globulin and methotrexate therapy of severe or persistent cardiac allograft rejection.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Cyclosporine; Evaluation Studies as Topic; Female; Graft Rejection; Heart Transplantation; Humans; Male; Methotrexate; Middle Aged; Prednisone; Retrospective Studies; Treatment Outcome | 1995 |
Effect of FK 506 and antiproliferative agents for heart and liver xenotransplantation from hamster to rat.
Topics: Animals; Antibodies; Antineoplastic Agents; Azathioprine; Biphenyl Compounds; Cricetinae; Cyclophosphamide; Graft Survival; Guanidines; Heart Transplantation; Immunosuppressive Agents; Liver Transplantation; Male; Mesocricetus; Methotrexate; Mycophenolic Acid; Rats; Rats, Inbred Lew; Ribonucleosides; Tacrolimus; Transplantation, Heterologous | 1993 |
Phosphorus 31 magnetic resonance spectroscopy for quantitative evaluation of therapeutic regimens in dermatomyositis.
Topics: Adenosine Triphosphate; Adult; Azathioprine; Dermatomyositis; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Immunosuppressive Agents; Longitudinal Studies; Magnetic Resonance Spectroscopy; Methotrexate; Muscle Contraction; Muscle, Skeletal; Phosphates; Phosphocreatine; Phosphorus Isotopes; Prednisone | 1995 |
Extensive extraspinal hyperostoses after long-term oral retinoid treatment in a patient with pityriasis rubra pilaris.
Topics: Acetabulum; Acitretin; Adolescent; Adult; Azathioprine; Child; Etretinate; Exostoses; Femur Neck; Follow-Up Studies; Humans; Hyperostosis; Male; Methotrexate; Pityriasis Rubra Pilaris; Retinoids; Tretinoin | 1995 |
The total costs of drug therapy for rheumatoid arthritis. A model based on costs of drug, monitoring, and toxicity.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Boston; Decision Trees; Diagnosis-Related Groups; Drug Costs; Drug Monitoring; Gold; Health Care Costs; Hospitals, University; Humans; Hydroxychloroquine; Massachusetts; Methotrexate; Models, Economic; New Hampshire; Penicillamine; Sensitivity and Specificity | 1995 |
Interference of circulating azathioprine but not methotrexate or sulfasalazine with measurements of interleukin-6 bioactivity.
Topics: Arthritis, Rheumatoid; Azathioprine; Biological Assay; Humans; Hybridomas; Interleukin-6; Methotrexate; Sulfasalazine | 1994 |
Immunoblastic lymphadenopathy in a five-month-old girl: successful treatment with immunosuppressants.
Topics: Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunoblastic Lymphadenopathy; Immunosuppressive Agents; Infant; Interferon-alpha; Lymph Nodes; Mercaptopurine; Methotrexate; Recurrence; Remission Induction | 1994 |
Variability in individual responses of 532 patients with rheumatoid arthritis to first-line and second-line drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Follow-Up Studies; Humans; Hydroxychloroquine; Methotrexate; Middle Aged; Organogold Compounds; Penicillamine; Prednisone; Probability | 1993 |
Ileitis after colectomy for ulcerative colitis or carcinoma.
Topics: Adult; Aged; Aminosalicylic Acids; Azathioprine; Colectomy; Colitis, Ulcerative; Colonic Neoplasms; Female; Humans; Ileitis; Ileum; Male; Mesalamine; Methotrexate; Middle Aged; Postoperative Complications | 1994 |
Limitations of randomized clinical trials to recognize possible advantages of combination therapies in rheumatic diseases.
Topics: Arthritis, Rheumatoid; Auranofin; Azathioprine; Drug Combinations; Humans; Lupus Erythematosus, Systemic; Methotrexate; Polymyositis; Prednisone; Randomized Controlled Trials as Topic; Selection Bias; Time Factors | 1993 |
Personal experience in the treatment of seropositive rheumatoid arthritis with drugs used in combination.
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Azathioprine; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Prognosis; Severity of Illness Index | 1993 |
Issues in the study of azathioprine, methotrexate, and combination therapy: comment on the article by Willkens et al.
Topics: Arthritis, Rheumatoid; Azathioprine; Drug Therapy, Combination; Humans; Methotrexate | 1993 |
Pregnancy outcome in women with systemic lupus erythematosus treated with immunosuppressive drugs.
Topics: Abortion, Spontaneous; Adolescent; Adult; Azathioprine; Cyclophosphamide; Female; Fetal Death; Humans; Immunosuppressive Agents; Incidence; Lupus Erythematosus, Systemic; Methotrexate; Middle Aged; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies | 1993 |
Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy.
Topics: Adult; Autoantibodies; Azathioprine; Cohort Studies; Female; Humans; Inclusion Bodies; Logistic Models; Male; Methotrexate; Myositis; Prednisone; Prognosis; Retrospective Studies; Sex Factors; Time Factors; Treatment Outcome | 1993 |
Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
Topics: Adolescent; Adult; Attitude of Health Personnel; Azathioprine; Child; Colitis; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Female; Gastroenterology; Health Surveys; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Methotrexate; Pediatrics; Remission Induction; Retrospective Studies; Societies, Medical; Surveys and Questionnaires | 1993 |
The monitoring of patients on disease-modifying antirheumatoid drugs.
Topics: Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Humans; Methotrexate; Rheumatic Diseases | 1993 |
Effects of chemotherapeutic and immunosuppressive drugs on the production of erythropoietin in human hepatoma cultures.
Topics: Animals; Antineoplastic Agents; Azathioprine; Colchicine; Cyclophosphamide; Cyclosporine; Cytarabine; Daunorubicin; Erythropoietin; Humans; Ifosfamide; Immunosuppressive Agents; L-Lactate Dehydrogenase; Liver Neoplasms, Experimental; Methotrexate; Organoplatinum Compounds; Tetrazolium Salts; Tumor Cells, Cultured; Vincristine | 1993 |
[Therapy of Wegener's granulomatosis. Experiences with conventional and stage-adjusted treatment in 111 patients over 24 years].
Topics: Adult; Aged; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisolone; Quality of Life; Retrospective Studies; Survival Rate; Trimethoprim, Sulfamethoxazole Drug Combination | 1993 |
Cytotoxic therapy in rheumatoid arthritis.
Topics: Antineoplastic Agents; Arthritis, Rheumatoid; Azathioprine; Cyclophosphamide; Humans; Methotrexate | 1993 |
Combination drug therapy of seropositive rheumatoid arthritis.
Topics: Administration, Oral; Adult; Aged; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cohort Studies; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Remission Induction; Survival Rate; Treatment Outcome | 1995 |
Toxicity of combination therapies in rheumatoid arthritis: comment on the article by Willkens et al.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Drug Therapy, Combination; Humans; Methotrexate | 1996 |
Does exposure to immunosuppressive therapy increase the 10 year malignancy and mortality risks in rheumatoid arthritis? A matched cohort study.
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Azathioprine; Cohort Studies; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Neoplasms; Risk Factors; Time Factors | 1996 |
Inclusion body myositis: clinical and pathological boundaries.
Topics: Aged; Azathioprine; Biopsy; Creatine Kinase; Dermatomyositis; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Muscle Weakness; Muscle, Skeletal; Myositis, Inclusion Body; Polymyositis; Retrospective Studies; Treatment Outcome | 1996 |
Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Anti-Inflammatory Agents; Antimalarials; Antineoplastic Agents, Alkylating; Azathioprine; Chlorambucil; Dermatologic Agents; Dermatomyositis; Drug Administration Schedule; Drug Combinations; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Nucleic Acid Synthesis Inhibitors; Prednisone; Remission Induction; Retrospective Studies; Sunscreening Agents | 1997 |
In vitro immunosuppressive effects of methotrexate and azathioprine on Langerhans cells.
Topics: Azathioprine; Humans; Immunosuppressive Agents; Langerhans Cells; Lymphocyte Transfusion; Methotrexate; T-Lymphocytes; Transplantation, Homologous | 1997 |
Effect of resumption of second line drugs in patients with rheumatoid arthritis that flared up after treatment discontinuation.
Topics: Acute Disease; Aged; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Organogold Compounds; Penicillamine; Recurrence; Sulfasalazine; Treatment Outcome | 1997 |
The effect of methotrexate and azathioprine on the serum levels of IgA-alpha 1-antitrypsin complex in juvenile chronic arthritis.
Topics: Adolescent; alpha 1-Antitrypsin; Antirheumatic Agents; Arthritis, Juvenile; Azathioprine; Child; Child, Preschool; Female; Humans; Immunosuppressive Agents; Male; Methotrexate | 1997 |
[The effects of intensive DMPA regimen in the treatment of Graves' ophthalmopathy].
Topics: Adult; Aged; Azathioprine; Dexamethasone; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Graves Disease; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prednisone | 1996 |
Immunomodulator therapy of inflammatory bowel disease.
Topics: Antimetabolites, Antineoplastic; Azathioprine; Blood Component Removal; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Cytokines; Folic Acid Antagonists; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate | 1997 |
Oxygen saturation of intracapillary haemoglobin in patients with systemic JCA (Still's disease).
Topics: Analysis of Variance; Antirheumatic Agents; Arthritis, Juvenile; Azathioprine; Capillaries; Child; Child, Preschool; Erythema; Glucocorticoids; Humans; Methotrexate; Oxygen; Regression Analysis; Salicylates; Skin; Statistics, Nonparametric | 1997 |
Twelve years of cyclosporine in pediatric heart transplantation: what is the future?
Topics: Adolescent; Azathioprine; Cardiomyopathies; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Heart Defects, Congenital; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infant; Infant, Newborn; Kidney Failure, Chronic; Kidney Transplantation; Methotrexate; Reoperation; Retrospective Studies; Steroids; Survival Rate; Time Factors | 1998 |
Wegener's granulomatosis: controversies and current concepts.
Topics: Adolescent; Adult; Anti-Infective Agents; Azathioprine; Cyclophosphamide; Female; Folic Acid Antagonists; Granulomatosis with Polyangiitis; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Photomicrography; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
Cyclosporin A therapy in refractory non-infectious childhood uveitis.
Topics: Adolescent; Arthritis, Juvenile; Azathioprine; Child; Child, Preschool; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Prednisolone; Retrospective Studies; Treatment Outcome; Uveitis; Visual Acuity | 1998 |
Azathioprine, mycophenolate mofetil, and methotrexate specifically modulate cytokine production by T cells.
Topics: Animals; Azathioprine; Cells, Cultured; Cytokines; Immunosuppressive Agents; Interferon-gamma; Methotrexate; Mice; Mice, Inbred BALB C; Mycophenolic Acid; Spleen; T-Lymphocytes; Tumor Necrosis Factor-alpha | 1998 |
Methotrexate in refractory Crohn's disease.
Topics: Adolescent; Adult; Azathioprine; Crohn Disease; Drug Administration Schedule; Drug Resistance; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Methotrexate; Middle Aged; Recurrence; Retrospective Studies; Treatment Outcome | 1999 |
Childhood pemphigus.
Topics: Adolescent; Azathioprine; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Methotrexate; Pemphigus; Prednisolone; Skin | 1999 |
Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis.
Topics: Adult; Aged; Arthritis, Rheumatoid; Azathioprine; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Radiography; Retrospective Studies; Time Factors | 1999 |
Long-term application of disease modifying antirheumatic drugs (DMARD). A single-center, observational study of 1681 patients with rheumatoid arthritis (RA).
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Chloroquine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Long-Term Care; Male; Methotrexate; Middle Aged; Organogold Compounds; Penicillamine; Sulfasalazine; Treatment Outcome | 1999 |
High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy.
Topics: Adult; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azathioprine; Colectomy; Colon; Cyclosporine; Female; Flow Cytometry; Genes, MDR; Glucocorticoids; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Lymphocytes; Male; Mesalamine; Methotrexate; Middle Aged; Reference Values; Treatment Failure | 2000 |
IOIBD questionnaire on the clinical use of azathioprine, 6-mercaptopurine, cyclosporin A and methotrexate in the treatment of inflammatory bowel diseases.
Topics: Azathioprine; Cyclosporine; Europe; Female; Gastroenterology; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Internal Medicine; Male; Mercaptopurine; Methotrexate; North America; Practice Patterns, Physicians'; Pregnancy; Pregnancy Complications; Surveys and Questionnaires | 2000 |
On the activity of trifluoperazine and palmitoylcarnitine in mice: delayed hypersensitivity models.
Topics: Animals; Anti-Inflammatory Agents; Azathioprine; Dexamethasone; Dinitrofluorobenzene; Enzyme Inhibitors; Erythrocytes; Female; Hypersensitivity, Delayed; Immunosuppressive Agents; Methotrexate; Mice; Palmitoylcarnitine; Protein Kinase C; Sheep; Trifluoperazine | 2000 |
Long-term effects of azathioprine therapy for juvenile rheumatoid arthritis.
Topics: Adolescent; Arthritis, Juvenile; Azathioprine; Child; Child, Preschool; Female; Humans; Immunosuppressive Agents; Infant; Male; Methotrexate; Retrospective Studies | 2000 |
Immunomodulatory therapy for chronic tubulointerstitial nephritis-associated uveitis.
Topics: Adolescent; Adult; Azathioprine; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Nephritis, Interstitial; Panuveitis; Retrospective Studies; Secondary Prevention; Uveitis, Anterior; Visual Acuity | 2000 |
Immunosuppressors for inflammatory bowel disease: how long is long enough?
Topics: Azathioprine; Drug Administration Schedule; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate; Time Factors | 2000 |
[Clinical manifestations and therapeutic approach in neurosarcoidosis].
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Brain; Brain Diseases; Cyclophosphamide; Cyclosporine; Electromyography; Female; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Retrospective Studies; Sarcoidosis; Severity of Illness Index; Steroids; Treatment Outcome | 2000 |
Polyarteritis nodosa in Arab children in Saudi Arabia.
Topics: Angiography; Azathioprine; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney; Male; Methotrexate; Methylprednisolone; Polyarteritis Nodosa; Prednisone; Retrospective Studies; Saudi Arabia; Treatment Outcome | 1999 |
Treatment of Behçet's disease--an update.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behcet Syndrome; Chlorambucil; Colchicine; Cyclophosphamide; Cyclosporine; Dapsone; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interferons; Levamisole; Male; Methotrexate; Pentoxifylline; Recombinant Proteins; Recurrence; Sulfasalazine; Thalidomide | 2001 |
[Transeptal steroids in necrotizing scleritis].
Topics: Adult; Aged; Aged, 80 and over; Azathioprine; Cyclophosphamide; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Injections; Male; Methotrexate; Middle Aged; Prednisone; Scleritis | 2001 |
The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; Azathioprine; Conjunctivitis; Cyclophosphamide; Dapsone; Disease Progression; Drug Hypersensitivity; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Pemphigoid, Benign Mucous Membrane; Prednisone; Visual Acuity | 2002 |
Autoimmune inner ear disease: steroid and cytotoxic drug therapy.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Azathioprine; Case-Control Studies; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Female; Hearing Loss, Sensorineural; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged | 2001 |
Multifocal choroiditis and panuveitis: immunomodulatory therapy.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Choroiditis; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Panuveitis; Retrospective Studies; Steroids; Treatment Outcome; Visual Acuity | 2002 |
[Infliximab in aggressive and refractory rheumatoid arthritis. A pilot study].
Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Pilot Projects; Prednisone; Time Factors; Tumor Necrosis Factor-alpha | 2002 |
Results of an international questionnaire on immunosuppressive treatment of multiple sclerosis.
Topics: Azathioprine; Canada; Cyclophosphamide; Drug Utilization; Europe; Health Facilities; Humans; Immunosuppressive Agents; International Cooperation; Methotrexate; Mitoxantrone; Multiple Sclerosis; Pilot Projects; Surveys and Questionnaires; United States | 2002 |
A successful second unrelated BMT (UBMT) from a different unrelated donor to treat ALL that relapsed after the initial UBMT.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Azathioprine; Bone Marrow Transplantation; Cyclophosphamide; Daunorubicin; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Living Donors; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Remission Induction; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Vincristine | 2002 |
[How long should cyclophosphamide therapy of Wegener's granulomatosis continue?].
Topics: Adjuvants, Immunologic; Administration, Oral; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Controlled Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Follow-Up Studies; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Prednisolone; Prognosis; Remission Induction; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2002 |
[Corticosteroid saving-up in giant cell arteritis?].
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Double-Blind Method; Follow-Up Studies; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Placebos; Prednisolone; Randomized Controlled Trials as Topic; Time Factors | 2002 |
Churg-Strauss syndrome: clinical and serological features of 19 patients from a single Italian centre.
Topics: Adult; Aged; Azathioprine; Biopsy, Needle; Churg-Strauss Syndrome; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunohistochemistry; Infusions, Intravenous; Italy; Male; Methotrexate; Methylprednisolone; Middle Aged; Pulse Therapy, Drug; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2002 |
Monitoring and assessing the safety of disease-modifying antirheumatic drugs: a West Midlands experience.
Topics: Antirheumatic Agents; Arthritis, Infectious; Azathioprine; Drug Monitoring; Humans; Hypokalemia; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neutropenia; Pancytopenia; Pneumonia; Product Surveillance, Postmarketing; Prostatic Neoplasms; Sepsis; Sulfasalazine; United Kingdom | 2002 |
The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses.
Topics: Acute Disease; Aged; Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Chronic Disease; Clinical Protocols; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Methotrexate; Middle Aged; Organogold Compounds; Penicillamine; Sulfasalazine; Treatment Outcome | 2002 |
[Diagnosis and treatment of rheumatoid arthritis].
Topics: Adult; Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cyclosporins; Diagnosis, Differential; Exercise Therapy; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prognosis; Radiography; Rheumatoid Factor; Sulfasalazine | 2002 |
Inflammatory bowel disease in pregnancy.
Topics: Aminosalicylic Acids; Azathioprine; Colitis, Ulcerative; Crohn Disease; Female; Humans; Infertility, Female; Infertility, Male; Inflammatory Bowel Diseases; Male; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Steroids; Sulfasalazine | 2003 |
[Chronically active Crohn's disease].
Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Child; Chronic Disease; Contraindications; Crohn Disease; Endoscopy; Enzyme Inhibitors; Female; Folic Acid Antagonists; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Methotrexate; Mycophenolic Acid; Nutritional Physiological Phenomena; Placebos; Prednisone; Pregnancy; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Retrospective Studies; Time Factors; Ultrasonography | 2003 |
[Maintaining a remission].
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Child; Crohn Disease; Enzyme Inhibitors; Female; Folic Acid Antagonists; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Mesalamine; Meta-Analysis as Topic; Methotrexate; Placebos; Postoperative Care; Prednisolone; Pregnancy; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Risk Factors; Time Factors | 2003 |
[Follow up of Crohn's disease under therapy with hydro-MRI].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azathioprine; Crohn Disease; Cyclosporins; Enema; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Metronidazole; Middle Aged; Recurrence; Retrospective Studies; Sulfonamides; Time Factors | 2003 |
Position statement: immunomodulator therapy for inflammatory Bowel disease.
Topics: Adjuvants, Immunologic; Azathioprine; Clinical Trials as Topic; Contraindications; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate; Safety; Tumor Necrosis Factor-alpha | 2003 |
[Psoriasis and systemic lupus erythematosus: a rare association with specific therapeutic problems].
Topics: Adrenal Cortex Hormones; Adult; Aged; Antirheumatic Agents; Azathioprine; Dermatologic Agents; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; Psoriasis; Time Factors | 2003 |
[Indication and effect of immunosuppression in patients with scleritis].
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; Azathioprine; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Retrospective Studies; Scleritis; Treatment Outcome | 2003 |
ALVEOLAR SURFACTANT IN LUNG HOMOTRANSPLANTATION AND HILAR STRIPPING.
Topics: Azathioprine; Dogs; Lung; Methotrexate; Pharmacology; Purines; Research; Surface Tension; Surface-Active Agents; Transplantation Immunology; Transplantation, Homologous | 1964 |
LUNG TRANSPLANTATION IN THE DOG.
Topics: Azathioprine; Blood Transfusion; Bone Marrow Transplantation; Dogs; Histology; Immunosuppressive Agents; Lung; Lung Transplantation; Methotrexate; Pharmacology; Radiation Effects; Research; Skin Transplantation; Transplantation Immunology; Transplantation, Homologous | 1964 |
IMMUNOLOGIC COMPETENCE OF PATIENTS WITH PSORIASIS RECEIVING CYTOTOXIC DRUG THERAPY.
Topics: Allergens; Allergy and Immunology; Aniline Compounds; Antibody Formation; Antigen-Antibody Reactions; Antineoplastic Agents; Azathioprine; Benzene; Catechols; Geriatrics; Humans; Hypersensitivity, Delayed; Immunocompetence; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Pharmacology; Plague Vaccine; Psoriasis; Thioguanine; Triethylenemelamine; Vinblastine | 1965 |
Is there any remaining role for methotrexate for Crohn's disease?
Topics: Azathioprine; Crohn Disease; Enzyme Inhibitors; Female; Humans; Male; Methotrexate | 2003 |
Differences and similarities among expert opinions on the diagnosis and treatment of pemphigus vulgaris.
Topics: Azathioprine; Biopsy; Drug Administration Schedule; Expert Testimony; Fluorescent Antibody Technique; Glucocorticoids; Health Care Surveys; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Pemphigus; Prednisolone; Referral and Consultation; Telephone | 2003 |
Periaortitis: gadolinium-enhanced magnetic resonance imaging and response to therapy in four patients.
Topics: Aged; Anti-Inflammatory Agents; Arteriosclerosis; Azathioprine; Contrast Media; Female; Gadolinium DTPA; Humans; Immunosuppressive Agents; Magnetic Resonance Angiography; Male; Methotrexate; Middle Aged; Prednisone; Retroperitoneal Fibrosis; Rheumatic Diseases; Tomography, X-Ray Computed; Treatment Outcome | 2004 |
Combining infliximab and methotrexate in fistulizing Crohn's disease resistant or intolerant to azathioprine.
Topics: Adult; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Drug Evaluation; Drug Resistance; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Intestinal Fistula; Male; Methotrexate; Middle Aged; Prospective Studies | 2004 |
Behçet's disease with relapsing cutaneous polyarteritis-nodosa-like lesions, responsive to oral cyclosporine therapy.
Topics: Adolescent; Anticoagulants; Azathioprine; Behcet Syndrome; Colchicine; Cyclosporine; Heparin; Humans; Immunosuppressive Agents; Male; Methotrexate; Polyarteritis Nodosa; Prednisone; Thrombophlebitis; Warfarin | 2003 |
Treatment with immunosuppressive and anti-inflammatory agents delays onset of canine genetic narcolepsy and reduces symptom severity.
Topics: Age of Onset; Animals; Anti-Inflammatory Agents; Azathioprine; Disease Models, Animal; Disease Progression; Dogs; Female; Glucocorticoids; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Narcolepsy; Nucleic Acid Synthesis Inhibitors; Severity of Illness Index; Sleep; Time Factors; Treatment Outcome | 2004 |
Rheumatologists and breasts: immunosuppressive therapy for granulomatous mastitis.
Topics: Adult; Azathioprine; Female; Humans; Immunosuppressive Agents; Mastitis; Methotrexate; Treatment Outcome | 2004 |
Clinical practice of immunosuppressive treatments in multiple sclerosis: results of a second international questionnaire.
Topics: Azathioprine; Canada; Clinical Trials as Topic; Cyclophosphamide; Europe; Humans; Immunosuppressive Agents; Immunotherapy; International Cooperation; Methotrexate; Mitoxantrone; Multiple Sclerosis; Practice Patterns, Physicians'; Scandinavian and Nordic Countries; South America; Surveys and Questionnaires; United Kingdom; United States | 2004 |
Joint lavage for treating recurrent knee involvement in patients with juvenile idiopathic arthritis.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Azathioprine; Child; Clinical Trials as Topic; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections, Intra-Articular; Knee Joint; Male; Methotrexate; Recurrence; Retrospective Studies; Therapeutic Irrigation; Treatment Outcome | 2004 |
Experience with the use of low-dose methotrexate for inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Azathioprine; Child; Colitis, Ulcerative; Crohn Disease; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Methotrexate; Middle Aged; Retrospective Studies; Treatment Outcome | 2004 |
[Ulcerative colitis. Chronic active course].
Topics: Administration, Oral; Adult; Age Factors; Anti-Infective Agents; Azathioprine; Child; Chronic Disease; Ciprofloxacin; Colectomy; Colitis, Ulcerative; Controlled Clinical Trials as Topic; Diabetes Mellitus; Diagnosis, Differential; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Mercaptopurine; Methotrexate; Nutritional Physiological Phenomena; Pregnancy; Recurrence; Remission Induction; Risk Factors; Time Factors | 2004 |
[Immunosuppressive therapy for inflammatory bowel disease: consensus by the Austrian working group on IBD].
Topics: Administration, Oral; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Injections, Intramuscular; Male; Mercaptopurine; Methotrexate; Placebos; Pregnancy; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Safety; Time Factors | 2004 |
Could immunosuppressive drugs reduce recurrence rate after second resection for Crohn disease?
Topics: Adult; Azathioprine; Colon; Crohn Disease; Female; Gastrointestinal Agents; Humans; Ileum; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Postoperative Care; Recurrence; Reoperation; Retrospective Studies; Treatment Outcome | 2004 |
Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study.
Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis; Autoantibodies; Azathioprine; Bacteremia; Cardiolipins; Complement System Proteins; DNA; Escherichia coli Infections; Female; Humans; Immunosuppressive Agents; Infliximab; Lupus Erythematosus, Systemic; Lupus Nephritis; Methotrexate; Middle Aged; Safety; Treatment Outcome; Tumor Necrosis Factor-alpha; Urinary Tract Infections | 2004 |
Immune-mediated inner ear disease: 10-year experience.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Female; Hearing Loss, Sensorineural; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Retrospective Studies; Treatment Outcome | 2004 |
Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery.
Topics: Adult; Azathioprine; Crohn Disease; Digestive System Surgical Procedures; Drug Administration Schedule; Drug Therapy, Combination; Drug Utilization; Female; Humans; Immunosuppressive Agents; Intestinal Obstruction; Male; Methotrexate; Middle Aged; Retrospective Studies | 2005 |
Crohn's disease over 20 years after diagnosis in a referral population.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Child; Child, Preschool; Crohn Disease; Female; Follow-Up Studies; France; Health Status; Humans; Immunosuppressive Agents; Intestinal Neoplasms; Male; Mesalamine; Methotrexate; Middle Aged; Multivariate Analysis; Parenteral Nutrition, Home; Quality of Life; Recurrence; Reoperation; Retrospective Studies; Surveys and Questionnaires | 2004 |
Localized nodular vasculitis: a new variant of localized cutaneous polyarteritis nodosa?
Topics: Adolescent; Adult; Arteries; Azathioprine; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Leg; Male; Methotrexate; Middle Aged; Polyarteritis Nodosa; Prednisone; Skin; Treatment Outcome | 2004 |
Bilateral ocular myositis as a late complication of dermatomyositis.
Topics: Adult; Azathioprine; Dermatomyositis; Drug Therapy, Combination; Electromyography; Humans; Immunoglobulins, Intravenous; Magnetic Resonance Imaging; Male; Methotrexate; Methylprednisolone; Oculomotor Muscles; Treatment Outcome | 2005 |
Oral methotrexate in ulcerative colitis.
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Colitis, Ulcerative; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Retrospective Studies; Treatment Outcome | 2005 |
Diagnosis and monitoring a case of light-chain deposition disease in the kidney using a new, sensitive immunoassay.
Topics: Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Basement Membrane; Disease Progression; Humans; Hypergammaglobulinemia; Immunoassay; Immunoglobulin kappa-Chains; Immunoglobulin lambda-Chains; Kidney; Kidney Tubules; Male; Methotrexate; Middle Aged; Nephrotic Syndrome; Prednisolone; Vincristine | 2005 |
Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Choroid Diseases; Cyclosporine; Daclizumab; Disease Progression; Drug Therapy, Combination; Electroretinography; Female; Follow-Up Studies; HLA-A Antigens; Humans; Immunoglobulin G; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Retinal Diseases; Retrospective Studies; Treatment Outcome; Visual Acuity | 2005 |
Primary CNS lymphoma in myasthenic on long-term azathioprine.
Topics: Antigens, CD20; Antimetabolites, Antineoplastic; Azathioprine; Brain Neoplasms; Diagnosis, Differential; Female; Humans; Immunohistochemistry; Immunosuppressive Agents; Lymphoma; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Myasthenia Gravis | 2005 |
Successful treatment with adalimumab in infliximab-resistant Crohn's disease.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Crohn Disease; Digestive System Surgical Procedures; Female; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Middle Aged; Prednisolone; Recurrence; Reoperation; Treatment Failure; Treatment Outcome; Tumor Necrosis Factor-alpha | 2005 |
[Symmetric polyarthritis in a patient with Churg-Strauss syndrome].
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Arthritis; Azathioprine; Churg-Strauss Syndrome; Cyclophosphamide; Drug Therapy, Combination; Etanercept; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Receptors, Tumor Necrosis Factor; Recurrence; Sulfasalazine | 2005 |
Twelve years experience of juvenile dermatomyositis in North India.
Topics: Adolescent; Age of Onset; Azathioprine; Calcinosis; Child; Child, Preschool; Deglutition Disorders; Dermatomyositis; Female; Follow-Up Studies; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulins; India; Lipodystrophy; Male; Medical Records; Methotrexate; Remission Induction; Retrospective Studies; Time Factors; Treatment Outcome; Ulcer | 2006 |
[Current imaging in Takayasu arteritis].
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Child; Contrast Media; Cyclophosphamide; Diagnosis, Differential; Female; Gadolinium DTPA; Humans; Immunosuppressive Agents; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Positron-Emission Tomography; Takayasu Arteritis; Tomography, Spiral Computed | 2005 |
Predictors of immunomodulator use as early therapy in pediatric Crohn's disease.
Topics: Adolescent; Azathioprine; Biomarkers; Chi-Square Distribution; Child; Child, Preschool; Crohn Disease; Disease Progression; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Predictive Value of Tests; Prospective Studies; Statistics, Nonparametric | 2006 |
De novo and salvage pathways of DNA synthesis in primary cultured neurall stem cells.
Topics: Age Factors; Animals; Antimetabolites; Azathioprine; Brain; Cell Count; Cell Proliferation; Cells, Cultured; Colony-Forming Units Assay; Deoxyribonucleosides; DNA; DNA Replication; Dose-Response Relationship, Drug; Embryo, Mammalian; Enzyme Inhibitors; Fluorescent Antibody Technique; Folic Acid; Glial Fibrillary Acidic Protein; In Situ Nick-End Labeling; Intermediate Filament Proteins; Methotrexate; Mice; Mice, Inbred C57BL; Microtubule-Associated Proteins; Models, Biological; Nerve Tissue Proteins; Nestin; Neurons; O Antigens; Stem Cells; Time Factors; Tubulin; Vitamin B Complex | 2006 |
American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Azathioprine; Cyclosporine; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Infliximab; Mercaptopurine; Methotrexate; Mycophenolic Acid | 2006 |
Rituximab as therapy for refractory polymyositis and dermatomyositis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD19; Azathioprine; B-Lymphocytes; Creatine Kinase; Dermatomyositis; Drug Resistance; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Muscle Weakness; Polymyositis; Prednisone; Rituximab; Time Factors | 2006 |
The dynamism of cutaneous lupus erythematosus: mild discoid lupus erythematosus evolving into SLE with SCLE and treatment-resistant lupus panniculitis.
Topics: Antimalarials; Azathioprine; Cyclophosphamide; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; Methylprednisolone; Middle Aged; Panniculitis, Lupus Erythematosus; Pulse Therapy, Drug; Tacrolimus; Treatment Failure | 2007 |
Safety of infliximab used in combination with leflunomide or azathioprine in daily clinical practice.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Drug Therapy, Combination; Female; Humans; Infliximab; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Surveys and Questionnaires; Treatment Outcome | 2006 |
[Infliximab-induced hepatitis in a patient with Crohn's disease].
Topics: Acute Disease; Adult; Antibodies, Monoclonal; Azathioprine; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Crohn Disease; Female; Humans; Immunosuppressive Agents; Infliximab; Leukapheresis; Mesalamine; Methotrexate; Pancreatitis; Prednisone; Rectovaginal Fistula | 2006 |
Cyclophosphamide pulse therapy followed by azathioprine or methotrexate induces long-term remission in patients with steroid-refractory Crohn's disease.
Topics: Adult; Azathioprine; Crohn Disease; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Prospective Studies; Remission Induction; Steroids; Treatment Outcome | 2006 |
Pharmacoeconomic analyses of azathioprine, methotrexate and prospective pharmacogenetic testing for the management of inflammatory bowel disease.
Topics: Azathioprine; Cost Savings; Cost-Benefit Analysis; Economics, Pharmaceutical; Genotype; Health Care Costs; Humans; Inflammatory Bowel Diseases; Methotrexate; Methyltransferases; Pharmacogenetics; Prospective Studies; Quality of Life | 2006 |
Methotrexate, azathioprine, cyclosporine, and risk of fracture.
Topics: Adult; Aged; Azathioprine; Case-Control Studies; Cyclosporine; Enzyme Inhibitors; Female; Fractures, Bone; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Registries; Risk | 2006 |
Diagnosis and management of spinal cord sarcoidosis.
Topics: Adult; Azathioprine; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Prednisone; Radiography; Sarcoidosis; Spinal Cord Diseases; Treatment Outcome | 2006 |
Efficacy of methotrexate in pediatric Crohn's disease: a French multicenter study.
Topics: Azathioprine; Child; Crohn Disease; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Methotrexate; Remission Induction; Retrospective Studies; Time Factors; Treatment Failure; Treatment Outcome | 2006 |
Severe gastrointestinal inflammation in adult dermatomyositis: characterization of a novel clinical association.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Dermatomyositis; Fatal Outcome; Female; Gastrointestinal Diseases; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunosuppressive Agents; Inflammation; Methotrexate; Prednisolone | 2006 |
Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibody Formation; Azathioprine; Crohn Disease; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Infusions, Parenteral; Male; Methotrexate; Middle Aged; Prospective Studies; Treatment Outcome | 2007 |
[Filgrastim in refractory Crohn's disease with an intra-abdominal abscess].
Topics: Abdominal Abscess; Adult; Anti-Bacterial Agents; Antibodies, Monoclonal; Azathioprine; Cell Differentiation; Combined Modality Therapy; Crohn Disease; Cytokines; Drug Resistance; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Infliximab; Macrophages; Male; Methotrexate; Neutrophils; Prednisone; Recombinant Proteins; Tumor Necrosis Factor-alpha | 2007 |
When should patients with ANCA-associated vasculitis be switched from induction to maintenance therapy?
Topics: Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Methotrexate; Randomized Controlled Trials as Topic; Remission Induction; Secondary Prevention; Vasculitis | 2007 |
Clinical features and outcome of pediatric Wegener's granulomatosis.
Topics: Adolescent; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Glomerulonephritis; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Lung Diseases; Male; Methotrexate; Prednisone; Retrospective Studies; Treatment Outcome | 2007 |
Prescribing of sulfasalazine, azathioprine and methotrexate round pregnancy--a descriptive study.
Topics: Antirheumatic Agents; Azathioprine; Databases, Factual; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization; Female; Humans; Inflammatory Bowel Diseases; Methotrexate; Practice Patterns, Physicians'; Pregnancy; Pregnancy Complications; Pregnancy Trimesters; Rheumatic Diseases; Risk Factors; Sulfasalazine | 2008 |
Clinical inquiries. Are DMARDs effective for rheumatologic diseases besides rheumatoid arthritis?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Azathioprine; Etretinate; Humans; Infliximab; Joint Diseases; Methotrexate; Nail Diseases; Spondylitis, Ankylosing; Sulfasalazine; Tumor Necrosis Factor-alpha | 2007 |
Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease.
Topics: Adolescent; Chi-Square Distribution; Child; Crohn Disease; Female; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Mercaptopurine; Methotrexate; Retrospective Studies; Statistics, Nonparametric; Treatment Failure; Treatment Outcome | 2007 |
Serpiginous choroiditis treated in a stepladder approach.
Topics: Azathioprine; Choroiditis; Drug Administration Schedule; Drug Therapy, Combination; Folic Acid; Humans; Male; Methotrexate; Methylprednisolone; Middle Aged; Recurrence | 2007 |
Use of methotrexate in refractory Crohn's disease: the Edinburgh experience.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Female; Humans; Immunosuppressive Agents; Infliximab; Injections, Intramuscular; Male; Methotrexate; Prednisolone; Remission Induction; Retrospective Studies | 2008 |
[Pneumonitis associated to methotrexate].
Topics: Adrenal Cortex Hormones; Azathioprine; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Methotrexate; Methylprednisolone; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Radiography | 2008 |
[Elevated liver enzymes in rheumatoid arthritis : differential diagnostic considerations based on a case report].
Topics: Adalimumab; Adolescent; Alanine Transaminase; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Juvenile; Aspartate Aminotransferases; Azathioprine; Biopsy; Chemical and Drug Induced Liver Injury; Cortisone; Diagnosis, Differential; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Isoxazoles; Leflunomide; Liver; Liver Function Tests; Methotrexate; Prednisolone | 2008 |
[Biological therapy as treatment of inflammatory bowel diseases].
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Humans; Immunologic Factors; Immunosuppressive Agents; Infliximab; Methotrexate; Treatment Outcome | 2008 |
Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites; Azathioprine; Daclizumab; Databases, Factual; Humans; Immunoglobulin G; Immunosuppressive Agents; Inflammation; Longitudinal Studies; Methotrexate; Mycophenolic Acid; Neoplasms; Risk Factors; Tumor Necrosis Factor-alpha; Uveitis | 2008 |
Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites; Azathioprine; Child; Female; Glucocorticoids; Humans; Inflammation; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prednisone; Retrospective Studies; Scleritis; Uveitis | 2008 |
Is it always therapeutically important to distinguish between Crohn's disease and ulcerative colitis?
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Infliximab; Mercaptopurine; Mesalamine; Methotrexate; Remission Induction; Treatment Outcome | 2008 |
Infliximab for inflammatory bowel disease in Denmark 1999-2005: clinical outcome and follow-up evaluation of malignancy and mortality.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Azathioprine; Child; Cohort Studies; Denmark; Female; Humans; Incidence; Inflammatory Bowel Diseases; Infliximab; Intestinal Neoplasms; Male; Methotrexate; Middle Aged; Treatment Outcome | 2008 |
Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Behcet Syndrome; Cyclosporine; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Infusions, Intravenous; Methotrexate; Prednisone; Recurrence; Retinal Vasculitis; Retrospective Studies; Treatment Outcome; Visual Acuity; Young Adult | 2008 |
Predicting factors of fistula healing and clinical remission after infliximab-based combined therapy for perianal fistulizing Crohn's disease.
Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Ciprofloxacin; Crohn Disease; Drainage; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Intestinal Fistula; Magnetic Resonance Imaging; Male; Methotrexate; Metronidazole; Middle Aged; Predictive Value of Tests; Remission Induction; Retrospective Studies | 2009 |
[Which place for methotrexate in treatment of luminal Crohn's disease?].
Topics: Azathioprine; Crohn Disease; Humans; Immunosuppressive Agents; Methotrexate; Tumor Necrosis Factor-alpha | 2009 |
Spinal cord sarcoidosis: report of seven cases.
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Cyclophosphamide; Female; Fungemia; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Sarcoidosis; Severity of Illness Index; Spinal Cord; Spinal Cord Diseases | 2009 |
Disease-modifying antirheumatic drugs.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Humans; Hydroxychloroquine; Isoxazoles; Leflunomide; Methotrexate; Sulfasalazine | 2009 |
Long-term maintenance treatment of moderate-to-severe plaque psoriasis with infliximab in combination with methotrexate or azathioprine in a retrospective cohort.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Azathioprine; Child; Cohort Studies; Drug Therapy, Combination; Female; Humans; Infliximab; Male; Methotrexate; Middle Aged; Psoriasis; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult | 2009 |
Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
Topics: Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Female; Glomerular Filtration Rate; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Kidney; Male; Methotrexate | 2009 |
Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
Topics: Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Methotrexate; Remission Induction | 2009 |
Vasculitis syndromes: vasculitis therapy--between Scylla and Charybdis.
Topics: Antirheumatic Agents; Azathioprine; Granulomatosis with Polyangiitis; Humans; Methotrexate | 2009 |
Interstitial pneumonitis associated with infliximab therapy without methotrexate treatment.
Topics: Aged; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Drug Therapy, Combination; Female; Humans; Infliximab; Lung Diseases, Interstitial; Methotrexate; Methylprednisolone; Mucin-1; Radiography; Severity of Illness Index; Treatment Outcome | 2009 |
[Present status and future perspective of RPGN in Japan].
Topics: Adrenal Cortex Hormones; Azathioprine; Blood Component Removal; Cyclophosphamide; Disease Progression; Drug Therapy, Combination; Glomerulonephritis; Humans; Immunosuppressive Agents; Japan; Methotrexate; Multicenter Studies as Topic; Prognosis; Recurrence; Severity of Illness Index; Surveys and Questionnaires | 2009 |
Medical therapy of IBD in 2009.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Clinical Trials as Topic; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Methotrexate; Natalizumab; Probiotics; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha | 2009 |
Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues.
Topics: Administration, Oral; Adolescent; Azathioprine; Child; Crohn Disease; Drug Resistance; Drug Tolerance; Female; Humans; Immunosuppressive Agents; Injections, Subcutaneous; Male; Mercaptopurine; Methotrexate; Remission Induction; Retrospective Studies; Steroids | 2009 |
[Therapeutic strategies in idiopatic inflammatory myopathies].
Topics: Adolescent; Age Factors; Anti-Inflammatory Agents; Autoantibodies; Azathioprine; Biopsy; Dermatomyositis; Diagnosis, Differential; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Muscles; Myositis; Polymyositis; Prednisone; Prognosis; Recurrence; Treatment Outcome | 2009 |
[Epidemiology of pemphigus in the Hospital Universitario Virgen Macarena, Seville, Spain, 2005-2006].
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Cushing Syndrome; Drug Therapy, Combination; Female; Hospitals, University; Hospitals, Urban; Humans; Hypertension; Immunosuppressive Agents; Infections; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Pemphigus; Retrospective Studies; Spain | 2009 |
Adverse events associated with common therapy regimens for moderate-to-severe Crohn's disease.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Budesonide; Case-Control Studies; Comorbidity; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Longitudinal Studies; Male; Mercaptopurine; Methotrexate; Middle Aged; Outcome Assessment, Health Care; Prednisone; Prevalence; Proportional Hazards Models; Steroids; United States | 2009 |
Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Drug Hypersensitivity; Drug Resistance; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Male; Mercaptopurine; Methotrexate; Middle Aged; Treatment Outcome; Young Adult | 2009 |
Pediatric inflammatory bowel disease in South India.
Topics: Adolescent; Anti-Inflammatory Agents; Antineoplastic Agents; Azathioprine; Budesonide; Catchment Area, Health; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; India; Infant; Inflammatory Bowel Diseases; Male; Methotrexate; Prednisolone; Prevalence | 2009 |
Immunomodulation with methotrexate: underused and undervalued?
Topics: Azathioprine; Clinical Trials as Topic; Crohn Disease; Humans; Immune Tolerance; Immunologic Factors; Immunomodulation; Immunosuppressive Agents; Methotrexate | 2009 |
Inflammatory bowel disease in young people: the case for transitional clinics.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Monoclonal; Azathioprine; Case-Control Studies; Child; Child, Preschool; Female; Humans; Immunosuppressive Agents; Incidence; Inflammatory Bowel Diseases; Infliximab; Male; Mesalamine; Methotrexate; Middle Aged; Radiation Injuries; Retrospective Studies; Young Adult | 2010 |
Graves' disease associated with primary systemic sclerosis.
Topics: Azathioprine; Bosentan; Cyclophosphamide; Drug Therapy, Combination; Female; Glucocorticoids; Graves Disease; Humans; Hypertension, Pulmonary; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Middle Aged; Mycophenolic Acid; Proteinuria; Raynaud Disease; Scleroderma, Systemic; Sulfonamides | 2009 |
Microscopic colitis and endoscopy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Azathioprine; Cholestyramine Resin; Colitis, Collagenous; Colitis, Lymphocytic; Colonoscopy; Cyclosporine; Gastric Mucosa; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Methotrexate; Proton Pump Inhibitors | 2009 |
Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome.
Topics: Aged; Azathioprine; B-Lymphocytes; Epstein-Barr Virus Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Methotrexate; Mycosis Fungoides; Prednisone; Sezary Syndrome; Skin Neoplasms | 2011 |
[Hepatotoxicity induced by new immunosuppressants].
Topics: Azathioprine; Chemical and Drug Induced Liver Injury; Cyclosporine; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Methotrexate; Tumor Necrosis Factor-alpha | 2010 |
Ocular manifestations in a community-based cohort of patients with inflammatory bowel disease.
Topics: Acute Disease; Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Cohort Studies; Cyclosporine; Dry Eye Syndromes; Eye Diseases; Female; Humans; Inflammatory Bowel Diseases; Infliximab; Male; Mesalamine; Methotrexate; Middle Aged; Steroids; Treatment Outcome | 2010 |
Should patients under long-term anti-TNF therapies be followed for tuberculosis contamination?
Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Colitis, Ulcerative; Corticosterone; Crohn Disease; Female; Gastrointestinal Agents; Humans; Infliximab; Latent Tuberculosis; Male; Methotrexate; Radiography; Tuberculosis, Pulmonary; Tumor Necrosis Factor-alpha | 2010 |
Is there a benefit from the concomitant use of immunosupression with anti-TNF in Crohn's disease; heads or tails?
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Certolizumab Pegol; Clinical Trials as Topic; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Immunoglobulin Fab Fragments; Immunosuppressive Agents; Infliximab; Methotrexate; Polyethylene Glycols; Steroids; Tumor Necrosis Factor-alpha | 2009 |
[Significant changes of pharmacotherapy in gastroenterological rehabilitation of Crohn's disease].
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biological Products; Combined Modality Therapy; Crohn Disease; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Germany; Guideline Adherence; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Middle Aged | 2009 |
A pilot study of paternal drug exposure: the Motherisk experience.
Topics: Azathioprine; Breast Feeding; Cohort Studies; Counseling; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Lactation; Male; Methotrexate; Paternal Exposure; Pharmaceutical Preparations; Pilot Projects; Pregnancy; Retrospective Studies; Telephone; Teratology | 2010 |
A probable case of transfusion-transmitted hepatitis B virus infection in an immunosuppressed recipient caused by an occult HBV-infected donor with negative ID-NAT.
Topics: Acute Disease; Adult; Azathioprine; Blood Donors; Carrier State; Crohn Disease; DNA, Viral; False Negative Reactions; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Methotrexate; Nucleic Acid Amplification Techniques; Prednisolone; Transfusion Reaction; Viral Load; Viremia | 2010 |
Proposing an algorithm for treatment of different manifestations of neuro-Behcet's disease.
Topics: Adrenal Cortex Hormones; Algorithms; Antibodies, Monoclonal; Azathioprine; Behcet Syndrome; Brain; Decision Support Techniques; Humans; Methotrexate; Tumor Necrosis Factor-alpha | 2010 |
[Drug therapy of Crohn's disease: slowly increase or start aggressively right away?].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Methotrexate; Practice Guidelines as Topic; Prednisolone; Remission Induction | 2010 |
Infliximab therapy in a patient with refractory ileocolic Crohn's disease and Takayasu arteritis.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Aorta, Abdominal; Aortitis; Azathioprine; Crohn Disease; Drug Resistance; Female; Humans; Immunosuppressive Agents; Infliximab; Magnetic Resonance Angiography; Mesalamine; Methotrexate; Methylprednisolone; Takayasu Arteritis; Tomography, X-Ray Computed; Tumor Necrosis Factor-alpha; Young Adult | 2010 |
Innovative management of lupus erythematosus.
Topics: Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents; Antimalarials; Azathioprine; Calcineurin Inhibitors; Calcium; Child; Combined Modality Therapy; Cyclophosphamide; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemic; Male; Methotrexate; Retinoids; Therapies, Investigational; Vitamin D; Young Adult | 2010 |
Patch testing in patients treated with systemic immunosuppression and cytokine inhibitors.
Topics: Adalimumab; Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Child; Cyclosporine; Cytokines; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Patch Tests; Prospective Studies; Tacrolimus; Treatment Outcome | 2010 |
Azathioprine as a treatment option for uveitis in patients with juvenile idiopathic arthritis.
Topics: Adolescent; Arthritis, Juvenile; Azathioprine; Child; Child, Preschool; Female; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Male; Methotrexate; Retrospective Studies; Treatment Outcome; Uveitis | 2011 |
Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy.
Topics: Adult; Aged; Antibodies, Monoclonal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Male; Methotrexate; Prospective Studies; Registries; Tumor Necrosis Factor-alpha; Young Adult | 2010 |
Current concepts in the genetic diagnostics of rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Genetic Predisposition to Disease; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Methotrexate; Pharmacogenetics; Polymorphism, Single Nucleotide; Protein Tyrosine Phosphatase, Non-Receptor Type 22; Sulfasalazine | 2010 |
Azathioprine-associated hypersensitivity reaction in a patient with Churg Strauss vasculitis.
Topics: Azathioprine; Churg-Strauss Syndrome; Drug Hypersensitivity; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Treatment Outcome | 2010 |
A comparison of an interferon-gamma release assay and tuberculin skin test in refractory inflammatory disease patients screened for latent tuberculosis prior to the initiation of a first tumor necrosis factor α inhibitor.
Topics: Arthritis, Rheumatoid; Azathioprine; Biological Assay; CD4-Positive T-Lymphocytes; Female; Glucocorticoids; Humans; Immunity, Cellular; Interferon-gamma; Isoxazoles; Latent Tuberculosis; Leflunomide; Male; Methotrexate; Middle Aged; Prospective Studies; Tuberculin Test; Tumor Necrosis Factor-alpha | 2011 |
Behçet disease presenting with frosted branch angiitis.
Topics: Arthritis; Azathioprine; Behcet Syndrome; Fundus Oculi; Hematocele; HLA-B Antigens; HLA-B51 Antigen; Humans; Male; Methotrexate; Middle Aged; Oral Ulcer; Papilledema; Prednisolone; Retinal Hemorrhage; Retinal Vasculitis; Treatment Outcome; Visual Acuity; Vitrectomy | 2011 |
Facial basal cell carcinoma in a young patient with Crohn disease.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Carcinoma, Basal Cell; Crohn Disease; Facial Neoplasms; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Methotrexate; Nose Neoplasms; Prednisolone | 2010 |
Immunoglobulins during different treatment regimes in Schnitzler's syndrome.
Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Azathioprine; Biomarkers; C-Reactive Protein; Cyclosporine; Drug Therapy, Combination; Etanercept; Humans; Immunoglobulin G; Immunoglobulin M; Interleukin 1 Receptor Antagonist Protein; Male; Methotrexate; Pain Measurement; Prednisone; Receptors, Tumor Necrosis Factor; Schnitzler Syndrome | 2011 |
Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease.
Topics: Adolescent; Adult; Aged; Anemia; Anti-Inflammatory Agents; Antimicrobial Cationic Peptides; Azathioprine; C-Reactive Protein; Cross-Sectional Studies; Drug Combinations; Enzyme Inhibitors; Female; Gastrointestinal Agents; Glucosamine; Hepcidins; Humans; Inflammatory Bowel Diseases; Iron; Male; Methotrexate; Middle Aged; Protein Precursors; Smoking; Sulfasalazine; Young Adult | 2011 |
VSL#3 and remission in active ulcerative colitis: larger studies required.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Bifidobacterium; Colitis, Ulcerative; Diet; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lactobacillus; Mesalamine; Methotrexate; Probiotics; Randomized Controlled Trials as Topic; Remission Induction; Reproducibility of Results; Severity of Illness Index | 2011 |
Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Colitis, Ulcerative; Crohn Disease; Cross-Sectional Studies; Cyclosporine; Female; Germany; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Mesalamine; Methotrexate; Middle Aged; Practice Patterns, Physicians'; Prospective Studies; Remission Induction; Severity of Illness Index; Sex Factors; Tacrolimus | 2011 |
Wegener granulomatosis (granulomatosis with polyangiitis): evolving concepts in treatment.
Topics: Adrenal Cortex Hormones; Age Factors; Aged; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Granulomatosis with Polyangiitis; Hemorrhage; Humans; Immunologic Factors; Immunosuppressive Agents; Methotrexate; Pulmonary Alveoli; Respiratory Tract Diseases; Rituximab; Severity of Illness Index | 2011 |
Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Axons; Azathioprine; Child; Cyclophosphamide; Cyclosporine; Drug Resistance; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Interferon beta-1a; Interferon-alpha; Interferon-beta; Italy; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Plasmapheresis; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Remission Induction; Retrospective Studies; Rituximab; Severity of Illness Index; Treatment Outcome; Young Adult | 2011 |
Survey of expert practice and perceptions of the supporting clinical evidence for the management of uveitis-related cataract and cystoid macular oedema.
Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Azathioprine; Cataract; Cataract Extraction; Cyclosporine; Expert Testimony; Female; Health Care Surveys; Health Knowledge, Attitudes, Practice; Humans; Macular Edema; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Ophthalmologic Surgical Procedures; Surveys and Questionnaires; Uveitis; Young Adult | 2011 |
Mesenchymal stromal cell function is not affected by drugs used in the treatment of inflammatory bowel disease.
Topics: Adipogenesis; Antibodies, Monoclonal; Azathioprine; Cell Differentiation; Cell Survival; Cells, Cultured; Combined Modality Therapy; Humans; Immune Tolerance; Immunosuppression Therapy; Inflammatory Bowel Diseases; Mercaptopurine; Mesenchymal Stem Cells; Methotrexate; Osteogenesis; Pluripotent Stem Cells; Tumor Necrosis Factor-alpha | 2011 |
[Therapy for anti-MuSK antibody positive myasthenia gravis].
Topics: Adult; Autoantibodies; Azathioprine; Female; Humans; Immunosuppressive Agents; Methotrexate; Myasthenia Gravis; Plasma Exchange; Receptor Protein-Tyrosine Kinases; Receptors, Cholinergic; Treatment Failure; Treatment Outcome | 2011 |
Long-term observational study of sporadic inclusion body myositis.
Topics: Aged; Azathioprine; Cohort Studies; Disability Evaluation; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Muscle Weakness; Muscle, Skeletal; Myositis, Inclusion Body; Prednisone | 2011 |
Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients.
Topics: Adult; Aged; Antirheumatic Agents; Azathioprine; Colchicine; Drug Therapy, Combination; Eosinophilia; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Middle Aged; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Scleroderma, Localized; Synovitis; Treatment Outcome | 2012 |
Behçet's disease: successful treatment with infliximab in 7 patients with severe vascular manifestations. A retrospective analysis.
Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Azathioprine; Behcet Syndrome; C-Reactive Protein; Drug Therapy, Combination; Female; Humans; Infliximab; Male; Methotrexate; Middle Aged; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2012 |
Prevalence and risk factors for liver biochemical abnormalities in Canadian patients with systemic lupus erythematosus.
Topics: Adult; Alanine Transaminase; Antibodies, Neutralizing; Antiphospholipid Syndrome; Aspartate Aminotransferases; Autoimmune Diseases; Azathioprine; Body Mass Index; Canada; DNA; Fatty Liver; Female; Humans; Hypertension; Immunosuppressive Agents; Liver; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Prevalence; Risk Factors; Severity of Illness Index; Ultrasonography | 2012 |
Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Chi-Square Distribution; Cohort Studies; Crohn Disease; Female; Gastrointestinal Agents; Humans; Hungary; Immunosuppressive Agents; Incidence; Infliximab; Logistic Models; Male; Mercaptopurine; Mesalamine; Methotrexate; Phenotype; Proportional Hazards Models; Retrospective Studies; Steroids; Sulfasalazine; Surveys and Questionnaires | 2012 |
Good response to infliximab in a patient with deep vein thrombosis associated with Behçet disease.
Topics: Antibodies, Monoclonal; Antirheumatic Agents; Azathioprine; Behcet Syndrome; Cyclosporine; Drug Resistance; Drug Substitution; Drug Therapy, Combination; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Recurrence; Treatment Outcome; Venous Thrombosis | 2012 |
Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine.
Topics: Administration, Intravenous; Administration, Oral; Adrenal Cortex Hormones; Adult; Azathioprine; Cohort Studies; Dermatomyositis; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Male; Methotrexate; Middle Aged; Multivariate Analysis; Outcome Assessment, Health Care; Polymyositis; Prednisone; Prognosis; Proportional Hazards Models; Time Factors | 2012 |
Efficacy, tolerability, and predictors of response to infliximab therapy for Crohn's disease: a large single centre experience.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Kaplan-Meier Estimate; Male; Methotrexate; Multivariate Analysis; Phenotype; Remission Induction; Retrospective Studies; Severity of Illness Index; Sex Factors; Treatment Outcome; Young Adult | 2012 |
Plasma soluble triggering receptor expressed on myeloid cells-1 in Crohn's disease.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Biomarkers; C-Reactive Protein; Crohn Disease; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Membrane Glycoproteins; Methotrexate; Prospective Studies; Receptors, Immunologic; Serum Albumin; Severity of Illness Index; Triggering Receptor Expressed on Myeloid Cells-1; Young Adult | 2012 |
Clinical features and outcomes of ANCA-associated renal vasculitis.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Churg-Strauss Syndrome; Creatinine; Cyclophosphamide; Female; Glomerulonephritis; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Induction Chemotherapy; Maintenance Chemotherapy; Male; Methotrexate; Microscopic Polyangiitis; Middle Aged; Plasmapheresis; Recurrence; Remission Induction; Renal Dialysis; Retrospective Studies | 2012 |
[Guidelines for the management of Crohn's disease].
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Budesonide; Crohn Disease; Databases, Factual; Female; Fistula; Humans; Infliximab; Intestinal Perforation; Male; Mercaptopurine; Mesalamine; Methotrexate; Prednisolone; Pregnancy; Recurrence; Risk Factors; Severity of Illness Index; Sulfasalazine | 2012 |
Adherence of gastroenterologists to European Crohn's and Colitis Organisation consensus on Crohn's disease: a real-life survey in Spain.
Topics: Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Crohn Disease; Gastroenterology; Glucocorticoids; Guideline Adherence; Hepatitis B; Humans; Immunosuppressive Agents; Infliximab; Influenza, Human; Methotrexate; Practice Guidelines as Topic; Prospective Studies; Spain; Specialization; Surveys and Questionnaires; Vaccination | 2012 |
Results of the 2nd scientific workshop of the ECCO (IV): therapeutic strategies to enhance intestinal healing in inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Endoscopy, Gastrointestinal; Humans; Inflammatory Bowel Diseases; Infliximab; Intestinal Mucosa; Mercaptopurine; Mesalamine; Methotrexate; Treatment Outcome | 2012 |
Azathioprine as monotherapy for scleritis in relapsing polychondritis.
Topics: Azathioprine; Child; Drug Therapy, Combination; Eye Pain; Female; Humans; Immunosuppressive Agents; Methotrexate; Polychondritis, Relapsing; Prednisone; Scleritis; Visual Acuity | 2012 |
[Systemic treatment of ocular cicatricial pemphigoid].
Topics: Adult; Aged; Aged, 80 and over; Autoimmune Diseases; Azathioprine; Dapsone; Delayed Diagnosis; Female; Follow-Up Studies; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Pemphigoid, Benign Mucous Membrane; Severity of Illness Index; Treatment Outcome | 2012 |
Infliximab exerts no direct hepatotoxic effect on HepG2 cells in vitro.
Topics: Analysis of Variance; Antibodies, Monoclonal; Azathioprine; Cell Survival; Dose-Response Relationship, Drug; Hep G2 Cells; Hepatoblastoma; Humans; In Vitro Techniques; Inflammatory Bowel Diseases; Infliximab; Liver Neoplasms; Mercaptopurine; Methotrexate; Sensitivity and Specificity; Thioguanine | 2012 |
Growth in children receiving contemporary disease specific therapy for Crohn's disease.
Topics: Adolescent; Azathioprine; Body Height; Child; Child Development; Child, Preschool; Crohn Disease; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Prednisolone; Puberty; Retrospective Studies; Young Adult | 2012 |
Role of sex in the treatment and clinical outcomes of pediatric patients with inflammatory bowel disease.
Topics: Adolescent; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Body Height; Body Mass Index; Child; Colitis, Ulcerative; Crohn Disease; Cross-Sectional Studies; Female; Growth; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Methotrexate; Severity of Illness Index; Sex Factors; Treatment Outcome | 2012 |
Vasculitis associated with tumor necrosis factor-α inhibitors.
Topics: Adalimumab; Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Arthritis, Rheumatoid; Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclophosphamide; Etanercept; Female; Glucocorticoids; Hematuria; Humans; Immunoglobulin G; Immunologic Factors; Infliximab; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Polyneuropathies; Prednisone; Proteinuria; Receptors, Tumor Necrosis Factor; Retrospective Studies; Rituximab; Tumor Necrosis Factor-alpha; Vasculitis; Young Adult | 2012 |
Calcinosis and antisynthetase syndrome.
Topics: Azathioprine; Calcinosis; Comorbidity; Drug Therapy, Combination; Electromyography; Female; Hand Joints; Humans; Methotrexate; Middle Aged; Myositis; Prednisone; Radiography; Shoulder Joint; Treatment Outcome | 2012 |
A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients.
Topics: Anti-Inflammatory Agents; Azathioprine; Churg-Strauss Syndrome; Cohort Studies; Cyclophosphamide; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Prednisolone; Remission Induction; Retrospective Studies; Secondary Prevention; Treatment Outcome | 2013 |
Negative predictive value of TST and IGRA in anti-TNF treated patients.
Topics: Adalimumab; Adult; Antibodies, Monoclonal, Humanized; Azathioprine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Interferon-gamma Release Tests; Latent Tuberculosis; Male; Methotrexate; Middle Aged; Natalizumab; Prednisolone; Reproducibility of Results; Retrospective Studies; Tuberculin Test; Tuberculosis; Tumor Necrosis Factor-alpha | 2012 |
Cyclosporine-induced haemolytic anaemia in a child with juvenile dermatomyositis.
Topics: Anemia, Hemolytic; Azathioprine; Child; Cyclosporine; Dermatomyositis; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Methotrexate; Methylprednisolone; Prednisolone; Pulse Therapy, Drug | 2012 |
Myelosuppression monitoring after immunomodulator initiation in veterans with inflammatory bowel disease: a national practice audit.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Azathioprine; Delivery of Health Care; Drug Monitoring; Drug Prescriptions; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Leukocyte Count; Leukopenia; Male; Medical Audit; Mercaptopurine; Methotrexate; Middle Aged; Practice Guidelines as Topic; Treatment Outcome; United States; United States Department of Veterans Affairs; Veterans | 2012 |
Addition of an immunomodulator to infliximab therapy eliminates antidrug antibodies in serum and restores clinical response of patients with inflammatory bowel disease.
Topics: Adolescent; Adult; Antibodies; Antibodies, Monoclonal; Azathioprine; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Infliximab; Male; Mercaptopurine; Methotrexate; Retrospective Studies; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult | 2013 |
Lymphoma risk in systemic lupus: effects of disease activity versus treatment.
Topics: Adult; Antimalarials; Azathioprine; Case-Control Studies; Cyclophosphamide; Female; Glucocorticoids; Hodgkin Disease; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Risk Factors; Young Adult | 2014 |
Primary sclerosing cholangitis, Crohn's disease and HLA-B27 in black South African women.
Topics: Adult; Alkaline Phosphatase; Azathioprine; Back Pain; Black People; Cholagogues and Choleretics; Cholangiopancreatography, Magnetic Resonance; Cholangitis, Sclerosing; Colonoscopy; Crohn Disease; Diarrhea; Female; gamma-Glutamyltransferase; Genetic Predisposition to Disease; HLA-B27 Antigen; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Severity of Illness Index; South Africa; Treatment Outcome; Ursodeoxycholic Acid | 2012 |
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
Topics: Adolescent; Adult; Aged; Antibodies; Aquaporin 4; Azathioprine; Child; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Neuromyelitis Optica; Retrospective Studies; Treatment Outcome; Young Adult | 2013 |
Methotrexate vs azathioprine in second-line therapy of sarcoidosis.
Topics: Azathioprine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Respiratory Function Tests; Retrospective Studies; Sarcoidosis, Pulmonary; Treatment Outcome; Vital Capacity | 2013 |
B cell homeostasis is disturbed by immunosuppressive therapies in patients with ANCA-associated vasculitides.
Topics: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Monoclonal, Murine-Derived; Azathioprine; B-Lymphocyte Subsets; Cyclophosphamide; Female; Homeostasis; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocyte Count; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Rituximab | 2013 |
Diagnostic and therapeutic aspects of Hashimoto's encephalopathy.
Topics: Adult; Aged; Autoantibodies; Azathioprine; Brain Diseases; Child; Child, Preschool; Electroencephalography; Encephalitis; Enzyme Inhibitors; Female; Hashimoto Disease; Humans; Immunoglobulins, Intravenous; Male; Methotrexate; Middle Aged; Retrospective Studies; Steroids | 2013 |
Systemic therapies for severe atopic dermatitis in children and adults.
Topics: Adult; Azathioprine; Child; Cyclosporine; Dermatitis, Atopic; Humans; Immunosuppressive Agents; Male; Methotrexate; Quality of Life | 2013 |
Infliximab and/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Viral; Azathioprine; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunity, Active; Immunosuppressive Agents; Infliximab; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza Vaccines; Male; Mercaptopurine; Methotrexate; Middle Aged; Prospective Studies; Tacrolimus | 2014 |
Increased effectiveness of early therapy with anti-tumor necrosis factor-α vs an immunomodulator in children with Crohn's disease.
Topics: Adalimumab; Adolescent; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Child; Child Development; Crohn Disease; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Induction Chemotherapy; Infliximab; Male; Matched-Pair Analysis; Mercaptopurine; Methotrexate; Propensity Score; Prospective Studies; Severity of Illness Index; Treatment Outcome | 2014 |
Factors associated with fatigue in sarcoidosis.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Cohort Studies; Fatigue; Female; Germany; Humans; Hypertension, Pulmonary; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prednisolone; Risk Factors; Sarcoidosis; Sleep Apnea Syndromes; Surveys and Questionnaires | 2014 |
American Gastroenterological Association Institute guideline on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.
Topics: Azathioprine; Crohn Disease; Gastroenterology; Humans; Mercaptopurine; Methotrexate; Remission Induction; Societies, Medical; Tumor Necrosis Factor-alpha; United States | 2013 |
Functional outcome and prognostic factors in anti-Jo1 patients with antisynthetase syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Antinuclear; Azathioprine; Female; Follow-Up Studies; Histidine-tRNA Ligase; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myositis; Outcome Assessment, Health Care; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Severity of Illness Index; Steroids; Surveys and Questionnaires; Young Adult | 2013 |
An open-label trial of abatacept (CTLA4-IG) in non-severe relapsing granulomatosis with polyangiitis (Wegener's).
Topics: Abatacept; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Cohort Studies; Drug Therapy, Combination; Female; Granulomatosis with Polyangiitis; Humans; Immunoconjugates; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prednisone; Prospective Studies; Recurrence; Remission Induction; Severity of Illness Index; Treatment Outcome; Young Adult | 2014 |
Coexistence of systemic lupus erythematosus and multiple sclerosis: prevalence, clinical characteristics, and natural history.
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Azathioprine; Comorbidity; Female; Glatiramer Acetate; Greece; Humans; Hydroxychloroquine; Immunologic Factors; Immunosuppressive Agents; Interferon-beta; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Multiple Sclerosis; Natalizumab; Peptides; Prevalence; Rituximab | 2014 |
Outcomes of changing immunosuppressive therapy after treatment failure in patients with noninfectious uveitis.
Topics: Adolescent; Adult; Aged; Azathioprine; Child; Child, Preschool; Cohort Studies; Cyclosporine; Drug Substitution; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prednisolone; Retrospective Studies; Treatment Failure; Treatment Outcome; Uveitis; Visual Acuity; Young Adult | 2014 |
Granulomatosis with polyangiitis (Wegener's): impact of maintenance therapy duration.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Child; Drug Administration Schedule; Female; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Recurrence; Remission Induction; Retrospective Studies; Time Factors; Young Adult | 2014 |
The effects of prednisone and steroid-sparing agents on decay accelerating factor (CD55) expression: implications in myasthenia gravis.
Topics: Animals; Azathioprine; CD55 Antigens; Cell Line; Chlorocebus aethiops; COS Cells; Cyclosporine; Glucocorticoids; Humans; Methotrexate; Mice; Myasthenia Gravis; Prednisone | 2014 |
Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents.
Topics: Anti-Infective Agents; Azathioprine; Cyclosporine; Dermatitis, Atopic; Histamine Antagonists; Humans; Immunologic Factors; Interferon-gamma; Methotrexate; Mycophenolic Acid; Phototherapy | 2014 |
Infliximab as a bridge to remission maintained by antimetabolite therapy in Crohn's disease: A retrospective study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antimetabolites; Azathioprine; Crohn Disease; Female; Follow-Up Studies; Humans; Infliximab; Maintenance Chemotherapy; Male; Mercaptopurine; Methotrexate; Recurrence; Remission Induction; Retreatment; Retrospective Studies; Risk Factors; Treatment Failure; Withholding Treatment; Young Adult | 2014 |
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease.
Topics: Adalimumab; Adolescent; Adrenal Cortex Hormones; Algorithms; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Child; Crohn Disease; Enteral Nutrition; Humans; Immunosuppressive Agents; Infliximab; Maintenance Chemotherapy; Mercaptopurine; Methotrexate; Remission Induction; Thalidomide; Tumor Necrosis Factor-alpha | 2014 |
Rituximab with or without a conventional maintenance agent in the treatment of relapsing granulomatosis with polyangiitis (Wegener's): a retrospective single-center study.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Drug Therapy, Combination; Female; Granulomatosis with Polyangiitis; Humans; Immunologic Factors; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Remission Induction; Retrospective Studies; Rituximab; Treatment Outcome | 2014 |
Crohn's disease outpatients treated with adalimumab have an earlier secondary loss of response and requirement for dose escalation compared to infliximab: a real life cohort study.
Topics: Adalimumab; Adult; Ambulatory Care; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Crohn Disease; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Immunosuppressive Agents; Infliximab; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Retreatment; Retrospective Studies; Risk Factors; Time Factors; Tumor Necrosis Factor-alpha | 2014 |
Treatment with immunosuppressive therapy in patients with pars planitis: experience of a reference centre in Mexico.
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Mexico; Middle Aged; Pars Planitis; Referral and Consultation; Retrospective Studies; Visual Acuity | 2014 |
Early use of thiopurines or methotrexate reduces major abdominal and perianal surgery in Crohn's disease.
Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Anal Canal; Azathioprine; Child; Child, Preschool; Crohn Disease; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Mercaptopurine; Methotrexate; Middle Aged; Prognosis; Retrospective Studies; Secondary Prevention; Young Adult | 2014 |
Psoriatic arthritis treatment and the risk of herpes zoster.
Topics: Adalimumab; Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Azathioprine; Cyclosporine; Drug Combinations; Drug Therapy, Combination; Etanercept; Female; Glucosamine; Herpes Zoster; Humans; Hydroxychloroquine; Incidence; Infliximab; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine; Tumor Necrosis Factor-alpha | 2016 |
Successful outcome of pregnancy in patients with anti-neutrophil cytoplasm antibody-associated small vessel vasculitis.
Topics: Abortion, Spontaneous; Adolescent; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Azathioprine; Cesarean Section; Cyclophosphamide; Female; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Live Birth; Methotrexate; Microscopic Polyangiitis; Plasma Exchange; Preconception Care; Pregnancy; Pregnancy Complications; Pregnancy, High-Risk; Pregnancy, Unplanned; Recurrence; Retrospective Studies; Term Birth; United Kingdom; Young Adult | 2015 |
[No best treatment for severe outbreaks: Maintenance, the key in colitis].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Azathioprine; Colitis, Ulcerative; Disease Management; Disease Progression; Humans; Immunosuppressive Agents; Infliximab; Maintenance Chemotherapy; Mercaptopurine; Methotrexate; Patient Preference; Practice Patterns, Physicians'; Salicylates; Tumor Necrosis Factor-alpha | 2011 |
Antiphospholipid antibodies-associated diffuse alveolar hemorrhage.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Azathioprine; Biopsy; Cohort Studies; Cyclophosphamide; Female; Hemorrhage; Humans; Hydroxychloroquine; Lung; Lung Diseases; Male; Methotrexate; Middle Aged; Plasma Exchange; Retrospective Studies; Rituximab | 2015 |
[Remission maintenance with methotrexate, azathioprine or mycophenolate-mofetil after induction therapy with rituximab for granulomatosis with polyangiitis].
Topics: Antirheumatic Agents; Azathioprine; Drug Administration Schedule; Drug Therapy, Combination; Granulomatosis with Polyangiitis; Humans; Methotrexate; Mycophenolic Acid; Remission Induction; Rituximab; Treatment Outcome | 2015 |
[Drugs news].
Topics: Abnormalities, Drug-Induced; Anti-Retroviral Agents; Azathioprine; Female; Humans; Infant, Newborn; Isotretinoin; Methotrexate; Pregnancy; Sumatriptan | 2015 |
Variability in the prescription of non-biologic disease-modifying antirheumatic drugs for the treatment of spondyloarthritis in Spain.
Topics: Adult; Antimalarials; Antirheumatic Agents; Azathioprine; Cohort Studies; Cyclophosphamide; Cyclosporine; Female; Humans; Inflammatory Bowel Diseases; Isoxazoles; Leflunomide; Logistic Models; Male; Methotrexate; Middle Aged; Odds Ratio; Practice Patterns, Physicians'; Psoriasis; Retrospective Studies; Severity of Illness Index; Sex Factors; Spain; Spondylarthropathies; Sulfasalazine; Uveitis | 2015 |
Incidence of herpes zoster infections in juvenile idiopathic arthritis patients.
Topics: Adalimumab; Adolescent; Adrenal Cortex Hormones; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Juvenile; Azathioprine; Child; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Herpes Zoster; Humans; Immunocompromised Host; Immunosuppressive Agents; Incidence; Longitudinal Studies; Male; Methotrexate; Prospective Studies; Risk Factors | 2015 |
Clinical consequences of sesquiterpene lactone mix contact allergy in Denmark.
Topics: Activities of Daily Living; Adrenal Cortex Hormones; Asteraceae; Azathioprine; Denmark; Dermatitis, Allergic Contact; Female; Humans; Immunosuppressive Agents; Lactones; Male; Methotrexate; Middle Aged; Patch Tests; Seasons; Sesquiterpenes | 2015 |
Systemic treatment of papular dermatitis: A retrospective study.
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Dermatitis; Drug Administration Schedule; Female; Humans; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Retrospective Studies; Treatment Outcome | 2015 |
Vulval Crohn's disease: a clinical study of 22 patients.
Topics: Adalimumab; Adolescent; Adult; Anti-Inflammatory Agents; Azathioprine; Child; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Methotrexate; Middle Aged; Tumor Necrosis Factor-alpha; Vulva; Vulvar Diseases; Young Adult | 2015 |
Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents.
Topics: Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cerebrovascular Disorders; Certolizumab Pegol; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Rare Diseases; Retreatment; Retrospective Studies; Tumor Necrosis Factor-alpha; Young Adult | 2015 |
Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres.
Topics: Academic Medical Centers; Administration, Oral; Adult; Azathioprine; Cyclosporine; Dermatitis, Atopic; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Tacrolimus; Young Adult | 2015 |
Addition of an immunomodulator as a rescue therapy for loss of response to adalimumab dose escalation in patients with Crohn's disease.
Topics: Adalimumab; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Crohn Disease; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Retrospective Studies; Salvage Therapy; Young Adult | 2015 |
Methotrexate is an efficient therapeutic alternative in children with thiopurine-resistant Crohn's disease.
Topics: Azathioprine; Child; Child, Preschool; Cohort Studies; Crohn Disease; Drug Resistance; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Methotrexate; Multivariate Analysis; Proportional Hazards Models; Remission Induction; Retrospective Studies; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome | 2015 |
Reply: To PMID 24943239.
Topics: Antibodies, Monoclonal, Murine-Derived; Azathioprine; Female; Granulomatosis with Polyangiitis; Humans; Immunologic Factors; Male; Methotrexate; Mycophenolic Acid | 2015 |
Does Concomitant Methotrexate During Rituximab Treatment in Granulomatosis With Polyangiitis (Wegener's) Increase the Risk of Severe Infection? Comment on the Article by Azar et al.
Topics: Antibodies, Monoclonal, Murine-Derived; Azathioprine; Female; Granulomatosis with Polyangiitis; Humans; Immunologic Factors; Male; Methotrexate; Mycophenolic Acid | 2015 |
[Uveitic macular edema and the pharmacotherapy].
Topics: Acetazolamide; Adrenal Cortex Hormones; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Azathioprine; Bevacizumab; Cyclosporine; Humans; Immunosuppressive Agents; Macular Edema; Methotrexate; Mycophenolic Acid; Tumor Necrosis Factor-alpha; Uveitis; Vision Disorders | 2015 |
Liver steatosis is a risk factor for hepatotoxicity in patients with inflammatory bowel disease under immunosuppressive treatment.
Topics: Adolescent; Adult; Age Factors; Aged; Alanine Transaminase; Aspartate Aminotransferases; Azathioprine; Body Mass Index; Chemical and Drug Induced Liver Injury; Colitis, Ulcerative; Crohn Disease; Fatty Liver; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Middle Aged; Retrospective Studies; Risk Factors; Sex Factors; Ultrasonography; Young Adult | 2015 |
Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study.
Topics: Adalimumab; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Chemical and Drug Induced Liver Injury; Cohort Studies; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Hepatitis C, Chronic; Humans; Hydroxychloroquine; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha | 2015 |
The anti-IL-4 receptor alpha antibody dupilumab: facing a new era in treating atopic dermatitis.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Clinical Trials as Topic; Cyclosporine; Dermatitis, Atopic; Humans; Immunosuppressive Agents; Methotrexate; Quality of Life; Receptors, Interleukin-4; Treatment Outcome | 2015 |
Thromboembolism as an important complication of inflammatory bowel disease.
Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Colitis, Ulcerative; Crohn Disease; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Mesalamine; Methotrexate; Middle Aged; Pulmonary Embolism; Recurrence; Retrospective Studies; Severity of Illness Index; Venous Thromboembolism; Venous Thrombosis | 2016 |
Increased binding of circulating systemic lupus erythematosus autoantibodies to recombinant interferon alpha 2b.
Topics: Antibody Affinity; Autoantibodies; Azathioprine; Cloning, Molecular; Enzyme-Linked Immunosorbent Assay; Female; Humans; Interferon-alpha; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Prednisolone; Recombinant Proteins | 2015 |
[Clinical features of patients with juvenile and adult dermatomyositis].
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Cyclosporine; Dermatomyositis; Female; Follow-Up Studies; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Muscle Weakness; Recurrence; Retrospective Studies; Young Adult | 2015 |
New Zealand Society of Gastroenterology Guidelines for the Management of Refractory Ulcerative Colitis.
Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Appendectomy; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Resistance; Drug Therapy, Combination; Fecal Microbiota Transplantation; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Leukapheresis; Mercaptopurine; Mesalamine; Methotrexate; New Zealand; Pediatrics; Piperidines; Proctocolectomy, Restorative; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Recurrence; Severity of Illness Index; Tacrolimus; Tumor Necrosis Factor-alpha | 2015 |
Idiopathic Dacryoadenitis: Clinical Features, Histopathology, and Treatment Outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Biopsy; Child; Dacryocystitis; Drug Resistance; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prednisolone; Recurrence; Retrospective Studies; Risk Factors; Tertiary Care Centers; Treatment Outcome; Triamcinolone Acetonide | 2016 |
[Clinical practice guideline for ANCA-associated vasculitis with renal involvement].
Topics: Adult; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antibodies, Antineutrophil Cytoplasmic; Antirheumatic Agents; Azathioprine; Child; Clinical Trials as Topic; Cyclophosphamide; Evidence-Based Medicine; Glucocorticoids; Humans; Induction Chemotherapy; Kidney Diseases; Maintenance Chemotherapy; Methotrexate; Organ Dysfunction Scores; Plasmapheresis; Recurrence; Severity of Illness Index | 2015 |
Anti-TNF Monotherapy for Crohn's Disease: a 13-year Multicentre Experience.
Topics: Adalimumab; Adolescent; Adult; Anti-Inflammatory Agents; Azathioprine; Crohn Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
Tumor Necrosis Factor-α Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid Arthritis.
Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Certolizumab Pegol; Cohort Studies; Cyclophosphamide; Etanercept; Female; Humans; Hydroxychloroquine; Hypertension; Incidence; Infliximab; Male; Methotrexate; Middle Aged; Minocycline; Penicillamine; Proportional Hazards Models; Retrospective Studies; Risk Factors; Sulfasalazine; Tumor Necrosis Factor-alpha | 2016 |
Drugs used in incident systemic lupus erythematosus - results from the Finnish nationwide register 2000-2007.
Topics: Adult; Aged; Antirheumatic Agents; Azathioprine; Chronic Disease; Female; Finland; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Registries | 2016 |
Breastfeeding in mothers with systemic lupus erythematosus.
Topics: Adult; Azathioprine; Breast Feeding; Databases, Factual; Decision Making; Female; Humans; Hydroxychloroquine; Infant; Lupus Erythematosus, Systemic; Methotrexate; Milk, Human; Mothers; Prednisolone; Pregnancy; Prospective Studies; Socioeconomic Factors; Young Adult | 2016 |
Long-term Use of Systemic Treatments for Moderate-to-Severe Atopic Dermatitis in Adults: A Monocentric Retrospective Study.
Topics: Adolescent; Adult; Aged; Azathioprine; Cyclosporine; Dermatitis, Atopic; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Retrospective Studies; Treatment Outcome | 2016 |
Immunosuppressive medication use and risk of herpes zoster (HZ) in patients with systemic lupus erythematosus (SLE): A nationwide case-control study.
Topics: Administration, Intravenous; Administration, Oral; Adrenal Cortex Hormones; Adult; Azathioprine; Case-Control Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Herpes Zoster; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Methotrexate; Methylprednisolone; Middle Aged; Mycophenolic Acid; Retrospective Studies; Risk Factors; Taiwan; Young Adult | 2016 |
Inflammatory bowel disease in the clinic: Escalation and de-escalation of therapy: A longitudinal case-based discussion.
Topics: Adolescent; Azathioprine; Crohn Disease; Drug Substitution; Drug Therapy, Combination; Enteral Nutrition; Guanine Nucleotides; Humans; Immunosuppressive Agents; Infliximab; Lymphoma, T-Cell; Male; Methotrexate; Recurrence; Remission Induction; Thionucleotides | 2016 |
Brief Report: Menopause and Primary Ovarian Insufficiency in Women Treated for Antineutrophil Cytoplasmic Antibody-Associated Vasculitides.
Topics: Adult; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Case-Control Studies; Cohort Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Incidence; Maintenance Chemotherapy; Menopause; Methotrexate; Middle Aged; Mycophenolic Acid; Prednisolone; Primary Ovarian Insufficiency; Remission Induction; Retrospective Studies; Risk Factors; Rituximab; Young Adult | 2016 |
Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study.
Topics: Adolescent; Adrenal Cortex Hormones; Age Distribution; Antibodies, Antineutrophil Cytoplasmic; Asia; Azathioprine; Canada; Child; Child, Preschool; Cohort Studies; Cyclophosphamide; Drug Therapy, Combination; Europe; Female; Granulomatosis with Polyangiitis; Hemorrhage; Humans; Immunosuppressive Agents; Infant; Kidney Failure, Chronic; Lung Diseases; Male; Methotrexate; Microscopic Polyangiitis; Mycophenolic Acid; Nephrotic Syndrome; Oxygen Inhalation Therapy; Plasmapheresis; Proteinuria; Renal Dialysis; Respiratory Insufficiency; Rituximab; United States | 2016 |
Mucosal Healing and Deep Remission: A New Treatment Paradigm for Inflammatory Bowel Disease.
Topics: Azathioprine; Biological Therapy; Colonoscopy; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Intestinal Mucosa; Methotrexate; Regeneration; Remission Induction; Tumor Necrosis Factor-alpha | 2015 |
Association Between Breast Cancer Recurrence and Immunosuppression in Rheumatoid Arthritis and Inflammatory Bowel Disease: A Cohort Study.
Topics: Adalimumab; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Azathioprine; Breast Neoplasms; Cohort Studies; Etanercept; Female; Humans; Immunosuppressive Agents; Incidence; Inflammatory Bowel Diseases; Infliximab; Medicare; Mercaptopurine; Methotrexate; Middle Aged; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Proportional Hazards Models; Retrospective Studies; Risk Factors; Tumor Necrosis Factor-alpha; United States | 2016 |
Neuromyelitis optica relapses: Race and rate, immunosuppression and impairment.
Topics: Adolescent; Adult; Age of Onset; Azathioprine; Black People; Disability Evaluation; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Least-Squares Analysis; Male; Methotrexate; Neuromyelitis Optica; Prospective Studies; Regression Analysis; Rituximab; Seasons; Severity of Illness Index | 2016 |
Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Topics: Adrenal Cortex Hormones; Age of Onset; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Carcinoma; Colitis, Ulcerative; Colorectal Neoplasms; Crohn Disease; Female; Follow-Up Studies; France; Humans; Immunosuppressive Agents; Incidence; Inflammatory Bowel Diseases; Intestinal Neoplasms; Lymphoproliferative Disorders; Male; Mesalamine; Methotrexate; Middle Aged; Myeloproliferative Disorders; Neoplasms; Proportional Hazards Models; Protective Factors; Registries; Retrospective Studies; Risk Factors; Time Factors; Tumor Necrosis Factor-alpha | 2016 |
Sepsis During Immunosuppression for Sight-threatening Uveitis: The Flip side.
Topics: Adult; Aged; Azathioprine; Bacteremia; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Klebsiella Infections; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Pneumocystis Infections; Prednisolone; Retrospective Studies; Uveitis | 2018 |
Rheumatologists and Ophthalmologists Differ in Treatment Decisions for Ocular Behçet Disease.
Topics: Administration, Topical; Azathioprine; Behcet Syndrome; Clinical Decision-Making; Eye Diseases; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Ophthalmologists; Patient Selection; Practice Patterns, Physicians'; Rheumatologists; Surveys and Questionnaires; United States; Vision Disorders | 2016 |
A case of refractory dermatomyositis responsive to tofacitinib.
Topics: Azathioprine; Dermatomyositis; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Middle Aged; Mycophenolic Acid; Piperidines; Pyrimidines; Pyrroles; Retreatment; Treatment Failure; Treatment Outcome | 2017 |
Hospital-diagnosed atopic dermatitis and long-term risk of myocardial infarction: a population-based follow-up study.
Topics: Adult; Aged; Ambulatory Care; Azathioprine; Case-Control Studies; Cyclosporine; Denmark; Dermatitis, Atopic; Eczema; Female; Follow-Up Studies; Hospitalization; Hospitals; Humans; Immunosuppressive Agents; Incidence; Male; Methotrexate; Middle Aged; Myocardial Infarction; Registries; Risk Factors; Young Adult | 2016 |
Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey.
Topics: Adult; Azathioprine; Canada; Child; Cyclosporine; Dermatitis, Atopic; Dermatology; Drug Prescriptions; Female; Health Care Surveys; Humans; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Pediatrics; Practice Patterns, Physicians'; Severity of Illness Index; United States | 2017 |
Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab.
Topics: Adalimumab; Adult; Anti-Inflammatory Agents; Antibodies; Antibody Formation; Azathioprine; Colitis, Ulcerative; Crohn Disease; Female; Humans; Immunologic Factors; Male; Mercaptopurine; Methotrexate; Treatment Outcome; Young Adult | 2017 |
Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermany.
Topics: Adult; Alitretinoin; Anti-Inflammatory Agents; Azathioprine; Cyclosporine; Dermatitis, Atopic; Female; Follow-Up Studies; Humans; Leflunomide; Long-Term Care; Male; Methotrexate; Mycophenolic Acid; Prednisolone; Registries; Treatment Outcome | 2017 |
Improvements in the Long-Term Outcome of Crohn's Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort.
Topics: Adalimumab; Adult; Antirheumatic Agents; Azathioprine; Biological Products; Crohn Disease; Digestive System Surgical Procedures; Female; Glucocorticoids; Hospitalization; Humans; Immunologic Factors; Infliximab; Kaplan-Meier Estimate; Male; Mercaptopurine; Methotrexate; Middle Aged; Multivariate Analysis; Netherlands; Prednisone; Propensity Score; Proportional Hazards Models; Severity of Illness Index; Young Adult | 2017 |
Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn's Disease Treated With Infliximab [Remicade®] or Conventional Therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azathioprine; Crohn Disease; Demyelinating Diseases; Drug Substitution; Drug Therapy, Combination; Female; Gastrointestinal Agents; Hematologic Diseases; Humans; Immunosuppressive Agents; Infections; Infliximab; Infusions, Intravenous; Lymphoproliferative Disorders; Male; Mercaptopurine; Mesalamine; Methotrexate; Middle Aged; Mortality; Narcotics; Prednisone; Prospective Studies; Registries; Risk Factors; Sulfasalazine; Time Factors; Young Adult | 2017 |
Takayasu's Arteritis with Isolated Pulmonary Artery Involvement in a Middle-Aged Asian Woman with Hepatitis B and Latent Tuberculosis Infection.
Topics: Angiography, Digital Subtraction; Antitubercular Agents; Antiviral Agents; Azathioprine; Female; Fluorodeoxyglucose F18; Glucocorticoids; Guanine; Hepatitis B, Chronic; Humans; Immunosuppressive Agents; Isoniazid; Latent Tuberculosis; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Positron-Emission Tomography; Pulmonary Artery; Radiopharmaceuticals; Recurrence; Stenosis, Pulmonary Artery; Takayasu Arteritis | 2017 |
Methotrexate for Refractory Crohn's Disease Compared with Thiopurines: A Retrospective Non-head-to-head Controlled Study.
Topics: Adult; Azathioprine; Crohn Disease; Drug Resistance; Female; Humans; Immunosuppressive Agents; Induction Chemotherapy; Male; Mercaptopurine; Methotrexate; Quality of Life; Research Design; Retrospective Studies; Treatment Outcome; Young Adult | 2017 |
Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia.
Topics: Aged; Aged, 80 and over; Arthritis, Rheumatoid; Autoimmune Diseases; Azathioprine; Case-Control Studies; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Incidence; Leukemia, Myeloid, Acute; Lupus Erythematosus, Systemic; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoxantrone; Mycophenolic Acid; Myelodysplastic Syndromes; Odds Ratio; Psoriasis; Retrospective Studies; Risk Factors; United States | 2017 |
Psoriasis in systemic lupus erythematosus: a single-center experience.
Topics: Adolescent; Adult; Antirheumatic Agents; Azathioprine; Cohort Studies; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Male; Methotrexate; Ontario; Psoriasis; Young Adult | 2017 |
Early Outcomes in Children With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Child; Cohort Studies; Cyclophosphamide; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Diseases; Lung Diseases; Male; Methotrexate; Mycophenolic Acid; Prospective Studies; Recurrence; Registries; Remission Induction; Retrospective Studies; Rituximab | 2017 |
Granulomatosis with polyangiitis in Tunisia.
Topics: Adult; Anti-Bacterial Agents; Antibodies, Antineutrophil Cytoplasmic; Azathioprine; Biomarkers; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Granulomatosis with Polyangiitis; Hospitals, University; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Prevalence; Recurrence; Retrospective Studies; Survival Rate; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Tunisia | 2017 |
Azathioprine-Associated Complete NK Cell Deficiency.
Topics: Azathioprine; CD56 Antigen; Child, Preschool; Cytotoxicity, Immunologic; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Immunologic Deficiency Syndromes; Immunophenotyping; Immunosuppressive Agents; Inflammatory Bowel Diseases; K562 Cells; Killer Cells, Natural; Methotrexate; Remission Induction; Tumor Necrosis Factor-alpha; Withholding Treatment | 2017 |
Ulcerative Pyoderma Gangrenosum and Leukocytoclastic Vasculitis in a Hypothyroid Woman: A Case Report.
Topics: Azathioprine; Drug Therapy, Combination; Female; Humans; Hypothyroidism; Immunosuppressive Agents; Methotrexate; Middle Aged; Pyoderma Gangrenosum; Remission Induction; Vasculitis, Leukocytoclastic, Cutaneous | 2017 |
Paternal use of azathioprine/6-mercaptopurine or methotrexate within 3 months before conception and long-term health outcomes in the offspring-A nationwide cohort study.
Topics: Azathioprine; Child Health; Cohort Studies; Denmark; Fathers; Female; Fertilization; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate | 2017 |
H syndrome: 5 new cases from the United States with novel features and responses to therapy.
Topics: Adult; Antibodies, Monoclonal, Humanized; Azathioprine; Child; Child, Preschool; Contracture; Diagnosis, Differential; Female; Glucocorticoids; Hearing Loss, Sensorineural; Histiocytosis; Humans; Infant; Male; Methotrexate; Nucleoside Transport Proteins; Prednisone; Treatment Outcome; United States | 2017 |
Paternal use of thiopurines and methotrexate: Are we reassured enough?
Topics: Azathioprine; Cohort Studies; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate | 2018 |
Methotrexate versus azathioprine in patients with atopic dermatitis: 2-year follow-up data.
Topics: Adult; Azathioprine; Dermatitis, Atopic; Female; Filaggrin Proteins; Follow-Up Studies; Humans; Intermediate Filament Proteins; Male; Methotrexate | 2018 |
Novel treatment regimen of Vogt-Koyanagi-Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents.
Topics: Acute Disease; Azathioprine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Off-Label Use; Prednisone; Recurrence; Retrospective Studies; Treatment Outcome; Uveomeningoencephalitic Syndrome; Visual Acuity | 2018 |
Cutaneous side effects caused by treatment for inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cyclosporine; Drug Eruptions; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Methotrexate; Tumor Necrosis Factor-alpha | 2016 |
Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling.
Topics: Antirheumatic Agents; Azathioprine; Child; Child, Preschool; Cohort Studies; Cyclophosphamide; Dermatomyositis; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Infliximab; Male; Methotrexate; Models, Statistical; Retrospective Studies; Severity of Illness Index; Treatment Outcome; United Kingdom | 2018 |
[Current and upcoming treatments of adult atopic dermatitis].
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Glucocorticoids; Humans; Methotrexate; Mycophenolic Acid; Piperidines; Pyrimidines; Pyrroles; Thalidomide; Ustekinumab | 2017 |
Suppression of infliximab antibody levels by azathioprine in patients with rheumatoid arthritis.
Topics: Adult; Antibodies; Arthritis, Rheumatoid; Azathioprine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Infliximab; Methotrexate | 2017 |
Sarcoidosis mortality in Sweden: a population-based cohort study.
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Cause of Death; Cohort Studies; Educational Status; Female; Humans; Male; Methotrexate; Middle Aged; Proportional Hazards Models; Registries; Risk Assessment; Sarcoidosis; Severity of Illness Index; Sweden | 2018 |
Use of oral immunosuppressive drugs in the treatment of atopic dermatitis in the Netherlands.
Topics: Administration, Oral; Azathioprine; Cyclosporine; Databases, Factual; Dermatitis, Atopic; Drug Prescriptions; Humans; Immunosuppressive Agents; Methotrexate; Mycophenolic Acid; Netherlands | 2018 |
Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azathioprine; Child; Cohort Studies; Cyclophosphamide; Cyclosporine; Female; Glucocorticoids; Glycosides; Humans; Immunoglobulin G4-Related Disease; Immunosuppressive Agents; Leflunomide; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prednisone; Prospective Studies; Remission Induction; Treatment Outcome; Young Adult | 2018 |
UVA-1 phototherapy for the management of atopic dermatitis: a large retrospective study conducted in a low-middle income country.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Colombia; Dermatitis, Atopic; Developing Countries; Emollients; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Radiotherapy Dosage; Recurrence; Retrospective Studies; Severity of Illness Index; Ultraviolet Therapy; Young Adult | 2018 |
Treatment of adult idiopathic inflammatory myopathies with conventional immunosuppressive drugs : Results of a retrospective study.
Topics: Adult; Azathioprine; Connective Tissue Diseases; Dermatomyositis; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Polymyositis; Retrospective Studies; Treatment Outcome | 2019 |
Myasthenic ophthalmoparesis: Time To resolution after initiating immune therapies.
Topics: Adult; Azathioprine; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myasthenia Gravis; Ophthalmoplegia; Plasma Exchange; Prednisone; Proportional Hazards Models; Recovery of Function; Time Factors; Treatment Outcome; Young Adult | 2018 |
Effects of Anti-TNF
Topics: Adalimumab; Adrenal Cortex Hormones; Azathioprine; Crohn Disease; Female; Flow Cytometry; Humans; Interleukin-17; Interleukin-22; Interleukins; Male; Methotrexate; T-Lymphocyte Subsets; Tumor Necrosis Factor-alpha | 2018 |
Building the evidence base for current systemic treatments for severe, chronic atopic dermatitis: methotrexate vs. azathioprine.
Topics: Azathioprine; Dermatitis, Atopic; Follow-Up Studies; Humans; Methotrexate; Mycophenolic Acid | 2018 |
Cogan's syndrome with pyoderma gangrenosum: management of two uncommon disorders with aggressive presentation in a patient.
Topics: Administration, Intravenous; Azathioprine; Biopsy; Cogan Syndrome; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Pyoderma Gangrenosum; Skin Ulcer | 2018 |
Cerebral granulomatosis as a manifestation of Crohn's disease.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Brain Diseases; Crohn Disease; Disease Progression; Female; Granuloma; Humans; Immunosuppressive Agents; Methotrexate; Vasculitis, Central Nervous System | 2018 |
Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study.
Topics: Adalimumab; Adult; Azathioprine; Cohort Studies; Colitis, Ulcerative; Crohn Disease; Digestive System Surgical Procedures; Drug Substitution; Drug Therapy, Combination; Female; Glucocorticoids; Hospitalization; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Infliximab; Male; Manitoba; Methotrexate; Prednisone; Proportional Hazards Models; Retrospective Studies; Tumor Necrosis Factor Inhibitors | 2019 |
Commonly used medication for Lupus.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Disease Management; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Methotrexate; Mycophenolic Acid; Rituximab | 2018 |
Infliximab biosimilar for treating neurosarcoidosis: tolerance and efficacy in a retrospective study including switch from the originator and initiation of treatment.
Topics: Adult; Antirheumatic Agents; Azathioprine; Biosimilar Pharmaceuticals; Central Nervous System Diseases; Drug Substitution; Female; Follow-Up Studies; Humans; Infliximab; Male; Methotrexate; Middle Aged; Retrospective Studies; Sarcoidosis; Statistics, Nonparametric; Treatment Outcome | 2019 |
Corneoscleral xanthogranuloma treated with chemotherapy: The room for nonsurgical management.
Topics: Azathioprine; Child; Corneal Diseases; Female; Humans; Immunosuppressive Agents; Methotrexate; Scleral Diseases; Treatment Outcome; Xanthogranuloma, Juvenile | 2020 |
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study.
Topics: Adalimumab; Adult; Age Factors; Antibodies; Azathioprine; Cohort Studies; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Leukocyte Count; Male; Mercaptopurine; Methotrexate; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors; Serum Albumin; Smoking; Treatment Failure; Treatment Outcome; Tumor Necrosis Factor Inhibitors; Young Adult | 2019 |
Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn's Disease.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Azathioprine; Budesonide; Canada; Crohn Disease; Gastroenterology; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Induction Chemotherapy; Maintenance Chemotherapy; Mesalamine; Methotrexate; Prednisolone; Societies, Medical; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor Inhibitors; Ustekinumab | 2019 |
Comparative efficacy and safety of immunosuppressive therapies for systemic sclerosis related interstitial lung disease: A Bayesian network analysis.
Topics: Adult; Azathioprine; Bayes Theorem; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Scleroderma, Systemic; Treatment Outcome; Vital Capacity | 2020 |
Azathioprine in combination with methotrexate: a therapeutic alternative in severe and recalcitrant forms of alopecia areata?
Topics: Alopecia Areata; Azathioprine; Drug Therapy, Combination; Humans; Methotrexate | 2019 |
Antimalarial agents diminish while methotrexate, azathioprine and mycophenolic acid increase BAFF levels in systemic lupus erythematosus.
Topics: Antimalarials; Azathioprine; B-Cell Activating Factor; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; Mycophenolic Acid | 2019 |
Pharmacology and Therapeutics of Corticosteroids Sparing Maintenance Immunosuppressive/Adjunct Therapy Drugs.
Topics: Anti-Infective Agents; Azathioprine; Cyclophosphamide; Dapsone; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferons; Methotrexate; Skin Diseases | 2019 |
EBV-positive mucocutaneous ulcer in a patient with systemic lupus erythematosus.
Topics: Azathioprine; Conservative Treatment; Deprescriptions; Epstein-Barr Virus Infections; Facial Dermatoses; Female; Forehead; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphoproliferative Disorders; Methotrexate; Middle Aged; Skin Ulcer | 2020 |
Perinatal use and discontinuation of disease-modifying anti-rheumatic drugs and biologics in women with rheumatoid arthritis: a cohort study.
Topics: Abatacept; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Biological Products; British Columbia; Chloroquine; Cohort Studies; Cyclophosphamide; Cyclosporine; Deprescriptions; Female; Glucocorticoids; Gold Compounds; Humans; Hydroxychloroquine; Interleukin 1 Receptor Antagonist Protein; Leflunomide; Logistic Models; Maternal Age; Methotrexate; Mycophenolic Acid; Odds Ratio; Preconception Care; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, First; Rheumatology; Rituximab; Sulfasalazine; Tumor Necrosis Factor Inhibitors | 2020 |
Prevalence and predictors of flare after immunosuppressant discontinuation in patients with systemic lupus erythematosus in remission.
Topics: Adult; Antimalarials; Antirheumatic Agents; Azathioprine; Cyclosporine; Deprescriptions; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Maintenance Chemotherapy; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Proportional Hazards Models; Protective Factors; Recurrence; Remission Induction; Risk Factors; Symptom Flare Up; Time Factors | 2020 |
Skin improvement is a surrogate for favourable changes in other organ systems in early diffuse cutaneous systemic sclerosis.
Topics: Adrenal Cortex Hormones; Adult; Azathioprine; Disease Progression; Female; Heart; Humans; Immunosuppressive Agents; Lung; Male; Methotrexate; Middle Aged; Prognosis; Registries; Scleroderma, Diffuse; Severity of Illness Index; Skin | 2020 |
A Long-Term Follow-up of Retinal Vasculitis - Do They Develop Systemic Disease?
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Psoriasis; Recurrence; Retinal Vasculitis; Retrospective Studies; Tuberculin Test; Tuberculosis, Ocular; Visual Acuity; Vitreous Hemorrhage | 2020 |
Patient preferences for maintenance therapy in Crohn's disease: A discrete-choice experiment.
Topics: Adalimumab; Adolescent; Adult; Antibodies, Monoclonal, Humanized; Azathioprine; Crohn Disease; Female; Health Surveys; Humans; Immunosuppressive Agents; Male; Methotrexate; Network Meta-Analysis; Patient Preference; Prednisone; Young Adult | 2020 |
Treatment and its side effects in ANCA-associated vasculitides - Study based on POLVAS registry data.
Topics: Adult; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Poland; Prognosis; Registries; Retrospective Studies; Rituximab; Survival Rate | 2020 |
Inclusion-body myositis and primary Sjögren syndrome: mechanisms for shared etiologies.
Topics: 5'-Nucleotidase; Adult; Autoantibodies; Azathioprine; CD8-Positive T-Lymphocytes; Female; Haplotypes; HLA Antigens; Humans; Hydroxychloroquine; Immunoglobulins, Intravenous; Immunologic Factors; Leukemia, Large Granular Lymphocytic; Magnetic Resonance Imaging; Methotrexate; Muscle, Skeletal; Myositis, Inclusion Body; Prednisolone; Rituximab; Sjogren's Syndrome | 2020 |
Adverse event monitoring in patients on oral systemic medications for inflammatory skin disease.
Topics: Azathioprine; Cross-Sectional Studies; Cyclosporine; Dermatitis, Atopic; Drug Eruptions; Drug Monitoring; Humans; Methotrexate; Mycophenolic Acid; Psoriasis; United States | 2020 |
Relapse predictors and serologically unstable condition of IgG4-related disease: a large Chinese cohort.
Topics: Adult; Age Factors; Azathioprine; Biomarkers; Cyclophosphamide; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunoglobulin G; Immunoglobulin G4-Related Disease; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prognosis; Recurrence; Retrospective Studies; Risk Factors; Treatment Outcome | 2020 |
Treatment of idiopathic granulomatous mastitis and factors related with disease recurrence
Topics: Adult; Breast; Female; Granulomatous Mastitis; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Recurrence; Retrospective Studies | 2020 |
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Azathioprine; Betacoronavirus; Clinical Laboratory Techniques; Cohort Studies; Coronavirus Infections; Cough; COVID-19; COVID-19 Testing; Cyclosporine; Diarrhea; Dysgeusia; Dyspnea; Fatigue; Female; Fever; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Incidence; Intensive Care Units; Italy; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Olfaction Disorders; Pandemics; Pneumonia, Viral; Prednisone; Respiratory Distress Syndrome; SARS-CoV-2; Telemedicine | 2020 |
Azathioprine in combination with methotrexate may not be a good therapeutic alternative in severe and recalcitrant forms of alopecia areata.
Topics: Alopecia Areata; Azathioprine; Humans; Methotrexate | 2020 |
Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related Complications.
Topics: Adalimumab; Adult; Azathioprine; Biological Products; Canada; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunologic Factors; Infliximab; Male; Methotrexate; Outcome and Process Assessment, Health Care; Patient Selection; Practice Patterns, Physicians'; Treatment Failure; Tumor Necrosis Factor Inhibitors | 2020 |
Utility of azathioprine, methotrexate and cyclosporine as steroid-sparing agents in chronic alopecia areata: a retrospective study of continuation rates in 138 patients.
Topics: Alopecia Areata; Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Methotrexate; Retrospective Studies | 2020 |
Incidence, Clinical Features, and Outcomes of Late-Onset Neutropenia From Rituximab for Autoimmune Disease.
Topics: Adult; Aged; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Asymptomatic Diseases; Autoimmune Diseases; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Fever; Filgrastim; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Segmental; Hematologic Agents; Humans; Immunologic Factors; Incidence; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Nephrosis, Lipoid; Neutropenia; Proportional Hazards Models; Recurrence; Retrospective Studies; Risk Factors; Rituximab; Sepsis | 2021 |
Infliximab, Immunomodulators and Treatment Failures in Paediatric and Adolescent Patients with Crohn's Disease: a Nationwide Cohort Study.
Topics: Adalimumab; Adolescent; Azathioprine; Child; Crohn Disease; Denmark; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Immunologic Factors; Infliximab; Male; Mercaptopurine; Methotrexate; Treatment Failure; Tumor Necrosis Factor-alpha; Young Adult | 2021 |
COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?
Topics: Adalimumab; Adult; Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; Azathioprine; Betacoronavirus; Biological Therapy; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Drug Combinations; Drug Therapy, Combination; Humans; Lopinavir; Male; Methotrexate; Oseltamivir; Pandemics; Pneumonia, Viral; Prednisolone; Ritonavir; SARS-CoV-2 | 2020 |
Clinical features and outcomes from the Singapore Sjögren's syndrome study.
Topics: Adult; Arthralgia; Azathioprine; Female; Humans; Hydroxychloroquine; Keratoconjunctivitis Sicca; Male; Methotrexate; Methylprednisolone; Middle Aged; Peripheral Nervous System Diseases; Retrospective Studies; Singapore; Sjogren's Syndrome; Xerostomia | 2021 |
Methotrexate or azathioprine-do differing rates of discontinuation settle the debate?
Topics: Azathioprine; Colitis; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate | 2020 |
Editorial: methotrexate vs azathioprine-do differential rates of discontinuation settle the debate? Authors' reply.
Topics: Azathioprine; Colitis; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Methotrexate | 2020 |
Treatment-based risk stratification of infections in inflammatory bowel disease: A comparison between anti-tumor necrosis factor-α and nonbiological exposure in real-world setting.
Topics: Azathioprine; Colitis; Humans; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate; Risk Assessment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha | 2021 |
Clinical phenotypes and therapeutic responses in cutaneous-predominant sarcoidosis: 6-year experience in a tertiary referral service.
Topics: Adrenal Cortex Hormones; Adult; Aged; Azathioprine; Clinical Protocols; Dermatologic Agents; Female; Humans; Hydroxychloroquine; Interleukin-12; Interleukin-23; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Phenotype; Prospective Studies; Quinacrine; Referral and Consultation; Remission Induction; Sarcoidosis; Skin Diseases; Tertiary Care Centers; Tumor Necrosis Factor Inhibitors; Young Adult | 2021 |
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alemtuzumab; Azathioprine; Black or African American; Cladribine; Comorbidity; COVID-19; Crotonates; Cyclophosphamide; Cyclosporine; Databases, Factual; Dimethyl Fumarate; Female; Fingolimod Hydrochloride; Hospitalization; Humans; Hydroxybutyrates; Immunologic Factors; Immunosuppressive Agents; Incidence; Interferon-beta; Logistic Models; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Mitoxantrone; Multiple Sclerosis; Mycophenolic Acid; Natalizumab; Nitriles; Obesity; Risk Factors; Rituximab; SARS-CoV-2; Toluidines; United States; White People; Young Adult | 2021 |
Drug survival rates and reasons for drug discontinuation in patients with atopic dermatitis: a retrospective study of adult outpatients.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Humanized; Azathioprine; Child; Child, Preschool; Cyclosporine; Dermatitis, Atopic; Dermatologic Agents; Female; Humans; Infant; Infant, Newborn; Kaplan-Meier Estimate; Male; Medication Adherence; Methotrexate; Middle Aged; Mycophenolic Acid; Outpatients; Patient Satisfaction; Probability; Proportional Hazards Models; Retrospective Studies; Young Adult | 2021 |
Ocular cicatricial pemphigoid: Methotrexate as an initial treatment?
Topics: Azathioprine; Cyclophosphamide; Humans; Immunosuppressive Agents; Methotrexate; Pemphigoid, Benign Mucous Membrane | 2022 |
Multifocal colorectal non-Hodgkin's lymphoma in a patient with ulcerative colitis: A case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Biopsy; Colitis, Ulcerative; Colonoscopy; Colorectal Neoplasms; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Positron Emission Tomography Computed Tomography; Treatment Outcome | 2021 |
Methotrexate as a Steroid-Sparing Agent in Myasthenia Gravis: A Preliminary Retrospective Study.
Topics: Azathioprine; Humans; Immunosuppressive Agents; Methotrexate; Myasthenia Gravis; Prednisone; Retrospective Studies | 2021 |
Antibody Response to SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease: Results of a Single-Center Cohort Study in a Tertiary Hospital in Germany.
Topics: Aged; Antibody Formation; Azathioprine; Cohort Studies; COVID-19; COVID-19 Vaccines; Crohn Disease; Female; Humans; Immunologic Factors; Immunosuppressive Agents; Inflammatory Bowel Diseases; Integrins; Male; Methotrexate; Retrospective Studies; SARS-CoV-2; Tertiary Care Centers; Tumor Necrosis Factor-alpha | 2022 |
Nationwide cross-sectional survey of patients with relapsing polychondritis in 2019 demonstrates reduction of airway involvement compared with that in 2009.
Topics: Adult; Azathioprine; Cross-Sectional Studies; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Infliximab; Japan; Male; Methotrexate; Middle Aged; Polychondritis, Relapsing; Respiratory Tract Diseases; Retrospective Studies; Surveys and Questionnaires | 2022 |
Parenteral Methotrexate Is Efficient in the Treatment of Azathioprine Refractory Crohn's Disease.
Topics: Azathioprine; Crohn Disease; Humans; Immunosuppressive Agents; Infliximab; Methotrexate; Remission Induction; Treatment Outcome; Tumor Necrosis Factor-alpha | 2022 |
Effect of gervital in attenuating hepatotoxicity caused by methotrexate or azathioprine in adult albino rats.
Topics: Animals; Antioxidants; Aspartate Aminotransferases; Azathioprine; Chemical and Drug Induced Liver Injury; Glutamates; Grape Seed Extract; Liver; Methotrexate; Oxidative Stress; Rats; Rats, Wistar | 2022 |
Persistently normal blood tests in patients taking methotrexate for RA or azathioprine for IBD: a retrospective cohort study.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Cohort Studies; Humans; Inflammatory Bowel Diseases; Methotrexate; Retrospective Studies | 2022 |
Nodular Regenerative Hyperplasia of the liver in Juvenile Dermatomyositis.
Topics: Abatacept; Adolescent; Arthritis; Autoantibodies; Azathioprine; Calcinosis; Child; Cyclophosphamide; Dermatomyositis; Female; Humans; Hyperplasia; Hypertension, Portal; Liver; Male; Methotrexate; Mycophenolic Acid; Prednisone; Rituximab; Splenomegaly; Thrombocytopenia; Transaminases; Young Adult | 2022 |
Impaired adrenal cortex reserve in patients with rheumatic and musculoskeletal diseases who relapse upon tapering of low glucocorticoid dose.
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Adrenal Insufficiency; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine; Chronic Disease; Cosyntropin; Glucocorticoids; Humans; Hydrocortisone; Hydroxychloroquine; Leflunomide; Methotrexate; Prednisolone; Recurrence; Tumor Necrosis Factor Inhibitors | 2022 |
Systemic treatment of children and adolescents with atopic dermatitis aged ≥2 years: a Delphi consensus project mapping expert opinion in Northern Europe.
Topics: Adolescent; Azathioprine; Biological Products; Child; Child, Preschool; Cyclosporine; Delphi Technique; Dermatitis, Atopic; Expert Testimony; Humans; Janus Kinase Inhibitors; Janus Kinases; Methotrexate; Mycophenolic Acid; Quality of Life | 2022 |
Monotherapy with thiopurines in stricturing Crohn's disease: A real-life experience from low- and middle-income countries.
Topics: Adult; Azathioprine; Constriction, Pathologic; Crohn Disease; Developing Countries; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Retrospective Studies; Young Adult | 2022 |
Perspective of sarcoidosis in terms of rheumatology: a single-center rheumatology clinic experience.
Topics: Adrenal Cortex Hormones; Ambulatory Care Facilities; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Azathioprine; Cross-Sectional Studies; Female; Humans; Hydroxychloroquine; Infliximab; Male; Methotrexate; Retrospective Studies; Rheumatic Diseases; Rheumatology; Sarcoidosis | 2022 |
Rheumatoid arthritis and Hailey-Hailey disease treated with methotrexate.
Topics: Aged; Arthritis, Rheumatoid; Azathioprine; Female; Humans; Methotrexate; Pemphigus, Benign Familial; Quality of Life | 2023 |
Systemic treatment for severe atopic dermatitis in children: a case series.
Topics: Azathioprine; Child; Child, Preschool; Cyclosporine; Dermatitis, Atopic; Humans; Methotrexate; Mycophenolic Acid; Prednisone; Thalidomide | 2022 |
Impact of gervital against histopathological, ultrastructural, and biochemical alterations caused by methotrexate or azathioprine in albino rat testis.
Topics: Animals; Antioxidants; Azathioprine; Male; Methotrexate; Oxidative Stress; Rats; Superoxide Dismutase; Testis; Testosterone | 2023 |
[Takayasu's disease: an underdiagnosed entity in Sub-Saharan Africa. Report of five Gabonese cases].
Topics: Adrenal Cortex Hormones; Adult; Africa South of the Sahara; Azathioprine; Female; Humans; Male; Methotrexate; Mycobacterium tuberculosis; Retrospective Studies; Takayasu Arteritis | 2022 |
Impact of the COVID-19 pandemic on prescription refills for immune-mediated inflammatory disorders: a time series analysis (January 2019 to January 2021) using the English Prescribing Dataset.
Topics: Azathioprine; Communicable Disease Control; COVID-19; Drug Prescriptions; Humans; Hydroxychloroquine; Leflunomide; Methotrexate; Pandemics; Sulfasalazine; Time Factors | 2022 |
[Therapeutic Strategies for Idiopathic Inflammatory Myopathies].
Topics: Adrenal Cortex Hormones; Azathioprine; Humans; Immunosuppressive Agents; Methotrexate; Myositis | 2023 |
Can Pharmacogenetic Variants in
Topics: Azathioprine; Genotype; Humans; Liver-Specific Organic Anion Transporter 1; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Scleroderma, Systemic | 2023 |
Pediatric-Onset Chronic Inflammatory Demyelinating Polyneuropathy: A Multicenter Study.
Topics: Azathioprine; Child; Female; Humans; Immunoglobulins, Intravenous; Male; Methotrexate; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Retrospective Studies | 2023 |
Real-world treatment patterns of immunosuppressants in Adults with systemic lupus erythematosus: A claims database analysis in the United States.
Topics: Adult; Azathioprine; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; Retrospective Studies; Treatment Outcome; United States | 2023 |
Comparative Risks of Infection With Belimumab Versus Oral Immunosuppressants in Patients With Nonrenal Systemic Lupus Erythematosus.
Topics: Azathioprine; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Methotrexate; Middle Aged; Treatment Outcome | 2023 |
What predicts the recurrence in ıdiopathic granulomatous mastitis?
Topics: Abscess; Adult; Aged; Azathioprine; Cross-Sectional Studies; Female; Granulomatous Mastitis; Humans; Immunoglobulin M; Methotrexate; Middle Aged; Recurrence; Retrospective Studies; Steroids; Treatment Outcome | 2023 |
Use of Immunosuppression and the Risk of Subsequent Overall or Cancer Mortality.
Topics: Adalimumab; Alkylating Agents; Antimetabolites; Azathioprine; Calcineurin Inhibitors; Cohort Studies; Cyclosporine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Infliximab; Methotrexate; Mycophenolic Acid; Neoplasms; Retrospective Studies; Tumor Necrosis Factor Inhibitors | 2023 |
Efficacy of azathioprine and methotrexate in patients with chronic inflammatory demyelinating polyneuropathy (CIDP).
Topics: Adolescent; Adult; Azathioprine; Humans; Immunosuppressive Agents; Methotrexate; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Prednisolone | 2023 |
Association of patient copayment and medication adherence in systemic lupus erythematosus.
Topics: Adult; Aged; Azathioprine; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Medication Adherence; Methotrexate; Middle Aged; Mycophenolic Acid; Retrospective Studies | 2023 |